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ABSTRACT	
	 Organic	small	molecules	possess	a	unique	capacity	to	promote	the	betterment	of	society,	acting	
as	medicines,	 biological	 probes,	 agrochemicals,	 and	materials.	 These	wide-ranging	 abilities	 can	 all	 be	
attributed	to	the	incredible	complexity	and	diversity	of	small	molecule	structures.	Over	the	last	century,	
chemists	have	developed	increasingly	sophisticated	synthesis	techniques	such	that	now	virtually	any	small	
molecule	 that	 could	 exist	 can	 be	made	 in	 a	 laboratory.	 These	 advancements	 have	 collectively	 saved	
countless	lives	and	drastically	improved	our	standard	of	living.	
	 Still,	there	is	a	limit	to	this	progress,	and	organic	synthesis	often	remains	a	bottleneck.	In	order	to	
optimize	a	small	molecule	to	perform	a	new	function,	chemists	must	synthesize	and	test	hundreds	or	even	
thousands	 of	 different	 derivatives.	 For	 each	 one,	 a	 different	 synthetic	 route	 must	 be	 planned	 and	
executed	 by	 hand.	 In	 contrast,	 automation	 has	 greatly	 simplified	 the	 syntheses	 of	 several	 classes	 of	
macromolecules,	 including	oligonucleotides,	peptides,	and	 increasingly	oligosaccharides.	Removing	the	
synthesis	bottleneck	has	accelerated	the	discovery	of	new	macromolecular	functions.	If	the	synthesis	of	
small	molecules	could	be	similarly	simplified	and	automated,	this	would	unleash	many	new	and	important	
functions	that	could	benefit	society.	
	 The	 strategy	of	 iteratively	 assembling	molecular	building	blocks	 into	more	 complex	 structures	
represents	a	promising	approach	to	automating	small	molecule	synthesis.	However,	many	challenges	will	
need	to	be	solved.	These	challenges	include	reversible	deactivation	of	building	block	attachment	points	
to	 facilitate	 controlled	 molecular	 growth,	 general	 purification	 strategies	 that	 work	 for	 a	 variety	 of	
structurally	dissimilar	compounds,	and	versatile	assembly	reactions	for	forging	new	C-C	and	C-X	bonds	
between	building	blocks.	Some	of	these	challenges	have	been	solved	in	the	development	of	customized	
iterative	 synthesis	 methods,	 which	 have	 expanded	 access	 to	 certain	 types	 of	 molecular	 structures	
(Chapter	1).	However,	a	more	general	approach	to	iterative	synthesis	would	be	even	more	impactful.	
	 	The	strategy	of	 iterative	cross-coupling	(ICC)	with	MIDA	boronate	building	blocks	represents	a	
promising	platform	for	automating	the	synthesis	of	many	different	kinds	of	small	molecules.	Pioneered	
by	the	Burke	group,	 ICC	constructs	complex	molecules	by	adding	one	new	building	block	at	a	time	via	
transition	metal-catalyzed	cross-coupling	reactions.	The	key	to	achieving	controlled	molecular	growth	is	
to	 reversibly	 attenuate	 the	 reactivity	 of	 building	 blocks	 by	 protecting	 boronic	 acids	 as	 stable	 MIDA	
boronates.	Moreover,	my	former	colleagues	discovered	that	MIDA	boronates	have	unique	properties	on	
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silica	 gel	 that	 facilitate	 a	 general	 purification	 strategy,	 which	 enabled	 them	 to	 design	 a	 machine	 for	
automated	small	molecule	synthesis	that	relies	on	ICC	(Chapter	2).	
	 A	crucial	research	objective	for	expanding	the	scope	of	this	automated	synthesis	platform,	and	
the	focus	of	my	thesis	work,	has	been	to	develop	new	C-C	bond-forming	reactions	to	assemble	structurally	
complex	building	blocks	(Chapter	3).	The	Suzuki-Miyaura	cross-coupling	reaction	has	been	widely	utilized	
in	the	synthesis	of	pharmaceuticals,	and	it	is	backbone	of	iterative	cross-coupling.	However,	the	biggest	
weakness	of	Suzuki	coupling	is	that	it	is	bad	at	making	the	kinds	of	molecules	that	society	could	benefit	
from	the	most-	molecules	containing	more	sp3	carbons	and	stereocenters.	New	methods	are	needed	for	
coupling	unactivated	alkylboronic	acids	with	control	over	stereochemistry.	
	 Theoretically,	 it	 should	be	possible	 to	perfectly	 translate	 the	 stereochemical	 information	 from	
chiral	 coupling	 partners	 into	 products.	However,	 even	 in	 state-of-the-art	 stereospecific	 cross-coupling	
methods,	 stereochemical	 control	 often	 suffers	 due	 to	 a	 competition	 between	 two	 different	
transmetalation	 pathways,	 one	 of	 which	 is	 stereoretentive	 and	 the	 other	 stereoinvertive.	 By	
systematically	studying	the	reaction	of	a	simple	chiral	unactivated	alkylboronic	acid,	we	have	discovered	
how	the	structure	of	the	phosphine	ligand	impacts	the	competition	between	these	two	transmetalation	
pathways.	Based	on	a	working	model	 for	 the	 two	corresponding	 transition	states,	we	have	developed	
rational	design	principles	related	to	both	ligand	sterics	and	electronics.	These	discoveries	have	enabled	
the	building	block-based	synthesis	of	natural	products	and	their	stereoisomeric	derivatives.	More	broadly,	
they	represent	another	step	towards	a	more	general	platform	for	the	automated,	building	block-based	
synthesis	of	small	molecules.	
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CHAPTER	1	
INTRODUCTION	
	 Small	molecules	can	perform	incredible	functions	and	benefit	society	in	countless	ways.	However,	
their	 synthesis	 is	often	challenging	and	 time-intensive,	creating	a	bottleneck	 to	 finding	new	functions.	
Most	 small	 molecules	 are	 currently	 made	 through	 customized	 synthesis	 methods,	 which	 require	 the	
development	of	a	new	synthetic	route	for	each	new	molecular	target.	To	simplify	the	synthesis	of	small	
molecules	and	accelerate	the	discovery	of	their	functions,	we	considered	if	it	might	be	possible	to	make	
most	small	molecules	using	the	same	iterative,	building	block-based	synthesis	approach.		
	 Despite	 their	 structural	 diversity,	 small	molecules	 of	 both	 natural	 and	non-natural	 origins	 still	
possess	a	 large	degree	of	 inherent	 structural	modularity.	Already,	many	 iterative	building	block-based	
synthesis	strategies	have	been	designed	to	leverage	this	inherent	modularity,	but	most	of	these	methods	
are	highly	customized	to	make	particular	classes	of	small	molecules.	 Iterative	cross-coupling	(ICC)	with	
MIDA	boronate	building	blocks	represents	a	step	towards	a	more	general	solution.	Harnessing	the	growing	
scope	of	cross-coupling	chemistry	and	the	robustness	of	 the	MIDA	boronate	 functional	group,	 ICC	has	
simplified	the	synthesis	of	many	different	kinds	of	small	molecules.	Continued	progress	in	this	direction	
will	be	highly	enabling	for	the	discovery	of	new	small	molecule	functions.	
	 Portions	of	 this	chapter	were	adapted	 from	Lehmann	et	al.,	Towards	 the	generalized	 iterative	
synthesis	of	small	molecules,	Nature	Reviews	Chemistry	2018,	2,	0115.	
	 		
1-1	 CUSTOMIZED	SYNTHESIS	VS.	GENERALIZED	ITERATIVE	SYNTHESIS	
	 Progress	in	the	field	of	organic	chemistry	is	directly	responsible	for	countless	small	molecules	that	
have	 changed	 our	world,1	 and	 this	 trend	 is	 only	 poised	 to	 grow.	 Small	molecules	 possess	 substantial	
untapped	 potential	 to	 perform	 many	 frontier	 functions2,	 including	 modulating	 protein–protein	
interactions,3	 allosterically	modifying	protein	 function,4	 acting	as	prostheses	on	 the	molecular	 scale,5-6	
serving	as	next	generation	biological	probes,7-10	enabling	miniaturized	diagnostics,11	transducing	energy,12-
17	emitting	light,18	 initiating	self-healing,19	acting	as	molecular	magnets,20	and	enabling	next-generation	
computing21	and	superconducting.22-23	However,	mainly	owing	 to	 limitations	 in	synthesis,	much	of	 this	
functional	potential	remains	untapped.	Eliminating	this	synthesis	bottleneck	thus	represents	both	a	major	
challenge	and	an	extraordinary	opportunity	for	the	field	of	chemistry.	
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	 Currently,	most	small	molecules	are	synthesized	using	customized	approaches,	where	a	unique	
synthetic	 route	 is	 developed	 for	 each	 different	 target.	 Corey’s	 introduction	 of	 retrosynthetic	 analysis	
systemized	 this	process.	 To	devise	a	 route	 to	a	 target,	 the	 chemist	works	backwards	by	 searching	 for	
substructural	retrons	that	enable	simplifying	transforms.24	A	considerable	investment	of	time	is	required	
not	only	for	this	route	selection	process,	but	also	for	the	extensive	optimization	of	chemical	reactions	in	
the	 execution	 phase.	 Today,	 this	 strategy	 is	 well-suited	 for	 the	 large-scale	 production	 of	 a	 particular	
compound,	 where	 the	 priority	 is	 on	 maximizing	 synthetic	 efficiency.	 However,	 it	 is	 also	 a	 laborious	
bottleneck	 for	 the	 discovery	 and	optimization	 of	 new	 functions,	which	 requires	 rapid	 access	 to	many	
different	 chemical	 compounds.	 Access	 to	myriad	 untapped	 small	molecule	 functions	 could	 be	 greatly	
accelerated	by	a	simpler	and	more	general	synthesis	strategy.	
	 Already,	access	to	macromolecules	has	been	revolutionized	due	to	the	development	of	iterative,	
building	 block-based	 approaches	 to	 their	 synthesis.	 Today,	 automated	 synthesizers	 can	 provide	 on-
demand	access	to	peptides25	and	oligonucleotides.26	The	technology	for	printing	oligonucleotide	probes	
that	correspond	to	every	gene	in	the	human	genome	helped	to	usher	in	the	era	of	genomics.27-28	Countless	
peptide-	and	oligonucleotide-based	drug	candidates	were	rapidly	tested	and	optimized,	yielding	entirely	
new	classes	of	therapeutics.29-30	Total	synthesis	of	genes,	proteins	and	even	complete	genomes	became	
possible,	 launching	 the	 field	 of	 synthetic	 biology.31-33	 Substantial	 recent	 progress	 in	 the	 automated	
iterative	synthesis	of	oligosaccharides	has	also	led	to	important	advances	in	vaccine	development.34-35	
	 Extending	the	building	block	method	to	small	molecule	synthesis	brings	a	unique	set	of	challenges.	
Compared	 to	 macromolecules,	 small	 molecule	 structures	 are	 particularly	 complex	 and	 diverse.	
Consequently,	 the	 development	 of	 a	 building	 block-based	 synthesis	 platform	 for	 small	molecules	will	
require	a	greater	number	of	building	blocks,	more	versatile	assembly	reactions,	and	new	strategies	for	
the	generalized	purification	of	a	range	of	structurally	dissimilar	intermediates.	However,	progress	in	this	
direction	will	be	highly	enabling	to	the	discovery	of	new	small	molecule	functions	and	the	betterment	of	
society.	
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Figure	1.1.		The	modular	biosynthetic	origins	of	different	classes	of	natural	products.	
4	
	
1-2	 INHERENT	MODULARITY	OF	SMALL	MOLECULES	
	 Small	molecules	are	highly	structurally	diverse,	which	makes	the	development	of	a	generalized	
building	block	approach	for	this	class	of	chemical	matter	especially	challenging.	However,	many	types	of	
small	molecules	are	inherently	modular,	suggesting	that	such	structures	and	their	accompanying	functions	
should	 be	 accessible	 using	 a	 generalized	 modular	 synthesis	 approach.	 Most	 natural	 products,	 which	
represent	the	source	or	inspiration	for	more	than	50%	of	all	human	therapeutics,36-37	are	derived	from	
only	a	few	major	biosynthetic	pathways	that	each	 involve	the	 iterative	assembly	of	a	small	number	of	
discrete	molecular	building	blocks	(Figure	1.1).	For	example,	polyketides	are	biosynthesized	from	malonyl-
CoA	 1.1	 and	 methylmalonyl-CoA	 1.2,	 fatty	 acids	 primarily	 from	 malonyl-CoA	 1.1,	 polyterpenes	 from	
isopentenyl	 pyrophosphate	 1.5	 and	 dimethylallylpyrophosphate	 1.6,	 polyphenylpropanoids	 from	
phenylpyruvic	acid	1.8,	and	non-ribosomal	peptides	from	amino	acids.38	
	 Even	highly	complex	molecular	structures	 from	natural	products	can	usually	be	traced	back	to	
these	 same	 modular	 pathways.	 Although	 the	 biosynthesis	 of	 many	 natural	 products	 also	 involves	
rearrangements,	 oxidations,	 and	 cyclizations,	 there	 is	 still	 evidence	 that	 this	 inherent	 modularity	
translates	to	the	final	products.	A	recent	analysis	revealed	that	more	than	75%	of	all	polyene	motifs	found	
in	 natural	 products	 can	 be	 prepared	 using	 only	 twelve	 building	 blocks	 and	 one	 coupling	 reaction.38	
Increasing	 evidence	 further	 suggests	 that	 natural	 product	 chemical	 space	 is	 bounded,39	 enabling	 the	
consideration	of	generalized	approaches	for	studying	the	complete	natural	productome.40	
	 Even	many	non-natural	small	molecules,	which	
lack	 such	 biosynthetic	 constraints,	 still	 contain	 a	
remarkable	 degree	 of	 structural	 redundancy.	 For	
example,	 a	 2014	 analysis	 of	 1,086	 Food	 and	 Drug	
Administration	 (FDA)	 approved	 small	molecule	 drugs	
revealed	 many	 recurring	 heterocyclic	 building	 blocks	
(Figure	 1.2).	 These	 include	 piperidine	 (72	 drugs),	
pyridine	(62	drugs),	piperazine	(59	drugs),	cephem	(41	
drugs),	pyrrolidine	(37	drugs)	and	thiazole	(30	drugs).41	
Seventeen	additional	heterocycles	are	found	in	at	least	
ten	drugs.	This	modularity	 suggests	 that	much	of	 the	
chemical	 space	 relevant	 to	 synthesizing	
pharmaceuticals	should	also	be	accessible	from	a	defined	set	of	building	blocks.	Materials	components	
Figure	1.2.	Common	heterocyclic	building	
blocks	found	in	pharmaceuticals.	
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also	display	a	high	degree	of	modularity.	Despite	performing	a	wide	range	of	different	functions,	they	are	
often	composed	of	common	repeating	substructural	motifs,	 such	as	oligoarenes,	oligothiophenes,	and	
polystyrenes.	 Collectively,	 this	 inherent	modularity	 suggests	 that	 a	wide	 range	 of	 different	molecular	
functions	should	be	accessible	by	simply	assembling	building	blocks	that	come	from	a	finite	set	of	common	
substructural	motifs.	
	
1-3	 CUSTOMIZED	ITERATIVE	SYNTHESIS	STRATEGIES	FOR	NATURAL	PRODUCTS	
	 Given	the	aforementioned	structural	modularity	found	in	natural	products,	it	is	not	surprising	that	
many	methods	have	been	developed	for	their	iterative,	building	block-based	synthesis.	The	vast	majority	
of	 these	methods	 are	 designed	 for	 specific	 structural	 classes	 of	molecules,	 so	 the	 reactions	 used	 for	
iterative	 assembly	 have	 a	 limited	 tolerance	 for	 structural	 variability	 in	 the	 building	 blocks.	 Still,	 these	
customized	iterative	synthesis	strategies	have	increased	synthetic	access	to	particular	regions	of	chemical	
space.	
	 Seminal	work	by	Masume	and	Sharpless	established	 that	an	 iterative	 four	 step	cycle	 could	be	
applied	to	access	all	eight	L-hexoses42	(Scheme	1.1	for	representative	examples).	The	cycle	begins	with	
asymmetric	epoxidation	of	an	allylic	alcohol	1.17.	In	basic	medium,	the	resulting	2,3-epoxy	alcohol	1.18	
can	rearrange	to	the	terminal	epoxide	1.19	(Payne	rearrangement),	which	is	a	substrate	for	nucleophilic	
Scheme	1.1.	Aldohexose	synthesis	via	iterative	Sharpless	epoxidation.	
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attack	by	sodium	thiophenolate.	A	sequence	of	acetal	protection	of	the	nascent	1,2-diol	1.20	followed	by	
oxidation	 to	 the	 sulfoxide	 1.22	 enables	 a	 Pummerer	 rearrangement	 to	 a	 gem-acetoxysulfide	 1.23.	
Subsequent	 hydrolysis	 through	 reductive	 (DIBAL)	 or	 basic	 (K2CO3	 /	MeOH)	 conditions	 allows	 selective	
retention	or	inversion	of	the	C2	stereogenic	center	in	formation	of	the	corresponding	aldehydes	1.24	and	
1.26.	Finally,	Wittig	olefination	and	aldehyde	reduction	produces	allylic	alcohols	1.25	and	1.27	for	further	
iteration.	Changing	the	conditions	of	the	two	stereocontrolling	steps,	Sharpless	asymmetric	epoxidation	
and	gem-acetoxysulfide	reduction,	allows	for	access	to	all	eight	L-hexoses.	The	versatility	of	this	strategy	
has	inspired	the	development	of	further	methods	for	the	de	novo	enantioselective	synthesis	of	sugars.43	
	 Polypropionates,	which	contain	repeating	three	carbon	motifs,	are	biosynthesized	by	assembly	of	
methylmalonyl-CoA	building	blocks.	Iterative	synthesis	strategies	that	harness	this	structural	modularity	
have	 simplified	 the	preparation	of	 even	highly	 stereochemically	 complex	natural	products.	 Pioneering	
work	 by	 Evans	 and	 Paterson	 used	 substrate-controlled	 diastereoselective	 aldol	 reactions	 and	
stereodivergent	ketone	reductions	to	access	libraries	of	stereotetrad	motifs.44-46	Auxiliary	cleavage	and	
the	 regeneration	 of	 aldehyde	 intermediates	 enabled	 both	 of	 these	 processes	 to	 be	 iterated.	 More	
recently,	 Crimmins	 has	 developed	 a	 variant	 of	 the	 Evans	 oxazolidinone	 methodology47	 that	 uses	 N-
acylthiazolidinethiones	 as	 chiral	 auxiliaries48-49	 (Scheme	 1.2),	which	 can	 be	 cleaved	 in	 a	 single	 step	 to	
generate	 a	 new	 aldehyde.	 Notably,	 the	 same	 chiral	 building	 block	 1.37	 can	 grant	 access	 to	 either	
stereoisomer	 of	 the	 syn	 aldol	 product	 depending	 on	whether	 the	 base	 is	 iPr2NEt	 or	 (−)-sparteine.	 To	
complete	 the	 formal	 synthesis	of	6-deoxyerythronolide	B,	Crimmins	 iterated	 this	 sequence	 five	 times,	
setting	10	of	the	11	stereocenters	using	a	single	type	of	reaction.50	
Scheme	1.2.	Formal	synthesis	of	6-deoxyerythronolide	B	via	iterative	aldol	reactions	
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	 Another	common	polyketide	motif,	the	1,3-polyol	unit,	has	been	the	subject	of	multiple	iterative	
synthesis	strategies.	Herbert	Brown’s	diastereoselective	allylboration	reaction51-53	can	be	iterated	by	using	
ozonolysis	to	generate	a	new	aldehyde	for	further	allylation.54	Marco	used	four	iterations	of	this	sequence	
to	prepare	the	1,3-polyol	fragment	1.49	in	the	synthesis	of	passifloricin	A	1.5054	(Scheme	1.3).	
	 Recently,	Krische	and	co-workers	pioneered	a	highly	efficient	C–C	bond-forming	transfer	
hydrogenation	strategy	involving	the	in	situ	generation	of	an	aldehyde	and	an	organometallic	
nucleophile.55	Application	of	this	iterative	strategy	in	a	two-directional	manner	expedited	the	
construction	of	the	key	1,3-polyol	portion	1.56	of	(+)-roxaticin	1.5756	(Scheme	1.4).	
	 Polydeoxypropionates	are	another	class	of	polyketides	that	contain	a	repeating	structural	motif.	
Several	different	iterative	synthesis	strategies	have	been	devised,	each	with	a	different	means	of	
achieving	stereocontrol.	Myers	has	developed	a	robust	iterative	alkylation	protocol	using	stoichiometric	
ephedrine-based	auxiliaries	that	provides	access	to	all	possible	stereochemical	variants,57-58	and	
Theodorakis	has	applied	this	methodology	to	complete	the	total	synthesis	of	(−)-borrelidin	1.6559-60	
(Scheme	1.5).	
Scheme	1.3.	Passifloricin	A	synthesis	via	iterative	allylboration	
Scheme	1.4.	(+)-Roxaticin	via	iterative	C-C	bond	forming	transfer	hydrogenation.	
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	 Minnaard	and	Feringa61	have	recently	developed	an	alternative	iterative	three-step	protocol	to	
access	 syn	 deoxypropionate	 motifs	 based	 on	 catalytic	 asymmetric	 conjugate	 additions	 (Scheme	 1.6).	
Starting	from	an	α,β-unsaturated	thioester	1.66,	a	highly	enantioselective	1,4-addition	of	MeMgBr	in	the	
presence	of	a	chiral	copper	catalyst	1.73	sets	the	first	methyl-bearing	stereocenter.	A	reduction	and	Wittig	
olefination	sequence	generates	a	new	α,β-unsaturated	thioester	1.69	for	further	1,4-addition	reactions.	
Repetition	of	these	three	steps	allows	seven	methyl	stereocenters	to	be	installed	with	excellent	levels	of	
stereoselectivity,	enabling	the	first	total	synthesis	of	phthioceranic	acid	1.72,61	as	well	as	the	first	total		
synthesis	of	sulfolipid-1.62	
	 Breit	has	also	developed	an	iterative	zinc-catalyzed	sp3–sp3	coupling	method	for	the	synthesis	of	
deoxypropionates63	 (Scheme	 1.7).	 Treatment	 of	 an	 alkyl	 Grignard	 1.74	 with	 ZnCl2	 generates	 a	
triorganozincate	species	(R3ZnMgCl),	which	displaces	a	secondary	triflate	1.75	to	generate	a	new	C–C	bond	
with	 inversion	of	 configuration.	Reduction	of	 the	ester	1.76	 followed	by	conversion	 to	a	primary	alkyl	
chloride	enables	further	iteration.	The	lack	of	reactivity	with	alkyllithium	species	suggests	that	magnesium	
coordination	to	the	triflate	may	play	a	role	in	Lewis	acid	activation	of	the	electrophile.	Using	this	iterative	
method,	Breit	was	able	to	access	a	library	of	different	diastereomers	of	trideoxypropionates,	all	in	>99%	
diastereomeric	excess.	The	modular	nature	of	polydeoxypropionates	has	also	inspired	the	development	
of	several	other	iterative	synthesis	strategies.64-65	
Scheme	1.5.	(−)-Borrelidin	via	iterative	Myers’	alkylation.	
Scheme	1.6.	Phthioceranic	acid	synthesis	via	iterative	conjugate	addition.	
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	 The	 aforementioned	 methods	 for	 deoxypropionate	 synthesis	 are	 all	 limited	 with	 respect	 to	
building	 block	 structural	 variability.	 Aggarwal’s	more	 versatile	 approach	 for	 the	 iterative	 synthesis	 of	
various	stereochemically	complex	Csp3-rich	motifs	is	demonstrated	with	his	route	to	(+)-kalkitoxin	1.9066	
(Scheme	 1.8).	 This	 approach	 leverages	 the	 stereospecificity	 of	 the	 1,2-metallate	 rearrangement	 of	
boronate	 complexes	 1.8267	 to	 install	 both	 stereochemistry	 and	 functionality	 through	 iterative	 chain	
extension	of	boronic	esters.	In	a	one-pot	procedure,	a	boronic	ester	1.80	was	subjected	to	a	series	of	six	
homologations,	installing	three	methylene	spacer	units	and	three	methyl-bearing	stereocenters	derived	
from	 the	 requisite	 enantiomerically	 pure	 lithiated	 benzoates	 1.81	 and	 1.85.68	 Amination	 followed	 by	
amide	formation	furnished	the	core	of	(+)-kalkitoxin	1.90	 in	52%	overall	yield.	The	same	approach	has	
been	used	to	synthesize	baulamycin	A,69	tatanan	A,70	fluorohexestrol,71	and	C30	botryococcene,72	among	
many	other	targets.73	More	broadly,	the	versatility	of	this	homologation	method,	which	tolerates	diverse	
structural	 variation	 in	 its	 building	 blocks,	 opens	 the	 door	 for	 divergent	 synthesis.	 This	 can	 be	 seen	 in	
Aggarwal’s	assembly-line	production	method	of	hydrocarbons	with	tailored	shapes.68	
Scheme	1.7.	Iterative	synthesis	of	polydeoxypropionates	via	stereospecific	displacement	of	
tosylates.	
	
Scheme	1.8.	(+)-Kalkitoxin	via	iterative	homologation	of	boronic	esters.	
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	 Terpene	 natural	 products	 are	 also	 amenable	 to	 iterative	 synthesis	 due	 to	 their	 recurring	 1,5-
trisubstituted	 olefin	 motifs.	 Harnessing	 this	 modularity,	 Negishi74	 has	 developed	 an	 iterative	 and	
convergent	 synthesis	 of	 coenzyme	 Q10	 1.100	 (Scheme	 1.9).	 A	 one-pot	 iterative	 cycle	 began	 with	 the	
formation	of	a	primary	alkylzinc	iodide	followed	by	a	chemoselective	cross-coupling	with	a	diiodo	building	
block	 1.92.	 Two	 further	 iterations	 followed	 by	 coupling	 with	 a	 diene-containing	 building	 block	 1.94	
installed	 five	 of	 the	 trisubstituted	 olefins	 of	 coenzyme	 Q10.	 To	 enable	 convergent	 synthesis,	 the	
trimethylsilyl	 (TMS)-protected	 alkyne	 also	 served	 as	 an	 attachment	 point.	 TMS	 deprotection	 and	
subsequent	carbometalation–iodination	generated	a	new	vinyl	iodide	1.96	that	served	as	a	substrate	in	a	
strategic	and	convergent	cross-coupling	with	an	earlier	homologue	1.97.	A	final	round	of	deprotection,	
hydrozirconation-iodination	and	cross-coupling	gives	coenzyme	Q10	1.100	in	only	11	steps.	
	 Long	polyene	chains	are	another	common	structural	motif	found	in	natural	products,	but	their	
preparation	is	often	challenging	due	to	their	sensitivity	to	light	and	acidic	conditions.	In	a	landmark	total	
synthesis	 of	 the	 complex	 polyene	 macrolide	 amphotericin	 B	 (AmB,	 1.3),	 Nicolaou	 used	 an	 iterative	
Horner–Wadsworth–Emmons	(HWE)	strategy	to	complete	the	all-trans-polyene	motif.	Starting	from	an	
Scheme	1.9.	Coenzyme	Q10	via	iterative	palladium-catalyzed	couplings	of	alkylzinc	reagents.	
Scheme	1.10.	Amphotericin	B	via	iterative	Horner-Wadsworth-Emmons	olefinations.	
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aldehyde	1.101,	the	first	triene	unit	was	installed	using	a	diene-containing	phosphonate	1.10275	(Scheme	
1.10).	 After	 a	 two-step	 conversion	 of	 the	 terminal	 ethyl	 ester	 into	 an	 aldehyde	 1.103,	 a	 second	
homologation	was	performed	with	the	same	phosphonate	building	block	1.102.	Deprotection	and	redox	
modification	furnished	a	hexaenal	1.104,	which	was	esterified	with	a	highly	functionalized	carboxylic	acid	
containing	 a	 phosphonate	 1.105	 to	 generate	 the	 open-chain	 molecule.	 A	 final	 intramolecular	 HWE	
reaction	 initiated	 by	 K2CO3	 /	 18-crown-6	 formed	 the	 desired	 cyclic	 heptaene	 1.106,	 completing	 the	
carbocyclic	core	of	AmB	1.3.76	
	 Complex,	polycyclic	molecules	may	appear	less	amenable	to	iterative	synthesis	than	linear	ones.	
However,	multistep	synthetic	sequences	can	still	be	designed	to	leverage	strategic	bond	disconnections	
at	common	substructural	motifs.	For	example,	Uenishi	and	co-workers	developed	an	iterative	approach	
to	the	stereoselective	synthesis	of	natural	products	containing	linked	tetrahydrofuran	(THF)	rings	1.11977	
(Scheme	1.11).	The	 iterative	sequence	commences	with	the	addition	of	an	allylic	Grignard	1.108	 to	an	
aldehyde	 or	 epoxide	 1.107.	 The	 resulting	 bis-homoallylic	 alcohol	 1.109	 is	 then	 a	 substrate	 for	 cross-
metathesis	followed	by	Pd(II)-mediated	ring	closure.	After	completion	of	the	THF	ring,	a	new	aldehyde	
1.113	 is	 generated	by	ozonolysis	of	 the	exocyclic	olefin	1.112.	 Synthesis	of	either	 trans-threo-trans	or	
trans-threo-cis	 THF	 rings	 is	 simply	 a	 case	 of	 exchanging	 the	 allylic	 alcohol	 building	 blocks	 during	 the	
metathesis	stage	of	the	iterative	cycle.	
	
Scheme	1.11.	Synthesis	of	goniocin	via	iterative	THF	ring	formation.	
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	 Mori	and	co-workers	leveraged	the	modularity	inherent	in	structurally	complex	polycyclic	ether	
natural	 products	 to	 enable	 their	 iterative	 construction78	 (Scheme	 1.12).	 In	 their	 approach,	 a	
diastereomerically	 pure	 oxiranyl	 anion	 1.121	 was	 used	 to	 displace	 a	 primary	 triflate	 1.120,	 and	 the	
resulting	epoxy	sulfone	product	1.122	was	then	subjected	to	an	acid-catalyzed	6-exo-tet	ring	closure.	A	
five-step	sequence	then	generated	a	new	triflate	1.124	for	further	iteration.	Six	repetitions	of	this	protocol	
led	to	the	efficient	construction	of	the	ABCDEF-ring	fragments	of	yessotoxin	and	adriatoxin	1.133,	with	
the	 stereochemistry	 of	 the	 cyclic	 ethers	 introduced	 through	 the	 selection	 of	 the	 appropriate	 oxirane	
building	 blocks.	 This	 iterative	 oxiranyl	 anion	 strategy	 has	 further	 been	 used	 for	 the	 synthesis	 of	
hemibrevetoxin	B,79	gambierol,80	and	even	gymnocin-A	with	14	contiguous	fused	rings.81	Other	iterative	
synthesis	 strategies	 have	 also	 been	 developed	 for	 polycyclic	 eithers,	 including	 iterative	 ring	 closing	
metathesis–hydroboration,	iterative	reductive	cyclizations,	and	iterative	oxonium	ylide	formation-[2,3]-
shift	processes.82	
	
	 	
Scheme	1.12.	Synthesis	of	the	ABCDEF	ring	system	of	yessotoxin	and	adriatoxin	via	an	iterative	
oxiranyl	anion	strategy.	
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1-4	 ITERATIVE	SYNTHESIS	STRATEGIES	FOR	NON-NATURAL	MOLECULES	
	 Beyond	natural	products,	customized	iterative	assembly	methods	have	also	enabled	the	synthesis	
of	many	other	types	of	molecules.	For	example,	polyaromatic	hydrocarbons	have	numerous	applications	
in	 solar	 cells	 and	 light-emitting	 diodes	 but	 can	 often	 prove	 challenging	 to	 prepare	when	 site-specific	
functionalization	is	required.	Kwon	and	co-workers	have	developed	an	efficient	strategy	for	the	iterative	
synthesis	 of	 polyaromatic	 hydrocarbons	 involving	 the	 reaction	 of	 a	 1,2-dialdehyde	 1.134	 and	 ethyl	
allenoate	1.13583	(Scheme	1.13).	A	two-step	modification	of	the	annulated	product	1.136	furnished	a	2,3-
dialdehyde	 1.137,	 which	 was	 ready	 for	 another	 annulation	 reaction.	 This	 iterative	 cycle	 can	 rapidly	
generate	2,3-disubstituted	anthracene	and	tetracene	structures	such	as	1.139.	
	 The	synthesis	of	larger	acenes	is	complicated	by	their	higher	reactivity,	but	these	structures	are	
highly	 sought	 after	 for	 their	 applications	 in	 organic	 electronic	 materials.	 For	 example,	 pentacene	 is	
currently	 the	 best	 available	 organic	 p-type	 semiconductor,	 but	 larger	 members	 could	 be	 even	 more	
useful.84	Bettinger	and	co-workers	have	developed	a	building	block-based	approach	using	iterative	Diels–
Alder	 reactions85	 (Scheme	 1.14).	 The	 reaction	 between	 an	 aryne	 dienophile	 and	 5,6,7,8-
tetramethylenebicyclo[2.2.2]oct-2-ene	 led	 to	 the	 formation	of	 a	 cycloadduct	with	a	 terminating	diene	
moiety.	This	was	treated	with	an	aryne	generated	from	1,2,4,5-tetrabromobenzene,	resulting	in	a	product	
terminating	in	another	dibromide	moiety.	A	final	iteration	of	aryne	formation	and	cycloaddition	generated	
a	stable	precursor	to	octacene.	After	a	sequence	of	aromatization	and	oxidation	reactions,	exposure	to	
low-wavelength	UV	light	generated	octacene	for	functional	studies.	
	
Scheme	1.13.	Iterative	arene	homologation.	
Scheme	1.14.	Iterative	synthesis	of	octacene.	
14	
	
	 Although	most	iterative	synthesis	methods	are	based	on	the	linear	assembly	of	building	blocks,	
Moore	and	 co-workers	have	developed	a	 convergent	 iterative	 synthesis	of	phenylacetylene	oligomers	
(Scheme	1.15)	using	Sonogashira	coupling.86-87	Moore’s	work	highlights	a	crucial	enabling	advance,	the	
ability	 to	orthogonally	protect	and	deprotect	each	of	 the	 two	different	 functional	groups	 required	 for	
building	block	assembly.	Here,	a	bifunctional	building	block	can	be	selectively	activated	in	two	different	
ways:	 a	 TMS	 protecting	 group	1.150	 can	 be	 removed	 to	 reveal	 a	 reactive	 terminal	 alkyne	1.151	 or	 a	
dialkyltriazene	1.152	can	be	converted	to	an	iodide	1.153.	These	two	differently	activated	building	blocks	
can	 then	 be	 assembled	 via	 Sonogashira	 coupling	 to	 form	 an	 advanced	 intermediate	 containing	 a	
dialkyltriazene	and	a	protected	alkyne	at	opposite	termini	1.154.	Repeating	this	process	of	using	advanced	
intermediates	as	building	blocks	enables	exponential	molecular	growth.	In	such	a	manner,	it	is	possible	to	
generate	repeating	tetramers	1.155,	octamers,	and	 longer	oligomers	1.156	with	precise	control	of	 the	
sequence	 of	 building	 blocks.	 Additionally,	 building	 blocks	 with	 other	 functional	 groups	 can	 also	 be	
incorporated	to	prepare	diverse	oligomeric	products	with	a	range	of	important	functions.88	
	 Moore	has	also	developed	a	convergent	approach	to	iterative	synthesis	for	the	assembly	of	large	
dendrimers89-91	(Scheme	1.16).	Compared	with	the	strategy	for	making	oligomers,	this	dendrimer	method	
is	 different	 in	 two	 respects.	 In	 this	 case,	 the	 building	 blocks	 are	 activated	 in	 a	 single	 direction,	 by	
unmasking	a	reactive	terminal	alkyne	for	Sonogashira	coupling	through	the	removal	of	a	TMS	protecting	
group.	However,	exponential	molecule	growth	can	still	be	achieved	via	double	Sonogashira	coupling	onto	
a	trifunctional	monomer	containing	two	bromines	1.158.	Four	iterations	of	TMS	deprotection	and	double	
Sonogashira	 coupling	enabled	 the	 rapid	 construction	of	a	monodendron	containing	31	building	blocks	
1.161.89	This	double	Sonogashira	approach	is	capable	of	quickly	making	large	molecules,	but	generating	
unsymmetrical	 targets	 represents	 an	 additional	 challenge.	 Such	 a	 limitation	 is	 not	 problematic	 for	
dendrimer	 synthesis,	 and	 these	 examples	 illustrate	 that	 convergent	 iterative	 synthesis	 can	 be	 most	
versatile	when	it	has	two	separate	masking	and	deprotection	strategies	for	orthogonal	functional	groups.	
Scheme	1.15.	Iterative	convergent	synthesis	of	phenylacetylene	oligomers.	
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	 Iterative	 synthesis	 methods	 have	 also	 been	 developed	 for	 molecules	 with	 defined	 three-
dimensional	architectures.	 Iptycenes	are	of	 interest	 in	materials	science	and	supramolecular	chemistry	
due	to	their	structural	rigidity	and	three-dimensionality.	Swager	and	co-workers	developed	an	iterative	
solid-state	synthesis	of	extended	iptycenes,	which	starts	with	a	Diels–Alder	reaction	between	anthracene	
1.162	 and	 1,4-anthraquinone	 1.163	 (Scheme	 1.17).	 After	 a	 rearomatization	 step,	 the	 cycle	 can	 be	
repeated	to	form	longer	iptycenes	1.166	and	1.167	in	a	modular	fashion.92	
	 Iterative	 synthesis	 has	 also	 been	 applied	 to	 create	 mechanically	 interlocked	 molecules.	 In	
Goldup’s	 iterative	 synthesis	 of	 oligo[n]rotaxanes,	 a	 bipyridyl-containing	 macrocycle	 1.168	 is	 used	 for	
copper-templating	 to	control	a	 three-component	click	 reaction93	 (Scheme	1.18).	The	product	 rotaxane	
1.171	has	a	terminus	containing	a	triisopropylsilyl	(TIPS)-protected	alkyne.	Cleavage	of	the	silyl	group	and	
iteration	of	this	reaction	allow	for	the	incorporation	of	different	macrocyclic	moieties.94	
	
Scheme	1.17.	Iterative	synthesis	of	extended	iptycenes	
Scheme	1.16.	Iterative	convergent	synthesis	of	hydrocarbon	dendrimers.	
Scheme	1.18.	Iterative	synthesis	of	rotaxanes.	
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	 Each	of	these	examples	represents	an	 important	advance	towards	to	the	 iterative	synthesis	of	
specific	types	of	small	molecules.		Still,	many	of	these	c	 ustomized	iterative	synthesis	methods	can	only	
access	a	small	range	of	chemical	space	due	to	the	nature	of	the	assembly	chemistry.	It	 is	evident	from	
several	 divergent	 iterative	 synthesis	methods45,	 58,	 63,	 68,	 95	 that	 the	 greater	 the	 potential	 for	 structural	
variation	in	the	building	blocks,	the	greater	the	scope	of	possible	products.	Taking	this	concept	to	its	logical	
conclusion,	it	may	be	possible	to	synthesize	most	small	molecules	by	iterative	assembly	of	building	blocks,	
provided	that	the	same	assembly	process	can	be	applied	to	all	of	the	fragments	corresponding	to	the	most	
common	structural	motifs	found	in	small	molecules.	
	
1-5	 A	GENERAL	PLATFORM	FOR	ITERATIVE	SYNTHESIS	
	 The	 ultimate	 goal,	 to	 make	 most	 small	 molecules	 with	 the	 same	 general	 iterative	 synthesis	
platform,	 requires	 highly	 versatile	 reactions	 for	 building	 block	 assembly.	 In	 particular,	 the	 assembly	
reactions	need	to	be	able	to	form	a	range	of	different	types	of	C–C	and	C–X	bonds	while	being	tolerant	of	
many	functional	groups.	Metal-mediated	cross-coupling	represents	an	especially	attractive	candidate.	The	
Suzuki–Miyaura	and	Buchwald–Hartwig	couplings	can	use	non-toxic	and	shelf-stable	building	blocks,	are	
highly	efficient	and	stereospecific,	and	can	proceed	under	mild	 reaction	conditions	with	high	 levels	of	
functional	group	tolerance.	Moreover,	the	scope	of	both	C–
C	 and	 C–X	 bonds	 that	 can	 be	 formed	 using	 such	
methodologies	has	been	extended	to	include	a	wide	range	
of	 Csp3	 and	 Xsp3	 coupling	 partners,96-98	 even	 including	
stereospecific	 Csp3	 cross-couplings	 of	 stereochemically	
defined	chiral	nonracemic	building	blocks.99-102,	104-109	
	 In	 order	 perform	 cross-coupling	 reactions	 in	 a	
controlled	 iterative	 fashion,	 there	 must	 be	 methods	 for	
reversibly	attenuating	the	reactivity	of	bifunctional	building	
blocks.	 (Figure	 1.3).	 Hiyama	 has	 devised	 a	 strategy	 for	
reversibly	 attenuating	 the	 reactivity	 of	 arylsilanes	 using	
specially	 designed	 organo[(2-
hydroxymethyl)phenyl]dimethylsilanes	 1.175.	 Under	
normal	 cross-coupling	 conditions,	 these	 arylsilanes	 are	
Figure	1.3.	Reversibly	attenuating	the	
reactivity	of	building	blocks	to	cross-
coupling	reactions.	
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‘switched	 off’	 and	 unreactive	 towards	 transmetalation,	 but	 upon	 deprotection	 of	 a	 strategically	
positioned	neighboring	alcohol,	the	resulting	intramolecular	O–Si	coordination	activates	the	silane	1.176	
and	promotes	 cross-coupling	 (Figure	1.3,	 top).	Using	 this	method,	Hiyama	completed	 the	 synthesis	of	
highly	conjugated	linear	oligoarenylsilanes.110	
	 Suginome	has	reported	an	alternative	method	for	switching	off	organometallic	coupling	partners	
(Figure	1.3,	middle).	 Complexing	 reactive	boronic	 acids	1.177	with	 the	1,8-diaminonaphthalene	 (DAN,	
1.178)	group	decreases	the	Lewis	acidity	of	the	p-orbital	of	the	sp2-hybridized	boron	atom	via	electron	
donation	from	neighboring	lone	pairs	on	planar	nitrogen	atoms.	The	resulting	BDAN	compounds	1.179	
are	 stable	 to	 both	 anhydrous	 and	 aqueous	 biphasic	 cross-coupling	 conditions.	 However,	 exposure	 to	
aqueous	HCl	or	H2SO4	removes	the	DAN	group	and	releases	the	reactive	boronic	acid	1.17.	This	iterative	
building	 block-based	 method	 has	 been	 applied	 to	 the	 synthesis	 of	 oligoarenes111	 and	
oligo(phenylenevinylene)s.112	
	
1-6	 MIDA	BORONATES	
	 Work	 by	 the	 Burke	 group	 identified	 that	 complexation	 with	 the	 trivalent	 ligand	 N-
methyliminodiacetic	 acid	 (MIDA,	 1.180)	 can	 alternatively	 attenuate	 boronic	 acid	 reactivity	 by	
rehybridizing	the	boron	atom	from	sp2	to	sp3	(Figure	1.3,	bottom).113	These	MIDA	boronates	1.181	have	
many	 advantageous	 physical	 and	 chemical	 features	 that	 make	 them	 especially	 good	 candidates	 for	
attenuating	the	reactivity	of	organometallics	in	iterative	synthesis.	They	are	readily	purified	by	silica	gel	
chromatography	 and/or	 recrystallization	 and	 are	 usually	 indefinitely	 stable	 on	 the	 benchtop	 as	 free-
flowing	crystalline	solids.113	Moreover,	the	same	reaction	procedure	can	be	used	to	convert	alkylboronic,	
vinylboronic,	and	arylboronic	acids	directly	 to	 their	MIDA	boronate	counterparts	 in	quantitative	yields	
under	mild	conditions.	To	drive	the	MIDA	complexation	to	completion,	water	can	be	removed	simply	via	
toluene	azeotrope	with	a	Dean–Stark	 trap114	or	by	 the	addition	of	 a	drying	agent	 such	as	magnesium	
sulfate.	
	 MIDA	 boronates	 are	 inert	 to	 anhydrous	 cross-coupling	 reactions,	 but	 they	 can	 be	 quickly	
deprotected	 under	 mild	 aqueous	 basic	 conditions.	 Deprotection	 can	 proceed	 through	 two	 different	
mechanisms:	either	under	strong	aqueous	basic	conditions	 in	which	a	rate-limiting	attack	of	hydroxide	
occurs	on	the	carbonyl	carbon,	or	under	weakly	basic	or	neutral	aqueous	conditions	in	which	a	slower	
rate-limiting	attack	of	water	occurs	on	the	B–N	bond.115	The	latter	mechanism	has	been	harnessed	for	the	
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in	situ	slow	release	of	MIDA	boronates.	Slow	release	deprotections	have	been	advantageous	for	many	
reactions,	 including	 couplings	 of	 unstable	 heteroaryl	 boronates,116-117	 polymerization	 reactions,118-119	
asymmetric	methodologies,120	the	synthesis	of	organic	photovoltaics,121	and	a	one-pot	homologation	of	
boronic	acids.122	
	 The	durability	of	MIDA	boronates	to	a	wide	range	of	different	reagents	and	reaction	conditions	
further	facilitates	the	synthesis	of	otherwise	challenging	to	access	boronate	building	blocks	from	simple	
boron-containing	 starting	 materials	 (Figure	 1.4).	 For	 example,	 many	 types	 of	 oxidations,123-127	
reductions,123,	 128-129	 and	 protecting	 group	 manipulations123	 are	 well-tolerated.	 MIDA	 boronates	 can	
likewise	survive	common	classes	of	nucleophilic	displacement	reactions123,	130-132	additions	across	multiple	
bonds,128,	 133-134	 aldehyde	 homologation	 reactions,123	 and	 electrophilic	 substitution	 reactions.126,	 135	 In	
addition	 to	 Suzuki	 cross-couplings,	 MIDA	 boronates	 are	 stable	 to	 other	 transition	 metal-catalyzed	
reactions	 including	Heck	 reactions,127,	136	Sonogashira	cross-couplings,128	olefin	metathesis	 reactions,127	
and	 C-H	 activation	 reactions.137	 Heterocycle-forming	 cyclization	 reactions	 containing	MIDA	 boronates	
have	 been	 developed	 to	 access	 borylated	 indoles	 1.234	 and	 1.256,137-139	 pyrroles	 1.237,137,	 140	 furans	
1.238,140	thiazoles	1.240,126	isoxazoles	1.269,141	triazoles	1.267,141	tetrazoles	1.263,129	pyridazines	1.236,140	
benzofurans	 1.258,139	 isoquinolines	 1.250,137	 isoquinolones	 1.252,137	 quinoxalines	 1.247,142	 and	
imidazo[1,2-a]pyridines	 1.243.132	 Diels-Alder	 reactions,128	 hetero-Diels-Alder	 reactions,143	 and	
cyclopropanation	reactions127	have	all	been	conducted	on	MIDA	boronate	containing	substrates.	Finally,	
chiral	 variants	 of	 MIDA	 have	 been	 developed	 for	 diastereoselective	 epoxidation	 reactions144	 and	
diastereomeric	resolutions.145	
	 MIDA	boronates	are,	however,	not	without	their	limitations	in	terms	of	scope	and	application.	A	
large	 number	 of	 Suzuki–Miyaura	 cross-coupling	 reactions	 require	 the	 use	 of	 an	 aqueous	 base,	which	
causes	the	hydrolysis	of	MIDA	boronates,	and	Buchwald–Hartwig	aminations	can	involve	the	use	of	strong	
bases	that	are	incompatible	with	the	acidic	protons	on	the	backbone	of	the	MIDA	ligand.	As	many	Csp3	
cross-coupling	methods	involve	aqueous	basic	reaction	conditions,	these	important	limitations	currently	
prevent	the	use	of	these	reactions	in	MIDA	boronate-based	ICC.	
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Figure	1.4.	Reaction	conditions	that	tolerate	MIDA	boronates.	
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1-7	 ITERATIVE	CROSS-COUPLING	WITH	MIDA	BORONATES	
	 As	 an	 important	 step	 towards	 the	 generalized	 synthesis	 of	 small	 molecules,	 iterative	 cross-
coupling	(ICC)	with	MIDA	boronates	has	been	used	to	prepare	a	wide	range	of	different	molecular	targets	
(Figure	1.5).	The	strategy	of	 ICC,	as	pioneered	by	the	Burke	group,	constructs	molecules	from	building	
blocks	by	alternating	between	MIDA	boronate	deprotection	reactions	and	cross-coupling	reactions.	Early	
applications	of	ICC	included	natural	products	such	as	ratanhine	1.299,113	(+)-crocacin	C	1.303,123	all-trans-
retinal	1.289,146	 and	β-parinaric	 acid	1.294.146	 Soon,	 the	Burke	 group	 applied	 ICC	 to	more	 structurally	
Figure	1.4.	Reaction	conditions	that	tolerate	MIDA	boronates,	continued.	
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complex	 polyene	 natural	 products,	 including	 peridinin	 1.305,134	 synechoxanthin	 1.292,147	 and	
neurosporaxanthin	β-D-glucopyranoside	1.287.38	
	 The	 ICC	 strategy	 has	 also	 empowered	 the	 study	 of	 small	molecule	 functions.	 Amphotericin	 B	
(AmB)	has	served	for	more	than	50	years	as	a	last	line	of	defense	against	invasive	and	drug-resistant	fungal	
infections,	but	 it	has	dose-limiting	side	effects.	With	the	goal	of	gaining	a	better	understanding	of	 the	
mechanism	of	toxicity	of	AmB,	the	Burke	group	used	ICC	to	synthesize	an	AmB	derivative	lacking	a	single	
hydroxyl	group.148	This	new	compound,	C35deOAmB	1.306,	 lacked	the	ability	to	form	ion	channels	but	
retained	 its	 toxicity	 to	 fungal	 pathogens,	 overturning	 decades	 of	 prior	 thinking	 about	 the	 primary	
mechanism	of	action	of	this	clinically	vital	but	unfortunately	highly	toxic	natural	product.148	This	discovery	
helped	to	build	a	strong	foundation	for	ongoing	efforts	 to	rationally	optimize	the	therapeutic	 index	of	
AmB.149-150	
	 Many	other	labs	have	also	harnessed	ICC	to	simplify	small	molecule	synthesis	(Figure	1.5).	Total	
syntheses	of	the	antibiotics	elansolid	B1	1.308	and	(-)-myxalamide	A	1.301	as	well	as	a	partial	synthesis	of	
the	antibiotic	filipin	III	1.307	have	been	reported	by	Kirschning,151	Kobayashi,152	and	Cossy,153	respectively.	
Other	natural	products	made	in	this	manner	include	hydroxyl-β-sanshool	1.296,154	paracentrone	1.300,155	
and	 a	 protected	 procyanidin	 derivative	1.302.156	 ICC	with	MIDA	 boronates	 has	 also	 empowered	 drug	
discovery	 efforts.	Medicinal	 chemists	 at	 Pfizer	 utilized	 an	 iterative	 cross-coupling	 sequence	 to	 rapidly	
explore	chemical	space,	leading	to	the	discovery	of	a	potent	and	selective	M1	PAM-agonist	1.293.131	To	
further	expand	the	scope	of	medicinal	chemistry	compatible	with	 ICC	of	MIDA	boronates,	chemists	at	
Novartis	 have	 developed	 a	 procedure	 for	 protective	 enolization	 of	 the	MIDA	 backbone	with	 LiHMDS.	
These	conditions	facilitated	a	one-pot	procedure	involving	a	Buchwald-Hartwig	coupling	followed	by	C-C	
bond	formation	to	rapidly	access	molecules	such	as	a	histamine	H3	antagonist	1.304.157	
	 Polycyclic	 molecules	 present	 an	 especially	 formidable	 challenge	 for	 building	 block-based	
construction.	However,	the	biosynthesis	of	complex,	Csp3-rich	polycyclic	natural	products	often	involves	
an	 actionable	 two-part	 strategy:	 the	 assembly	 of	 building	 blocks	 into	 a	 linear	 precursor	 and	 then	 a	
cyclization	reaction	to	transform	this	linear	molecule	into	a	complex	(poly)cyclic	skeleton.158	The	Burke	
group	 first	 applied	 this	 strategy	 of	 linear-to-cyclized	 ICC	 in	 their	 syntheses	 of	 oblongolide	 1.312,	 a	
hexahydroindene	 core	1.313,	 citreofuran	1.314,	 a	 steroid-like	 core	1.315,	 and	 the	 pentacyclic	 core	 of	
secodaphnane	1.310	 (Figure	1.5,	bottom).	 In	each	case,	 iterative	building	block	assembly	was	used	 to	
generate	a	linear	precursor,	which	was	then	subjected	to	cyclization	reactions	to	give	the	natural	product.	
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Vosburg	has	used	a	similar	approach	for	the	ICC	synthesis	of	the	ethyl	ester	of	cryptobeilic	acid	D	1.309	
and	the	core	of	endriandric	acid	1.311.159	
	 	
Figure	1.5.	Small	molecules	made	via	iterative	cross-coupling	with	MIDA	boronate	building	blocks.	
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1-8	 SUMMARY	
	 Even	after	a	century	of	exciting	progress,	chemical	synthesis	still	poses	a	serious	bottleneck	to	
exploring	 the	 untapped	 potential	 of	 small	 molecules	 to	 act	 as	 frontier	 medicines,	 biological	 probes,	
agrochemicals,	and	materials.	In	contrast,	the	synthesis	of	various	classes	of	macromolecules	has	been	
expedited	by	iterative,	building	block-based	synthetic	approaches,	resulting	in	an	explosion	of	applications	
for	peptides,	oligonucleotides,	and	oligosaccharides.	Because	many	lines	of	evidence	suggest	that	natural	
and	non-natural	small	molecules	also	possess	a	high	degree	of	structural	modularity,	 it	should	also	be	
possible	to	generalize	small	molecule	synthesis.	
	 Many	customized	iterative	synthesis	methods	have	been	developed,	both	for	natural	and	non-
natural	 small	molecules.	However,	 the	kinds	of	 reactions	used	 to	assemble	 the	building	blocks	have	a	
limited	 tolerance	 for	 structural	variation,	 restricting	 the	scope	of	each	 iterative	synthesis	method	to	a	
relatively	narrow	region	of	chemical	space.	Transition	metal-mediated	cross-coupling	reactions	represent	
a	much	more	promising	basis	for	a	more	general	building	block-based	synthesis	platform.	
	 	The	application	of	cross-coupling	reactions	in	a	controlled,	iterative	sequence	requires	methods	
for	reversibly	attenuating	the	reactivity	of	the	building	blocks.	The	ability	of	the	MIDA	ligand	to	reversibly	
“switch	off”	boronic	acid	reactivity,	along	with	the	many	advantageous	physical	and	chemical	features	of	
MIDA	boronates,	have	enabled	the	Burke	group	to	develop	a	general	synthesis	strategy	called	iterative	
cross-coupling	 (ICC).	 A	wide	 range	 of	 different	molecular	 structures	 have	 been	 synthesized	 using	 ICC,	
including	even	complex	polycyclic	natural	products.	Most	importantly,	ICC	has	already	begun	empowering	
the	 discovery	 of	 new	molecular	 functions.	 Continued	 progress	 in	 building	 block	 synthesis	 and	 cross-
coupling	 chemistry	will	 further	 generalize	 the	 scope	 of	molecules	 that	 can	 be	made	with	 generalized	
synthesis.	
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CHAPTER	2	
AUTOMATED	SYNTHESIS	OF	SMALL	MOLECULES	
	 Small	molecules	possess	 tremendous	diversity,	both	 in	 structure	and	 function.	They	 represent	
some	of	the	best	medicines,	biological	probes,	agrochemicals,	and	materials.	After	more	than	a	century	
of	exciting	progress	in	organic	synthesis,	nearly	any	small	molecule	that	is	sufficiently	stable	can	be	made	
in	 a	 lab.	 However,	 practical	 access	 to	 small	 molecules,	 especially	 structurally	 complex	 ones,	 is	 still	 a	
challenge	that	often	impedes	exploration	of	their	functions.	To	facilitate	the	discovery	and	optimization	
of	 new	 drug	 candidates,	 agrochemicals,	 and	 materials,	 many	 different	 small	 molecules	 need	 to	 be	
synthesized	and	tested.	
	 	For	biomolecules	such	as	DNA	and	peptides,	automated	synthesis	has	greatly	accelerated	 the	
exploration	of	new	functions.	Automatically	synthesized	oligonucleotide	probes	corresponding	to	every	
gene	 in	 the	 human	 genome	 printed	 on	 a	 glass	 slide	 helped	 usher	 in	 the	 era	 of	 genomics.1	 Countless	
peptide-	and	oligonucleotide-based	drug	candidates	were	rapidly	tested	and	optimized	yielding	entirely	
new	classes	of	therapeutics.2-3	Total	synthesis	of	genes,	proteins,	and	even	complete	genomes	became	
possible,	launching	the	field	of	synthetic	biology.4-6	A	similar	revolution	in	small	molecule	synthesis	would	
be	highly	enabling	for	discovering	and	optimizing	new	small	molecule	functions.	
	 As	a	first	step	in	this	direction,	we	have	designed	a	machine	that	can	carry	out	the	fully	automated	
synthesis	 of	 a	 range	 of	 different	 small	 molecules.7	 Harnessing	 the	 iterative	 cross-coupling	 synthesis	
platform	 (Figure	 2.1),	 this	 synthesis	machine	 assembles	 small	molecules	 from	bifunctional	 halo	MIDA	
boronate	 building	 blocks.	 Enabled	 by	 a	 general	 purification	 strategy,	 multiple	 synthetic	 steps	 can	 be	
performed	in	sequence	without	any	user	input.	Although	the	machine	is	capable	of	making	structurally	
dissimilar	molecules	including	natural	products,	pharmaceuticals,	and	materials,	the	automated	chemistry	
is	always	the	same.	
	 The	automated	synthesis	machine	was	designed	and	built	by	Dr.	Steven	G.	Ballmer	and	Dr.	Eric	P.	
Gillis.	Portions	of	this	chapter	were	adapted	from	Li	et.	al.,	Synthesis	of	many	different	types	of	organic	
small	molecules	using	one	automated	process,	Science	2015,	347,	1221-1225	as	well	as	Lehmann	et.	al.,	
Towards	the	generalized	iterative	synthesis	of	small	molecules,	Nature	Reviews	Chemistry	2018,	2,	0115.	
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2-1	 CUSTOMIZED	VS	GENERALIZED	AUTOMATED	SYNTHESIS	
	 The	customized	approach	to	automated	synthesis	 involves	automating	many	different	kinds	of	
chemical	reactions.	This	kind	of	automation,	which	mirrors	the	traditional	customized	synthesis	approach,	
has	 been	developed	extensively	 in	 the	 laboratories	 of	 Eli	 Lilly.8	 Their	 automated	 synthesis	machine	 is	
capable	 of	 performing	 amide	 bond	 formations,	 Suzuki	 couplings,	 heterocycle	 formations,	 heteroatom	
alkylations,	aromatic	nucleophilic	substitutions,	olefin	metathesis	reactions,	Buchwald-Hartwig	couplings,	
reductive	 aminations,	 and	 many	 more.	 This	 automated	 system8	 and	 others9-13	 have	 had	 substantial	
impacts.	Still,	the	strategy	of	customized	automated	synthesis	is	better	suited	to	process	scale	than	to	the	
discovery	of	new	molecular	functions	due	to	several	key	limitations.	Each	new	type	of	reaction	requires	
the	inclusion	of	different	kinds	of	starting	materials	and	reagents.	Synthetic	routes	must	still	be	developed	
de	novo	for	each	new	target,	and	reaction	conditions	may	require	optimization.	These	challenges	often	
necessitate	the	involvement	of	a	specialist.14	Finally,	one	of	the	most	significant	challenges,	automation	
of	the	purification	step,	must	be	solved	again	for	each	new	type	of	transformation.	
	 The	 automated	 synthesis	 of	macromolecules	 has	 been	 accomplished	with	 a	more	 generalized	
strategy.	For	peptides,15	oligonucleotides,16	and	oligosaccharides,17	automated	synthesis	was	enabled	by	
using	 one	 type	 of	 reaction	 to	 iteratively	 assemble	 building	 blocks.	 Such	 standardization	 reduced	 the	
number	of	processes	employed	and	thus	decreased	the	number	of	challenges	involved	in	automating	the	
synthesis	platform.7	
	 Iterative	 cross-coupling	 (ICC,	 Figure	 2.1)	 represents	 a	 promising	 platform	 for	 generalized	
automated	synthesis	of	small	molecules.	For	this	strategy,	only	two	types	of	reactions	require	automation,	
deprotection	 reactions	 and	 cross-coupling	
reactions.	Leveraging	this	simplicity,	it	should	be	
possible	to	design	dedicated	modules	 for	each	
kind	 of	 reaction	 to	 maximize	 reliability	 and	
efficiency.	 The	 deprotection	 reactions	 afford	
pure	 boronic	 acids,	which	 can	 be	 easily	 dried,	
deoxygenated,	 and	 transferred	 into	 a	 cross-
coupling	 reaction.	 After	 completion	 of	 the	
coupling,	 the	 new	 MIDA	 boronate-containing	
product	 can	 be	 returned	 to	 the	 deprotection	
module,	allowing	the	cycle	to	be	iterated.	 Figure	2.1.		Iterative	cross-coupling.	
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2-2	 DISCOVERY	OF	GENERALIZED	PURIFICATIONS	CONDITIONS	
	 The	remaining	key	challenge	for	multistep	automated	synthesis	is	purification.	A	platform	based	
on	cross-coupling	reactions	will	need	to	be	capable	of	removing	a	variety	of	impurities.	Often,	one	of	the	
coupling	partners	is	used	in	excess,	and	there	will	also	be	residual	transition	metal	catalyst,	ligand,	and	
base.	The	inorganic	byproducts,	such	as	boric	acid	and	salts,	can	be	removed	by	simple	silica	gel	filtration,	
but	separating	 the	organic	 impurities	 from	the	product	 typically	 requires	customized	chromatographic	
conditions.	Moreover,	the	presence	of	impurities	could	be	detrimental	for	the	subsequent	cross-coupling	
reaction.	Small	impurities	can	sometimes	interfere	with	the	activity	of	the	catalyst,	and	excess	coupling	
partners	from	a	previous	step	could	result	in	multiple	products	in	the	next	cross-coupling	step.	
	 	Small-molecule	 synthesis	 typically	 requires	 that	 purifications	 be	 customized	 for	 each	
intermediate,	 such	 as	 chromatography	 with	 eluents	 optimized	 to	 match	 compound	 polarity.	 Such	
customization	 is	 incompatible	 with	 generalized	 automated	 purification.	 Solid-phase	 synthesis	 has	
addressed	 this	 problem	 for	 peptides,15	 oligonucleotides,16	 oligosaccharides,17	 and	 some	 organic	
polymers.18	In	some	cases,	syntheses	of	natural	products	and	pharmaceuticals	have	also	been	aided	by	
solid-phase	methods.19	This	approach	is	well	established,	is	compatible	with	a	wide	range	of	chemistries,	
and	has	been	employed	 in	 industry.20	However,	 small	molecules	do	not	possess	a	 common	 functional	
group	handle	for	attachment	to	a	solid	support,	which	precludes	generalized	application	of	this	approach.	
	 In	pursuit	of	a	purification	strategy	that	would	be	applicable	to	every	intermediate,	we	recognized	
that	every	cross-coupled	product	in	ICC	contains	a	MIDA	boronate	functional	group.	Serendipitously,	we	
discovered	that	all	MIDA	boronates	(such	as	2.1-2.15)	possess	binary	affinities	for	silica	gel	with	certain	
eluents	(Figure	2.2).	Regardless	of	the	characteristics	of	the	organic	fragment,	MIDA	boronates	possess	
minimal	mobility	in	a	solution	of	1.5%	methanol	in	diethyl	ether.	However,	these	same	MIDA	boronates	
can	be	rapidly	eluted	by	THF.	Taken	together,	 these	properties	enabled	the	development	of	a	general	
catch-and-release	purification	strategy.	A	crude	reaction	can	first	be	loaded	onto	a	silica	gel	plug.	To	elute	
any	 excess	 reagents,	 catalysts,	 and	 organic	 byproducts,	 the	 silica	 gel	 plug	 can	 be	 washed	 with	 1.5%	
methanol	in	diethyl	ether.	Finally,	the	purified	MIDA	boronate	can	be	released	by	switching	the	solvent	to	
THF.7	
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	 One	 important	 limitation	 of	 this	 generalized	 purification	 strategy	 is	 the	 formation	 of	
protodehalogenated	side	products.	In	ICC,	these	impurities	would	also	contain	MIDA	boronate	functional	
groups,	 so	 they	 would	 coelute	 with	 the	 product	 during	 catch-and-release	 purification.	 Subsequent	
deprotection	 and	 coupling	 steps	 would	 thus	 competitively	 incorporate	 boronic	 acids	 derived	 from	
protodehalogenated	 side	 products.	 However,	 provided	 that	 protodehalogenation	 is	 minimal	 in	
comparison	to	productive	cross-coupling,	this	should	not	pose	a	major	problem	to	general	purification.	
	
2-3	 HOW	THE	SMALL	MOLECULE	SYNTHESIS	MACHINE	WORKS	
	 The	fully	automated	synthesis	commences	at	the	deprotection	module	(Figure	2.3).	Here,	THF	and	
water	are	syringed	into	a	cartridge	containing	the	MIDA	boronate	and	solid	sodium	hydroxide.	After	20	
minutes	 of	 room	 temperature	 agitation	with	 argon	 gas,	 the	MIDA	 boronate	 is	 fully	 converted	 to	 the	
boronic	 acid.	 Before	 the	 boronic	 acid	 can	 enter	 the	 subsequent	 cross-coupling	 reaction,	 it	 must	 be	
prepared	as	a	dry	THF	solution.	First,	 the	 reaction	 is	quenched	 (either	with	pH=6	phosphate	buffer	or	
saturated	NH4Cl),	and	then	diethyl	ether	is	added.	The	layers	are	mixed	via	pulses	of	nitrogen	gas,	and	
then	the	aqueous	layer	is	removed.	In	the	same	manner,	the	THF	/	Et2O	layer	is	washed	with	saturated	
sodium	chloride.	This	organic	layer	is	then	exposed	to	two	drying	cartridges	and	a	concentration	cartridge,	
where	a	final	solvent	switch	to	deoxygenated	THF	prepares	the	boronic	acid	for	the	cross-coupling	step.7	
Figure	2.2.		Design	of	a	general	catch-and-release	purification	strategy	by	taking	advantage	of	the	
unique	binary	elution	properties	of	MIDA	boronates.	
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	 For	 the	 coupling	 step,	 a	
cartridge	is	charged	with	a	bifunctional	
halo	MIDA	 boronate	 building	 block,	 a	
palladium	 catalyst,	 an	 inorganic	 base,	
and	 a	 magnetic	 stir	 bar.	 A	 standard	
stirring	 hot	 plate	 and	 custom	 metal	
heat	block	are	used	to	heat	the	mixture	
to	 the	 necessary	 temperature	 for	 the	
coupling	step,	and	then	the	mixture	is	
deoxygenated	 by	 flushing	with	 argon.	
THF	 is	 then	 added,	 followed	 by	 the	
gradual	addition	of	anhydrous	boronic	
acid	 solution	 from	 the	 deprotection	
step	 (Figure	 2.3).	 After	 12	 hours,	 the	
cross-coupling	reaction	is	complete.7	
	 The	 purification	 step	 begins	
with	 removal	 of	 THF	 from	 the	 crude	
reaction.	This	 is	accomplished	by	transferring	the	crude	product	to	a	precipitation	cartridge	containing	
hexanes,	which	causes	the	MIDA	boronate	to	crash	out	of	solution.	The	organic	solvent	is	removed	from	
the	bottom	of	the	precipitation	cartridge	and	pulled	through	a	silica	gel	plug.	The	remaining	solid	crude	
product	in	the	precipitation	cartridge	is	then	purified	by	the	catch-and-release	method.	First,	this	crude	
material	 is	 washed	 with	 1.5%	 methanol	 in	 diethyl	 ether,	 which	 readily	 dissolves	 impurities,	 excess	
reagents,	and	catalysts.	This	solution	is	then	removed	by	passing	through	the	silica	gel	plug,	leaving	the	
purified	MIDA	boronate	in	the	precipitation	cartridge	and	trapped	on	the	silica	gel	plug.	This	product	is	
then	dissolved	in	THF,	filtered	through	the	silica	gel	plug,	and	then	transferred	to	the	next	deprotection	
step	(Figure	2.3).7	
	 	
Figure	2.3.		Design	of	an	automated	synthesis	machine.	
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2-4	 AUTOMATED	SYNTHESIS	OF	LINEAR	SMALL	MOLECULE	TARGETS	
	 A	range	of	different	linear	molecules	were	prepared	by	automated	building	block	assembly	on	the	
synthesis	machine.	In	each	case,	the	fully	automated	synthesis	was	accomplished	by	repeating	the	same	
deprotection,	 coupling,	 and	 purification	 steps.	 This	 automated	method	 enabled	 the	 preparation	 of	 a	
variety	of	different	targets	including	natural	products	2.16-2.19,	pharmaceuticals	2.20-2.22,	and	materials	
2.23-2.24	 (Figure	 2.4).7	 Due	 to	 the	 mild	 nature	 of	 the	 automated	 synthesis	 conditions,	 structural	
information	encoded	in	the	building	blocks	was	faithfully	translated	into	the	products,	including	functional	
groups,	oxidation	states,	and	stereochemistry.	Reactions	for	C-X	bond	construction	(including	Buchwald-
Hartwig	couplings	and	amide	bond	formations)	were	also	used	for	building	block	assembly	and	subjected	
to	the	same	catch-and-release	purification	protocol.	Moreover,	a	key	advantage	of	building	block-based	
synthesis	 is	 access	 to	 different	 structural	 derivatives	 of	 a	 parent	 compound.	 For	 the	 natural	 product	
ratanhine	2.19,	19	structural	derivatives	were	also	prepared	on	the	automated	synthesis	machine	using	a	
standard	set	of	reaction	conditions	and	different	combinations	of	building	blocks.7	
	
	2-5	 LINEAR-TO-CYCLIZED	SYNTHESIS	STRATEGY	
	 Cyclic	and	polycyclic	natural	products	represent	especially	formidable	targets	for	an	automated	
synthesis	platform	based	on	iterative	building	block	assembly.	In	particular,	many	of	these	molecules	are	
rich	 in	 sp3-hybridized	carbons	and	 stereocenters.	However,	 such	compounds	often	perform	 important	
functions,	so	we	sought	a	general	strategy	for	the	automated	synthesis	of	polycyclic	natural	products.	
Figure	2.4.		Automated	synthesis	of	linear	targets.	D	=	Deprotection;	C	=	Coupling;	P	=	Purification	
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	 The	biosynthesis	of	cyclic	and	polycyclic	natural	products	suggests	a	promising	general	strategy.	
The	first	step	 involves	 iteratively	assembling	smaller	building	blocks	 into	a	 linear	precursor.	This	 linear	
intermediate	is	then	cyclized	by	enzymes	to	form	a	complex	cyclic	or	polyclic	scaffold.21-23	Based	on	this	
concept,	we	developed	a	biomimetic	linear-to-cyclized	synthesis	strategy	and	targeted	all	of	the	natural	
products	shown	in	Figure	2.5.	In	each	case,	the	automated	synthesis	machine	would	iteratively	assemble	
the	linear	precursors	(2.25,	2.27,	2.29,	2.31,	and	2.33)	from	halo	MIDA	boronate	building	blocks,	which	in	
some	 cases	 involved	 challenging	 Csp3	 cross-coupling	 reactions.	 These	 intermediates	 would	 then	 be	
manually	purified	and	subjected	to	cyclization	reactions	to	generate	the	final	natural	products	(2.26,	2.28,	
2.30,	2.32,	and	2.34).	
	 The	 macrocyclic	 natural	 product	 citreofuran	 2.26	 possesses	 both	 Csp3	 and	 atropisomerism	
stereochemical	elements	 (Figure	2.5).	All	of	 the	required	stereochemical	 information	for	citreofuran	 is	
preencoded	in	the	linear	precursor	2.25,24	which	is	itself	prepared	from	stereochemically-defined	building	
blocks.	 Automated	building	 block	 assembly	was	 used	 to	 form	 the	 linear	 precursor,	 and	 then	 this	was	
deprotected	 and	 atropdiastereoselectively	 macrocyclized	 with	 a	 Mitsunobu	 reaction	 to	 generate	
citreofuran	2.26.	
	 Oblongolide	2.28	is	a	norsesquiterpene	γ-lactone	natural	product	containing	a	6,6,5-tricyclic	core	
with	 five	 Csp3	 stereogenic	 centers,	 one	 of	 which	 is	 quaternary	 (Figure	 2.5).	 After	 completion	 of	 the	
automated	 synthesis	 of	 the	 linear	 precursor	 2.27,	 it	 was	 then	 subjected	 to	 a	 cascade	 intramolecular	
substrate-controlled	diastereoselective	Diels-Alder	 reaction	 and	 lactonization	process,25	which	defined	
the	four	contiguous	stereocenters.	
	 In	 cases	 where	 no	 Csp3	 stereogenic	 centers	 are	 present	 in	 the	 linear	 precursors,	 the	
enantioselectivity	of	cyclizations	can	be	controlled	using	a	rapidly	expanding	toolbox	of	chiral	catalysts.26	
This	approach	enabled	the	stereoselective	construction	of	the	natural	product–like	hexahydroindene	core	
Figure	2.5.		Linear-to-cyclized	strategy	for	the	automated	synthesis	of	cyclic	and	polycylic	natural	
products.	
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2.30	 and	steroid-like	core	2.32	 structures	using	 the	same	 linear-to-cyclized	strategy	 (Figure	2.5).	After	
automated	 assembly,	 the	 linear	 precursor	 2.29	 to	 the	 hexahydroindene	 core	 was	 subjected	 to	
deprotection	 and	 a	 chiral	 imidazolidinone-promoted	 organocatalytic	 enantio-	 and	 diastereoselective	
Diels-Alder	 reaction	 to	 generate	 the	 polycyclic	 natural	 product	 2.30.27	 Similarly,	 a	 catalyst-promoted	
enantio-	and	diastereoselective	 cation-π	 cyclization28	 followed	by	 reduction	generated	 the	 steroid-like	
core	2.32.	
	
2-6	 PREPARATION	OF	BUILDING	BLOCKS	FOR	THE	CORE	OF	SECODAPHNANE	
	 Our	approach	for	the	pentacyclic	secodaphnane	core	2.34	was	to	use	the	same	linear-to-cyclized	
strategy	 involving	 automated	 synthesis	 of	 the	 linear	 precursor	 2.39	 followed	 by	 manual	 cyclization	
reactions	(Figure	2.6).	For	the	cyclization	step,	previous	work	by	Heathcock	and	coworkers	had	identified	
a	 bioinspired	 cascade	 involving	 amine	 condensation	 and	 intramolecular	 Diels-Alder	 and	 Prins	
cyclizations.29	The	direct	precursor	for	this	cyclization,	a	dialdehyde	2.40,	should	be	readily	accessible	from	
a	stable	linear	precursor	2.39	(Figure	2.6).	However,	the	synthesis	of	the	requisite	linear	precursor	2.39	
was	 complicated	 by	 two	 challenging	 Csp3	 cross-coupling	 reactions.	 For	 the	 first	 coupling,	 we	 simply	
substituted	the	boronic	acid	with	a	primary	alkylzinc	reagent	2.35,	simplifying	the	reaction.	This	Negishi	
reaction	proved	compatible	with	the	same	cross-coupling	platform	and	could	easily	be	reproduced	on	the	
automated	synthesis	machine.7	However,	 for	 the	second	and	 final	coupling,	we	needed	to	carry	out	a	
more	challenging	Suzuki	reaction	between	a	primary	alkylboronic	acid	(derived	from	MIDA	boronate	2.37)	
and	a	vinyl	halide	2.38	(Figure	2.6).	I	synthesized	the	requisite	vinyl	halide	2.38	in	multigram	quantities	to	
enable	optimization	studies.	
	 Our	 efforts	 to	 carry	 out	 this	 demanding	 cross-coupling	 reaction	 were	 unsuccessful,	 despite	
exploring	numerous	different	combinations	of	catalysts,	bases,	and	reaction	conditions.	Ultimately,	my	
colleague	Dr.	Junqi	Li	identified	two	factors	contributing	to	the	poor	reactivity	(Figure	2.7).	The	benzoyl	
protecting	group	used	on	the	third	building	block	2.38	was	liable	to	a	Tsuji-Trost	side	reaction,	which	could	
easily	be	fixed	by	switching	the	protecting	group.	After	I	resynthesized	this	vinyl	halide	with	an	inert	TIPS	
protecting	group,	 this	building	block	was	still	 susceptible	to	an	additional	decomposition	pathway.	My	
colleague	Junqi	isolated	two	side	products	2.44	and	2.45	that	were	likely	derived	from	an	intramolecular	
Heck	 reaction	 (Figure	2.7).	Although	 the	geometry	of	 the	olefin	at	 this	position	was	 irrelevant	 for	 the	
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cyclization,	we	had	 initially	anticipated	 that	 the	Z	double	bond	would	be	 less	prone	 to	competitive	β-
hydride	elimination.		
	 To	circumvent	the	intramolecular	Heck	reaction,	I	resynthesized	the	vinyl	halide	with	an	E	double	
bond	2.55	(final	route	in	Figure	2.8),	which	enabled	the	automated	synthesis	of	the	linear	precursor	2.33.7	
Construction	of	 this	 building	block	 began	with	 a	 Z-selective	 Still-Genari	 olefination	 reaction	 to	 form	a	
trisubstituted	 olefin	 2.48.	 DIBAL-H	 reduction	 of	 the	 methyl	 ester	 followed	 by	 TIPS	 protection	 of	 the	
resulting	alcohol	gave	an	intermediate	2.50	ready	for	homologation.	Removal	of	the	PMB	protecting	group	
followed	by	bromination	and	treatment	with	zinc	and	iodine	gave	a	primary	alkylzinc	reagent	2.53.	This	
Figure	2.7.		Side	reactions	with	the	vinyl	halide	building	block.	
Figure	2.6.		Planned	linear-to-cyclized	route	to	access	the	secodaphnane	alkaloid	core.	
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organometallic	was	coupled	with	a	dibrominated	building	block	2.54	 selectively	at	 the	more	activated	
halide.	
	
2-7	 AUTOMATED	SYNTHESIS	OF	THE	CORE	OF	SECODAPNANE	
	 With	optimized	conditions	for	the	challenging	Csp3	coupling	reactions,	the	linear	precursor	2.33	
was	assembled	on	the	machine,	setting	the	stage	for	the	cyclization.7	My	colleague	Junqi	Li	used	several	
reactions	to	convert	the	linear	precursor	2.33	to	the	requisite	dialdehyde	2.40	 (Figure	2.9).	A	selective	
reduction	of	the	enoate	ester	in	the	presence	of	three	other	olefins	was	accomplished	with	magnesium	
and	methanol.30	A	sequence	of	ester	reduction	and	TIPS	deprotection	afforded	a	diol	2.57	that	served	as	
a	 substrate	 for	 Swern	 oxidation.	 Finally,	 the	 in	 situ	 generated	 dialdehyde	 2.40	 was	 treated	 with	
methylamine	 for	 four	 hours	 followed	by	heating	 to	 80°C	with	 acetic	 acid	 to	 effect	 the	polycyclization	
reaction.29	
	 A	plausible	mechanism	for	the	cyclization	reaction	may	involve	a	sequence	of	two	intramolecular	
Diels-Alder	reactions	and	an	aza-Prins	reaction	(Figure	2.9).	Initially,	condensation	of	the	dialdehyde	2.40	
with	methylamine	could	generate	two	imines,	one	of	which	is	stabilized	by	conjugation	with	an	olefin.	The	
other	imine	could	readily	tautomerize	to	the	enamine,	setting	the	stage	for	the	first	intramolecular	hetero-
Diels-Alder	reaction.	The	resulting	cycloadduct	2.60	could	readily	eliminate	methylamine	to	form	another	
unsaturated	 imine	 2.61.	 This	 intermediate	 would	 be	 primed	 to	 undergo	 a	 second	 hetero-Diels-Alder	
reaction	 to	 form	 a	 tetracyclic	 intermediate	 2.62	 containing	 a	 reactive	 imine.29	 Finally,	 the	 aza-Prins	
reaction	between	this	imine	and	the	tethered	olefin	would	lead	to	a	tertiary	carbocation	2.63,	which	could	
tautomerize	 via	 a	 hydride	 shift	 to	 give	 an	 imine	 2.64.	 Aqueous	 hydrolysis	 would	 then	 afford	 the	
secodaphnane	alkaloid	core	2.34.	
	 	
Figure	2.8.		Enabling	route	to	the	vinyl	halide	building	block.	
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2-8	 SUMMARY	AND	OUTLOOK	
	 There	 has	 been	 exciting	 progress	 in	 the	 automated	 synthesis	 of	 complex	 small	 molecules.	
Although	 customized	 automated	 synthesis	 has	 been	 enabling	 in	 some	 contexts	 including	 process	
Figure	2.9.		Cyclization	reaction	sequence	and	plausible	mechanism.	
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chemistry,	the	alternative	strategy	of	automating	more	generalized	synthetic	methods	has	the	potential	
to	more	broadly	expedite	access	to	small	molecules	on	the	discovery	scale.	We	have	found	that	iterative	
cross-coupling	 of	 MIDA	 boronates	 along	 with	 catch-and-release	 chromatography	 can	 facilitate	
generalized	 automated	 synthesis.	 A	 machine	 designed	 around	 this	 strategy	 afforded	 completely	
automated	 access	 to	 natural	 products	2.16-2.19,	 pharmaceuticals	2.20-2.22,	 and	materials	2.23-2.24.	
Even	 complex	 cyclic	 and	 polycyclic	 natural	 products	 were	 accessed	 through	 a	 biomimetic	 “linear-to-
cyclized”	 strategy.	 In	 the	 case	 of	 the	 secodaphnane	 alkaloid	 core	 2.34,	 the	 challenging	 automated	
assembly	of	the	linear	precursor	2.33	required	some	optimization	of	the	building	blocks	to	carry	out	the	
requisite	Csp3	coupling	reactions.	Elaboration	of	the	linear	precursor	2.33	to	a	dialdehyde	2.40	followed	
by	 treatment	 with	 methylamine	 and	 acetic	 acid	 initiated	 a	 cascade	 cyclization	 reaction,	 ultimately	
resulting	in	the	pentacyclic	natural	product	target	2.34.	
	 	Extending	 the	 scope	 of	 the	 automated	 synthesis	 platform	 will	 require	 solving	 several	 key	
challenges.	The	Suzuki-Miyaura	cross-coupling	reaction	has	proven	versatile	and	reliable	at	forging	Csp2-
Csp2	 connections,	 but	 Csp2-Csp3	 and	 particularly	 Csp3-Csp3	 couplings	 are	much	 less	 well-developed.31	
Given	 the	 prevalence	 of	 Csp3	 hybridized	 carbons	 in	 natural	 products	 and	 the	 advantages	 of	 Csp3-rich	
molecules	 in	drug	development,32-33	 iterative	cross-coupling	would	greatly	benefit	 from	methodologies	
for	 coupling	 Csp3	 boronic	 acids	 and	 Csp3	 halides.	 Ideally,	 these	 Csp3	 coupling	 reactions	would	 deliver	
products	with	complete	control	over	the	regiochemistry	and	stereochemistry,	enabling	purification	by	the	
same	simple	catch-and-release	protocol.	Achieving	this	goal	will	require	finding	solutions	to	challenging	
side	reactions	in	transition	metal-catalyzed	Csp3	couplings,	such	as	competitive	β-hydride	elimination	and	
stereodivergent	transmetalation	pathways.	
	
2-9	 EXPERIMENTAL	SECTION	
	
2.48.	A	dry	1	L	two	neck	round	bottom	flask	was	charged	with	18-crown-6	(30.34	g,	115	mmol,	5.0	equiv.),	
fitted	with	a	thermometer,	sealed	with	a	septum,	and	vac-filled	with	nitrogen.	THF	(450	mL)	was	added,	
and	the	resulting	clear,	colorless	solution	was	cooled	to	-78	°C.	Phosphonoacetate	2.47	(7.31	g,	22.0	mmol,	
1.0	equiv.)	was	added,	using	THF	(25	mL)	for	quantitative	transfer.	KHMDS	(1	M	in	THF,	22	mL,	1.0	equiv.)	
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was	added	dropwise	to	the	reaction	flask	over	10	min,	accompanied	by	a	color	change	to	light	orange	/	
pink.	The	resulting	solution	was	stirred	at	-78	°C	for	30	min	before	adding	the	aldehyde	2.46	(4.28	g,	22.0	
mmol,	1.0	equiv.),	using	25	mL	THF	for	quantitative	transfer.	The	resulting	reaction	mixture	was	stirred	at	
-78	°C	for	2	hours	and	20	minutes.	
	 The	 reaction	 was	 quenched	 with	 saturated	 aqueous	 NH4Cl	 (100	 mL).	 The	 resulting	 biphasic	
mixture	was	transferred	to	a	1	L	separatory	funnel	using	100	mL	H2O	and	300	mL	Et2O.	After	mixing	and	
phase	separation,	the	aqueous	layer	was	extracted	with	diethyl	ether	(2	×	200	mL	Et2O).	The	combined	
organic	layers	were	washed	with	brine	(300	mL),	dried	over	Na2SO4,	and	concentrated	in	vacuo	to	afford	
a	crude	mixture.	The	same	reaction	was	repeated	(23	mmol	scale)	and	crude	products	were	combined	for	
chromatographic	purification	(10:1	to	8:1	hexanes/EtOAc)	to	give	the	product	2.48	as	a	clear,	colorless	oil	
(6.1	g,	51%	yield).	TLC	(3:1	hexanes/EtOAc):	Rf	=	0.52,	stained	by	KMnO4;	
1H-NMR	(500	MHz,	CDCl3):	δ	7.26	
(d,	J	=	8.5	Hz,	2H),	6.88	(d,	J	=	8.5	Hz,	2H),	6.03	(dt,	J	=	7.5	Hz,	J	=	1.8	Hz,	1H),	4.45	(s,	2H),	3.81	(s,	3H),	3.72	
(s,	3H),	3.52	(t,	J	=	6.0	Hz,	2H),	2.77	(m,	2H),	1.91	(m,	3H);	13C-NMR	(125	MHz,	CDCl3):	δ	168.5,	159.4,	140.1,	
130.7,	129.5,	128.5,	114.0,	72.7,	69.4,	55.5,	53.6,	51.5,	30.4,	20.9;	HRMS	(ESI+)	calculated	for	C15H21O4	
[M+H+]	m/z	265.1440,	found	265.1436.	
	
	
2.49.	A	1	L	two	neck	round	bottom	flask	was	fitted	with	a	thermometer,	sealed	with	a	rubber	septum,	and	
vac-filled	with	nitrogen.	THF	(280	mL)	and	the	α,β-unsaturated	ester	2.48	(6.1	g,	23.1	mmol,	1.0	equiv.)	
were	added	to	the	flask,	and	the	mixture	was	cooled	to	-78	°C	in	a	dry	ice	/	acetone	bath.	DIBAL-H	(1.0	M	
in	hexanes,	69	mL,	3.0	equiv.)	was	added	gradually	to	the	reaction	flask	over	20	min,	and	the	resulting	
reaction	mixture	was	stirred	at	-78	°C	for	5	minutes	before	switching	to	a	-15	°C	dry	ice	/	brine	cooling	
bath.	
	 After	 1.5	 hours,	 MeOH	 (60	mL)	 was	 added	 to	 quench	 the	 reaction	 at	 -15°C.	 Using	 Et2O,	 the	
reaction	mixture	was	transferred	to	a	2	L	Erlenmeyer	flask,	and	saturated	Rochelle’s	salt	(280	mL)	was	
added.	After	stirring	overnight	 to	complex	aluminum	salts,	 the	crude	mixture	was	transferred	to	a	1	L	
separatory	funnel	using	Et2O	(50	mL)	and	water	(50	mL).	After	mixing	and	phase	separation,	the	aqueous	
layer	 was	 extracted	 (3	 ×	 250	 mL	 EtOAc).	 The	 combined	 organics	 were	 washed	 with	 brine	 (400	 mL),	
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concentrated	in	vacuo	to	approximately	50	mL,	diluted	in	Et2O,	dried	with	Na2SO4,	vacuum	filtered,	and	
concentrated	to	give	a	cloudy	oil.	Chromatographic	purification	(9	cm	diameter	column,	500	mL	SiO2,	2:1	
hexanes/EtOAc)	yielded	the	product	alcohol	2.49	(5.3	g,	97%	yield).	TLC	(2:1	hexanes/EtOAc):	Rf	=	0.26,	
stained	by	KMnO4;	
1H-NMR	(500	MHz,	CDCl3):	δ	7.24	(d,	J	=	8.6	Hz,	2H),	6.87	(d,	J	=	8.6	Hz,	2H),	5.32	(td,	J	
=	8.0	Hz,	J	=	1.3	Hz,	1H),	4.44	(s,	2H),	4.01	(s,	2H),	3.80	(s,	3H),	3.43	(t,	J	=	6.0,	2H),	2.34	(app.	q,	2H),	1.82	
(s,	3H);	13C-NMR	(125	MHz,	CDCl3):	δ	159.4,	138.2,	130.0,	129.6,	124.7,	114.0,	73.0,	69.0,	61.4,	55.4,	28.6,	
22.4;	HRMS	(ESI+)	calculated	for	C14H21O3	[M+H
+]	m/z	237.1491,	found	237.1494.	
	
	
2.50.	A	500	mL	3-neck	round	bottom	flask	was	charged	with	imidazole	(3.67	g,	54.0	mmol,	2.4	eq),	sealed	
with	three	rubber	septa,	and	vac-filled	with	nitrogen.	Under	nitrogen,	DCM	(200	mL)	and	the	allylic	alcohol	
2.49	(5.31	g,	22.5	mmol,	1.0	eq)	were	added	by	cannulation	with	rinsing	for	quantitative	transfer.	After	
cooling	to	0°C	in	an	ice/water	bath,	TIPSCl	(5.8	mL,	27.0	mmol,	1.2	eq)	was	added	dropwise	over	7	minutes.	
The	reaction	was	allowed	to	warm	to	room	temperature	with	stirring	overnight.	
	 After	8	hours,	the	reaction	mixture	was	transferred	to	a	500	mL	separatory	funnel.	The	organic	
layer	was	washed	(2	×	150	mL	water),	and	combined	aqueous	layers	were	extracted	(250	mL	DCM).	The	
combined	 organic	 layers	 were	 washed	 with	 brine	 (300	mL),	 dried	 with	MgSO4,	 vacuum	 filtered,	 and	
concentrated	in	vacuo	to	yield	the	product	as	an	oil.	Chromatographic	purification	(25:3:1	hexanes	/	DCM	
/	Et2O	to	25:4:1)	gave	the	pure	product	2.50	 (7.26	g,	82%	yield).	TLC	 (10:1	hexanes/EtOAc):	Rf	=	0.46,	
stained	by	KMnO4;	
1H-NMR	(500	MHz,	CDCl3):	δ	7.26,	(d,	J	=	8.7	Hz,	2H),	6.87	(d,	J	=	8.7	Hz,	2H),	5.20	(dt,	J	
=	7.3	Hz,	1.2	Hz,	1H),	4.43	(s,	2H),	4.23	(s,	2H),	3.80	(s,	3H),	3.41	(t,	J	=	7.2	Hz,	2H),	2.33	(app	q,	2H),	1.78	
(d,	J	=	1.1	Hz,	3H),	1.14-1.04	(m,	21H);	13C-NMR	(125	MHz,	CDCl3):	δ	159.3,	137.5,	130.8,	129.5,	121.8,	
114.0,	 72.7,	 70.1,	 62.3,	 55.5,	 28.5,	 21.3,	 18.3,	 12.2;	HRMS	 (ESI+)	 calculated	 for	C23H41O3Si	 [M+H
+]	m/z	
393.2825,	found	393.2818.	
	 	
47	
	
	
2.51.	To	a	500	mL	round	bottom	flask	were	added	the	PMB-protected	alcohol	2.50	(7.26	g,	18.5	mmol,	
1.0	 eq)	 chloroform	 (160	mL),	 and	water	 (8	mL).	 The	mixture	was	 stirred	 at	 room	 temperature	 for	 10	
minutes	before	2,3-dichloro-5,6-dicyano-1,4-benzoquinone	(DDQ,	12.6	g,	55.5	mmol,	3.0	eq)	was	added	
portionwise	over	10	minutes.	
	 After	 1	 hour,	 the	 reaction	was	 quenched	with	 the	 addition	 of	 sat.	 aq.	NaHCO3	 (100	mL).	 The	
mixture	 was	 filtered	 through	 celite,	 which	 was	 rinsed	 with	 EtOAc.	 The	 resulting	 red	 filtrate	 was	
concentrated	and	then	transferred	to	a	500	mL	separatory	funnel,	rinsing	with	EtOAc	(200	mL)	and	H2O	
(150	 mL).	 Brine	 (60	 mL)	 was	 added	 to	 improve	 phase	 separation,	 and	 then	 the	 aqueous	 layer	 was	
extracted	with	EtOAc	(2	×	200	mL).	The	combined	organics	were	washed	with	brine	(250	mL),	dried	with	
Na2SO4,	vacuum	filtered,	and	concentrated	to	give	a	dark	red	oil.	Chromatographic	purification	(8:1	to	5:1	
to	3:1	hexanes/Et2O)	gave	the	pure	product	2.51	(4.55	g,	90%	yield).	TLC	(3:1	hexanes/EtOAc):	Rf:	0.46;	
1H-NMR	(400	MHz,	CDCl3):	δ	5.26	(t,	J	=	7.7	Hz,	1H),	4.23	(s,	2H),	3.61	(t,	J	=	6.2	Hz,	2H),	2.32	(app.	q,	2H),	
1.82	(s,	3H),	1.18-1.04	(m,	21H);	13C-NMR	(125	MHz,	CDCl3):	138.7,	122.6,	62.20,	62.16,	31.3,	21.9,	18.2,	
12.2;	HRMS	(ESI+)	calculated	for	C15H33O2Si	[M+H
+]	m/z	273.2250,	found	273.2245.	
	
	
2.52.	A	dry	50	mL	Schlenk	flask	was	charged	with	PPh3	(4.12	g,	15.7	mmol,	1.1	eq),	sealed	with	a	rubber	
septum,	and	vac-filled	with	nitrogen	 three	 times.	DCM	 (35	mL)	was	added.	The	 resulting	mixture	was	
stirred	and	cooled	to	0°C.	Bromine	(2.39	g,	15.7	mmol,	1.1	eq)	was	gradually	added	until	the	yellow	color	
persisted,	and	then	several	additional	crystals	of	PPh3	were	added	until	the	color	vanished.	The	resulting	
off-white,	opaque	mixture	was	treated	with	a	dropwise	addition	of	pyridine	(2.26	g,	28.6	mmol,	2.0	eq),	
followed	by	a	dropwise	addition	of	the	alcohol	2.51	(3.89	g,	14.29	mmol,	1.0	eq)	as	a	solution	in	DCM	(5	
mL)	with	rinsing	(10	mL	DCM)	for	quantitative	transfer.	
	 After	 1.5	 hours	 TLC	 indicated	 that	 the	 reaction	was	 almost	 complete.	 The	 crude	mixture	was	
transferred	to	a	round	bottom	flask	and	concentrated	in	vacuo,	giving	an	off-white	powder.	The	solid	was	
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triturated	with	pentane	and	then	filtered.	Along	with	additional	crude	bromide	product	from	a	parallel	
reaction,	chromatographic	purification	(hexanes	to	10:1	Et2O/hexanes)	gave	the	pure	product	2.52	as	a	
colorless	oil	(5.65	g	93%	yield).	TLC	(hexanes):	Rf	=	0.25,	stained	by	KMnO4;	
1H-NMR	(400	MHz,	CDCl3):	δ	
5.21	(dt,	J	=	7.3	Hz,	J	=	1.2	Hz,	1H),	4.23	(s,	2H),	3.34	(t,	J	=	7.2	Hz,	2H),	2.60	(app	q,	2H),	1.80	(d,	J	=	1.0	Hz,	
3H),	1.16-1.04	(m,	21H);	13C-NMR	(100	MHz,	CDCl3):	δ	138.8,	122.4,	62.4,	33.0,	31.5,	21.4,	18.3,	12.2.	
	
	
2.55.	In	an	unoptimized	procedure,	in	the	glovebox,	the	alkyl	bromide	2.52	(2.01	g,	6.0	mmol,	1.0	equiv)	
was	weighed	into	a	flame-dried	40	mL	vial.	Zn	dust	(1.18	g,	18	mmol,	3.0	equiv)	was	weighed	into	another	
flame-dried	40	mL	vial	equipped	with	a	stir	bar.	Dimethylacetamide	(DMA,	8	mL)	was	added	to	the	vial	
containing	 the	alkyl	bromide	 to	give	a	 colorless	 solution.	The	vials	were	 sealed	with	 septum	caps	and	
brought	out	of	the	glovebox.	To	the	vial	containing	Zn	dust	was	added	iodine	(45.7	mg,	0.18	mmol,	0.03	
equiv).	The	vial	was	resealed	and	vac-filled	with	nitrogen	three	times.	DMA	(2	mL)	was	added,	and	the	
mixture	stirred	for	two	minutes	during	which	the	brown	color	of	iodine	disappeared.	The	solution	of	the	
alkyl	bromide	was	then	cannulated	into	the	Zn	dust,	rinsing	with	DMA	(2	x	2	mL).	The	mixture	was	stirred	
at	80	°C	for	14	hours	and	then	cooled	to	room	temperature	and	taken	into	the	glovebox.	
	 In	 the	 glovebox,	 (E)-ethyl	 2,3-dibromoacrylate	2.54	 (430	mg,	 1.67	mmol)	was	weighed	 into	 a	
flame-dried	40	mL	vial	equipped	with	a	stir	bar.	THF	(15	mL)	was	added,	followed	by	PdCl2(PPh3)2	(35.1	
mg,	0.05	mmol,	0.03	equiv	wrt	 the	dibromide).	Two	of	 these	 reactions	were	prepared	 in	parallel.	The	
organozinc	solution	2.53	(5	mL)	was	filtered	directly	into	each	of	the	reaction	vials.	The	reactions	were	
sealed	with	PTFE-lined	caps,	brought	out	of	the	glovebox	and	stirred	at	45	°C	for	6	hours,	then	cooled	to	
room	temperature.	
	 The	reaction	mixtures	in	the	two	vials	were	combined	into	a	separatory	funnel	containing	40	mL	
saturated	aq.	NH4Cl	solution,	rinsing	with	H2O	and	Et2O.	Et2O	(10	mL)	was	added	and	the	layers	mixed	and	
separated.	The	aqueous	layer	was	extracted	with	Et2O	(2	x	30	mL).	The	combined	organics	were	washed	
with	H2O,	brine,	dried	over	MgSO4	and	Darco,	filtered	through	celite	and	concentrated	in	vacuo.	The	crude	
product	was	purified	by	silica	gel	chromatography	(20-25-30%	DCM/hexanes).	The	mixed	fractions	were	
pooled	and	re-purified	by	silica	gel	chromatography	(15-20-25%	DCM/hexanes).	The	fractions	containing	
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the	pure	product	were	concentrated,	then	taken	up	in	hexanes	and	stirred	with	activated	charcoal.	The	
mixture	was	filtered	through	celite	and	concentrated	in	vacuo	to	give	a	very	slightly	brown	liquid	as	the	
pure	product	2.55	(526	mg,	36%	yield).	TLC	(30%	DCM/hexanes):	Rf	=	0.41,	visualized	with	UV,	stained	
with	KMnO4.	
1H-NMR	(500	MHz,	CDCl3):	δ	6.64	(t,	J	=	7.7	Hz,	1H),	5.15	(tq,	J	=	7.3,	1.3	Hz,	1H),	4.26	(q,	J	=	
7.0	Hz,	2H),	4.22	(s,	2H),	2.53	(q,	J	=	7.5	Hz,	2H),	2.22-2.13	(m,	2H),	1.78	(q,	J	=	1.3	Hz,	3H),	1.33	(t,	J	=	7.1	
Hz,	3H),	1.22-0.96	(m,	21H);	13C-NMR	(125	MHz,	CDCl3):	δ	162.8,	147.8,	137.0,	123.9,	111.6,	62.1,	62.1,	
31.6,	26.6,	21.1,	18.0,	14.1,	12.0;	HRMS	(ESI+)	calculated	for	C20H38O3SiBr	[M+H
+]	m/z	433.1774,	found	
433.1772.	
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CHAPTER	3	
RATIONAL	LIGAND	DESIGN	FOR	HIGHLY	STEREORETENTIVE	SP
3
	CROSS-COUPLINGS	
	 A	 general	 solution	 to	 stereocontrolled	 Csp
3
	 cross-coupling	 reactions	 could	 ultimately	
revolutionize	organic	synthesis,	and	practical	access	to	architecturally-complex	molecules	would	greatly	
improve	human	health	and	well-being.	However,	compared	to	their	Csp
2
	counterparts,	the	reactivity	of	
Csp
3
	 coupling	partners	 is	more	difficult	 to	 control	 and	understand.	 In	 pursuit	 of	 a	 general	 solution	 to	
stereocontrolled	Csp
3
	coupling,	we	have	systemically	studied	stereospecific	cross-coupling	reactions	of	
unactivated	chiral	nonracemic	boronic	acids.	This	work	has	led	to	the	elucidation	of	two	rational	ligand	
design	 principles	 for	 maximizing	 stereochemical	 control	 in	 systems	 where	 there	 are	 competing	
stereodivergent	transmetalation	pathways.	
	 The	 phosphine	 ligand,	 which	 is	 present	 during	 every	 fundamental	 step	 of	 the	 cross-coupling	
reaction,	has	a	profound	effect	on	the	steric	and	electronic	environment	of	the	transition	metal	catalyst.	
By	designing	a	ligand	to	have	steric	bulk	projected	above	and	below	the	Pd(II)	coordination	sphere,	we	
were	 able	 to	 selectively	 	 inhibit	 stereoinvertive	 transmetalation	 and	 render	 the	 reaction	 highly	
stereoretentive.	In	addition,	tuning	the	electronic	properties	of	the	triarylphosphine	with	para-electron-
withdrawing	 groups	 can	 further	 increase	 stereoretention.	 These	 two	 design	 principles,	 which	 are	
applicable	across	a	broad	range	of	substrates	and	under	different	reaction	conditions,	demonstrate	that	
it	 is	 possible	 to	 understand	 and	 control	 the	 reactivity	 of	 Csp
3
	 coupling	 partners	 in	 a	 practical	 sense.	
Moreover,	the	discovery	of	a	ligand	that	can	both	maximize	stereoretention	and	simultaneously	inhibit	
detrimental	β-hydride	elimination	suggests	that	rational	ligand	design	is	a	promising	strategy	for	solving	
multifactorial	problems,	which	are	never	lacking	in	Csp
3
	coupling	reactions.	
	 The	discovery	of	these	design	principles	was	an	arduous	process	with	many	twists	and	turns,	and	
it	would	not	have	been	possible	except	for	the	creativity	and	dedication	of	so	many	people.	 I	am	very	
fortunate	to	have	worked	alongside	Dr.	Ian	T.	Crouch,	whose	insights	and	experimental	prowess	resulted	
in	 the	discovery	of	 the	best	 ligand	P(2-Bn-Ph)3,	 crystal	 structures	 that	helped	us	understand	how	 this	
ligand	works,	and	a	way	to	actually	prepare	clean	secondary	alkylboronic	acids	without	which	we	could	
not	have	tested	any	ligands	at	all.	Our	colleagues	Dr.	Daniel	J.	Blair,	Dr.	Melanie	Trobe,	Dr.	Junqi	Li,	and	
Tyler	Smolczyk	also	each	made	substantial	marks	on	this	project.	Dr.	Pulin	Wang	rightly	deserves	credit	
for	discovering	the	first	stereospecific	cross-coupling	reaction	of	unactivated	secondary	alkylboronic	acids.	
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contagious	enthusiasm	for	going	after	the	really	impactful	problems.	
	 Portions	of	this	chapter	were	adapted	from	Lehmann	and	Crouch	et	al.,	Ligand	design	principles	
for	 perfecting	 stereoretention	 in	 Suzuki-Miyaura	 cross-coupling	 of	 unactivated	 Csp
3
	 boronic	 acids,	 in	
review,	 and	 Lehmann	 et	 al.,	 Towards	 the	 generalized	 iterative	 synthesis	 of	 small	 molecules,	Nature	
Reviews	Chemistry	2018,	2,	0115.	
	
3-1	 THE	UNREALIZED	POTENTIAL	OF	CSP
3
	COUPLING	
	 The	Suzuki-Miyaura	cross-coupling	 reaction	has	quickly	become	one	of	 the	most	versatile	and	
practical	ways	of	making	 complex	molecules.
1
	Organoboronic	 acids	 and	organohalides	 represent	 ideal	
reagents	for	their	ease	of	synthesis,	good	chemical	and	configurational	stability,	tunable	reactivity,	and	
low	toxicity.	The	ability	of	the	Suzuki	cross-coupling	reaction	to	reliably	forge	carbon-carbon	bonds	allows	
for	 complex	 disconnections	 and	 simplifies	 synthesis.	 Finally,	 the	 application	 of	 Suzuki	 couplings	 in	 an	
iterative	fashion	with	MIDA	boronates,
2
	as	described	in	chapters	1	and	2,	has	enabled	the	development	
of	an	automated	building	block-based	synthesis	platform.
3
	
	 In	spite	of	all	the	advantages	of	Suzuki	cross-coupling,	this	reaction	is	poorly	suited	for	making	
some	of	the	most	valuable	kinds	of	small	molecules,	ones	that	are	rich	in	sp
3
	carbons	and	stereocenters.	
Natural	products,	which	have	served	as	the	source	or	inspiration	of	65%	of	small	molecules	drugs,
4-5
	often	
have	architecturally	complex	structures	composed	of	saturated	carbons	and	stereocenters.	Regardless	of	
a	molecule’s	origins,	a	higher	 fraction	of	sp
3
-hybridized	carbons	 (Fsp
3
)	and	number	of	stereocenters	 is	
correlated	 with	 increased	 probability	 of	 progressing	 through	 clinical	 trials.
6-7
	 However,	 Suzuki	 cross-
coupling	reactions	between	Csp
3
	coupling	partners	are	far	less	reliable	than	for	their	aryl,	heteroaryl,	and	
vinyl	Csp
2
	counterparts.	A	general	solution	to	stereocontrolled	Csp
3
	couplings	would	highly	enabling	for	
drug	discovery
8
	and	the	expansion	of	iterative	building	block-based	synthesis	methods.
9
	
	
3-2	 STEREOSELECTIVE	VS.	STEREOSPECIFIC	CROSS-COUPLING	REACTIONS	
	 Two	 different	 strategies	 have	 emerged	 for	 controlling	 stereochemistry	 in	 Csp
3
	 cross-coupling	
reactions,	stereoselective	couplings	and	stereospecific	couplings	 (Figure	3.1).	Progress	 in	both	kinds	of	
coupling	methods	has	already	been	enabling	for	complex	molecule	synthesis.
10
	However,	if	the	goal	is	to	
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develop	a	simple	and	general	synthesis	strategy,	then	the	ideal	solution	should	be	applicable	to	a	broad	
substrate	scope	with	minimal	reoptimization	of	catalyst	or	reaction	conditions.	
	 Although	 they	possess	 some	advantageous	 features,	 stereoselective	couplings	also	have	some	
inherent	 limitations	to	the	generality	of	stereocontrol.	 In	a	stereoselective	coupling,	a	chiral	catalyst	 is	
responsible	 for	 the	 stereochemical	 outcome.	 This	 chiral	 environment	 interacts	 with	 a	 prochiral	 or	
configurationally	dynamic	substrate	in	such	a	way	as	to	favor	the	formation	of	one	product	enantiomer	
over	the	other.	The	degree	of	stereochemical	control	in	a	stereoselective	coupling	is	related	to	the	energy	
difference	between	two	bimolecular	diastereomeric	transition	states	(Figure	3.1).	As	a	result,	the	degree	
of	 stereocontrol	 can	 vary	 substantially	 depending	 on	 the	 structure	 of	 the	 coupling	 partner.
11
	
Stereoselective	 couplings	 enjoy	 several	 advantages,	 including	 operational	 simplicity	 of	 starting	 with	
racemic	coupling	partners	and	higher	functional	group	tolerance	due	to	the	mild	reaction	conditions.
12-14
	
However,	 because	 the	 origin	 of	 stereocontrol	 involves	 competing	 bimolecular	 diastereomic	 transition	
states,	changing	the	structure	of	the	substrate	will	frequently	require	reoptimization	of	the	chiral	catalyst.	
This	 limitation	 is	 not	 compatible	 with	 the	 goal	 of	 developing	 a	 simple	 and	 general	 solution	 to	
stereocontrolled	Csp
3
	cross-couplings.	
	 In	contrast,	stereospecific	couplings	have	the	theoretical	potential	to	maintain	a	very	high	level	of	
stereochemical	 control	 even	 over	 a	 broad	 substrate	 scope.	 The	 crucial	 difference	 is	 in	 the	 origin	 of	
stereocontrol.	In	stereospecific	couplings,	the	stereochemistry	is	preencoded	in	configurationally	stable	
coupling	partners,	and	this	information	is	translated	through	each	step	of	the	catalytic	cycle.	As	a	result,	
stereospecific	 couplings	 should	 theoretically	 be	 capable	 of	 maintaining	 the	 same	 high	 level	 of	
Figure	3.1.		Stereochemical	control	in	two	different	coupling	strategies.	
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stereocontrol	even	with	structurally	dissimilar	coupling	partners.	As	a	well-acknowledged	limitation,	the	
two-electron	 transmetalation	 mechanism	 required	 to	 preserve	 the	 stereochemical	 information	 has	 a	
higher	energy	barrier	that	often	requires	elevated	temperatures	and	reaction	conditions	that	pose	some	
limitations	 on	 the	 substrate	 scope.
12
	 Furthermore,	 stereospecific	 couplings	 require	 the	 use	 of	 chiral	
nonracemic	 substrates	 to	 achieve	 high	 levels	 of	 stereochemical	 control.	 These	 limitations	
notwithstanding,	 stereospecific	 couplings	 are	 inherently	more	 compatible	 to	 the	 goal	 of	 developing	 a	
simple	and	general	solution	to	Csp
3
	coupling	reactions.	
	
3-3	 MECHANISTIC	CHALLENGES	IN	STEREOSPECIFIC	CSP
3
	CROSS-COUPLING	REACTIONS	
	 The	aforementioned	potential	for	stereospecific	couplings	to	achieve	perfect	stereocontrol	is	in	
reality	often	impaired	by	two	key	mechanistic	challenges.	Palladium-catalyzed	cross-couplings	of	chiral	
alkylboronic	acids	are	prone	to	two	detrimental	side	reactions	that	can	give	rise	to	isomerized	products	
(Figures	3.2	and	3.4).	
		 Two	different	mechanisms	are	possible	for	the	transmetalation	of	secondary	alkylboronic	acids	to	
palladium	(Figure	3.2),	and	if	these	two	mechanisms	occur	with	similar	rates,	then	the	product	will	be	a	
mixture	of	enantiomers.	Ideally	however,	the	reaction	would	be	either	entirely	stereoretentive	or	entirely	
stereoinvertive.	Several	 lines	of	evidence	attest	to	these	two	competing	stereodivergent	stereospecific	
Figure	3.2.		Stereoretentive	and	stereoinvertive	transmetalation	pathways.	
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transmetalation	pathways.	Across	a	wide	range	of	organoboronate	substrates,	some	reactions	have	been	
shown	 to	 be	 stereoretentive
15-19
	 and	 others	 stereoinvertive
20-23
	 (Figure	 3.3).	 The	 potential	 for	 both	
stereochemical	outcomes	to	be	achieved,	although	often	with	imperfect	stereocontrol,	suggests	that	the	
substrate	and	reaction	conditions	can	affect	the	relative	rates	of	retentive	and	invertive	transmetalation	
mechanisms.
24
	Moreover,	Suginome	has	shown	that	the	stereochemical	outcome	of	cross-couplings	with	
α-(acetylamino)benzylboronic	esters	 such	as	3.7	 can	 turned	over	by	 the	 identity	of	 the	acidic	additive	
(Figure	3.3).
22
	Despite	 this	progress,	 there	 is	 still	a	major	 lack	of	understanding	around	the	underlying	
factors	controlling	the	competition	between	these	pathways	and	their	respective	transition	states.
24
	
	 After	transmetalation	occurs,	there	is	often	a	second	challenge	that	can	lead	to	isomerized	
products,	β-hydride	elimination	(Figure	3.4).	Compared	to	their	Csp
2
	counterparts,	Csp
3
	boronic	acids	
have	slower	rates	of	reductive	elimination	and	faster	rates	of	competing	β-hydride	elimination.	After	the	
formation	of	a	palladium	hydride,	several	downstream	processes	can	occur	that	lead	to	a	cornucopia	of	
undesired	products.	Immediate	reductive	elimination	can	generate	a	protodehalogenated	side	product.	
Figure	3.3.		Palladium-catalyzed	stereospecific	couplings	of	organoboronates	in	the	literature.	
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Additionally,	the	palladium	hydride	can	reinsert	on	the	olefin	in	several	different	ways.	Reinsertion	at	
the	original	(and	possibly	more	hindered)	position	could	lead	to	racemized	branched	product,	and	
reinsertion	at	the	terminal	(and	possibly	more	favorable)	position	could	give	the	linear	product	(Figure	
3.4).	In	a	wide	range	of	different	palladium-catalyzed	Csp
3
	coupling	reactions,	the	goal	of	suppressing	β-
hydride	elimination	has	been	accomplished	by	judicious	choice	of	a	phosphine	ligand
25-32,	34
	that	
sterically	blocks	the	requisite	agostic	interaction.
35
	
	 With	the	goal	of	developing	a	simple	and	general	solution	to	stereocontrolled	Csp
3
	coupling,	we	
needed	to	address	both	of	these	challenges.	The	solution	to	this	multiparameter	optimization	problem	
also	needed	to	be	broadly	applicable	across	a	wide	scope	of	unactivated	secondary	alkylboronic	acids.	
Given	the	lack	of	literature	addressing	the	problem	of	competing	transmetalation	mechanisms,	we	sought	
to	develop	an	actionable	picture	of	the	two	corresponding	transition	states.	
	
3-4	 A	MODEL	FOR	COMPETING	STEREODIVERGENT	STEREOSPECIFIC	TRANSMETALATION
	 PATHWAYS	
Multiple	 lines	 of	 evidence	 suggest	 that	 the	 stereoretentive	 transmetalation	 pathway	 for	 Csp
3
	
boronates	 likely	 proceeds	 through	 a	 closed,	 four-membered	 transition	 state	 within	 the	 Pd(II)	 square	
Figure	3.4.		Products	derived	from	competitive	β-hydride	elimination.	
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plane,	where	the	new	Pd-Csp
3
	bond	forms	at	the	position	trans	to	the	phosphine	ligand	(Figure	3.5A).	For	
arylboronic	acids,	kinetic	studies	suggest	that	coordination	of	a	boronic	acid	with	a	palladium	hydroxo	
complex	 precedes	 transmetalation.
36-37
	 Recently,	 rapid	 injection,	 low	 temperature	 NMR	 studies	 have	
characterized	 these	 elusive	 Pd-O-B	 intermediates	 and	 shown	 that	 they	 are	 competent	 for	
transmetalation,	as	long	as	there	is	an	open	coordination	site	on	palladium	to	facilitate	bond	formation.
38
	
The	 site	 for	 this	 bond	 formation	 event	 could	 be	 at	 two	 possible	 locations,	 either	 cis	 or	 trans	 to	 the	
phosphine	ligand.	Computational	studies	indicate	that	the	transition	state	for	transmetalation	from	the	
trans	position	is	nearly	10	kcal/mol	lower	in	energy	due	to	less	steric	crowding.39	This	model	(Figure	3.5A)	
is	also	consistent	with	previous	proposals	for	Csp
3
	boronic	acids.
24
	
Alternatively,	 the	 transition	 state	 for	 stereoinvertive	 transmetalation	 likely	 involves	 backside	
electrophilic	attack	by	palladium	on	the	boron-bearing	carbon	of	the	organoboronate	(Figure	3.5B).	This	
mechanism	features	a	bimolecular	reaction	between	a	square	planar	Pd(II)	species	(the	electrophile)	and	
an	 anionic	 trihydroxyborate	 (the	 nucleophile).	 Ligand	 substitution	 reactions	 on	 16-electron	 d8	 square	
planar	 complexes	 usually	 proceed	 through	 associative	 mechanisms	 which	 involve	 lower	 energy	 18-
electron	 complexes,	 rather	 than	 dissociative	 processes	 that	 require	 higher	 energy	 14-electron	
counterparts.
40-41
		Brookhart	has	measured	rate-constants	for	associative	substitution	of	olefins	on	Pd(II)	
complexes	and	shown	that	this	process	can	be	slowed	down	by	sterically	blocking	the	axial	sites	above	
and	below	the	Pd(II)	square	plane.
42
	
Consistent	 with	 this	 precedent,	 stereoinvertive	 transmetalation	 of	 alkylstannanes	 has	 been	
proposed	to	occur	through	an	associative	mechanism	involving	approach	of	an	alkylstannane	orthogonal	
to	the	Pd(II)	square	plane.	In	couplings	of	benzylic	trifluorosilanes,	the	stereochemical	outcome	can	be	
shifted	from	retention	to	 inversion	by	addition	of	the	strongly-coordinating	solvent	HMPA.
43
	 	A	similar	
HMPA	 effect	 has	 also	 been	 observed	 in	 the	 stereoinvertive	 couplings	 of	 alkylstannanes,
44
	 and	 this	
observation	has	been	attributed	to	the	ability	of	HMPA	to	occupy	the	equatorial	coordination	sites	on	
palladium	 and	 thereby	 disfavor	 inner-sphere	 stereoretentive	 transmetalation	 relative	 to	 associative	
Figure	3.5.		Transition	states	for	(A)	stereoretentive	and	(B)	stereoinvertive	transmetalation.	
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stereoinvertive	 transmetalation.
45
	 Based	 on	 this	 precedent,	 we	 reasoned	 that	 stereoinvertive	
transmetalation	 of	 Csp
3
	 boronates	 should	 similarly	 involve	 rate-limiting	 associative	 addition	 of	 the	
trihydroxyborate	above	or	below	the	square	plane	of	a	Pd(II)	oxidative	addition	adduct	(Figure	3.5B).
40,	46
	
	
3-5	 STERIC	DESIGN	PRINCIPLES	FOR	MAXIMIZING	STEREORETENTION	
	 To	 achieve	 high	 stereocontrol,	 we	 sought	 to	 rationally	 design	 phosphine	 ligands	 that	 could	
discriminate	between	the	two	stereodivergent	transmetalation	pathways	in	Figure	3.5.	Specifically,	the	
invertive	pathway	involves	approach	of	the	organoboronate	at	the	axial	position	on	palladium,	whereas	
the	retentive	pathway	occurs	entirely	within	the	Pd(II)	square	plane.	Thus,	 ligands	which	project	steric	
bulk	above	and	below	the	Pd(II)	square	plane	should	selectively	block	stereoinvertive	transmetalation,	
thus	favoring	stereoretention	(Figure	3.6A).	
	 Encouraging	precedent	for	blocking	axial	approach	can	be	found	in	Brookhart’s	classic	studies	on	
the	rates	of	associative	addition	of	ethylene	to	Pd(II)	complexes	with	variably	shielded	axial	sites	(Figure	
3.6B-C).
42,	47
	In	these	olefin	polymerization	reactions,	the	process	of	chain	growth	can	be	interrupted	by	
associative	exchange	of	the	growing	polymer	chain	with	an	olefin	monomer	(Figure	3.6B).	Brookhart	was	
able	to	inhibit	this	associative	substitution	process	using	diimine	ligands	that	projected	steric	bulk	above	
and	 below	 the	 Pd(II)	 square	 plane,	which	 resulted	 in	 substantial	 improvements	 in	 polymer	molecular	
weight	(Figure	3.6C).	Brookhart	then	measured	the	rates	of	associative	substitution	by	NMR	for	different	
diimine	ligands	and	demonstrated	that	axial	shielding	could	effectively	attenuate	this	process.
42,	47
	
	 We	sought	to	use	a	similar	strategy	in	Csp
3
	coupling	reactions	to	selectively	inhibit	stereoinvertive	
transmetalation.	 However,	 when	 designing	 ligands	 for	 blocking	 axial	 approach,	 two	 additional	 design	
constraints	needed	to	be	followed.	First,	the	ligand	also	had	to	allow	stereoretentive	transmetalation	to	
occur,	requiring	an	open	coordination	site	on	palladium.
38-39
	Consequently,	the	bidentate	diimine	ligands	
used	by	Brookhart	would	need	to	be	replaced	with	some	kind	of	monodentate	ligand.	Secondly,	the	ligand	
would	also	need	to	inhibit	β-hydride	elimination	(Figure	3.4)	by	blocking	the	requisite	agostic	interaction.	
	 The	 ligand	P(o-tol)3	 represented	a	promising	starting	point	 for	accomplishing	all	of	 these	goals	
(Figure	3.6D).	In	a	crystal	structure	of	a	P(o-tol)3-bound	oxidative	addition	adduct	3.21,	the	intermediate	
prior	 to	 transmetalation,	 one	 ortho-methyl	 group	 was	 projected	 above	 the	 Pd(II)	 square	 plane	 and	
another	 was	 projected	 below.
48
	 This	 suggested	 that	 P(o-tol)3	 or	 a	 similar	 ligand	might	 be	 capable	 of	
inhibiting	 the	 stereoinvertive	 transmetalation	 pathway	 by	 sterically	 blocking	 associative	 addition.	
60	
	
Secondly,	due	to	the	monodentate	nature	of	P(o-tol)3,	it	could	also	conceivably	free	up	a	coordination	site	
on	 palladium	 and	 permit	 the	 stereoretentive	 transmetalation	 pathway	 to	 occur.	 Finally,	 P(o-tol)3	 has	
shown	the	ability	to	inhibit	β-hydride	elimination	in	a	mechanistically-analogous	aryl	amination	reaction.
25
	
	 Based	 on	 these	 arguments,	 we	 hypothesized	 that	 increasing	 the	 steric	 bulk	 of	 the	 ortho-
substituent	 on	 a	 symmetrically-substituted	 triarylphosphine	 ligand	 should	 increasingly	 disfavor:	 (1)	
stereoinvertive	 transmetalation	 by	 blocking	 axial	 approach	 of	 the	 organoboronate,	 and	 (2)	 β-hydride	
elimination	by	blocking	the	requisite	agostic	interaction.	
	 	
Figure	3.6.		Steric	design	principles.		A)	Ligands	that	project	steric	bulk	above	and	below	the	Pd(II)	
square	plane	could	selectively	inhibit	invertive	transmetalation.		B)	In	olefin	polymerization	
reactions,	associative	substitution	processes	are	also	undesired.		C)	Brookhart	found	that	axial	
blocking	with	diimine	ligands	prevents	associative	substitution,	leading	to	higher	molecular	weight	
polymers.		D)	The	phosphine	ligand	P(o-tol)3	appears	to	be	a	promising	starting	point	for	axial	
blocking	and	meeting	the	other	requirements	for	catalyzing	Csp
3
	coupling	reactions.	
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3-6	 SYNTHESIS	AND	TESTING	OF	ORTHO-SUBSTITUTED	TRIARYLPHOSPHINES	
	 We	sought	 to	synthesize	and	 test	a	wide	 range	of	different	ortho-substituted	 triarylphosphine	
ligands	 and	ultimately	 identify	 a	 ligand	 framework	 that	 rendered	Csp
3
	 couplings	 both	highly	 site-	 and	
stereoretentive	(Figure	3.7).	The	first	step	was	to	identify	a	model	Csp
3
	coupling	reaction	(Figure	3.7A).	As	
a	starting	point	for	the	initial	reaction	conditions,	we	chose	Crudden’s	conditions	for	the	stereoretentive	
cross-coupling	 of	 benzylic	 pinacol	 boronic	 esters	 using	 silver	 oxide	 and	 anhydrous	 organic	 solvent.	
Although	the	boronic	esters	failed	to	react,	switching	to	the	free	boronic	acid	3.22	gave	some	success.	To	
meet	 the	 requirements	of	 the	 reaction	 for	anhydrous	and	pure	boronic	acids,	my	colleague	Dr.	 Ian	 T.	
Crouch	 identified	 a	 reproducible	 procedure	 that	 involved	 preparing	 the	 corresponding	 sodium	
trihydroxyborate	 salts.
49
	 These	 air-stable	 intermediates	were	 then	 treated	with	 one	 equivalent	 of	 the	
Lewis	acid	BF3*OEt2	 followed	by	 filtration	 through	celite	 to	generate	anhydrous,	pure	 solutions	of	 the	
boronic	acids	suitable	for	the	coupling	reaction.	
	 With	 these	 conditions	 in	 hand,	 we	 chose	 to	 examine	 in	 detail	 the	 cross-coupling	 of	 sec-
butylboronic	acid	3.22	and	4-bromobiphenyl	3.23	(Figure	3.7A).	For	these	representative	substrates,	we	
quantified	the	effect	of	the	 ligand	on	the	branched:linear	ratio	and	the	enantiospecificity	of	the	cross-
coupling	reaction	(Figure	3.7B).	These	metrics	would	provide	readouts	of	β-hydride	elimination	(Figure	
3.4)	 and	 the	 competition	 between	 the	 retentive	 and	 invertive	 transmetalation	 pathways	 (Figure	 3.2),	
respectively.	I	developed	a	quantitative	chiral	HPLC	assay	to	rapidly	and	reliably	measure	the	formation	
of	both	enantiomers	of	the	branched	product	3.24	and	3.25	and	also	the	linear	product	isomer	3.26.		
	 Most	of	the	ortho-substituted	phosphine	ligands	were	synthesized	with	straightforward	methods	
by	myself	and	my	colleagues.	In	a	general	procedure,	lithium	halogen	exchange	was	performed	on	the	
requisite	aryl	bromide	followed	by	treatment	with	PCl3	to	give	the	triarylphosphine,	which	could	then	be	
purified	 with	 standard	 column	 chromatography.	 The	more	 substituted	 aryl	 bromide	 precursors	 were	
generally	 prepared	 through	 a	 sequence	 involving	 monolithiation	 of	 1,2-dibromobenzene	 followed	 by	
treatment	with	a	ketone	and	reduction	of	the	corresponding	alcohol	to	the	alkane.	My	colleague	Dr.	Ian	
T.	 Crouch	 also	 identified	 an	 alternative	 one-step	 route	 involving	 the	 triple	 deprotonation	 of	 P(o-tol)3	
followed	by	treatment	with	an	alkyl	electrophile	to	afford	the	ligands	P(2-nPr-Ph)3	3.30	and	P(2-CH2Bn-
Ph)3	3.36.		Details	for	compound	preparation	can	be	found	in	the	experimental	section	(Section	3.18).	
	 The	 identity	 of	 the	ortho-substituent	 exerted	 a	 profound	effect	 on	 the	outcome	of	 the	 cross-
coupling	reaction	(Figure	3.7C).	With	PPh3	3.27,	where	the	ortho-substituent	was	only	a	hydrogen	atom,	
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the	 reaction	 gave	 a	 poor	 yield	 (9%),	 disappointing	 branched:linear	 ratio	 (1.6/1),	 and	 abysmal	
enantiospecificity	(21%).	Upon	switching	to	the	ligand	P(o-tol)3	3.28	containing	an	ortho-methyl	group,	
we	observed	a	substantial	improvement	in	all	three	metrics.	This	result	was	consistent	with	the	design	
principles	in	Figure	3.6	and	encouraged	us	to	explore	further	ortho-substituents.	
Figure	3.7.	Testing	ortho-substituted	triarylphosphines.		A)	Model	Csp3	coupling	reaction	for	
evaluating	ligands.	B)	Formulas	for	branched:linear	ratio	and	%	enantiospecificity.		C)	Effect	of	
phosphine	ligand	on	yield,	branched:linear	ratio,	and	%	enantiospecificity.		All	data	was	
obtained	by	quantitative	chiral	HPLC	and	represents	an	average	of	two	individual	reactions.	
*Pd(PPh3)4	was	used	due	to	insufficient	yield	with	Pd2dba3	/	PPh3			
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	 Increasing	the	length	of	the	ortho-alkyl	group	on	the	phosphine	ligand	initially	improved	the	cross-
coupling	reaction.	For	P(2-Et-Ph)3	3.29,	there	was	a	significant	 improvement	over	P(o-tol)3	 in	the	yield,	
branched:linear	ratio	and	%	enantiospecificity.	However,	when	going	up	to	the	n-propyl	and	n-butyl	ligand	
variants	3.30	and	3.31,	these	reaction	metrics	actually	decreased	slightly.	Based	on	these	results,	there	
seem	to	be	diminishing	returns	for	longer	ortho-alkyl	substituents.	
	 These	results	encouraged	us	to	consider	branched	substituents	at	the	ortho-position	(Figure	3.7C).	
Interestingly,	the	ligand	P(2-iPr-Ph)3	3.32	gave	an	enantiospecificity	of	only	76%,	substantially	worse	than	
P(o-tol)3	3.28.	This	surprising	result	suggests	that	too	much	steric	bulk	at	the	ortho-position	can	actually	
be	detrimental	 to	disfavoring	stereoinvertive	 transmetalation,	possibly	because	 it	 causes	 the	 ligand	to	
adopt	a	different	conformation	where	more	of	the	substituents	point	backwards	away	from	the	metal	
center.	 We	 probed	 this	 region	 of	 steric	 bulk	 in	 more	 detail	 by	 examining	 ligands	 containing	 ortho-
cycloalkyl	groups.	For	the	slightly	less	bulky	cyclobutyl	substituent	in	3.33,	the	enantiospecificity	increased	
back	up	to	90%.	However,	as	the	size	of	the	cycloalkyl	group	increased	to	cyclopentyl	in	3.34	or	cyclohexyl	
in	3.35,	the	enantiospecificity	plummeted.	We	also	examined	a	cyclopropyl	variant,	but	very	little	product	
formed,	possibly	because	the	ligand	itself	was	not	stable	to	the	reaction	conditions.	Based	on	all	these	
results,	 there	 is	 not	 a	 one-to-one	 correlation	 between	 steric	 properties	 of	 the	 ortho-substituent	 and	
enantiospecificity,	possibly	because	the	ligand	can	adopt	a	range	of	different	conformations.	
	 After	testing	more	phosphines,	we	eventually	discovered	that	the	novel	ligand	P(2-Bn-Ph)3	3.37	
gives	a	uniquely	high	enantiospecificity	of	98%	in	the	cross-coupling	reaction	(Figure	3.7C).	Moreover,	this	
promising	 ligand	 was	 also	 accompanied	 with	 a	 good	 yield	 (72%)	 and	 a	 superb	 branched:linear	 ratio	
(>250/1).	For	all	of	these	reasons,	we	chose	to	examine	this	ligand	framework	in	more	detail.	
	
3-7	 CRYSTAL	STRUCTURES	OF	P(2-BENZYL-PHENYL)3	
	 We	 sought	 to	 understand	 why	 the	 ligand	 P(2-Bn-Ph)3	 3.37	 is	 so	 effective	 at	 favoring	
stereoretentive	 transmetalation	 over	 stereoinvertive	 transmetalation.	My	 colleague	 Dr.	 Ian	 T.	 Crouch	
obtained	a	crystal	structure	of	the	oxidative	addition	adduct	 ligated	to	P(2-Bn-Ph)3	3.38.	Similar	to	the	
corresponding	P(o-tol)3	complex	3.21	(Figure	3.6D),	one	of	the	benzyl	groups	is	rotated	to	project	away	
from	Pd	center,	and	the	remaining	two	sterically	bulky	benzyl	substituents	are	projected	above	and	below	
the	square	plane	of	the	Pd(II)	complex	(Figure	3.8).	These	results	are	consistent	with	the	model	in	which	
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sterically	blocking	 these	sites	selectively	 inhibits	a	competing	stereoinvertive	 transmetalation	pathway	
(Figure	3.6A).	
	 Some	caveats	are	worth	mentioning.	The	oxidative	addition	adduct	3.38	in	the	crystal	structure,	
which	is	a	dimeric	complex,	is	probably	not	the	exact	intermediate	to	undergo	transmetalation.	Buchwald	
has	shown	that	the	addition	of	silver	salts	to	dimeric	oxidative	addition	adducts	ligated	to	P(o-tol)3	results	
in	fragmentation	to	their	monomeric	counterparts.
50
	Given	that	the	base	in	the	reaction	is	silver	(I)	oxide,	
this	process	likely	occurs	rapidly	and	irreversibly.	The	true	conformation	of	the	P(2-Bn-Ph)3	ligand	in	the	
monomeric	oxidative	addition	adduct	is	difficult	to	determine	because	these	monomeric	intermediates	
are	unstable	to	isolation.
50
	However,	it	stands	to	reason	that	there	are	more	degrees	of	freedom	in	the	
monomeric	species.	 In	the	absence	of	the	other	half	of	the	dimer,	 it	 is	possible	that	the	benzyl	groups	
could	 be	 positioned	 even	 closer	 to	 the	 palladium	 center.	 The	 possibility	 of	 a	 π-stacking	 interaction	 is	
discussed	later	in	section	3-16,	but	further	investigations	will	be	needed	to	clarify	exactly	what	role	the	
ortho-benzyl	groups	play	in	selectively	disfavoring	stereoinvertive	transmetalation.	
	 	
Figure	3.8.		Crystal	structure	cutaway	of	the	oxidative	addition	adduct	of	P(2-Bn-Ph)3	showing	axial	
blocking	of	the	ortho-benzyl	substituents.	
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3-8	 β-HYDRIDE	ELIMINATION	IS	NOT	A	MAJOR	CONTRIBUTOR	TO	EROSION	OF	ENANTIOSPECIFICITY	
	 In	these	Csp
3
	coupling	reactions,	imperfect	enantiospecificity	has	been	primarily	attributed	to	a	
competition	 between	 two	 stereodivergent	 transmetalation	 pathways	 (Figure	 3.2).	 However,	 we	 also	
sought	to	test	an	alternative	explanation	involving	β-hydride	elimination	(Figure	3.4).	Reinsertion	of	the	
palladium	hydride	on	the	prochiral	olefin	could	give	rise	to	either	enantiomer	of	the	branched	product	
3.24	or	3.25,	which	could	also	be	a	contributing	factor	to	a	loss	of	enantiospecificity.	If	this	were	true,	then	
the	high	level	of	stereoretention	with	the	ligand	P(2-Bn-Ph)3	could	possibly	be	explained	by	suppression	
of	β-hydride	elimination.	Moreover,	the	relative	contributions	of	both	of	these	pathways	(Figure	3.2	and	
3.4)	to	a	loss	of	enantiospecificity	could	vary	depending	on	the	ligand,	substrate,	temperature,	and	other	
variables.	We	sought	to	probe	these	two	pathways	with	a	simple	model	system.			
	 By	testing	ligand	derivatives	of	P(o-tol)3	containing	variable	levels	of	deuterium	incorporation	at	
the	 ortho-methyl	 group	 (3.28,	 3.39-3.41),	 we	 have	 gained	 some	 evidence	 suggesting	 that	 β-hydride	
elimination	is	not	a	major	contributor	to	loss	of	enantiospecificity.	Our	initial	motivation	for	testing	these	
deuterated	 ligand	 derivatives	 was	 actually	 quite	 different.	 The	 following	 paragraph	 contains	 a	 brief	
tangential	discussion	of	these	ideas.	
	 We	originally	wanted	to	test	 if	 the	ability	of	P(o-tol)3	3.28	and	related	P(2-alkyl-Ph)3	 ligands	to	
inhibit	 β-hydride	 elimination	 might	 be	 related	 to	 a	 competitive	 agostic	 interaction.	 If	 the	 open	
coordination	site	on	palladium	were	engaging	in	an	agostic	interaction	with	the	ortho-alkyl	group	of	the	
ligand,	 this	could	conceivably	disfavor	 the	other	agostic	 interaction	with	the	substrate	and	mitigate	β-
hydride	elimination.	The	literature	is	inconclusive	about	the	existence	of	an	agostic	interaction	between	
Figure	3.9.		Higher	levels	of	deuterium	incorporation	in	P(o-tol)3	lead	to	improved	branched:linear	
ratios	but	unchanged	enantiospecificities.	
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palladium	and	the	ortho-methyl	group	of	P(o-tol)3	3.28,51	so	we	sought	to	test	this	hypothesis	ourselves.	
It	has	been	established	that	transition	metals	have	stronger	agostic	interactions	with	C-H	bonds	than	with	
C-D	 bonds	 due	 to	 an	 equilibrium	 isotope	 effect.
52-53
	 Based	 on	 this	 precedent,	 we	 expected	 that	
sequentially	 replacing	 the	 hydrogens	 with	 deuteriums	 on	 the	 ortho-methyl	 group	 of	 P(o-tol)3	 would	
weaken	the	putative	agostic	interaction	between	palladium	and	the	phosphine	ligand,	leading	to	more	β-
hydride	 elimination.	 Instead,	 the	 experimental	 outcome	 was	 the	 opposite,	 with	 the	 branched	 ratios	
increasing	in	the	order	CH3	<	CH2D	<	CHD2	<	CD3	(Figure	3.9).	We	are	not	sure	why	this	experiment	gave	
the	outcome	that	it	did,	but	this	ligand	data	alternatively	turned	out	to	be	helpful	for	testing	the	main	
hypothesis	of	this	section.	
	 To	return	to	the	main	hypothesis,	we	would	expect	that	if	β-hydride	elimination	was	contributing	
to	a	loss	in	stereochemical	information,	then	there	would	a	correlation	between	the	branched:linear	ratio	
and	the	enantiospecificity.	This	is	because	the	same	palladium	hydride	intermediate	would	be	responsible	
for	forming	both	the	linear	product	isomer	and	the	racemized	branched	product	(Figure	3.4).	However,	
when	we	tested	the	series	of	ligands	containing	different	levels	of	deuterium	incorporation	(CH3,	CH2D,	
CHD2,	 and	 CD3	 in	 Figure	 3.9),	we	 observed	 no	 correlation	 between	 the	 branched:linear	 ratio	 and	 the	
enantiospecificity.	 Instead,	 across	 this	 series,	 the	 branched:linear	 ratio	 increased	 and	 the	
enantiospecificity	 stayed	 almost	 the	 same	 or	 even	 decreased	 slightly.	 Based	 on	 this	 data,	 β-hydride	
elimination	appears	to	be	at	most	a	minor	contributor	to	a	loss	in	enantiospecificity.	
	
3-9	 ELECTRONIC	DESIGN	PRINCIPLES	FOR	MAXIMIZING	STEREORETENTION	
Figure	3.10.		Electron-withdrawing	phosphine	ligands	should	(A)	accelerate	
stereoretentive	transmetalation	and	(B)	decelerate	stereoinvertive	transmetalation.	
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Separate	 from	 ligand	 steric	 contributions,	 ligand	 electronic	 effects	 offer	 another	 means	 to	
rationally	bias	the	competition	between	stereoretentive	and	stereoinvertive	transmetalation	pathways.	
An	 electron-withdrawing	 phosphine	 ligand	 should	 increase	 stereoretention	 in	 two	 ways:	 (1)	 by	
accelerating	stereoretentive	transmetalation	and	(2)	decelerating	stereoinvertive	transmetalation	(Figure	
3.10).	
For	 the	 stereoretentive	 transmetalation	 mechanism	 as	 depicted	 in	 Figures	 3.5	 and	 3.9,	 the	
transition	 state	 is	 structurally	 similar	 to	 the	 closed	 four-membered	 transition	 state	 proposed	 for	
arylboronic	acids.
38-39
	Computational	studies	show	that	oxygen-bridged	transmetalations	of	Csp
2
	boronic	
acids	within	the	Pd(II)	square	plane	are	accelerated	by	electron-poor	phosphines	due	to	stabilization	of	
negative	charge	build-up	on	the	Pd(II)	center.
54
	Because	the	nascent	palladium-carbon	bond	most	likely	
forms	 at	 the	 position	 on	 palladium	 trans	 to	 the	 phosphine	 ligand,39	 it	 stands	 to	 reason	 that	 a	more	
electron-deficient	ligand	could	accelerate	this	process	of	nucleophilic	attack.	
Alternatively,	in	the	proposed	pathway	for	stereoinvertive	transmetalation,	there	uniquely	exists	
a	 trans-relationship	between	 the	phosphine	 ligand	and	 the	 leaving	group	X.54-55	This	predicts	a	kinetic	
trans-effect,56	 such	 that	 an	 electron-poor	 phosphine	 ligand	 should	 increase	 the	 activation	 barrier	 for	
associative	addition	and	thus	decelerate	stereoinvertive	transmetalation.
57
	This	effect	can	be	explained	
by	a	ground	state	argument,	where	a	more	electron-deficient	and	weakly	σ-donating	phosphine	ligand	
lowers	the	energy	of	the	ground	state	by	strengthening	the	interaction	between	palladium	and	the	leaving	
group	X,	ultimately	increasing	the	activation	barrier.	Alternatively,	it	could	be	argued	that	the	stronger	π-
accepting	 character	 of	 an	 electron-deficient	 phosphine	 ligand	 could	 actually	 lower	 the	 barrier	 to	
stereoinvertive	transmetalation	by	removing	electron-density	from	the	transition	state	on	the	way	to	the	
trigonal	pyramidal	intermediate.
57
	Provided	that	the	weaker	σ-donation	effect	lowers	the	energy	of	the	
ground	state	to	a	greater	extent	than	the	stronger	π-accepting	effect	lowers	the	energy	of	the	transition	
state,	 then	 electron-withdrawing	 phosphine	 ligands	 should	 decelerate	 the	 rate	 of	 stereoinvertive	
transmetalation	(Figure	3.10B).	
	
3-10	 LIGAND-MEDIATED	STEREOCHEMICAL	DIVERGENCE	
Previously,	 Biscoe	 showed	 that	 unactivated	 secondary	 organotrifluoroborates	 can	 be	 cross-
coupled	with	 stereoinversion,
23
	opposite	 to	 the	 stereochemical	outcome	 that	we	observed.	 There	are	
many	differences	between	the	reaction	conditions,	one	of	which	is	the	electronic	nature	of	the	phosphine	
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ligand.	The	invertive	conditions	employ	the	electron-rich	ligand	P(tBu)3	3.42	(Tolman	electronic	parameter	
ν	=	2056.1	cm
-1
)
58
,	whereas	the	retentive	conditions	use	comparatively	electron-poor	triarylphosphines	
such	as	P(o-tol)3	3.28	(Tolman	electronic	parameter	ν	=	2066.6	cm-1)58.	
Aside	 from	 ligand	 electronic	 properties,	 there	 are	 also	 other	 factors	 that	 could	 explain	 this	
stereochemical	 divergence.	 Ligand	 steric	 properties	 can	 strongly	 affect	 the	 stereochemical	 outcome	
(Figure	3.7).	However,	these	two	ligands	have	similar	cone	angles	(P(tBu)3,	cone	angle	θ	=	182°;	P(o-tol)3,	
θ	=	194°)
58
.	Furthermore,	other	ligands	that	also	cannot	effectively	block	the	axial	sites	on	palladium,	such	
as	 PPh3	3.27,	 still	 favor	 stereoretention	 (Figure	 3.7).	 Alternatively,	 the	base	 and	 solvent	 system	 could	
influence	the	stereochemical	outcome	by	shifting	the	equilibrium	between	the	boronic	acid	and	anionic	
trihydroxyborate.	 Boronic	 acids	 likely	 participate	 in	 retentive	 transmetalation,
36
	 whereas	 anionic	
trihydroxyborates	 are	 capable	 of	 going	 through	 invertive	 transmetalation	 (Figure	 3.5).	 The	 anhydrous	
solvent	used	in	our	retentive	couplings	could	favor	the	boronic	acid,	and	the	aqueous	biphasic	nature	of	
Biscoe’s	 invertive	 couplings	 could	 shift	 the	 equilibrium	 towards	 the	 trihydroxyborate.	 One	 additional	
difference	between	these	conditions	is	the	identity	of	the	organoboronate,	which	is	a	boronic	acid	in	our	
system	and	a	trifluoroborate	in	Biscoe’s	system.	
To	 determine	 the	 effect	 of	 just	 the	 phosphine	 ligand	 on	 the	 stereochemical	 outcome,	 we	
performed	a	comparison	of	both	sets	of	reaction	conditions	with	both	phosphine	ligands	(Figure	3.11).	
Under	 Biscoe’s	 aqueous	 conditions,	 we	 independently	 confirmed	 that	 P(tBu)3	 3.42	 resulted	 in	
stereoinversion.	However,	switching	to	P(o-tol)3	3.28	caused	a	turnover	to	stereoretention,	albeit	with	a	
modest	enantiospecificity	of	55%	(Figure	3.11A).	Based	on	this	result,	the	ligand	appeared	to	be	primary	
determinant	 of	 the	 stereochemical	 outcome,	 with	 the	 aqueous	 biphasic	 conditions	 still	 exerting	 a	
Figure	3.11.		Ligand-mediated	stereodivergence.		A)	Under	the	aqueous	biphasic	coupling	conditions	
reported	by	Biscoe,	the	stereochemical	outcome	can	be	changed	from	inversion	to	retention	by	
switching	the	phosphine	from	the	electron-rich	ligand	P(tBu)3	3.42	to	the	comparatively	electron-
poor	P(o-tol)3	3.28.		B)	The	anhydrous	conditions	we	developed	also	exhibit	the	same	ligand-
mediated	stereodivergence.	
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moderate	preference	for	stereoinversion.	In	our	anhydrous	system,	we	again	observed	this	phenomenon	
of	 ligand-mediated	stereodivergence	(Figure	3.11B),	where	switching	from	P(o-tol)3	to	P(tBu)3	changed	
the	reaction	from	stereoretentive	to	stereoinvertive.	The	modest	enantiospecificity	of	51%	with	P(tBu)3	
again	suggests	that	the	anhydrous	conditions	are	more	prone	to	stereoretention.	
	 Given	the	electronic	dissimilarities	between	the	ligands	P(o-tol)3	3.28	and	P(tBu)3	3.42,	the	above	
observations	are	consistent	with	the	design	principles	for	ligand	electronic	properties	outlined	in	Figure	
3.10.	However,	the	effect	of	ligand	steric	properties	cannot	be	fully	ruled	out	as	an	alternative	explanation	
for	the	ligand-mediated	stereodivergence.	We	thus	sought	to	test	the	effect	of	ligand	electronic	effects	in	
a	more	controlled	manner.	
3-11	 SYNTHESIS	OF	ELECTRONICALLY-TUNED	LIGAND	DERIVATIVES	
	 An	ideal	test	of	the	ligand	electronic	properties	design	principle	would	involve	comparing	ligands	
with	identical	steric	profiles	but	different	electronic	natures.	This	was	accomplished	by	designing	a	series	
of	 triarylphosphine	 ligand	 derivatives	 that	 were	 otherwise	 identical	 except	 for	 their	 para-substituent	
Figure	3.12.		Design	of	ligands	with	electronic-tuning	at	the	para-position	and	steric	tuning	at	the	
ortho-position.		
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(Figure	3.12).	These	electronically-tuned	 ligands	were	designed	based	on	the	P(o-tol)3	and	P(2-Bn-Ph)3	
scaffolds.	 In	 this	manner,	 the	 steric	properties	 and	electronic	properties	of	 the	 ligand	 could	be	 tuned	
separately,	at	the	ortho-	and	para-positions	relative	to	the	phosphorus	(Figure	3.12).	
	 Most	of	these	ligand	derivatives	were	not	known	compounds	and	required	new	synthetic	routes.	
For	the	P(o-tol)3	derivatives,	the	precursor	aryl	bromide	was	often	commercially	available	and	served	as	a	
convenient	 starting	 material.	 In	 most	 cases,	 this	 organobromide	 was	 directly	 converted	 to	 the	
arylmagnesium	or	 aryllithium	 species	 and	 then	 treated	with	 PCl3	 to	 give	 the	 desired	 triarylphosphine	
ligand	 (Figure	 3.13A).	 However,	 different	 routes	 were	 required	 for	 ligands	 bearing	 more	 sensitive	
functional	groups	at	the	para-position,	 including	NMe2,	CO2Me,	CN,	and	NO2	(full	details	are	in	section	
3.18).	Richard	Heck	had	previously	prepared	the	ligand	(P-2-Me-4-NMe2-Ph)3	3.44	through	electrophilic	
aromatic	substitution	with	PBr3	and	the	corresponding	aniline.
59
	The	ligand	P(2-Me-4-CN-Ph)3	3.52	was	
prepared	through	a	low	temperature	magnesium	halogen	exchange	reaction,	which	had	been	shown	by	
Knochel	to	tolerate	cyano	functional	groups.
60
	The	methyl	ester	functional	group	required	even	milder	
conditions,	but	a	modified	prep	using	the	corresponding	aryl	zinc	reagent
61
	proved	successful.	Finally,	the	
para-nitro	derivative	3.53	was	prepared	by	my	colleagues	Dr.	 Ian	T.	Crouch	and	Dr.	Melanie	Trobe	by	
carrying	out	a	recently	published	aryl	nitration	procedure
62
	on	the	compound	P(2-Me-4-Cl-Ph)3.	
	 For	the	electronically-tuned	variants	of	P(2-Bn-Ph)3,	I	developed	a	modular	synthetic	route	that	
was	generally	applicable	to	many	different	derivatives	(Figure	3.13B).	Beginning	with	many	of	the	same	
aryl	bromide	precursors	that	were	used	to	prepare	the	P(o-tol)3	derivatives,	I	carried	out	a	radical	benzylic	
bromination	 followed	 by	 a	 selective	 Suzuki	 coupling	with	 phenylboronic	 acid.	 Finally,	 lithium	halogen	
exchange	 and	 treatment	 with	 PCl3	 gave	 the	 desired	 phosphine.	 My	 colleague	 Dr.	 Ian	 T.	 Crouch	 also	
developed	an	alternative	route	to	the	ligand	P(2-Bn-4-CF3-Ph)3	3.57	that	installed	the	ortho-benzyl	group	
Figure	3.13.		General	syntheses	of	electronically-tuned	derivatives	of	A)	P(o-tol)2	and	B)	P(2-Bn-Ph)3.		
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via	a	Friedel	Crafts	reaction	between	the	requisite	benzylic	alcohol	and	benzene.	Complete	syntheses	and	
characterization	can	be	found	in	section	3-18.	
3-12	 TESTING	OF	ELECTRONICALLY-TUNED	LIGAND	DERIVATIVES	
	 Testing	 of	 the	 electronically-tuned	 ligand	 derivatives	 under	 the	 anhydrous	 cross-coupling	
conditions	 revealed	 a	 strong	 correlation	 between	 ligand	 electronic	 properties	 and	 enantiospecificity	
(Figure	3.14).	This	trend	was	true	for	both	the	P(o-tol)3	and	P(2-Bn-Ph)3	ligand	frameworks	(R2	=	0.96	and	
0.93,	 respectively).	 Consistent	 with	 the	 design	 principle	 (Figure	 3.10),	 more	 electron-deficiency	 was	
correlated	with	higher	stereoretention.	An	important	caveat	to	note	is	that	this	enantiospecificity	data	
reveals	 relative	 rates	 for	 the	 two	 competing	 transmetalation	pathways,	 not	 absolute	 rates.	 There	 are	
several	plausible	interpretations	of	these	results,	which	include	acceleration	of	retentive	transmetalation	
/	deceleration	of	invertive	transmetalation,	selective	acceleration	of	retention,	selective	deceleration	of	
inversion,	or	some	combination	of	these	outcomes.	
Figure	3.14.		Testing	ligand	electronic	properties	under	anhydrous	conditions.	All	data	was	obtained	
by	quantitative	chiral	HPLC	and	represents	an	average	of	two	individual	reactions.	
72	
	
	 The	 electronic	 properties	 of	 the	 ligand	 had	 mixed	 effects	 on	 the	 yield	 of	 the	 cross-coupling	
reaction	 (Figure	 3.14).	 On	 the	 P(o-tol)3	 framework,	more	 electron-deficient	 ligands	 resulted	 in	 higher	
yields	until	the	para-CN	derivative	3.52,	where	the	yield	precipitously	declined.	Although	this	could	be	
attributed	to	functional	group	incompatibilities	of	the	para-cyano	and	para-nitro	ligands	3.52	and	3.53,	
both	of	these	functional	groups	were	well	tolerated	in	substrates	(section	3.14).	As	an	alternative	possible	
explanation,	ligand	electron-deficiency	could	be	beneficial	to	yield	for	one	reason	(such	as	accelerating	
rate-limiting	 retentive	 transmetalation)	 but	 also	 detrimental	 to	 yield	 for	 a	 different	 reason	 (such	 as	
weakening	 the	binding	affinity	of	 the	phosphine	 for	palladium).	On	 the	P(2-Bn-Ph)3	 ligand	 framework,	
ligand	electron-deficiency	was	negatively	correlated	with	yield,	a	result	that	currently	limits	the	practical	
application	of	ligand	electronic	effects	to	maximizing	stereoretention.	Interestingly,	for	the	more	electron-
deficient	derivatives	such	as	P(2-Bn-4-CF3-Ph)3	3.57,	the	mass	balance	of	the	reaction	could	not	be	readily	
accounted	for.	As	measured	by	HPLC,	these	couplings	still	went	to	full	conversion	and	had	relatively	small	
amounts	of	protodehalogenation	 (see	 Section	3.18).	 Finding	an	answer	 to	 the	question	of	why	 ligand	
electron-deficiency	 is	negatively	correlated	with	yield	could	have	 important	 implications	 for	 improving	
these	coupling	reactions	moving	forward.	
	 Ligand	 electronic	 properties	 also	 had	mixed	 effects	 on	 the	 branched:linear	 ratio	 of	 the	 cross-
coupling	 reaction.	 On	 the	 P(o-tol)3	 framework,	 more	 electron-deficient	 ligands	 generally	 gave	 lower	
branched:linear	ratios,	although	this	trend	was	relatively	weak.	Fortunately,	the	electronically-deficient	
derivatives	of	P(2-Bn-Ph)3	still	gave	exceptionally	good	branched:linear	ratios.		
	 Separately,	 I	 also	 tested	 the	 same	 series	 of	 electronically-tuned	 ligands	 under	 the	 aqueous	
biphasic	conditions	recently	reported	by	Biscoe	and	coworkers	(Figure	3.15).
23
	Overall,	the	trends	were	
fairly	 similar	 to	 those	 observed	 in	 the	 anhydrous	 couplings	 (Figure	 3.14).	 Every	 ligand	 tested	 gave	 a	
stereoretentive	outcome,	including	even	the	most	electron-rich	derivative	P(2-Me-4-NMe2-Ph)3	3.44.	The	
correlation	 between	 ligand	 electron-deficiency	 and	 stereoretention	 was	 stronger	 for	 the	 P(o-tol)3	
framework	 (R
2
	 =	 0.91)	 than	 for	 the	 P(2-Bn-Ph)3	 framework	 (R
2
	 =	 0.69).	 In	 both	 cases,	 the	 level	 of	
stereoretention	 plateaued	 at	 around	 70-75%.	 This	 observation	 suggests	 that	 the	 aqueous	 biphasic	
conditions	are	fundamentally	more	prone	to	stereoinversion,	possibly	because	they	push	the	equilibrium	
in	favor	of	the	trihydroxyborate	over	the	boronic	acid.	
	 With	 regard	 to	 the	 yield	 and	 branched:linear	 ratio	 of	 the	 coupling	 reaction,	 ligand	 electronic	
properties	again	had	very	similar	effects	in	the	aqueous	system	compared	to	the	anhydrous	system	(Figure	
3.15).	For	the	P(o-tol)3	framework,	the	yield	initially	 increased	and	then	decreased;	for	the	P(2-Bn-Ph)3	
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framework,	the	yield	decreased.	Branched:linear	ratios	seemed	to	be	negatively	correlated	with	electron-
deficiency	on	the	P(o-tol)3	framework	but	not	strongly	correlated	at	all	on	the	P(2-Bn-Ph)3	framework.	
	 Broadly	speaking,	the	aqueous	biphasic	conditions	gave	relatively	poor	reaction	outcomes	for	all	
of	 the	 triarylphosphines	 tested.	 This	 stands	 in	 contrast	 to	 the	 good	 results	 for	 these	 ligands	 in	 the	
anhydrous	system	(Figure	3.14)	and	the	positive	results	for	P(tBu)3	in	the	aqueous	system.23	
	 Taken	 together,	 there	appear	 to	be	 two	different	ways	 to	maximize	 stereospecificity	 in	 cross-
coupling	reactions	of	unactivated	secondary	organoboronates:	
	(1)	In	favor	of	stereoretention:	
• Electron-poor	phosphine	(triarylphosphine)	
• Ligand	that	blocks	axial	approach	of	the	organoboronate	
• Anhydrous	reaction	conditions	
Figure	3.15.		Testing	ligand	electronic	properties	under	aqueous	biphasic	coupling	conditions.	All	
data	was	obtained	by	quantitative	chiral	HPLC	and	represents	an	average	of	two	individual	reactions.	
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(2)	In	favor	of	stereoinversion:	
• Electron-rich	phosphine	(trialkylphosphine)	
• Ligand	that	allows	axial	approach	of	the	organoboronate	
• Aqueous	biphasic	reaction	conditions	
	
3-13	 BIDA	BORONATE	RESOLUTION	PLATFORM	
	 Exploring	the	reaction	scope	required	practical	access	to	a	series	of	unactivated	chiral	nonracemic	
boronic	acids	in	highly	enantiomerically	enriched	form.	Several	methods	have	been	developed	to	prepare	
chiral	nonracemic	alkylboronic	acids,	but	they	each	have	drawbacks	that	limit	their	generality.	Brown’s	
asymmetric	hydroboration	method	utilizes	chiral	diisopinocampheylborane	to	access	boronic	acids	and	
alcohols	in	enantiomeric	optical	purity.
63-64
	However,	this	method	is	limited	to	certain	kinds	of	alkenes.	
Unsymmetrical	 cis	 alkenes	 give	 product	 mixtures,	 and	 trans	 alkenes	 proceed	 with	 lower	
enantioselectivity.	 Matteson’s
65
	 and	 Aggarwal’s
66
	 methods	 for	 homologation	 of	 boronic	 esters	 are	
versatile	but	require	the	use	of	harsh	organomagnesium	or	organolithium	reagents,	limiting	the	substrate	
scope.	
	 We	 sought	 a	 mild	 and	 general	 method	 for	 preparing	 chiral	 secondary	 unactivated	
organoboronates	in	high	enantiomeric	access.	 	Chiral	derivatives	of	N-methyliminodiacetic	acid	(MIDA)	
have	 previously	 been	 used	 to	 promote	 diastereoselective	 epoxidations
67
	 and	 resolutions	 of	
atropdiastereomeric	biaryl	boronic	acids.
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		My	colleagues	Dr.	Pulin	Wang	and	Dr.	Ian	T.	Crouch	found	that	
upon	 complexing	 racemic	 secondary	 alkylboronic	 acids	 with	 an	 enantiopure	 MIDA	 variant,	 N-2-
benzyloxycyclopentyl-iminodiacetic	 acid	 (BIDA),	 the	 resulting	 diastereomeric	 BIDA	 boronates	 could	
usually	 be	 separated	 by	 chromatography	 and/or	 recrystallization.	 Once	 resolved,	 the	 BIDA	 boronates	
3.58-3.65	can	be	hydrolyzed	to	provide	highly	enantioenriched	boronic	acids	(≥99:1	e.r.).	This	method	was	
applicable	to	a	wide	range	of	organoboronates	(Figure	3.16).	
	 There	 are	 aspects	 of	 the	 BIDA	 boronate	 resolution	 platform	 that	 could	 be	 improved.	 The	
diastereomeric	separations	are	often	nontrivial	and	occasionally	nearly	impossible,	as	was	the	case	with	
the	BIDA	boronate	derived	from	3-hexylboronic	acid.	The	physical	properties	of	BIDA	boronates	are	similar	
to	those	of	their	MIDA	boronate	counterparts,	but	BIDA	boronates	tend	to	have	slightly	lower	hydrolytic	
stability.	In	the	future,	an	improved	version	of	the	BIDA	ligand	could	be	highly	enabling	for	boronic	acid	
preparation.	 Given	 the	 ease	 with	 which	 BIDA	 can	 be	 synthesized	 (Section	 3.18)	 and	 the	 commercial	
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availability	of	chiral	amines	in	high	enantiomeric	excess,	it	should	be	relatively	straightforward	to	screen	
new	chiral	MIDA	variants.	
	
3-14	 EXPLORATION	OF	SUBSTRATE	SCOPE	
	 The	Csp
3
	cross-coupling	reaction	proceeded	with	very	high	stereoretention	and	branched:linear	
ratios	over	 the	entire	 substrate	 scope	 (Figure	3.17B-C).	Perfect	 stereoretention	was	observed	 in	most	
cases.	β-branching	on	the	boronic	acid	was	tolerated,	as	were	a	trifluoromethyl	group	and	a	benzyl	ether.	
For	3-hexylboronic	acid,	a	unique	example	of	an	ethyl-branched	Csp
3
	boronic	acid,	we	observed	a	150/4/1	
product	distribution	of	the	desired	3-hexyl	to	2-hexyl	to	1-hexyl	isomers	and	near	perfect	stereoretention.	
However,	organoboronic	acid	substrates	with	α-branching	tended	to	couple	with	much	lower	yields	(≈10-
20%).	
	 Perfect	stereoretention	and	good	branched:linear	ratios	were	also	observed	for	cross-couplings	
with	 a	 wide	 range	 of	 electron-rich	 and	 electron-poor	 aryl	 halides	 (Fig.	 3.17C).	 The	 functional	 group	
Figure	3.16.		BIDA	boronates	prepared	by	diastereomeric	resolution.	
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tolerance	of	this	method	was	found	to	include	ethers,	nitro	groups,	esters,	sulfones,	silanes,	ketones,	and	
nitriles.	 Although	 aryl	 chlorides	 and	 aryl	 triflates	were	 poor	 coupling	 partners,	 their	 lack	 of	 reactivity	
provided	 the	 opportunity	 for	 halide-selective	 couplings.	 Some	 heterocycles,	 including	 pyrroles	 and	
indoles,	were	also	well-tolerated.	Finally,	we	observed	perfectly	double	stereoretentive	Csp
3
-Csp
2
	cross-
coupling	between	a	secondary	alkylboronic	acid	and	an	activated	vinyl	halide.	
Figure	3.17.		Substrate	scope	of	the	stereoretentive	Csp
3
	cross-coupling	reaction.		A)	General	
reaction	conditions.		B)	Scope	of	the	organoboronic	acid.		C)	Scope	of	the	organohalide.	
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	 The	scope	of	organohalide	is	currently	subject	to	some	notable	limitations.	Strongly	coordinating	
heterocycles	 (pyridyl	 halides,	 pyrimidyl	 halides,	 quinolinyl	 halides,	 etc.)	 give	 no	 product	 under	 these	
conditions,	 possibly	 due	 to	 heteroatom	 coordination	 to	 palladium	 outcompeting	 the	 weakly	 binding	
phosphine	 ligand.	 Similarly,	 strongly	 Lewis	 basic	 functional	 groups	 are	 not	 tolerated	 on	 substrates,	
including	unhindered	amides,	amines,	and	sulfonamides.	Unprotected	alcohols,	aldehydes,	alkenes,	and	
alkynes	are	also	generally	not	compatible	with	the	reaction.	Finally,	unactivated	vinyl	halides	(i.e.	lacking	
2,2-disubstitution	and	electron-withdrawing	groups)	 give	poor	 yields,	despite	going	 to	 full	 conversion.	
Potential	 means	 of	 addressing	 some	 of	 these	 limitations	 include	 designing	 a	 more	 strongly	 binding	
phosphine	ligand	and	finding	a	substitute	for	silver	(I)	oxide.	
	 Although	 there	 are	 still	 many	 limitations	 in	 the	 substrate	 scope,	 this	 cross-coupling	 reaction	
demonstrates	a	major	step	forward	in	controlling	site-	and	stereospecificity.	Across	the	scope	of	coupling	
partners	 that	work	 in	 the	 reaction,	 the	 products	were	 obtained	with	 universally	 high	 branched:linear	
ratios	 and	 enantiospecificities.	 In	 comparison	 to	 stereoselective	 couplings	 (Figure	 3.1),	 stereospecific	
couplings	have	the	potential	for	near-perfect	stereochemical	control	over	the	whole	substrate	scope.	The	
ligand	design	principles	disclosed	here	have	helped	us	begin	to	realize	this	potential.	
	
3-15	 BUILDING	BLOCK-BASED	SYNTHESIS	OF	XYLARINIC	ACID	B	
We	finally	tested	the	capacity	of	this	method	to	enable	stereocontrolled	assembly	of	Csp
3
-rich	
natural	products.	One	of	the	key	strengths	of	building	block	based-synthesis	is	the	theoretical	potential	
to	access	all	possible	Csp
3
	stereoisomers	with	perfect	stereocontrol	by	employing	the	corresponding	series	
Figure	3.18.		Building	block-based	synthesis	of	xylarinic	acid	B.		Yield,	b:l,	and	%ds	refer	to	the	cross-
coupling	step.	
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of	 pre-fabricated,	 stereochemically	 defined	 chiral	 building	 blocks.	 The	 recently	 discovered	 antifungal	
natural	product	xylarinic	acid	B
69-70
	served	as	an	excellent	case	study	(Figure	3.18).	
Leveraging	 the	 simple	 BIDA	 boronate	 resolution	 method,	 all	 of	 the	 required	 secondary	 Csp
3
	
boronate	building	blocks	were	prepared	in	≥99:1	d.r.	(3.62-3.65,	Figure	3.16).	All	four	of	these	building	
blocks	proved	to	be	air-	and	chromatographically-	stable	crystalline	solids.	This	set	the	stage	for	the	simple	
modular	assembly	of	xylarinic	acid	B	3.85,	and	all	of	its	Csp3	stereoisomers	3.86-3.88,	via	cross-coupling	
of	these	four	stereodefined	building	blocks.	Each	building	block	was	deprotected	to	the	corresponding	
boronic	acid,	stereospecifically	cross-coupled	to	the	requisite	vinyl	bromide	using	P(2-Bn-Ph)3	3.37,	and	
then	deprotected	under	standard	conditions	(TFA/DCM).	Through	this	simple	approach,	xylarinic	acid	B	
and	all	three	of	its	Csp
3
	stereoisomers	were	readily	accessed	in	perfect	diastereospecificity	(≥99%),	>250/1	
b:l	ratios,	and	≥50%	yield	(Figure	3.18).	
	
3-16	 PRELIMINARY	INVESTIGATIONS	INTO	THE	ROLE	OF	THE	BENZYL	GROUP	
	 The	 ligand	 P(2-Bn-Ph)3	 3.37	 was	 able	 to	 promote	 the	 reaction	 with	 a	 singularly	 high	
enantiospecificity	when	 compared	with	many	 other	ortho-substituted	 triarylphosphines	 (Figure	 3.7C).	
This	observation	raised	the	question	of	why	the	ortho-benzyl	group	was	so	uniquely	effective.	Possibly	
the	 benzyl	 group	 was	 simply	 preventing	 stereoinvertive	 transmetalation	 by	 sterically	 blocking	 the	
approach	of	the	organoboronate	to	the	axial	position	on	Pd(II),	which	would	be	consistent	with	the	crystal	
structure	 of	 the	 oxidative	 addition	 adduct	 3.38	 (Figure	 3.8).	 Alternatively,	 the	 benzyl	 group	 could	 be	
shielding	the	axial	positions	by	engaging	in	some	kind	of	π-stacking	interaction	with	the	Pd(II)	oxidative	
addition	adduct.	Although	this	kind	of	interaction	was	not	visible	in	the	crystal	structure	of	the	dimer	3.38	
(Figure	3.8),	its	monomeric	counterpart	generated	by	silver	halide	precipitation	would	have	more	degrees	
of	freedom	for	the	benzyl	groups	to	move	in	the	vicinity	of	the	Pd(II)	center.	
	 To	gain	some	preliminary	evidence	for	this	putative	π-stacking	interaction,	the	structure-activity	
relationship	of	the	ortho-benzyl	group	was	probed	(Figure	3.19).	If	steric	shielding	was	the	mechanism	for	
blocking	axial	approach,	then	all	three	benzyl	groups	would	probably	be	required	to	maintain	the	ligand	
conformation	 necessary	 for	 high	 enantiospecificity.	 However,	 a	 hybrid	 ligand	 with	 two	 ortho-methyl	
groups	and	just	one	ortho-benzyl	group	3.89	catalyzed	the	model	coupling	reaction	(Figure	3.19A)	with	
94%	enantiospecificity	(Figure	3.19B).	This	value	for	enantiospecificity	is	much	closer	to	the	P(2-Bn-Ph)3	
3.37	ligand	than	P(o-tol)3	3.28.	As	an	important	future	experiment,	we	plan	to	test	the	hybrid	ligand	with	
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two	ortho-benzyl	groups.	If	this	ligand	gives	an	enantiospecificity	very	similarly	to	P(2-Bn-Ph)3,	then	the	π-
stacking	interaction	would	seem	to	be	a	more	reasonable	explanation	than	simple	steric	shielding.	
	 If	steric	shielding	were	responsible	for	the	high	enantiospecificity,	then	any	steric	perturbation	of	
the	ortho-benzyl	 group,	 such	 as	 changing	 to	 a	 different	 π-system,	 should	 change	 its	 ability	 to	 inhibit	
stereoinvertive	transmetalation.	A	series	of	ligand	derivatives	containing	other	pendant	π-systems	were	
prepared	and	tested	(Figure	3.19C).	The	introduction	of	a	meta-methoxy	group	on	the	pendant	aromatic	
ring	was	well-tolerated	 in	3.90,	 still	 giving	an	enantiospecificity	of	 98%.	 Similarly,	 replacing	 the	CH2Ph	
group	with	 CH2-(1-naphthyl)	 in	3.91	 and	 CH2(2-naphthyl)	 in	3.92	 groups	 did	 not	 cause	 any	 erosion	 in	
enantiospecificity.	The	observation	that	all	of	these	sterically	dissimilar	ortho-aryl	substituents	catalyzed	
the	coupling	with	98%	enantiospecificity	hints	once	again	at	the	involvement	of	a	π-stacking	interaction	
in	preventing	stereoinvertive	transmetalation.	
	
Figure	3.19.		Investigation	into	the	role	of	the	benzyl	group	in	promoting	high	enantiospecificity.		A)	
Model	coupling	reaction.		B)	Testing	unsymmetrical	ligands.		C)	Testing	other	appended	aryl	groups.		
D)	Testing	the	tether	length.		E)	Testing	different	coordinating	groups.	
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	 The	length	of	the	tether	to	the	π-system	could	be	critical	to	maintaining	the	requisite	π-stacking	
interaction.	 When	 we	 changed	 the	 ortho-benzyl	 group	 to	 an	 ortho-homobenzyl	 group	 in	 3.36,	 we	
observed	a	drop-off	in	the	enantiospecificity	down	to	89%	(Figure	3.19D).	However,	although	this	data	is	
consistent	with	a	π-stacking	interaction,	it	could	also	be	explained	by	a	difference	in	steric	shielding	for	
P(2-CH2Bn-Ph)3.	In	order	to	gain	stronger	evidence,	we	required	ligands	that	were	isosteric	but	possessed	
different	capacities	to	have	an	interaction	with	the	axial	position	of	Pd.	
	 	Although	 we	 were	 testing	 for	 π-stacking,	 we	 also	 considered	 exploring	 the	 possibility	 of	 a	
heteroatom	binding	interaction	(Figure	3.19E).	The	two	ligands	P(2-nBu-Ph)3	3.31	and	P(2-CH2CH2OMe-
Ph)3	 3.93	 are	 sterically	 very	 similar,	 but	 the	 latter	 ligand	 has	 a	 terminal	 methoxy	 group	 that	 could	
conceivably	have	a	weak	binding	 interaction	with	 the	axial	position	on	Pd.	 Interestingly,	 these	 ligands	
performed	very	differently;	 the	methoxy	group-containing	 ligand	gave	an	enantiospecificity	6%	higher	
than	its	hydrocarbon	variant.	
	 Collectively,	all	of	this	data	suggests	that	a	π-stacking	interaction	with	the	axial	position	on	Pd(II)	
may	be	a	reasonable	explanation	for	why	P(2-Bn-Ph)3	3.37	gives	a	uniquely	high	enantiospecificity.	Further	
studies	will	be	needed	to	probe	this	possibility	and	investigate	if	this	interaction	can	be	optimized	further.	
Gaining	 a	 deeper	 understanding	 of	 why	 P(2-Bn-Ph)3	 is	 so	 uniquely	 effective	 could	 also	 help	 when	
optimizing	related	cross-coupling	reactions.	
	
3-17	 SUMMARY	AND	OUTLOOK	
	 The	ligand	design	principles	and	results	outlined	here	represent	a	promising	early	step	towards	a	
more	 general	 and	 modular	 approach	 to	 the	 synthesis	 of	 complex	 small	 molecules.	We	 solved	 a	 key	
mechanistic	 challenge-	 to	 selectively	 attenuate	 one	 of	 the	 competing	 stereodivergent	 stereospecific	
transmetalation	 pathways-	 by	 designing	 symmetrical	ortho-substituted	 triarylphosphines	 that	 prevent	
stereoinvertive	 transmetalation	 by	 sterically	 shielding	 the	 axial	 positions	 above	 and	 below	 the	 Pd(II)	
square	 plane.	 Control	 experiments	 with	 P(o-tol)3	 derivatives	 containing	 variable	 levels	 of	 deuterium	
incorporation	indicated	that	these	enhancements	in	stereospecificity	could	not	be	alternatively	attributed	
to	the	simple	suppression	of	β-hydride	elimination.	However,	our	best	ligand,	P(2-Bn-Ph)3	was	also	able	
to	effectively	prevent	β-hydride	elimination	and	render	the	reaction	highly	site-retentive	as	well.	Further	
enhancements	in	stereoretention	could	be	achieved	with	electron-withdrawing	variants	of	these	ligands,	
albeit	with	a	decrease	in	reaction	yield.	
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	 Many	 challenges	 still	 limit	 the	 application	 of	 this	 cross-coupling	 methodology.	 From	 an	
operational	 standpoint,	 it	 is	 difficult	 to	 prepare	 clean	 secondary	 alkylboronic	 acids	 due	 to	 undesired	
boroxine	 formation,	 protodeboronation,	 and	 oxidation.	 Our	 current	 procedure	 is	 reproducible	 and	
applicable	 to	most	 alkylboronic	 acids,	 but	 it	 is	 also	 time-consuming	 and	 not	 amenable	 to	 automated	
synthesis.	These	problems	could	be	ameliorated	by	the	development	of	a	more	stable	organoboronate	
species	 that	 also	 displays	 suitable	 reactivity	 under	 our	 anhydrous	 coupling	 conditions.	 Separately,	
limitations	in	substrate	scope,	such	as	coupling	partners	containing	problematic	functional	groups	or	steric	
congestion,	will	require	innovations	in	catalyst	design.	Towards	this	end,	the	design	principles	for	ligand	
steric	and	electronic	properties	may	help	guide	these	problem-solving	endeavors.	
	 With	an	improved	notion	about	how	to	control	the	reactivity	of	secondary	unactivated	boronic	
acids,	another	important	future	goal	is	to	move	beyond	aryl	bromides.	To	extend	these	couplings	to	new	
substrate	classes	(such	as	vinylic,	benzylic,	allylic,	and	alkyl	halides),	systematic	studies	will	be	needed	to	
uncover	 new	 catalyst	 design	 principles.	 Ultimately,	 with	 an	 expanded	 knowledge	 of	 the	 bounds	 of	
reactivity	 and	 selectivity	 pertaining	 to	 different	 substrate	 classes,	 it	 may	 be	 possible	 to	 find	 general	
conditions	 for	 stereocontrolled	 Csp
3
-Csp
3
	 cross-couplings.	 These	 coupling	 methods	 would	 collectively	
accelerate	 breakthroughs	 in	 drug	 discovery	 and	 eventually	 enable	 the	 development	 of	 a	 generalized	
synthesis	platform	capable	of	making	most	small	molecules.	
	
3-18	 EXPERIMENTAL	SECTION	
GENERAL	METHODS	
Materials	
Commercial	 reagents	 were	 purchased	 from	 Sigma-Aldrich,	 Fisher	 Scientific,	 Alfa	 Aesar,	 TCI	 America,	
Frontier	 Scientific,	 or	Matrix	 Scientific,	 and	were	used	without	 further	purification,	with	 the	 following	
exceptions.	 	All	commercially	available	aryl	halides	were	purified	by	either	column	chromatography	or	
silica	gel	 filtration	to	remove	baseline	 impurities,	 followed	by	concentration	under	vacuum.	 	Ag2O	was	
purchased	from	Sigma-Aldrich.	A	gift	of	Pd(P(o-tol)3)2	was	donated	by	Johnson	Matthey.	Solvents	were	
purified	 via	 passage	 through	 packed	 columns	 as	 described	 by	 Pangborn	 and	 coworkers
71
	 (THF,	 Et2O,	
CH3CN,	CH2Cl2:	dry	neutral	alumina;	hexane,	benzene,	and	toluene,	dry	neutral	alumina	and	Q5	reactant;	
DMSO,	DMF:	activated	molecular	sieves).	 	Acetone	was	dried	by	stirring	24	hours	with	boric	anhydride	
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followed	by	 distillation.	 	 Anhydrous	 1,4-dioxane	was	 purchased	 from	 Sigma-Aldrich	 and	 used	without	
further	manipulation.		All	water	was	deionized	prior	to	use.	
General	experimental	procedures	
Unless	noted,	all	reactions	were	performed	in	round	bottom	flasks	fitted	with	rubber	septa	or	Teflon-lined	
screw-cap	vials	(vials:	VWR	catalog	number	66022-300;	vial	caps:	VWR	catalog	number	16198-911)	under	
argon	or	nitrogen.	Organic	solutions	were	concentrated	via	rotary	evaporation	under	reduced	pressure	
with	a	bath	temperature	of	30°C	unless	otherwise	noted.		Reactions	were	monitored	by	analytical	thin	
layer	chromatography	(TLC)	performed	using	the	indicated	solvent	on	normal	phase	Merck	silica	gel	60	
F254	plates	(0.25mm)	or	reverse	phase	Merck	silica	gel	60	RP-18	F254s	plates.		Compounds	were	visualized	
by	 exposure	 to	 a	 UV	 lamp	 (λ	 =	 254	 nm),	 and/or	 a	 solution	 of	 KMnO4	 and/or	 a	 solution	 of	 cerium	
ammonium	 molybdate	 followed	 by	 brief	 heating	 using	 a	 Varitemp	 heat	 gun.	 Normal	 phase	 column	
chromatography	was	performed	using	Merck	silica	gel	grade	9385	60Å	(230-400	mesh),	and	reverse	phase	
column	chromatography	was	performed	with	Luknova	C-18	silica	gel	SGFLASHC18-1.		Preparative	HPLC	
was	 performed	 with	 a	 Waters	 SunFire
TM
	 Prep	 C18	 OBD
TM
	 5µm	 30mm	 x	 150mm	 column,	 Part	 No.	
186002797.		Chiral	HPLC	was	performed	with	a	Chiralcel®	OD-H	column	(4.6mm	x	250mm,	5µm	particle	
size,	part	No.	14325),	a	Chiralcel®	AD-H	column	(4.6mm	x	250mm,	5µm	particle	size,	part	No.	19325),	and	
a	Chiralcel	AD-RH	column	(4.6mm	x	150mm,	5μm	particle	size,	part	No.	19724).		Chiral	GC	was	performed	
with	a	Cyclodex-B	column	(30m	x	0.250mm,	0.25μm	film,	part.	No.	112-2532).	
Structural	analysis	
1
H-NMR	and	
13
C-NMR	spectra	were	recorded	on	Varian	Unity	500,	Varian	Unity	Inova	500NB,	Varian	Unity	
400,	 Varian	 Unity	 500,	 or	 Carver	 B500	 instruments.	 	
11
B-NMR	 were	 recorded	 on	 a	 Varian	 Unity	 400	
spectrometer.	 	
31
P-NMR	and	
19
F-NMR	were	 recorded	on	Varian	Unity	 Inova	500,	Varian	Unity	 500,	 or	
Varian	Unity	400	instruments.		Chemical	shifts	(δ)	are	reported	in	parts	per	million	(ppm)	downfield	from	
tetramethylsilane	and	referenced	to	residual	protium	in	the	NMR	solvent	(benzene,	δ	=	7.16;	CHCl3,	δ	=	
7.26;	acetone,	δ	=	2.05,	center	line;	DMSO	δ	=	2.50,	center	line)	or	to	added	tetramethylsilane	(δ	=	0.00).		
13
C	NMR	spectra	in	D2O	are	referenced	to	added	acetonitrile	(δ	=	119.68,	1.47).		For	
1
H	spectra	taken	at	
50°C,	the	HOD	peak	was	set	to	4.496	ppm.
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			Data	are	reported	as	follows:	chemical	shift,	multiplicity	(s	
=	singlet,	d	=	doublet,	t	=	triplet,	q	=	quartet,	quint	=	quintet,	sept	=	septet,	m	=	multiplet,	b	=	broad,	app	
=	 apparent),	 coupling	 constant	 (J)	 in	Hertz	 (Hz),	 and	 integration.	 	 Chemical	 shifts	 (δ)	 for	 13C	NMR	are	
reported	 in	 ppm	downfield	 from	 tetramethylsilane	 and	 referenced	 to	 carbon	 resonances	 in	 the	NMR	
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solvent	(benzene-d6,	δ	=	128.06,	center	line;	CDCl3,	δ	=	77.0,	center	line;	acetone-d6,	δ	=	29.5,	center	line;	
DMSO-d6	δ	=	39.52,	center	 line).	Carbons	bearing	boron	substituents	were	not	observed	 (quadrupolar	
relaxation).	
	
GENERAL	PROCEDURES	
A.	 Synthesis	of	MIDA	and	BIDA	Boronates	
To	a	250-mL	round-bottom	flask	with	a	stir	bar	was	added	racemic	sec-butylboronic	acid	(±)-3.22	(1.02	g,	
10	mmol,	1.0	eq,	obtained	from	Frontier	Scientific),	N-methyliminodiacetic	acid	(MIDA	SI-3.1)	(1.77	g,	12	
mmol,	1.2	eq),	DMSO	(10	mL,	1.0	Molar	in	boronic	acid),	and	toluene	(90	mL,	0.11	Molar	in	boronic	acid).		
The	mixture	was	fitted	with	a	Dean	Stark	trap,	on	top	of	which	was	fitted	a	reflux	condenser.		The	mixture	
was	heated	to	reflux	and	water	was	collected	in	the	trap	for	2	hours,	at	which	point	complete	conversion	
of	the	boronic	acid	was	confirmed	by	TLC	(100%	EtOAc,	KMnO4).		The	toluene	was	then	removed	by	rotary	
evaporation.	 	 H2O	 (75	mL)	 was	 added,	 and	 the	mixture	 was	 extracted	with	 EtOAc	 (5	 x	 75	mL).	 	 The	
combined	organic	phase	was	washed	with	H2O	(5	x	75	mL).		The	organic	phase	was	then	dried	over	Na2SO4	
and	concentrated	under	vacuum	to	give	2-butyl	MIDA	boronate	SI-3.2	as	a	white	solid	(1.49	g,	70%),	which	
was	used	without	purification.		This	material	was	stable	in	a	capped	vial	under	air	on	a	bench	top	for	at	
least	4	months.	
The	synthesis	of	BIDA	boronates	was	performed	with	this	same	procedure,	using	BIDA	SI-3.3	 (0.83	eq)	
instead	of	MIDA.		The	resulting	diastereomeric	mixtures	were	resolved	by	recrystallization	and/or	column	
chromatography.	 	Specifically,	crude	BIDA	boronate	(mixture	of	3.58	and	epi-3.58,	prepared	from	41.2	
mmol	of	boronic	acid	(±)-3.22	and	34.4	mmol	BIDA	SI-3.3)	was	filtered	through	a	pad	of	silica	gel,	rinsing	
with	acetone.	After	rotary	evaporation,	the	crude	product	(12.03	g,	94%	crude	yield)	was	dissolved	under	
nitrogen	in	anhydrous	boiling	acetone	(35	mL).		After	cooling	to	room	temperature,	anhydrous	Et2O	(70	
mL)	was	added	gradually.		The	mixture	was	cooled	to	0°C	and	filtered	through	a	medium	porosity	glass	
frit,	 affording	 a	 partially	 resolved	 product	 (4.72	 g,	 12.7	 mmol).	 	 This	 diastereomeric	 mixture	 was	
recrystallized	in	the	same	manner	(24	mL	acetone,	48	mL	Et2O,	giving	9.37	mmol	product,	98:2	d.r.).		A	
third	recrystallization	(20	mL	acetone,	40	mL	Et2O)	gave	the	≥99:1	d.r.	BIDA	boronate	3.58	(2.836	g,	7.598	
mmol,	22%	yield).	 	
1
H-NMR	in	CDCl3	showed	a	diastereomeric	ratio	of	≥99:1	by	 integrating	the	methyl	
signals	of	3.58	and	epi-3.58	at	0.88	and	1.00	ppm,	respectively.	
3.58,	99:1	d.r.:	1H	NMR	(500	MHz,	CDCl3)	δ	7.43	–	7.35	(m,	3H),	7.32	–	7.28	(m,	2H),	4.65	(d,	J	=	11.5	Hz,	
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1H),	4.38	(d,	J	=	11.5	Hz,	1H),	4.01	(d,	J	=	16.7	Hz,	1H),	3.90	(q,	J	=	6.8	Hz,	1H),	3.65	–	3.58	(m,	2H),	3.44	(d,	
J	=	16.6	Hz,	1H),	3.32	(d,	J	=	16.9	Hz,	1H),	2.23	(m,	1H),	2.07	(m,	1H),	1.93	–	1.62	(m,	4H),	1.49	(m,	1H),	1.27	
(m,	1H),	0.93	(t,	J	=	7.4	Hz,	3H),	0.88	(d,	J	=	7.0	Hz,	3H),	0.76	(m,	1H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	168.91,	167.35,	136.41,	128.99,	128.76,	128.45,	79.16,	72.11,	72.09,	61.07,	
56.13,	29.62,	26.60,	25.25,	21.42,	14.30,	12.79.	
11
B	NMR	(128	MHz,	CDCl3)	δ	14.03.	
HRMS	(ESI
+
)	
Calculated	for	C20H29BNO5	(M+H)
+
:	374.2139	
Found:	374.2140	
B.	Synthesis	of	Sodium	Alkyltrihydroxyborate	Salts	
	
To	a	stir	bar-equipped	250-mL	round-bottom	flask	under	air	was	added	BIDA	boronate	3.58	(2.426	g,	6.499	
mmol,	1.00	eq),	THF	(33	mL,	0.20	Molar)	and	freshly	prepared	1	Molar	NaOH	(33	mL,	5.0	eq).		The	mixture	
was	stirred	at	23	°C	until	complete	conversion	was	confirmed	by	TLC	(1:1	Hex/EtOAc,	KMnO4).		THF	was	
removed	under	rotary	evaporation	(bath	temperature	40°C).		When	most	of	the	THF	was	removed,	the	
receiving	 flask	 was	 emptied	 and	 dried	 and	 rotary	 evaporation	 was	 then	 continued	 until	 water	
condensation	began	to	collect	in	the	receiving	flask.		Saturated	NH4Cl	(33	mL)	was	added	to	the	resulting	
aqueous	 solution	and	 this	was	extracted	with	MTBE	 (4x33	mL)	 in	a	 separatory	 funnel.	 	 The	combined	
MTBE	phase	was	dried	over	Na2SO4	and	partially	concentrated	(volume	=	33	mL,	0.20	Molar)	by	rotary	
evaporation.		To	this	solution	was	added	aqueous	50%	NaOH	(0.343	mL,	0.520	g	solution,	0.260	g	NaOH,	
6.50	mmol)	 over	 one	minute	with	 rapid	 stirring.	 	 The	 suspension	was	 stirred	 for	 20	minutes	 at	 23°C,	
causing	a	white	precipitate	to	form.		The	flask	was	then	sonicated	for	5	minutes.		The	white	precipitate	
was	collected	by	concentration	in	vacuo	or	by	filtration	through	a	medium	porosity	glass	frit,	rinsing	with	
MTBE.		The	product	was	dried	under	vacuum	at	<	1	mbar	at	23	°C	for	10	hours	to	give	(S)-SI-3.4	(0.8982	
g,	6.328	mmol,	97%	yield)),	as	a	colorless,	free-flowing	powder.		This	product	was	generally	stored	at	23	
°C	under	nitrogen.	
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1
H	NMR	(500	MHz,	D2O,	50°C)	δ	1.48	–	1.36	(m,	1H),	1.00	–	0.89	(m,	1H),	0.85	(t,	J	=	7.2	Hz,	3H),	0.75	(d,	J	
=	7.5	Hz,	3H),	0.20	(m,	1H). 
13
C	NMR	(126	MHz,	D2O,	50°C)	δ	26.56,	15.52,	14.14.	
11
B	NMR	(128	MHz,	D2O,	50°C)	δ	8.29.	
C.	Synthesis	of	Boronic	Acids	as	Dioxane	Solutions	
	
	 Sodium	alkyltrihydroxyborate	(S)-SI-3.4	(0.213	g,	1.50	mmol,	1.00	eq)	was	added	to	a	2	mL	screw-
cap	vial	with	a	stir	bar.		Anhydrous	dioxane	(1.15	mL,	1.3	Molar)	was	added	and	the	slurry	was	vigorously	
stirred.		BF3·OEt2	(0.185	mL,	0.213	g,	1.50	mmol,	1.00	eq)	was	added	dropwise	over	15	minutes	under	air.		
If	the	mixture	became	unstirrable,	it	was	periodically	capped	and	shaken	by	hand.		After	completion	of	
the	addition,	the	vial	was	capped	and	stirred	for	20	minutes.		The	resulting	thin	suspension	was	filtered	
by	passing	through	a	Pasteur	pipette	containing	40	mg	of	Celite	over	a	small	cotton	plug,	using	pressure	
from	an	applied	air	hose.		The	residue	from	the	vial	was	washed	through	with	additional	dioxane	(0.35	
mL,	1.0	Molar	theoretical	concentration).		The	resulting	homogeneous	solution	amounted	to	1.15	mL.		An	
aliquot	of	this	solution	(30	µl,	30	µmol	theoretical)	was	combined	with	a	standard	solution	DMSO-d6	and	
1,4-dimethoxybenzene	 (0.050	Molar,	 0.60	mL,	 30	µmol	1,4-dimethoxybenzene)	 in	 an	NMR	 tube.	 	 The	
boronic	acid	was	analyzed	by	
1
H-NMR	with	the	relaxation	delay	(d1)	set	to	10	seconds.			The	concentration	
of	boronic	acid	3.22	was	determined	to	be	1.07M,	giving	a	yield	of	82%.		The	only	visible	impurity	was	
diethyl	 ether.	 	 This	 solution	 was	 diluted	 to	 0.91	 Molar	 by	 adding	 dioxane	 (0.20	 mL)	 and	 was	 then	
transferred	in	a	capped	vial	into	a	glovebox	and	used	in	the	cross	coupling	step.		In	a	stability	test,	this	
boronic	 acid	 solution	was	 stored	on	 the	benchtop	under	 air	 for	 4	months	 and	 showed	 less	 than	10%	
decomposition.	
This	procedure	proved	to	be	scalable	and	could	also	be	carried	out	in	7	mL	vials	using	3-4	mmol	of	the	
sodium	alkyltrihydroxyborate.	
3.22:	1H	NMR	(400	MHz,	DMSO-d6)	δ	7.25	(s,	2H),	1.33	(dq,	J	=	15.2,	7.8	Hz,	1H),	1.17	(dq,	J	=	13.5,	6.7	Hz,	
1H),	0.88	–	0.74	(m,	6H),	0.69	(quint,	J	=	7.2	Hz,	1H).	 	
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D.	Set-up	of	the	Csp
3
	Cross-Coupling	Reaction	
Ligand	Testing	
To	a	stir	bar-equipped	7	mL	vial	were	added	phosphine	ligand	(0.010	mmol,	10	mol%),	Pd2dba3	(4.6	mg,	
0.0050	mmol,	5	mol%),	4-bromobiphenyl	3.23	(23.3	mg,	0.100	mmol,	1.00	eq),	and	Ag2O	(69.5	mg,	0.3	
mmol,	3	eq).		A	dioxane	solution	of	boronic	acid	(S)-3.22	(0.91	Molar,	0.220	mL,	0.200	mmol,	2.00	eq)	
was	added	by	pipette.		The	vial	was	tightly	sealed	with	a	teflon-lined	screw	cap	and	stirred	at	200	rpm	at	
85°C	for	24	hours.		Upon	completion,	the	reaction	mixture	was	filtered	through	a	silica	gel	plug	in	a	
Pasteur	pipette,	rinsing	with	HPLC	grade	hexanes.		The	filtrate	was	collected	in	a	25	mL	volumetric	flask	
and	diluted	with	hexanes	up	to	the	mark.		After	thorough	mixing,	an	aliquot	of	this	solution	was	
transferred	to	an	HPLC	vial	and	immediately	subjected	to	HPLC	analysis	(OD-H	chiral	column,	2.0	
mL/min,	isocratic	100%	hexanes,	214.4	nm	absorbance).		On	each	new	day	of	HPLC	analysis,	a	standard	
solution	of	the	branched	product	standard	was	analyzed	in	duplicate	to	confirm	the	bulb	brightness	and	
to	adjust	response	factors	if	necessary.		If	peak	retention	times	drifted,	standards	were	repeated	as	
necessary	to	confirm	the	identity	of	the	peaks.	
Substrate	Table	
The	reaction	was	assembled	as	described	above,	except	using	1.5	equivalents	of	Ag2O	(34.8	mg,	0.15	
mmol).		After	24	hours,	the	reactions	were	cooled	and	filtered	through	silica	gel	in	a	glass	pipet,	rinsing	
with	Et2O	or	EtOAc.		An	aliquot	of	the	crude	reaction	mixture	was	first	subjected	to	HPLC	analysis	to	
determine	the	branched/linear	product	ratio,	comparing	with	an	authentic	sample	of	the	linear	product	
isomer.		The	crude	reaction	was	then	purified	by	column	chromatography,	and	then	the	
enantiospecificity	was	determined	by	chiral	HPLC.	
E.	Improved	Synthesis	and	Recovery	of	the	BIDA	Ligand	
	
2,2'-(((1S,2S)-2-(benzyloxy)cyclopentyl)azanediyl)diacetic	acid	(BIDA)	SI-3.3.		A	stir	bar-equipped,	3-
neck	5	liter	round	bottom	flask	was	fitted	with	a	reflux	condenser	and	a	thermometer.		Under	air,	this	
flask	was	charged	with	K2CO3	(213	g,	1.54	mol,	5.00	eq),	MeCN	(500	mL),	and	(1S,2S)-(+)-2-
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benzyloxycyclopentylamine	(58.8	g,	308	mmol,	1.00	eq).		This	mixture	was	cooled	to	0°C,	and	a	solution	
of	tert-butyl	bromoacetate	(109	mL,	144	g,	740	mmol,	2.40	eq)	in	MeCN	(250	mL)	was	added,	rinsing	
with	MeCN	(for	a	total	volume	of	935	mL	MeCN,	0.33	Molar).		The	mixture	was	stirred	at	70°C	for	24	
hours.	
	 The	next	day,	the	mixture	was	filtered	through	celite,	rinsing	with	EtOAc.		The	filtrate	was	
concentrated	thoroughly	in	vacuo	to	afford	a	viscous	oil.		Using	formic	acid	(310	mL,	378	g,	8.21	mol,	
26.7	eq),	the	crude	product	was	transferred	to	a	stir	bar	equipped	3-neck	3	liter	round	bottom	flask.		
The	flask	was	equipped	with	a	Vigreux	condenser	and	heated	at	85°C	for	2	hours.		An	aliquot	of	the	
reaction	was	examined	by	NMR,	confirming	that	the	deprotection	was	complete.	
	 The	reaction	was	thoroughly	concentrated	in	vacuo	to	remove	all	formic	acid.		The	resulting	
viscous	red	oil	was	dissolved	in	hot	EtOH	(1250	mL),	creating	a	super	saturated	solution.		Soon	after,	a	
white	powder	began	to	crash	out.		The	mixture	was	cooled	to	0°C	and	filtered	through	a	medium	
porosity	glass	frit,	rinsing	with	additional	cold	EtOH.		The	product	was	dried	in	vacuo	to	afford	an	off-
white	powder	of	SI-3.3	(56.6	g,	184	mmol,	70%	overall	yield).		Product	characterization	matched	a	
previous	report.
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BIDA	Recovery.		After	hydrolysis	of	BIDA	boronates	and	the	preparation	of	sodium	alkyltrihydroxyborate	
salts,	the	BIDA	ligand	could	be	recovered	in	85%	yield.		Specifically,	BIDA	boronate	3.58	(≥99:1	d.r.,	0.933	
g,	2.50	mmol)	was	converted	to	sodium	alkyltrihydroxyborate	salt	(S)-3.4	by	General	Procedure	B.		After	
addition	of	saturated	aqueous	NH4Cl	and	MTBE	extraction,	the	aqueous	phase	was	acidified	to	pH	3	with	
4	Molar	HCl	and	then	concentrated	by	rotary	evaporation	with	a	40°C	bath	until	precipitation	began.		
The	solution	was	then	stirred	in	an	ice	bath	for	one	hour.		Filtration	through	a	medium	porosity	glass	frit	
followed	by	drying	on	high	vacuum	afforded	BIDA	SI-3.3	as	a	white	solid	(0.651	g,	2.12	mmol).	
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SYNTHESIS	AND	CHARACTERIZATION	OF	PHOSPHINE	LIGANDS	
	
	
Tris(2-methylphenyl)phosphine	3.28.	 	This	 ligand	was	purchased	from	Sigma	Aldrich	 (Product	number	
287822,	Lot	number	MKBK8331V).	
	
	
Tris(2-ethylphenyl)phosphine	3.29.		An	oven	dried,	50	mL	3-neck	round	bottom	flask	equipped	with	a	
stir	bar	was	fitted	with	a	thermometer	adapter,	a	nitrogen	inlet,	and	a	rubber	septum.		The	apparatus	
was	vac-filled	three	times	with	nitrogen	and	charged	with	1-bromo-2-ethylbenzene	(0.55	mL,	740	mg,	
4.0	mmol,	1.0	equiv.)	and	THF	(6.5	mL,	1.6	Molar).	The	RBF	was	lowered	into	a	dry	ice/acetone	bath	and	
allowed	to	equilibrate	for	over	20	minutes.		nbutyllithium	(1.6	Molar	in	hexanes,	2.4	mL,	3.8	mmol,	0.95	
equiv.)	was	added	dropwise	over	10	minutes,	keeping	temperature	below	-60°C.		The	reaction	
appearance	changed	from	colorless	to	green.	Following	the	addition,	the	reaction	mixture	was	allowed	
to	stir	for	one	hour	and	50	minutes	in	the	dry	ice	/	acetone	bath.	
An	oven	dried	40	mL	vial	equipped	with	a	stir	bar	was	backfilled	with	nitrogen	and	charged	with	
phosphorus	trichloride	(0.36	mL,	0.565	g,	4.12	mmol)	and	THF	(8.0	mL;	0.515	Molar).	2.1	mL	of	the	
resulting	PCl3	solution	(1.08	mmol,	0.27	eq)	was	transferred	to	the	reaction	mixture	over	10	minutes	
(maintaining	a	temperature	below	-54°C).	Following	the	addition,	the	reaction	mixture	was	allowed	to	
stir	and	warm	to	room	temp	overnight.	The	reaction	mixture	was	cooled	to	0°C	in	an	ice	/	water	bath	
and	was	quenched	with	0.7mL	water	and	8mL	NH4Cl	following	equilibration.	The	quenched	solution	was	
then	transferred	to	a	separatory	funnel,	rinsing	with	water	and	toluene.	After	removing	the	organic	
layer,	the	aqueous	layer	was	extracted	with	toluene	(2	x	10	mL).	Combined	organics	were	washed	with	
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brine,	dried	over	Na2SO4,	filtered,	and	concentrated	by	rotary	evaporation	to	afford	a	sticky	
white/yellow	solid	was	allowed	to	dry	overnight	on	high	vac.		The	crude	product	was	purified	by	normal	
phase	column	chromatography	(4.5	x	9	cm	silica	gel	column,	isocratic	100%	hexanes),	affording	the	pure	
3.29	as	a	white	solid	(251.4	mg,	0.7256	mmol,	67%	yield).	
1
H	NMR	(500	MHz,	acetone-d6)	δ	7.30-7.23	(m,	6H),	7.05	(m,	3H),	6.70	(m,	3H),	2.76	(dq,	J	=	7.5,	1.2	Hz,	
6H),	1.07	(t,	J	=	7.5	Hz,	9H).	
13
C	NMR	(126	MHz,	acetone-d6)	δ	149.31	(d,	JC-P	=	25.7	Hz),	135.60	(d,	JC-P	=	11.6	Hz),	134.60,	130.06,	
129.45	(d,	JC-P	=	5.0	Hz),	126.96,	28.19	(d,	JC-P	=	22.4	Hz),	15.69	(d,	JC-P	=	3.0	Hz).	
31
P	NMR	(202	MHz,	acetone-d6,	referenced	to	H3PO4	in	D2O)	δ	-35.62.	
Rf	=	0.31	on	normal	phase	TLC	in	100%	hexanes	
HRMS	(ESI
+
)	
Calculated	for	C24H28P	(M+H)
+
:	347.1929	
Found:	347.1926	
	
	
Tris(2-npropylphenyl)phosphine	3.30.		To	a	dry	100	mL	recovery	flask	equipped	with	a	stir	bar,	charged	
with	P(2-Me-Ph)3	3.28	(0.30636	g,	1.007	mmol,	1.0	equiv),	and	vac-filled	with	nitrogen	was	added	
TMEDA	(0.53	mL,	0.4108	g,	3.53	mmol,	3.51	equiv)	and	dry	hexanes	(30	mL,	0.034	Molar).	Once	the	
solution	became	homogeneous,	nbutyllithium	(1.6	Molar	in	hexanes,	2.2	mL;	3.52	mmol;	3.5	equiv.)	was	
added	dropwise	over	10	minutes.	The	resulting	solution	was	allowed	to	stir	overnight	as	it	progressed	
from	a	bright	yellow	solution	to	a	deep	red	mixture	with	an	orange	precipitate.		To	the	stirring	reaction	
mixture	was	added	1-bromoethane	(0.42	mL;	0.613	g;	5.6	mmol;	5.6	equiv.)	as	a	solution	in	hexanes	
(10%	v/v;	3.8	mL;	0.26	Molar)	dropwise	over	10	minutes	at	room	temperature.	The	resulting	solution	
was	allowed	to	stir	at	that	temperature	for	two	hours	as	it	progressed	from	a	deep	red	solution	to	an	
opaque	bright	yellow	mixture.	
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The	reaction	mixture	was	transferred	to	a	separatory	funnel	rinsing	with	NH4Cl	and	hexanes.	The	
crude	mixture	was	washed	with	NH4Cl	(2	x	50	mL)	and	brine	(2	x	50	mL),	dried	over	Darco	+	Na2SO4,	and	
concentrated	in	vacuo	to	afford	a	clear	oil.		The	crude	product	was	left	on	high	vac	overnight,	causing	
the	formation	of	a	white	precipitate.		This	crude	product	was	purified	by	normal	phase	column	
chromatography	(3	x	13	cm	silica	gel,	isocratic	100%	hexanes),	affording	the	product	3.30	as	a	white	
solid	(0.238	g;	0.613	mmol,	61%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.26	(dt,	J	=	7.4,	1.3	Hz,	3H),	7.22	(m,	3H),	7.05	(td,	J	=	7.4,	1.5	Hz,	3H),	6.76	
(ddd,	J	=	7.6,	4.0,	0.7	Hz,	3H),	2.74	(t,	J	=	7.7	Hz,	6H),	1.60	(h,	J	=	8.1	Hz,	6H),	0.89	(t,	J	=	7.3	Hz,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	147.31	(d,	J	=	26.0	Hz),	135.53	(d,	J	=	12.4	Hz),	134.23,	129.21	(d,	J	=	5.1	Hz),	
128.74,	126.12,	36.92	(d,	J	=	20.5	Hz),	24.50	(d,	J	=	3.3	Hz),	14.24.	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-33.65.	
Rf	=	0.29	on	normal	phase	TLC	in	100%	hexanes	
HRMS	(EI
+
)	
Calculated	for	C27H33P:	388.23199	
Found:	388.23177	
	
	
Tris(2-butylphenyl)phosphine	3.31.		To	an	oven	dried	100	mL	recovery	flask	equipped	with	a	stir	bar,	
charged	with	P(2-Me-Ph)3	(0.30535	g,	1.00	mmol,	1.00	equiv),	and	vac-filled	with	nitrogen	was	added	
TMEDA	(0.53	mL,	0.4108	g,	3.53	mmol,	3.53	equiv)	and	dry	hexanes	(30	mL,	0.033	Molar).	Once	the	
solution	was	homogeneous,	nbutyllithium	(1.6	Molar	in	Hexanes,	2.2	mL,	3.52	mmol,	3.52	equiv.)	was	
added	dropwise	over	10	minutes.	The	resulting	solution	was	allowed	to	stir	overnight	as	it	progressed	
from	a	bright	yellow	solution	to	a	deep	red	solution	with	orange	precipitate.		The	next	day,	to	the	
stirring	reaction	mixture	was	added	1-bromopropane	(0.45	mL,	0.608	g,	4.94	mmol,	4.94	equiv.)	as	a	
solution	in	hexanes	(10%	v/v,	3.8	mL,	0.26	Molar)	dropwise	over	10	minutes	at	room	temperature.	The	
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reaction	was	allowed	to	stir	for	two	hours	as	it	progressed	from	a	deep	red	solution	to	an	opaque	bright	
yellow	solution.		
The	reaction	mixture	transferred	to	a	separatory	funnel	rinsing	with	NH4Cl	and	hexanes.	The	
crude	mixture	washed	with	NH4Cl	(2	x	50	mL)	and	brine	(2	x	50	mL),	dried	over	Darco	+	Na2SO4,	and	
concentrated	in	vacuo	to	afford	a	clear	oil.	The	crude	product	left	on	high	vac	overnight	which	started	
the	formation	of	white	precipitate.	The	crude	material	was	purified	by	normal	phase	column	
chromatography	(3	x	9	cm	silica	gel,	isocratic	100%	hexanes),	affording	the	pure	product	3.31	as	a	white	
solid	(0.31392	g,	0.7290	mmol,	73%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.26	(dt,	J	=	7.4,	1.4	Hz,	3H),	7.21	(ddd,	J	=	7.6,	4.6,	1.5	Hz,	3H),	7.05	(td,	J	=	
7.4,	1.6	Hz,	3H),	6.76	(ddd,	J	=	7.7,	4.0,	1.4	Hz,	3H),	2.76	(t,	J	=	7.8	Hz,	6H),	1.55	(m,	6H),	1.31	(h,	J	=	7.4	
Hz,	6H),	0.84	(t,	J	=	7.4	Hz,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	147.55	(d,	J	=	25.9	Hz),	135.45	(d,	J	=	12.2	Hz),	134.25,	129.19	(d,	J	=	5.1	Hz),	
128.75,	126.07,	34.60	(d,	J	=	20.6	Hz),	33.59	(d,	J	=	3.2	Hz),	22.83,	14.06.	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-33.63	
Rf	=	0.38	on	normal	phase	TLC	in	100%	hexanes	
HRMS	(ES
+
)	
Calculated	for	C30H40P:	431.2868	
Found:	431.2870	
	
	
Tris(2-isopropylphenyl)phosphine	3.32.		An	oven	dried,	50mL	3-neck	round	bottom	flask	equipped	with	
a	stir	bar	was	fitted	with	a	thermometer	adapter,	a	nitrogen	inlet,	and	a	rubber	septum.		The	apparatus	
was	vac-filled	three	times	with	nitrogen	and	charged	with	1-bromo-2-isopropylbenzene	(0.61	mL,	793	
mg,	3.98	mmol,	1.0	equiv.)	and	THF	(6.5	mL,	0.61	M).		The	round	bottom	flask	was	lowered	into	a	dry	ice	
/	acetone	bath	and	allowed	to	equilibrate	over	20	minutes.	At	this	point,	n-butyllithium	(1.6M	in	
Hexanes,	2.4	mL,	3.84	mmol,	0.96	equiv.)	was	added	dropwise	over	10	minutes	(keeping	the	internal	
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temperature	below	-60°C),	causing	the	reaction	appearance	to	change	from	colorless	to	green.	
Following	the	addition,	the	reaction	mixture	was	allowed	to	stir	for	1	hour	and	50	minutes	in	the	dry	ice	
/	acetone	bath.	
An	oven	dried	40	mL	vial	equipped	with	a	stir	bar	was	vac-filled	with	nitrogen	and	charged	with	
phosphorus	trichloride	(0.36	mL,	0.565	g,	4.12	mmol)	and	THF	(8.0	mL;	0.514	M).		A	portion	of	the	
resulting	PCl3	(2.1	mL,	1.08	mmol,	0.27	eq)	solution	was	transferred	to	the	reaction	mixture	over	10	
minutes	(keeping	the	internal	temperature	below	-54°C).	Following	the	addition,	the	reaction	mixture	
was	allowed	to	stir	and	warm	to	room	temp	overnight.	
The	next	day,	the	reaction	mixture	was	cooled	to	0°C	in	an	ice	/	water	bath	and	then	quenched	
with	water	(0.7	mL)	and	NH4Cl	(8	mL).	Quenched	solution	was	then	transferred	to	separatory	funnel,	
rinsing	with	water	and	toluene.	After	removing	the	organic	layer,	the	aqueous	layer	was	extracted	with	
toluene	(2	x	10	mL).	Combined	organics	were	washed	with	brine,	dried	over	Na2SO4,	
filtered,	and	concentrated	in	vacuo	to	afford	a	sticky	white/yellow	solid	was	allowed	to	dry	overnight	on	
high	vac.		The	crude	product	was	purified	by	normal	phase	column	chromatography	(4.5	x	8	cm	silica	gel,	
isocratic	100%	hexanes),	affording	the	product	3.32	as	a	white	solid	(206.7	mg,	0.532	mmol	49%	yield).	
1
H	NMR	(500	MHz,	acetone-d6)	δ	7.42	(ddd,	J	=	7.9,	4.5,	1.4	Hz,	3H),	7.37	(td,	J	=	7.4,	1.4	Hz,	3H),	7.10	
(dt,	J	=	7.5,	1.3	Hz,	3H),	6.78	(dddd,	J	=	7.7,	4.0,	1.4,	0.5	Hz,	3H),	3.70	(o,	J	=	7.0	Hz,	3H)	1.12	(d,	J	=	6.8	Hz,	
18H).	
13
C	NMR	(126	MHz,	acetone-d6)	δ	153.86	(d,	J	=	24.4	Hz),	135.51	(d,	J	=	10.8	Hz),	134.72,	130.22,	126.83,	
126.36	(d,	J	=	4.7	Hz),	32.01	(d,	J	=	25.9	Hz),	24.02.	
31
P	NMR	(202	MHz,	acetone-d6,	referenced	to	H3PO4	in	D2O)	δ	-37.87.	
Rf	=	0.29	on	normal	phase	TLC	in	100%	hexanes.	
HRMS	(ES
+
)	
Calculated	for	C27H34P:	389.2398	
Found:	389.2387	
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1-(2-bromophenyl)cyclobutan-1-ol	SI-3.5.		A	dry,	stir	bar-equipped	250	mL	Schlenk	flask	was	put	under	
nitrogen.		To	a	dry	40	mL	vial	was	added	1,2-dibromobenzene	(2.359	g,	10.00	mmol,	1.00	eq),	and	the	
vial	was	carefully	put	under	nitrogen	(using	brief	vac-fill	cycles	in	case	of	compound	volatility).		The	
dibromide	was	transferred	to	the	Schlenk	flask	using	Et2O,	and	then	additional	Et2O	(20	mL	total)	and	
THF	(20	mL)	were	added.		The	stirring	mixture	was	cooled	to	-114°C	in	an	EtOH	/	liquid	nitrogen	bath.		
To	this	colorless	solution	was	added	n-butyllithium	(1.6	M	in	hexanes,	5.81	mL,	9.3	mmol,	9.3	eq,	
dropwise	over	15-20	minutes),	causing	the	reaction	appearance	to	gradually	change	to	light	yellow	and	
then	to	a	white	suspension.		After	50	minutes,	cyclobutanone	(0.70	mL,	0.657	g,	9.37	mmol,	0.94	eq)	
was	added	(neat,	dropwise	over	5	minutes).		Several	minutes	after	the	addition	was	complete,	the	-
116°C	bath	was	exchanged	for	a	-78°	C	dry	ice	/	acetone	bath.		With	efficient	stirring,	the	reaction	was	
allowed	to	gradually	warm	to	room	temperature	overnight.	
	 The	next	day,	the	reaction	was	quenched	with	saturated	NH4Cl	(20	mL)	and	H2O	(30	mL).		The	
aqueous	layer	was	extracted	with	Et2O	(2x50	mL).		The	combined	organic	layers	were	washed	with	brine	
(80	mL),	dried	with	Na2SO4,	decanted,	and	concentrated.		The	crude	product	was	purified	by	normal	
phase	column	chromatography	(isocratic	10:1	Hex/EtOAc),	which	gave	the	product	as	a	fluffy	white	solid	
(1.350	g,	5.599	mmol,	60%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.57	(dd,	J	=	7.9,	1.2	Hz,	1H),	7.40	(dd,	J	=	7.7,	1.7	Hz,	1H),	7.31	(td,	J	=	7.5,	
1.3	Hz,	1H),	7.14	(ddd,	J	=	8.0,	7.4,	1.7	Hz,	1H),	2.69	(tdd,	J	=	8.9,	7.4,	3.2	Hz,	3H),	2.53-2.46	(m,	2H),	2.19	
(dtt,	J	=	11.0,	9.0,	7.5	Hz,	1H),	1.70	(dtt,	J	=	11.0,	8.9,	5.1	Hz,	1H).	
13
C	NMR	(500	MHz,	CDCl3)	δ	143.72,	134.23,	129.19,	127.52,	127.42,	121.96,	79.32,	35.52,	14.63.	
Rf	=	0.22	on	normal	phase	TLC	in	10/1	Hex/EtOAc.	
HRMS	(EI
+
)	
Calculated	for	C10H10OBr:	224.99150		
Found:	224.99167	
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1-bromo-2-cyclobutylbenzene	SI-3.6.		To	a	40	mL	vial	was	added	1-(2-bromophenyl)cyclobutan-1-ol	
(0.9084	g,	4.00	mmol,	1.00	eq)	and	dry	THF	(4	mL,	1.00	Molar)	under	air.		The	headspace	of	the	vial	was	
flushed	with	nitrogen,	and	then	it	was	capped.		BF3OEt2	(2.96	mL,	3.41	g,	24.0	mmol,	6.00	eq)	was	added	
to	the	reaction	dropwise	over	two	or	three	minutes.		NaCNBH3	(1.005	g,	16.0	mmol,	4.00	eq)	was	then	
added	portionwise,	causing	intense	bubbling	with	some	heat.		The	resulting	suspension	was	stirred	
overnight	under	nitrogen	at	67°C.	
After	24	hours,	the	reaction	was	cooled	reaction	to	room	temperature	and	treated	with	1	Molar	
NaOH	(50	mL).		The	aqueous	layer	was	extracted	with	methyl	tert-butyl	ether	(2x50	mL),	and	the	
combined	organics	were	washed	with	1M	NaOH	(100	mL),	dried	(Na2SO4),	decanted,	and	concentrated,	
affording	a	viscous	oil	with	some	low-boiling	impurities.		The	crude	product	was	purified	by	normal	
phase	column	chromatography	(250	mL	SiO2,	isocratic	100%	hexanes),	giving	partially	pure	product.		
This	material	was	purified	by	reverse	phase	MPLC	(gradient	of	50%	-	85%	MeCN	in	H2O,	extracting	
aqueous	fractions	with	pentane),	giving	the	desired	product	(0.3176	g,	1.505	mmol,	38%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.50	(dd,	J	=	7.9,	1.2	Hz,	1H),	7.32	(dd,	J	=	7.8,	1.9	Hz,	1H),	7.28	(td,	J	=	7.5,	
1.3	Hz,	1H).	7.04	(td,	J	=	7.6,	1.9	Hz,	1H),	3.76	(p,	J	=	9.1	Hz,	1H),	2.46-2.39	(m,	2H),	2.16-2.06	(m,	2H),	
2.05-1.97	(m,	1H),	1.82	(m,	1H).	
	
	
Tris(2-cyclobutylphenyl)phosphine	3.33.		To	a	dry	25	mL	Schlenk	flask	under	nitrogen	was	added1-
bromo-2-cyclobutylbenzene	(0.291	g,	1.376	mmol,	1.00	eq)	as	a	solution	in	dry	THF,	using	two	rinsings	
with	THF	for	quantitative	transfer	(total	volume	2.2	mL	THF).		The	solution	was	cooled	with	stirring	to	-
78	C	in	a	dry	ice	/	acetone	bath.		n-butyllithium	(1.6	Molar	in	hexanes,	0.82	mL,	1.307	mmol,	0.95	eq)	
was	added	dropwise	over	five	minutes,	resulting	in	a	yellow	solution	that	eventually	turned	into	a	light	
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yellow	suspension.		After	stirring	for	1.5	hours	at	-78°C,	phosphorus	trichloride	(31.9	μL,	50.3	mg,	0.366	
mmol,	0.27	eq)	was	added	neat	and	dropwise	over	2	or	3	minutes.		The	reaction	was	allowed	to	
gradually	warm	to	room	temperature.	
Two	days	later,	the	reaction	was	quenched	with	saturated	NH4Cl	(5	mL).		Transferred	to	a	30	mL	
separatory	funnel	(10	mL	H2O	and	15	mL	DCM).		The	aqueous	layer	was	extracted	with	DCM	(4x15	mL),	
and	combined	organics	were	washed	with	brine	(50	mL),	dried	(Na2SO4),	decanted,	and	concentrated.		
The	crude	product	was	purified	by	normal	phase	column	chromatography	(2.5	cm	diameter,	40	mL	silica	
gel,	isocratic	100%	hexanes),	giving	pure	product	as	a	white	powder	(93.9	mg,	0.221	mmol,	60%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.45	(ddd,	J	=	7.3,	4.5,	0.5	Hz,	3H),	7.33	(td,	J	=	7.5,	1.4	Hz,	3H),	7.02	(td,	J	=	
7.5,	1.3	Hz,	3H),	6.64	(ddd,	J	=	7.7,	4.2,	1.4	Hz,	3H),	4.04	(dqd,	J	=	13.7,	8.7,	5.0	Hz,	3H),	2.7-1.4	(br.	s,	
12H),	1.87	(h,	J	=	9.4	Hz,	3H),	1.77-1.68	(m,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	149.80	(d,	J	=	25.4	Hz),	135.59	(d,	J	=	12.4	Hz),	134.26,	128.95,	126.12	(d,	J	=	
5.5	Hz),	126.08,	39.50	(d,	J	=	22.4	Hz),	30.26	(br.	s),	18.33.	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-33.18.	
HRMS	(EI
+
)	
Calculated	for	C30H33P:	424.23199	
Found:	424.23205	
	
	
1-(2-bromophenyl)cyclopentan-1-ol	SI-3.7.		A	dry,	stir	bar-equipped	250	mL	Schlenk	flask	was	put	under	
nitrogen.		To	a	dry	40	mL	vial	was	added	1,2-dibromobenzene	(2.359	g,	10.00	mmol,	1.00	eq),	and	the	
vial	was	carefully	put	under	nitrogen	(using	brief	vac-fill	cycles	in	case	of	compound	volatility).		The	
dibromide	was	transferred	to	the	Schlenk	flask	using	Et2O,	and	then	additional	Et2O	(20	mL	total)	and	
THF	(20	mL)	were	added.		The	stirring	mixture	was	cooled	to	-114°C	in	an	EtOH	/	liquid	nitrogen	bath.		
To	this	colorless	solution	was	added	n-butyllithium	(1.6	M	in	hexanes,	5.81	mL,	9.3	mmol,	9.3	eq,	
dropwise	over	15-20	minutes),	causing	the	reaction	appearance	to	gradually	change	to	light	yellow	and	
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then	to	a	white	suspension.		After	50	minutes,	cyclopentanone	(0.84	mL,	0.799	g,	9.5	mmol,	0.95	eq)	
was	added	(neat,	dropwise	over	5	minutes).		About	2/3	of	the	way	through	the	addition,	the	reaction	
become	clear	and	mostly	colorless	again.		Several	minutes	after	the	addition	was	complete,	the	-116°C	
bath	was	exchanged	for	a	-78°	C	dry	ice	/	acetone	bath.		With	efficient	stirring,	the	reaction	was	allowed	
to	gradually	warm	to	room	temperature	overnight.	
The	next	day,	the	reaction	was	quenched	with	saturated	NH4Cl	(20	mL)	and	H2O	(30	mL).		The	
aqueous	layer	was	extracted	with	Et2O	(2x50	mL).		The	combined	organic	layers	were	washed	with	brine	
(80	mL),	dried	with	Na2SO4,	decanted,	and	concentrated,	affording	an	orange/red	oil	of	low	viscosity.		
The	crude	product	was	purified	by	normal	phase	column	chromatography	(8.5	cm	diameter,	9.5	cm	
height,	isocratic	10:1	Hex/EtOAc),	which	gave	the	product	as	a	fluffy	white	solid	(1.350	g,	5.599	mmol,	
60%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.59	(dt,	J	=	7.9,	1.9	Hz,	2H),	7.28	(td,	J	=	7.6,	1.4	Hz,	1H),	7.11	(td,	J	=	7.6,	1.7	
Hz,	1H),	2.31-2.23	(m,	2H),	2.22-2.16	(m,	2H),	2.02-1.93	(m,	2H),	1.86-1.78	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	144.53,	134.98,	128.73,	127.75,	127.43,	122.01,	84.04,	39.74,	23.97.	
Rf	=	0.17	on	normal	phase	TLC	in	10/1	Hex/EtOAc	
HRMS	(EI
+
)	
Calculated	for	C11H13OBr:	240.01498	
Found:	240.01507	
	
	
1-bromo-2-cyclopentylbenzene	SI-3.8.		A	dry,	stir-bar	equipped,	25	mL,	3-neck	round	bottom	flask	was	
fitted	with	a	reflux	condenser,	connected	to	a	Schlenk	line,	and	put	under	nitrogen.		1-(2-
bromophenyl)cyclopentan-1-ol	(0.7234	g,	3.00	mmol,	1.00	eq)	was	massed	out	in	a	dry	40	mL	vial	and	
then	put	under	nitrogen.		The	alcohol	was	transferred	to	the	round	bottom	flask	using	dry	THF	(3.2	mL	
total,	0.94	Molar).		At	room	temperature,	BF3OEt2	(2.22	mL,	2.56	g,	18.0	mmol,	6.0	eq)	was	added	
(dropwise	over	five	minutes)	to	the	stirring	reaction.		By	briefly	removing	one	of	the	septa	while	under	a	
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slight	positive	nitrogen	pressure,	NaCNBH3	(0.754	g,	12.0	mmol,	4.00	eq)	was	added	portionwise.		The	
reaction	was	stirred	at	70°	Celsius	overnight.	
After	being	cooled	to	room	temperature,	the	reaction	was	treated	with	1	Molar	NaOH	(50	mL)	
and	diluted	with	methyl	tert-butyl	ether	(50	mL).		*NOTE:	NaCNBH3	should	always	be	quenched	with	
base	to	avoid	formation	of	toxic	HCN.		The	aqueous	layer	was	extracted	with	MTBE	(2x50	mL).		
Combined	organics	were	washed	with	brine	(100	mL),	dried	with	Na2SO4,	and	concentrated	in	vacuo.		
The	crude	product	was	purified	via	normal	phase	column	chromatography	(isocratic	100%	hexanes),	
giving	1-bromo-2-(cyclopent-1-en-1-yl)benzene	(0.4133	g,	1.852	mmol,	62%	yield).	
A	portion	of	this	alkene	(0.3941	g,	1.766	mmol,	1.00	eq)	was	transferred	to	a	dry,	stir	bar-
equipped	40	mL	vial.		EtOH	(0.94	mL)	and	PtO2	(1.9	mg,	0.008	mmol,	0.8	mol%)	were	added,	and	the	
mixture	was	vac-filled	with	nitrogen.		Using	a	hydrogen	balloon,	the	reaction	was	then	vac-filled	5x	and	
allowed	to	stir	at	room	temperature	under	hydrogen	for	24	hours.		The	reaction	was	then	filtered	
through	a	silica	gel	plug,	rinsing	with	methanol.		The	filtrate	was	concentrated	and	then	purified	by	
normal	phase	column	chromatography	(60	mL	silica	gel,	isocratic	100%	hexanes),	giving	partially	pure	
product.		This	mixture	(0.3025	g)	was	characterized	by	NMR	and	found	to	consist	of	the	desired	product	
(1-bromo-2-cyclopentylbenzene,	92%	of	the	mixture	by	mass,	0.2782	g,	1.236	mmol,	70%	yield)	and	a	
reduced	side	product	(cyclopentylbenzene,
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	8%	of	the	mixture	by	mass,		24.3	mg,	0.166	mmol,	9%	
yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.53	(dd,	J	=	8.0,	1.3	Hz,	1H),	7.31-7.23	(m,	2H),	7.02	(ddd,	J	=	8.0,	7.0,	2.0	Hz,	
1H),	3.41	(tt,	J	=	9.2,	7.5	Hz,	1H),	2.15-2.06	(m,	2H),	1.86-1.77	(m,	2H),	1.76-1.66	(m,	2H),	1.62-1.51	(m,	
2H).		
13
C	NMR	(126	MHz,	CDCl3)	δ	145.48,	132.85,	127.62,	127.28,	127.23,	125.17,	44.93,	33.57,	25.62.	
HRMS	(EI
+
)	
Calculated	for	C11H13Br:	224.02006	
Found:	224.02012	
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Tris(2-cyclopentylphenyl)phosphine	3.34.		A	mixture	of	1-bromo-2-cyclopentylbenzene	(92%	by	mass)	
and	cyclopentylbenzene	(8%	by	mass)	was	massed	out	(0.2683	g	total,	0.2468	g	aryl	bromide,	1.096	
mmol	aryl	bromide,	1.00	eq.	aryl	bromide)	into	a	dry	40	mL	vial.		A	dry,	stir	bar-equipped	25	mL	Schlenk	
flask	was	put	under	nitrogen.		The	aryl	bromide	mixture	was	transferred	to	the	Schlenk	flask	using	dry	
THF	(2.2	mL	total),	and	the	mixture	was	cooled	to	-78°C	in	a	dry	ice	/	acetone	bath.		nbutyllithium	(1.6	
Molar	in	hexanes,	0.617	mL,	0.987	mmol,	0.90	eq)	was	added	dropwise	over	five	minutes.		The	reaction	
was	stirred	for	1	hour	and	20	minutes	at	-78°C,	and	phosphorus	trichloride	(23.9	μL,	37.6	mg,	0.274	
mmol,	0.25	eq)	was	added	neat	and	dropwise	over	1-2	minutes,	causing	the	reaction	appearance	to	
change	from	colorless	to	light	yellow.		The	reaction	was	allowed	to	stir	and	gradually	warm	to	room	
temperature	overnight.	
	 The	next	day,	the	reaction	was	quenched	with	saturated	NH4Cl	(5	mL).		Water	(10	mL)	and	DCM	
(15	mL)	were	added,	and	the	aqueous	layer	was	extracted	(4x15	mL	DCM).		Combined	organics	were	
washed	with	brine	(50	mL),	dried	with	Na2SO4,	decanted,	and	concentrated	in	vacuo.		The	crude	product	
was	purified	by	normal	phase	column	chromatography	(2	cm	diameter,	40	mL	silica	gel,	100%	hexanes	
to	10/1	Hex/DCM),	giving	pure	product	as	a	white	powder	(83.5	mg,	0.179	mmol,	65%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.35	(ddd,	J	=	7.9,	4.3,	1.4	Hz,	3H),	7.30	(td,	J	=	7.5,	1.4	Hz,	3H),	7.03	(td,	J	=	
7.4,	1.4	Hz,	3H),	6.78	(ddd,	J	=	7.7,	4.0,	1.4	Hz,	3H),	3.70	(ddt,	J	=	17.1,	9.5,	7.8	Hz,	3H),	2.05-1.65	(br.	s,	
6H),	1.80-1.70	(m,	6H),	1.62-1.52	(m,	6H),	1.52-1.40	(m,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	151.44	(d,	JC-P	=	24.2	Hz),	136.24	(d,	JC-P	=	10.5	Hz),	134.35,	129.03,	126.12	
(d,	JC-P	=	4.6	Hz),	125.79,	43.64	(d,	JC-P	=	24.9	Hz),	35.39,	26.20.	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-34.34.	
HRMS	(ES
+
)	
Calculated	for	C33H40P:	467.2868	
Found:	467.2887	
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Tris(2-cyclohexylphenyl)phosphine	3.35.		n-butyllithium	(1.6	Molar	in	hexanes,	0.625	mL,	1.00	mmol,	
0.97	eq)	was	added	to	a	-78°C	solution	of	1-bromo-2-cyclohexylbenzene	(0.246	g,	1.03	mmol,	1.00	eq)	in	
THF	(2.0	mL).		The	reaction	was	allowed	to	stir	for	one	hour	at	-78°C,	and	then	phosphorus	trichloride	
(29	μL,	45.4	mg,	0.332	mmol,	0.32	eq.)	was	added	(as	a	1.0	Molar	solution,	dropwise	over	five	minutes).		
The	reaction	was	allowed	to	continue	stirring	for	one	hour	and	then	warmed	to	room	temperature.	
	 The	reaction	was	quenched	by	addition	of	saturated	NH4Cl,	and	the	aqueous	layer	was	extracted	
with	EtOAc.		Combined	organics	were	dried	with	Na2SO4	and	concentrated	in	vacuo.		The	crude	product	
was	purified	by	normal	phase	column	chromatography	(isocratic	100%	hexanes),	giving	product	as	a	
white	powder	(70	mg,	0.138	mmol,	42%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.30	(m,	6H),	7.03	(m,	3H),	6.81	(qdd,	J	=	3.8,	1.1,	0.6	Hz,	3H),	3.28	(tdt,	J	=	
11.4,	7.7,	3.1	Hz,	1H),	1.77-1.63	(m,	15H),	1.43-1.31	(m,	6H),	1.28-1.15	(m,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	152.23	(d,	J	=	24.3	Hz),	135.53	(d,	J	=	11.2	Hz),	134.36,	128.90,	125.93	(d,	J	=	
4.9	Hz),	125.88,	42.16	(d,	J	=	24.9	Hz),	34.27,	27.17,	26.42.	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-37.11.	
Rf	=	0.20	on	normal	phase	TLC	in	isocratic	100%	hexanes.	
HRMS	(ES
+
)	
Calculated	for	C36H46P:	509.3337	
Found:	509.3343	
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Tris(2-phenethylphenyl)phosphine	3.36.		A	dry,	stir	bar-equipped	40	mL	vial	was	put	under	nitrogen	
before	adding	P(2-Me-Ph)3	(0.152	g,	0.500	mmol,	1.00	eq),	TMEDA	(0.249	mL,	0.193	g,	1.66	mmol,	3.33	
eq),	and	hexanes	(15.0	mL,	0.033	Molar).		To	this	stirring	solution	was	added	Nbutyllithium	(1.6	Molar	in	
hexanes,	1.04	mL,	1.67	mmol,	3.33	eq)	dropwise	at	room	temperature.		After	stirring	for	15	hours	at	
room	temperature,	the	solution	was	cooled	to	-78°C.		Benzyl	bromide	(0.297	mL,	0.428	g,	2.50	mmol,	
5.00	eq)	was	added	dropwise,	and	the	solution	was	allowed	to	warm	to	room	temperature	over	three	
hours.		Monitoring	of	the	reaction	by	TLC	(100%	hexanes)	showed	that	it	had	gone	to	full	conversion.	
	 The	reaction	was	quenched	by	adding	saturated	ammonium	chloride	and	then	extracted	with	
Et2O.		Combined	organic	layers	were	dried	with	Na2SO4	and	concentrated	in	vacuo.		The	crude	product	
was	purified	by	normal	phase	column	chromatography	(gradient	100%	hexanes	to	2%	EtOAc	in	hexanes)	
followed	by	reverse	phase	column	chromatography	(isocratic	100%	MeCN),	giving	the	pure	product	as	a	
viscous	oil	(0.110	g,	0.191	mmol,	38%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.29	(td,	J	=	7.4,	1.4	Hz,	3H),	7.24	(ddd,	J	=	7.6,	4.9,	1.7	Hz,	3H),	7.18	(m,	6H),	
7.15-7.10	(m,	6H),	7.08	(m,	6H),	6.87	(ddd,	J	=	7.7,	4.1,	1.4	Hz,	3H),	3.14	(t,	J	=	8.2	Hz,	6H),	2.83	(dd,	J	=	
10.2,	6.3	Hz,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	146.56	(d,	JC-P	=	25.9	Hz),	142.07,	135.05	(d,	JC-P	=	11.2	Hz),	134.50,	129.67	
(d,	JC-P	=	5.0	Hz),	129.20,	128.52,	128.41,	126.66,	125.94,	37.92	(d,	JC-P	=	2.9	Hz),	37.28	(d,	JC-P	=	21.2	Hz).	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-34.09	
HRMS	(EI
+
)	
Calculated	for	C14H10BrF3:	313.99179	
Found:	313.99135	
	
	
1-benzyl-2-bromobenzene	SI-3.9.		This	procedure	was	based	on	a	previous	report	of	the	selective	
coupling	of	benzylic	bromides.
74
		While	in	an	argon-filled	atmosphere	glovebox,	Pd(PPh3)4	(0.6933	g,	
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0.600	mmol,	2	mol%)	was	massed	out	into	a	stir	bar-equipped,	3-neck	500	mL	round	bottom	flask.		The	
flask	was	sealed	with	three	septa,	brought	out	into	a	fume	hood,	and	then	equipped	with	a	reflux	
condenser	attached	to	a	nitrogen	inlet.		After	the	system	was	put	under	nitrogen,	additional	reagents	
and	solvents	were	added	by	briefly	removing	a	septum	while	under	a	positive	nitrogen	pressure.		In	this	
manner,	ethanol	(48	mL,	0.63	Molar),	water	(13	mL,	2.3	Molar),	toluene	(58	mL,	0.52	Molar),	2-
bromobenzyl	bromide	(7.498	g,	30.0	mmol,	1.00	eq),	phenylboronic	acid	(3.66	g,	30.0	mmol,	1.00	eq),	
and	an	aqueous	solution	of	sodium	carbonate	(3.58	g,	33.8	mmol,	1.13	eq	in	34	mL	H2O)	were	added	to	
the	reaction.	
The	reaction	was	heated	to	80°C	for	24	hours,	cooled	to	room	temperature,	and	then	filtered	
through	celite.		After	concentration,	the	crude	material	was	diluted	with	H2O	and	extracted	with	Et2O.		
Combined	organics	were	washed	with	brine,	dried	with	Na2SO4,	decanted,	and	reconcentrated.		The	
product	was	purified	by	normal	phase	column	chromatography	(100%	hexanes)	followed	by	vacuum	
distillation	using	a	kugelrohr,	giving	aryl	bromide	SI-3.9	as	a	clear	colorless	oil	(4.189	g,	16.95	mmol,	56%	
yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.57	(dd,	J	=	8.0,	1.3	Hz,	1H),	7.30	(t,	J	=	7.4	Hz,	2H),	7.25-7.18	(m,	4H),	7.14	
(dd,	J	=	7.6,	1.7	Hz,	1H),	7.09	(td,	J	=	7.6,	1.7	Hz,	1H),	4.13	(s,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	140.50,	139.60,	132.98,	131.21,	129.13,	128.60,	128.01,	127.58,	126.38,	
125.03,	41.87.	
	
	
Tris(2-benzyl-phenyl)phosphine	3.37.	A	flame	dried,	250	mL,	1	neck	round	bottom	flask	was	equipped	
with	a	stir	bar,	sealed	with	a	septum,	and	put	under	nitrogen.		To	a	separate,	flame-dried	40	mL	vial	was	
added	2-benzyl-1-bromobenzene	SI-3.9	(4.19	g,	16.95	mmol,	1.00	eq).		The	vial	put	under	nitrogen,	and	
THF	(28	mL	total)	was	used	to	transfer	the	aryl	bromide	to	the	reaction	flask,	with	rinsing	for	
quantitative	transfer.		The	solution	was	cooled	by	submerging	in	a	dry	ice	/	acetone	bath.		To	the	-78°C	
mixture	was	added	nbutyllithium	(1.6	Molar	in	hexanes,	9.5	mL,	15.3	mmol,	0.90	eq)	dropwise	over	5-10	
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minutes,	causing	the	reaction	to	turn	a	cloudy	brownish/yellow.		The	reaction	was	allowed	to	stir	for	1.5	
hours	at	-78°C.		Phosphorus	trichloride	(0.37	mL,	0.582	g,	4.24	mmol,	0.25	eq)	was	added	neat	in	a	
dropwise	manner	over	2-3	minutes.		The	reaction	was	allowed	to	gradually	warm	to	room	temperature	
and	stirred	overnight.	
After	12	hours,	the	reaction	was	quenched	with	NH4Cl	(40	mL).		Water	(80	mL)	and	DCM	(120	
mL)	were	added,	and	the	aqueous	layer	was	extracted	(3x120	mL	DCM).		The	combined	organics	were	
washed	with	brine	(250	mL),	dried	(Na2SO4),	decanted,	and	concentrated,	giving	a	crude	mixture	
consisting	of	a	white	solid	and	an	oil.		The	crude	product	was	purified	by	normal	phase	column	
chromatography	(6	cm	diameter,	500	mL	SiO2,	isocratic	4/1	Hex/DCM),	giving	1.96	grams	of	mostly	pure	
product.		This	mixture	was	recrystallized	from	boiling	hexanes	(200-250	mL).		After	cooling	to	room	
temperature	and	then	to	0°C,	the	product	was	filtered,	giving	3.37	as	a	white	crystalline	powder	(1.385	
grams,	2.60	mmol,	61%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.25	(td,	J	=	7.3,	0.9	Hz,	3H),	7.14	(t,	J	=	7.5	Hz,	6H),	7.12-7.06	(m,	9H),	7.02	
(dd,	J	=	7.0,	1.7	Hz,	6H),	6.82	(ddd,	J	=	7.7,	4.0,	1.4	Hz,	3H),	4.09	(s,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	145.78	(d,	JC-P	=	26.3	Hz),	140.73,	134.99	(d,	JC-P	=	11.7	Hz),	134.31,	130.13	
(d,	JC-P	=	5.0	Hz),	129.44,	129.06,	128.27,	126.66,	125.94,	40.23	(d,	JC-P	=	22.3	Hz).	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-31.42	
HRMS	(EI
+
)	
Calculated	for	C39H33P	(M)
+
:	532.23199	
Found:	532.23141	
	
	
SI-3.10.	In	an	argon-filled	glovebox,	a	dry	40	mL	vial	was	charged	with	LiAlD4	(84.0	mg,	2.00	mmol,	1.00	
eq),	followed	by	a	stir	bar.	The	vial	was	capped,	brought	out	of	the	glovebox	and	into	a	fume	hood,	and	
put	under	nitrogen.	Dry	THF	(1.0	mL)	was	added,	and	the	mixture	was	cooled	to	0°C	in	an	ice/water	
bath.		In	a	separate	dry	40	mL	vial	under	nitrogen,	a	solution	was	prepared	of	2-bromobenzyl	bromide	
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(499.9	mg,	2.00	mmol,	1.00	eq)	in	dry	THF	(1.0	mL).		This	solution	was	then	added	to	the	LiAlD4	
suspension	dropwise	over	two	minutes,	rinsing	with	THF	(1.0	mL)	for	quantitative	transfer.		After	10	
minutes	of	stirring	at	0°C,	the	reaction	was	allowed	to	warm	to	room	temperature.		The	sides	of	the	vial	
were	rinsed	with	an	additional	1.0	mL	THF.	
	 After	another	10	minutes,	the	reaction	was	worked	up	by	the	Fieser	method.
75
		Et2O	(5.3	mL)	
was	added,	and	the	reaction	was	cooled	to	0°C.		Deionized	water	(0.08	mL)	was	then	added,	followed	by	
15%	NaOH	(0.23	mL)	and	another	portion	of	deionized	water	(0.08	mL).		The	mixture	was	then	allowed	
to	warm	to	room	temperature	and	stir	overnight.		The	next	day,	MgSO4	was	added	to	soak	up	the	
remaining	water.		After	15	minutes	of	stirring,	the	mixture	was	filtered	through	a	2	cm	long	SiO2	plug,	
rinsing	with	pentane.		The	crude	product	was	concentrated	by	rotary	evaporation	in	a	0°C	ice/water	
bath	to	retain	the	volatile	product.	This	material	was	purified	by	normal	phase	silica	gel	chromatography	
using	100%	pentane,	followed	by	rotary	evaporation	in	a	0°C	ice/water	bath	to	give	pure	product	as	a	
colorless	oil	of	low	viscosity	(252.5	mg,	1.47	mmol,	73%).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.52	(dd,	J	=	7.9,	1.2	Hz,	1H),	7.25-7.18	(m,	2H),	7.04	(t,	J	=	7.8	Hz,	1H),	2.38	
(app.	t,	J	=	2.1	Hz,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	137.97,	132.46,	130.97,	127.45,	127.37,	125.08,	22.81	(app.	t,	JC-D	=	19.7	
Hz).	
HRMS	(EI
+
)	
Calculated	for	C7H6BrD	(M)
+
:	170.97938	
Found:	170.97946	
	
	
3.39.	A	dry,	stir	bar-equipped	25	mL	recovery	flask	was	put	under	nitrogen.		Aryl	bromide	SI-3.10	(224.0	
mg,	1.30	mmol,	1.00	eq)	was	massed	out	in	a	separate	dry	40	mL	vial	and	put	under	nitrogen.		Dry	THF	
(1.0	mL)	was	added,	and	the	solution	of	SI-3.10	was	transferred	to	the	reaction	flask,	using	1.2	mL	THF	
for	quantitative	transfer.		This	solution	was	cooled	with	stirring	to	-78°C	in	a	dry	ice	/	acetone	bath.		
nbutyllithium	(1.6	M	in	hexanes,	0.73	mL,	1.17	mmol,	0.90	eq)	was	added	dropwise	over	5	minutes.		The	
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reaction	appearance	changed	to	cloudy	and	slightly	off-white.		After	stirring	for	one	hour	and	45	
minutes	at	-78°C,	the	reaction	was	treated	with	PCl3	(neat,	28.3	μL,	44.6	mg,	0.325	mmol,	0.25	eq,	
dropwise	over	3-4	minutes).		The	reaction,	which	had	turned	bright	orange,	was	allowed	to	stir	
overnight,	gradually	warming	to	room	temperature	over	four	hours.	
	 The	reaction	was	quenched	with	saturated	aqueous	NH4Cl	(5	mL).		The	crude	mixture	was	
diluted	with	water	(10	mL)	and	DCM	(15	mL).		The	aqueous	layer	was	extracted	with	DCM	(3	x	15mL),	
and	the	combined	organics	were	washed	with	brine	(50	mL),	dried	with	Na2SO4,	decanted,	and	
concentrated.		The	crude	product	was	purified	by	normal	phase	column	chromatography	(2	cm	
diameter,	35	mL	SiO2,	isocratic	20/1	hexanes/DCM),	giving	the	pure	product	as	a	free-flowing	white	
powder	(62.7	mg,	0.204	mmol,	63%	yield).		
1
H	NMR	(500	MHz,	CDCl3)	δ	7.29-7.21	(m,	6H),	7.08	(t,	J	=	7.2	Hz,	3H),	6.73	(ddd,	J	=	7.6,	4.6,	1.4	Hz,	3H),	
2.38	(s,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	142.81	(d,	JC-P	=	26.3	Hz),	134.55	(d,	JC-P	=	10.6	Hz),	133.17,	130.19	(d,	JC-P	=	
4.8	Hz),	128.80,	126.29,	21.07	(dt,	JC-P	=	21.4	Hz,	JC-D	=	19.5	Hz).	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-28.89	
HRMS	(EI
+
)	
Calculated	for	C21H18D3P	(M)
+
:	307.15692	
Found:	307.15628	
	
	
SI-3.11.		In	an	argon-filled	glovebox,	a	flame-dried,	stir	bar-equipped,	3-neck	100	mL	round	bottom	flask	
was	charged	with	LiAlD4	(420	mg,	10.0	mmol,	1.09	eq).		The	flask	was	sealed	with	a	rubber	septum,	
brought	out	of	the	glovebox	and	into	a	chemical	fume	hood,	and	put	under	nitrogen	atmosphere.		Dry	
THF	(8	mL)	was	added,	and	the	stirring	suspension	was	cooled	to	0°C.		In	a	separate	dry	40	mL	vial	under	
nitrogen,	a	solution	was	prepared	of	methyl	2-bromobenzoate	(1.97	g,	9.16	mmol,	1.00	eq)	and	dry	THF	
(3.5	mL).		The	solution	was	added	to	the	LiAlD4	suspension	dropwise	over	5	minutes.	
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	 After	stirring	for	an	hour	at	0°C,	the	reaction	was	worked	up	by	the	Fieser	method.
75
		Et2O	(12	
mL)	was	added.		Deionized	water	(0.42	mL)	was	then	added	(dropwise	over	five	minutes,	causing	
bubbling),	followed	by	15%	NaOH	(0.42	mL)	and	another	portion	of	deionized	water	(1.26	mL).		The	
mixture	was	then	allowed	to	warm	to	room	temperature	and	stir	overnight.		The	next	day,	MgSO4	was	
added	to	soak	up	the	remaining	water.		After	15	minutes	of	stirring,	the	mixture	was	filtered	through	
celite,	rinsing	with	Et2O.		After	rotary	evaporation,	the	crude	product	was	purified	by	normal	phase	silica	
gel	chromatography	(3	cm	diameter,	100	mL	SiO2,	isocratic	3/1	pentane/Et2O),	giving	the	pure	product	
as	a	fluffy	white	solid	(1.563	g,	8.268	mmol,	90%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.55	(dd,	J	=	7.9,	1.2	Hz,	1H),	7.48	(dd,	J	=	7.6,	1.7	Hz,	1H),	7.34	(td,	J	=	7.5,	
1.2	Hz,	1H),	7.17	(ddd,	J	=	8.1,	7.3,	1.7	Hz,	1H),	1.93	(p,	J	=	1.0	Hz,	1H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	139.77,	132.75,	129.31,	129.15,	127.80,	122.79,	64.61	(p,	JC-D	=	22.3	Hz).	
HRMS	(EI
+
)	
Calculated	for	C7H5OBrD2	(M)
+
:	187.98058	
Found:	187.98046	
	
	
SI-3.12.	A	flame-dried,	stir	bar-equipped	200	mL	round	bottom	flask	was	charged	with	PPh3	(2.75	g,	10.5	
mmol,	1.50	eq)	and	imidazole	(0.715	g,	10.5	mmol,	1.50	eq)	and	put	under	nitrogen.		Dry	DCM	(14	mL)	
was	added,	and	the	stirring	mixture	was	cooled	to	0°C.		Bromine	(0.54	mL,	1.68	g,	10.5	mmol)	was	added	
dropwise	over	five	minutes,	using	DCM	to	rinse	the	sides	of	the	flask.		The	reaction	was	allowed	to	warm	
to	room	temperature,	stirred	for	an	additional	10	minutes,	and	then	cooled	to	0°C	again.		A	solution	of	
the	benzylic	alcohol	SI-3.11	(1.32	g,	7.00	mmol,	1.00	eq)	in	dry	DCM	(10	mL)	was	added	dropwise	over	
five	minutes,	causing	a	precipitate	to	form.		Additional	DCM	(2.0	mL)	was	used	to	rinse	for	quantitative	
transfer	of	the	alcohol.		The	reaction	was	allowed	to	warm	to	room	temperature	and	stir	for	an	
additional	40	minutes.	
	 At	this	point,	the	stir	bar	was	removed,	and	the	crude	reaction	was	concentrated	by	rotary	
evaporation.		Pentane	(20	mL)	was	added	to	the	crude	product,	and	it	was	again	concentrated.		The	
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crude	material	was	purified	by	normal	phase	column	chromatography	(6	cm	diameter,	400	mL	SiO2,	
isocratic	100%	pentane),	giving	the	pure	product	as	a	colorless	oil	of	low	viscosity	(981	mg,	3.89	mmol,	
56%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.58	(dd,	J	=	8.0,	1.2	Hz,	1H),	7.46	(dd,	J	=	7.6,	1.7	Hz,	1H),	7.30	(td,	J	=	7.5,	
1.2	Hz,	1H),	7.17	(td,	J	=	7.7,	1.7	Hz,	1H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	137.07,	133.49,	131.38,	130.25,	128.08,	124.60,	33.09	(p,	JC-D	=	23.6	Hz).	
HRMS	(EI
+
)	
Calculated	for	C7H4Br2D2	(M)
+
:	249.8962	
Found:	249.8961	
	
	
SI-3.13.	To	a	dry	40	mL	vial	was	added	LiAlH4	(56.9	mg,	1.50	mmol,	1.00	eq),	followed	by	a	stir	bar.		The	
vial	was	capped	and	put	under	nitrogen.		Dry	THF	(1.0	mL)	was	added,	and	the	stirring	suspension	was	
cooled	to	0°C	with	an	ice/water	bath.		In	a	separate	dry	40	mL	vial	under	nitrogen,	a	solution	of	benzylic	
bromide	SI-3.12	(379	mg,	1.50	mmol,	1.00	eq)	was	prepared	in	dry	THF	(1.0	mL).		This	solution	was	
added	to	the	LiAlH4	vial	dropwise	over	two	minutes,	using	THF	(1.0	mL)	for	quantitative	transfer	and	THF	
(1.0	mL)	to	rinse	the	sides	of	the	reaction	vial.	
	 After	another	10	minutes	of	stirring,	the	reaction	was	worked	up	according	the	Fieser	method.
75
		
Et2O	(4.0	mL)	was	added.		Deionized	water	(0.06	mL)	was	then	added,	followed	by	15%	NaOH	(0.17	mL)	
and	another	portion	of	deionized	water	(0.06	mL).		The	mixture	was	then	allowed	to	warm	to	room	
temperature	and	stir	overnight.		The	next	day,	MgSO4	was	added	to	soak	up	the	remaining	water.		After	
15	minutes	of	stirring,	the	mixture	was	filtered	through	a	2	cm	long	SiO2	plug,	rinsing	with	pentane.		The	
filtrate	was	concentrated	by	rotary	evaporation	in	a	0°C	ice/water	bath	to	retain	the	volatile	product,	
which	was	isolated	without	further	purification	as	a	colorless	oil	of	low	viscosity	(250.6	mg,	1.44	mmol,	
96%).	
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1
H	NMR	(500	MHz,	CDCl3)	δ	7.52	(dd,	J	=	7.9,	1.2	Hz,	1H),	7.25-7.18	(m,	2H),	7.04	(m,	1H),	2.37	(p,	J	=	2.4	
Hz,	1H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	137.94,	132.47,	130.97,	127.46,	127.37,	125.09,	22.52	(p,	J	=	19.6	Hz).	
HRMS	(EI
+
)	
Calculated	for	C7H5BrD2	(M)
+
:	171.9857	
Found:	171.9861	
	
	
3.40.	A	dry,	stir	bar-equipped	25	mL	recovery	flask	was	put	under	nitrogen.		Aryl	bromide	SI-3.13	(207.7	
mg,	1.20	mmol,	1.00	eq)	was	massed	out	in	a	separate	dry	40	mL	vial	and	put	under	nitrogen.		Dry	THF	
(1.0	mL)	was	added,	and	the	solution	of	SI-3.13	was	transferred	to	the	reaction	flask,	using	1.0	mL	THF	
for	quantitative	transfer.		This	solution	was	cooled	with	stirring	to	-78°C	in	a	dry	ice	/	acetone	bath.		
nbutyllithium	(1.6	M	in	hexanes,	0.675	mL,	1.08	mmol,	0.90	eq)	was	added	dropwise	over	5	minutes.		
The	reaction	appearance	changed	to	cloudy	and	slightly	off-white.		After	stirring	for	one	hour	and	30	
minutes	at	-78°C,	the	reaction	was	treated	with	PCl3	(neat,	26.2	μL,	41.2	mg,	0.300	mmol,	0.25	eq,	
dropwise	over	3-4	minutes).		The	reaction,	which	had	turned	bright	orange,	was	allowed	to	stir	
overnight,	gradually	warming	to	room	temperature	over	four	hours.	
	 The	reaction	was	quenched	with	saturated	aqueous	NH4Cl	(5	mL).		The	crude	mixture	was	
diluted	with	water	(10	mL)	and	DCM	(15	mL).		The	aqueous	layer	was	extracted	with	DCM	(3	x	15mL),	
and	the	combined	organics	were	washed	with	brine	(50	mL),	dried	with	Na2SO4,	decanted,	and	
concentrated.		The	crude	product	was	purified	by	normal	phase	column	chromatography	(isocratic	100%	
hexanes),	giving	the	pure	product	as	a	free-flowing	white	powder	(53.0	mg,	0.169	mmol,	56%	yield).		
1
H	NMR	(500	MHz,	CDCl3)	δ	7.28-7.20	(m,	6H),	7.08	(t,	J	=	7.6	Hz,	3H),	6.72	(ddd,	J	=	7.6,	4.3,	1.3	Hz,	1H),	
2.36	(s,	1H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	142.80	(d,	JC-P	=	26.2	Hz),	134.64	(d,	JC-P	=	10.8	Hz),	133.20,	130.19	(d,	JC-P	=	
4.8	Hz),	128.79,	126.29,	20.79	(dp,	JC-P	=	21.2	Hz,	JC-D	=	19.4	Hz).	
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31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-28.90.	
HRMS	(EI
+
)	
Calculated	for	C21H15D6P	(M)
+
:	310.1757	
Found:	310.1761	
	
	
SI-3.14.	To	a	dry	40	mL	vial	was	added	LiAlD4	(63.0	mg,	1.50	mmol,	1.01	eq),	followed	by	a	stir	bar.		The	
vial	was	capped	and	put	under	nitrogen.		Dry	THF	(1.0	mL)	was	added,	and	the	stirring	suspension	was	
cooled	to	0°C	with	an	ice/water	bath.		In	a	separate	dry	40	mL	vial	under	nitrogen,	a	solution	of	benzylic	
bromide	SI-3.12	(373	mg,	1.48	mmol,	1.00	eq)	was	prepared	in	dry	THF	(1.0	mL).		This	solution	was	
added	to	the	LiAlD4	vial	dropwise	over	two	minutes,	using	THF	(1.0	mL)	for	quantitative	transfer	and	THF	
(1.0	mL)	to	rinse	the	sides	of	the	reaction	vial.	
	 After	another	10	minutes	of	stirring,	the	reaction	was	worked	up	according	the	Fieser	method.
75
		
Et2O	(4.0	mL)	was	added.		Deionized	water	(0.06	mL)	was	then	added,	followed	by	15%	NaOH	(0.17	mL)	
and	another	portion	of	deionized	water	(0.06	mL).		The	mixture	was	then	allowed	to	warm	to	room	
temperature	and	stir	overnight.		The	next	day,	MgSO4	was	added	to	soak	up	the	remaining	water.		After	
15	minutes	of	stirring,	the	mixture	was	filtered	through	a	2	cm	long	SiO2	plug,	rinsing	with	pentane.		The	
filtrate	was	concentrated	by	rotary	evaporation	in	a	0°C	ice/water	bath	to	retain	the	volatile	product,	
which	was	isolated	without	further	purification	as	a	colorless	oil	of	low	viscosity	(238.2	mg,	1.368	mmol,	
93%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.52	(dt,	J	=	8.0,	1.0	Hz,	3H),	7.24-1.18	(m,	6H),	7.04	(m,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	137.91,	132.47,	130.98,	127.47,	127.37,	125.09.	
HRMS	(EI
+
)	
Calculated	for	C7H4BrD3	(M)
+
:	172.9919	
Found:	172.9923	
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3.41.	A	dry,	stir	bar-equipped	25	mL	recovery	flask	was	put	under	nitrogen.		Aryl	bromide	SI-3.14	(208.9	
mg,	1.20	mmol,	1.00	eq)	was	massed	out	in	a	separate	dry	40	mL	vial	and	put	under	nitrogen.		Dry	THF	
(1.0	mL)	was	added,	and	the	solution	of	SI-3.14	was	transferred	to	the	reaction	flask,	using	1.0	mL	THF	
for	quantitative	transfer.		This	solution	was	cooled	with	stirring	to	-78°C	in	a	dry	ice	/	acetone	bath.		
nbutyllithium	(1.6	M	in	hexanes,	0.675	mL,	1.08	mmol,	0.90	eq)	was	added	dropwise	over	five	minutes.		
The	reaction	appearance	changed	to	cloudy	and	slightly	off-white.		After	stirring	for	one	hour	and	30	
minutes	at	-78°C,	the	reaction	was	treated	with	PCl3	(neat,	26.2	μL,	41.2	mg,	0.300	mmol,	0.25	eq,	
dropwise	over	two	minutes).		The	reaction,	which	had	turned	bright	orange,	was	allowed	to	stir	
overnight,	gradually	warming	to	room	temperature	over	four	hours.	
	 The	reaction	was	quenched	with	saturated	aqueous	NH4Cl	(5	mL).		The	crude	mixture	was	
diluted	with	water	(10	mL)	and	DCM	(15	mL).		The	aqueous	layer	was	extracted	with	DCM	(3	x	15mL),	
and	the	combined	organics	were	washed	with	brine	(50	mL),	dried	with	Na2SO4,	decanted,	and	
concentrated.		The	crude	product	was	purified	by	normal	phase	column	chromatography	(2	cm	
diameter,	50	mL	SiO2,	isocratic	100%	hexanes),	giving	the	pure	product	as	a	free-flowing	white	powder	
(53.0	mg,	0.169	mmol,	56%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.28-7.20	(m,	6H),	7.08	(td,	J	=	7.3,	1.5	Hz,	1H),	6.72	(ddd,	J	=	7.8,	4.4,	1.3	Hz,	
1H).	
13
C	NMR	(126	MHz,	CDCl3)	δ		142.75	(d,	J	=	25.5	Hz),	134.61	(d,	JC-P	=	10.8	Hz),	133.17	,	130.18	(d,	J	=	4.7	
Hz),	128.79,	126.29.	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-28.87.	
HRMS	(EI
+
)	
Calculated	for	C21H12D9P	(M)
+
:	313.1946	
Found:	313.1949	
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Tris(2-methyl-4-dimethylaminophenyl)phosphine	3.44.		This	procedure	was	based	on	previously	
reported	synthesis	of	this	compound.
59
		A	dry,	stir	bar-equipped	50	mL	3-neck	round	bottom	flask	was	
fitted	with	a	reflux	condenser	and	put	under	nitrogen.		N,N,3-trimethylaniline	(1.45	mL,	1.352	g,	10.0	
mmol,	3.03	eq)	was	added,	followed	by	pyridine	(5.0	mL),	resulting	in	a	clear,	homogeneous,	slightly	
yellow	solution.		The	mixture	was	cooled	to	0°C,	and	phosphorus	tribromide	(0.31	mL,	0.901	g,	3.33	
mmol,	1.00	eq)	was	added	in	a	neat	fashion	dropwise	over	three	or	four	minutes.		The	reaction	
immediately	changed	to	a	yellow	color	and	precipitate	began	to	gradually	form.		After	five	minutes	of	
stirring	at	0°C,	the	reaction	was	heated	to	125°C	for	one	hour	and	then	cooled	to	room	temperature.	
	 The	crude	reaction	was	diluted	in	benzene	(50	mL)	and	washed	with	6	N	NaOH	(20	mL),	H2O	(20	
mL),	and	brine	(20	mL).		The	organic	layer	was	dried	with	Na2SO4,	decanted,	and	concentrated	on	strong	
vacuum	to	remove	all	solvent.		The	crude	material	was	then	transferred	to	a	small	round	bottom	flask	
(50	mL)	and	dissolved	in	degassed	acetone.		After	heating	to	boiling	and	stirring,	a	white	powder	was	
present	that	still	would	not	dissolve.		The	mixture	was	cooled	to	room	temperature	and	filtered	through	
a	medium	porosity	glass	frit.		The	filtrate	was	reconcentrated	and	triturated	again,	and	this	process	was	
repeated	once	more.		The	combined	crystals	were	triturated	with	acetone	and	filtered	again,	this	time	
under	nitrogen.		The	crystalline	product	3.44	was	crushed	to	a	white	powder	and	stored	under	in	an	
argon-filled	glovebox	(0.233	g,	0.537	mmol,	16%	yield).	
1
H	NMR	(500	MHz,	C6D6)	δ	7.19	(dd,	J	=	8.5,	4.2	Hz,	3H),	6.63	(app.	t,	J	=	3.4	Hz,	3H),	6.40	(dd,	J	=	8.5,	2.7	
Hz,	3H),	2.69	(s,	9H),	2.51	(s,	18H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	150.54,	143.32	(d,	JC-P	=	26.6	Hz),	134.36,	122.10	(d,	JC-P	=	6.3	Hz),	114.10	(d,	
JC-P	=	5.0	Hz),	110.37,	40.46,	21.85	(d,	JC-P	=	21.0	Hz).	
31
P	NMR	(202	MHz,	C6D6,	referenced	to	H3PO4	in	D2O)	δ	-34.90.	
HRMS	(ESI
+
)	
Calculated	for	C27H37N3P	(M+H)
+
:	434.2725	
Found:	434.2714	
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Tris(4-isopropoxy-2-methylphenyl)phosphine	3.45.		A	solution	of	1-bromo-4-isopropoxy-2-
methylbenzene	(0.6874	g,	3.00	mmol,	1.00	eq)	in	dry	THF	(5.0	mL)	in	a	three-neck,	100	mL	round	bottom	
flask	was	cooled	to	-78°C	before	adding	nbutyllithium	(1.6	Molar	in	hexanes,	1.84	mL,	2.94	mmol,	0.98	
eq)	dropwise	over	five	minutes.		The	reaction	was	allowed	to	stir	for	1	hour	and	45	minutes	at	-78°C,	
resulting	in	a	cloudy,	orange/sherbet-colored	suspension.		A	solution	of	phosphorus	trichloride	(78	μL,	
0.124	g,	0.90	mmol,	0.30	eq)	in	THF	(2.0	mL)	was	added	to	the	reaction	dropwise	over	about	five	
minutes.		The	resulting	clear,	homogeneous	orange-colored	reaction	was	stirred	for	40	minutes	at	-78°C	
and	then	allowed	to	warm	to	room	temperature.	
	 The	reaction	was	quenched	with	saturated	NH4Cl	(10	mL),	and	diluted	with	H2O	(20	mL)	and	
DCM	(30	mL).		The	aqueous	layer	was	extracted	with	DCM	(3x30	mL).		The	combined	organics	were	
washed	with	brine	(100	mL),	dried	(MgSO4),	filtered,	and	concentrated	to	afford	a	viscous	yellow	oil.		
The	crude	product	was	purified	by	normal	phase	column	chromatography	(5	cm	diameter,	200	mL	silica	
gel,	isocratic	30/1	Hex/EtOAc),	giving	3.45	as	a	white	powder	(0.1876	g,	0.3920	mmol,	44%	yield).	
1
H	NMR	(500	MHz,	C6D6)	δ	7.08	(dd,	J	=	8.4,	4.0	Hz,	3H),	6.88	(dd,	J	=	4.0,	2.6	Hz,	3H),	6.59	(dd,	J	=	8.4,	2.6	
Hz,	3H),	4.20	(sext,	J	=	6.0	Hz,	3H),	2.50	(s,	9H),	1.11	(d,	J	=	6.0	Hz,	18H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	158.44,	144.20	(d,	JC-P	=	27.4	Hz),	134.56,	126.11	(d,	JC-P	=	8.3	Hz),	117.77	(d,	
J	=	5.1	Hz),	112.99	(d,	J	=	0.9	Hz),	69.61,	22.30,	21.49	(d,	J	=	21.4	Hz).	
31
P	NMR	(202	MHz,	C6D6,	referenced	to	H3PO4	in	D2O)	δ	-33.72	
Rf	=	0.20	on	normal	phase	TLC	in	20/1	Hex/EtOAc	
HRMS	(ESI
+
)	
Calculated	for	C30H40O3P	(M+H)
+
:	479.2715	
Found:	479.2710	
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Tris(4-methoxy-2-methylphenyl)phosphine	3.46.		This	compound	has	been	previously	synthesized	and	
characterized.
76
		A	dry,	stir	bar-equipped	100	mL	recovery	flask	was	charged	with	magnesium	turnings	
(0.3975	g,	16.35	mmol,	1.01	eq)	in	an	argon-filled	glovebox.		The	flask	was	sealed	with	a	septum,	
brought	out	into	the	hood,	equipped	with	a	reflux	condenser,	attached	to	a	Schlenk	line,	and	put	under	
nitrogen.		Dry	THF	(8	mL)	was	added,	followed	by	1-bromo-4-methoxy-2-methylbenzene	(2.29	mL,	3.26	
g,	16.2	mmol,	1.00	eq)	dropwise	over	eight	minutes.		An	additional	8	mL	of	dry	THF	was	added.		The	
reaction	began	to	reflux	without	any	external	heat	or	initiating	agent.		In	a	separate	round	bottom	flask,	
a	solution	of	phosphorus	trichloride	(0.44	mL,	0.69	g,	5.0	mmol,	0.31	eq)	in	dry	THF	(14	mL)	was	
prepared	under	nitrogen.		After	the	Grignard	had	turned	to	a	cloudy	grey	and	most	of	the	magnesium	
was	gone	(about	one	hour),	the	solution	of	phosphorus	trichloride	was	added	at	0°C	dropwise	over	10	
minutes.		The	reaction	was	allowed	to	warm	to	room	temperature	and	stirred	overnight.	
	 The	next	day,	the	reaction	was	quenched	with	addition	of	saturated	NH4Cl	(40	mL)	and	diluted	
with	H2O	(80	mL)	and	toluene	(100	mL).		The	aqueous	layer	was	extracted	with	toluene	(3x100	mL),	and	
the	combined	organics	were	washed	with	brine,	dried	with	MgSO4,	filtered,	and	concentrated.		The	
crude	product	was	purified	by	column	chromatography	(4	cm	diameter,	130	mL	silica	gel,	30/1	
Hex/EtOAc),	giving	3.46	as	a	white	powder	(0.4652	g,	1.179	mmol,	24%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	6.78	(m,	3H),	6.65-6.62	(m,	6H),	3.79	(s,	9H),	2.36	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	160.13,	144.23	(d,	JC-P	=	27.6	Hz),	134.53,	126.37	(d,	JC-P	=	8.5	Hz),	116.02	(d,	
JC-P	=	5.2	Hz),	111.60	55.20,	21.49	(d,	JC-P	=	21.4	Hz).	
31
P	NMR	(202	MHz,	C6D6,	referenced	to	H3PO4	in	D2O)	δ	-33.95	
HRMS	(EI
+
)	
Calculated	for	C24H27O3P	(M)
+
:	394.16979	
Found:	394.16897	
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Tris(2,4-dimethylphenyl)phosphine	3.47.		This	ligand	was	purchased	from	Sigma-Aldrich	(Product	
number	710547,	Lot	number	MKBB9858V).	
	
	
Tris(4-fluoro-2-methylphenyl)phosphine	3.48.		A	dry,	stir	bar-equipped	25	mL	three	neck	round	bottom	
flask	was	charged	with	magnesium	turnings	(0.1535	g,	6.314	mmol,	1.05	eq)	in	an	argon-filled	glovebox.		
The	flask	was	sealed	with	septa,	brought	out	into	the	hood,	equipped	with	a	reflux	condenser,	attached	
to	a	Schlenk	line,	and	put	under	nitrogen.		To	a	separate	10	mL	pear	flask	under	nitrogen	was	added	1-
bromo-4-fluoro-2-methylbenzene	(0.76	mL,	1.136	g,	6.011	mmol,	1.00	eq)	and	dry	THF	(6.0	mL).		This	
solution	was	added	in	a	dropwise	fashion	to	the	magnesium-containing	flask,	causing	initiation	of	the	
Grignard	reaction.			After	about	1.5	hours,	the	reaction	had	turned	cloudy	and	a	brownish/grey	color	and	
cooled	to	room	temperature.		The	Grignard	was	added	to	a	-78°C	solution	of	phosphorus	trichloride	
(0.155	mL,	0.243	g,	1.77	mmol,	0.295	eq)	in	THF	(5.0	mL)	in	a	50	mL	pear	flask.		The	reaction	was	allowed	
to	gradually	warm	to	room	temperature	and	stir	overnight.	
	 The	next	day,	the	reaction	was	cooled	to	0°C	and	quenched	with	addition	of	saturated	NH4Cl	(20	
mL)	and	diluted	with	H2O	(10	mL)	and	toluene	(30	mL).		The	aqueous	layer	was	extracted	with	toluene	
(3x30	mL),	and	the	combined	organics	were	washed	with	brine,	dried	with	MgSO4,	filtered,	and	
concentrated.		The	crude	product	was	purified	by	normal	phase	column	chromatography	(2.5	cm	
diameter,	40	mL	silica	gel,	isocratic	3/1	Hex/DCM,	then	a	second	column	of	same	dimensions	with	
isocratic	100%	hexanes),	giving	3.48	as	a	white	powder	(0.2611	g,	0.7286	mmol,	41%	yield).	
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1
H	NMR	(500	MHz,	CDCl3)	δ	6.96	(dt,	J	=	9.8,	3.3	Hz,	3H),	6.80	(td,	J	=	8.5,	2.7	Hz,	3H),	6.64	(ddd,	J	=	8.6,	
6.3,	3.7	Hz,	3H),	2.36	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	163.58	(d,	JC-F	=	248.5	Hz),	145.35	(dd,	J	=	28.4,	7.8	Hz),	134.83	(d,	J	=	8.1	
Hz),	129.66	(dd,	J	=	10.6,	3.2	Hz),	117.45	(dd,	J	=	20.7,	5.1	Hz),	113.45	(d,	J	=	20.2	Hz),	21.31	(dd,	JC-P	=	
21.8,	JC-F	1.6	Hz).	
31
P	NMR	(202	MHz,	C6D6,	referenced	to	H3PO4	in	D2O)	δ	-33.00	(q,	J	=	3.5	Hz).	
19
F	NMR	(470	MHz,	CDCl3,	referenced	to	CFCl3	in	CDCl3)	δ	-114.60	(q,	J	=	8.3	Hz).	
HRMS	(EI
+
)	
Calculated	for	C21H18F3P	(M)
+
:	358.10982	
Found:	358.10935	
	
	
Tris(2-methyl-4-(trifluoromethoxy)phenyl)phosphine	3.49.		Caution:	the	synthesis	of	these	ligands	
through	the	arylmagnesium	species	is	potentially	hazardous.
77
		A	solution	of	1-bromo-2-methyl-4-
(trifluoromethoxy)benzene	(0.82	mL,	1.28	g,	5.00	mmol,	1.00	eq)	in	dry	THF	(8.0	mL)	in	a	three-neck,	100	
mL	round	bottom	flask	was	cooled	to	-78°C	before	adding	nbutyllithium	(1.6	Molar	in	hexanes,	2.97	mL,	
4.75	mmol,	0.95	eq).		The	resulting	homogeneous,	clear,	slightly	orange	solution	was	allowed	to	stir	for	
1.5	hours	at	-78°C.		A	solution	of	phosphorus	trichloride	(125	μL,	0.196	g,	1.43	mmol,	0.285	eq)	in	THF	
(3.0	mL)	was	added	to	the	reaction	dropwise	over	about	three	minutes.		The	resulting	clear,	
homogeneous	orange/red-colored	reaction	was	stirred	for	five	hours	at	-78°C	and	then	allowed	to	warm	
to	room	temperature.	
	 The	reaction	was	quenched	with	saturated	NH4Cl	(10	mL),	and	diluted	with	H2O	(20	mL)	and	
toluene	(30	mL).		The	aqueous	layer	was	extracted	with	toluene	(3x30	mL).		The	combined	organics	were	
washed	with	brine	(100	mL),	dried	(MgSO4),	filtered,	and	concentrated.		The	crude	product	was	purified	
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by	normal	phase	column	chromatography	(4	cm	diameter,	150	mL	silica	gel,	isocratic	100%	hexanes),	
giving	3.49	as	a	white	powder	(0.4389	g,	0.7889	mmol,	55%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.11	(app.	s,	3H),	6.97	(d,	J	=	8.4	Hz,	3H),	6.69	(dd,	J	=	8.4,	3.7	Hz,	3H),	2.39	
(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	150.22	(q,	JC-F	=	1.8	Hz),	145.10	(d,	JC-P	=	28.3	Hz),	134.52,	132.25	(d,	JC-P	=	
11.5	Hz),	122.53	(d,	JC-P	=	5.0	Hz),	120.59	(q,	JC-F	=	258.0	Hz),	118.53,	21.39	(d,	JC-P	=	21.7	Hz).	
31
P	NMR	(202	MHz,	C6D6	referenced	to	H3PO4	in	D2O)	δ	-32.12	
19
F	NMR	(470	MHz,	C6D6,	referenced	to	CFCl3	in	CDCl3)	δ	-57.79	
Rf	=	0.29	on	normal	phase	TLC	in	100%	hexanes	
HRMS	(ESI
+
)	
Calculated	for	C24H19O3F9P	(M+H)
+
:	557.0928	
Found:	557.0918	
	
	
Trimethyl	4,4',4''-phosphanetriyltris(3-methylbenzoate)	3.50.		This	synthesis	was	based	on	a	procedure	
previously	reported	for	the	corresponding	phosphine	lacking	the	ortho-methyl	groups.61		To	a	dry,	100	
mL	3-neck	round	bottom	flask	were	added	CoBr2	(0.1094	g,	0.50	mmol,	0.10	eq),	zinc	(1.092	g,	16.7	
mmol,	3.33	eq),	and	ZnBr2	(0.1126	g,	0.50	mmol,	0.10	eq).		The	mixture	was	crushed	to	a	fine	powder	
and	then	heated	at	160°C	for	two	hours	on	high	vac	while	the	stir	bar	agitated	the	powder.		Upon	
cooling	to	room	temperature,	MeCN	(5.0	mL)	was	added,	resulting	in	a	blue	suspension.		Trifluoroacetic	
acid	(17	μL,	25	mg,	0.22	mmol,	4.4	mol%)	was	added,	resulting	in	a	grey	suspension.	
	 Separately,	a	solution	of	methyl	4-bromo-3-methylbenzoate	(1.145	g,	5.00	mmol,	1.00	eq)	in	
MeCN	(3.0	mL)	was	prepared	under	nitrogen	in	a	10	mL	recovery	flask.		A	small	amount	of	the	aryl	
bromide	solution	(about	0.2	mL)	was	added	to	the	zinc	suspension	and	allowed	to	stir	for	25	minutes	at	
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room	temperature.		The	remainder	of	the	aryl	bromide	solution	was	then	added	(dropwise	over	five	
minutes	at	room	temperature,	with	rinsing	2x0.5	mL	of	MeCN	for	quantitative	transfer).	
	 After	stirring	at	room	temperature	for	1	hour	and	35	minutes,	the	reaction	was	monitored	by	
NMR.		A	small	aliquot	(0.2	mL)	was	removed	via	needle	and	added	to	a	solution	of	iodine	in	pentane.		
The	vial	was	capped	and	shaken,	and	then	3	mL	of	saturated	Na2S2O3	was	added.		The	organic	layer	was	
removed,	concentrated,	and	analyzed	by	
1
H-NMR	in	C6D6.		No	aryl	bromide	remained	(complete	
conversion).		There	was	approximately	75%	of	the	aryl	iodide	and	25%	protodehalogenated	side	
product.	
	 The	arylzinc	solution	was	filtered	by	the	following	procedure.		First,	a	dry,	stir	bar-equipped	100	
mL	Schlenk	flask	was	put	under	nitrogen.		The	arylzinc	was	drawn	into	a	24	mL	syringe	through	a	needle.		
The	needle	was	then	quickly	removed	and	replaced	with	a	dry	0.2	micron	HPLC	filter	with	a	needle	on	
the	end.		The	arylzinc	was	pushed	through	the	filter	and	the	needle	into	the	receiving	Schlenk	flask.	
To	this	room	temperature	stirring	solution	was	added	phosphorus	trichloride	(110	μL,	0.173	g,	
1.25	mmol,	0.33	eq	relative	to	the	arylzinc	as	read	out	by	NMR	yield	of	the	aryl	iodide).		During	the	
addition,	the	reaction	changed	from	an	orange	homogeneous	solution	to	a	yellow	cloudy	suspension.		
After	the	addition	was	complete,	the	reaction	was	heated	to	45°C	with	vigorous	stirring.	
After	one	hour,	the	reaction	was	monitored	by	NMR.		A	small	aliquot	was	removed,	quenched	
by	1	M	HCl,	extracted	with	DCM,	and	concentrated.		Only	traces	of	product	had	formed,	with	most	
material	converted	to	the	protodehalogenated	side	product.		The	reaction	was	then	heated	to	65°C	and	
allowed	to	stir	overnight.	
After	13	hours,	the	reaction	was	again	monitored	by	NMR.		Two	aliquots	were	removed.		One	
was	quenched	with	1	M	HCl	(to	check	for	product	formation),	and	the	other	was	quenched	with	iodine	
(to	check	for	consumption	of	the	arylzinc	reagent).		By	NMR	analysis,	there	was	a	5:5:1	ratio	of	arylzinc	/	
protodehalogenated	side	product	/	triarylphosphine	product.		To	accelerate	the	reaction	by	enhancing	
the	nucleophilicity	of	the	arylzinc	reagent,
78-79
	anhydrous	lithium	bromide	beads	(0.436	g,	5.00	mmol,	
1.00	eq	relative	to	original	ArBr)	in	THF	was	added	in	one	portion.		The	reaction	changed	from	a	pale,	
cream-colored	suspension	to	an	opaque,	green/blue	suspension.		After	another	hour,	the	reaction	was	
monitored	by	NMR	using	the	same	dual	aliquot	procedure.		It	was	approximately	3:3:1	arylzinc	/	
protodehalogenated	side	product	/	triarylphosphine	product.		The	reaction	was	allowed	to	continue	
stirring	at	65°C	for	another	three	hours	and	then	cooled	to	room	temperature.		The	reaction	was	
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quenched	with	1	Molar	HCl	(30	mL)	and	extracted	with	DCM	(3x30	mL).		The	combined	organics	were	
washed	with	H2O	(100	mL)	and	brine	(100	mL),	dried	with	Na2SO4,	decanted,	and	concentrated.		The	
crude	material	was	dried	on	high	vac	overnight.	
The	next	day,	the	crude	reaction	was	purified	by	normal	phase	column	chromatography	(6	cm	
diameter,	200	mL	silica	gel,	isocratic	6/1	Hex/EtOAc),	giving	3.50	as	a	white	solid	(64.6	mg,	0.135	mmol,	
11%	yield).	
1
H	NMR	(500	MHz,	C6D6)	δ	8.00	(ddd,	J	=	4.7,	1.1,	0.5	Hz,	3H),	7.81	(ddd,	J	=	7.9,	1.2,	0.4	Hz,	3H),	6.86	(dd,	
J	=	7.9,	3.9	Hz,	3H),	3.50	(s,	9H),	2.24	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	167.10,	143.19	(d,	JC-P	=	26.5	Hz),	139.42	(d,	JC-P	=	12.8	Hz),	133.11,	131.18	
(d,	JC-P	=	4.9	Hz),	131.00,	127.34,	52.37,	21.30	(d,	JC-P	=	21.1	Hz).	
31
P	NMR	(202	MHz,	C6D6	referenced	to	H3PO4	in	D2O)	δ	-27.25.	
Rf	=	0.16	on	normal	phase	TLC	in	6/1	Hex/EtOAc	
HRMS	(ESI
+
)	
Calculated	for	C27H28O6P	(M+H)
+
:	479.1624	
Found:	479.1614	
	
	
	
Tris(2-methyl-4-(trifluoromethyl)phenyl)phosphine	3.51.		Caution:	the	synthesis	of	these	ligands	
through	the	arylmagnesium	species	is	potentially	hazardous.
77
		A	dry,	stir	bar-equipped,	50	mL	3-neck	
round	bottom	flask	was	put	under	nitrogen	before	adding	1-bromo-2-methyl-4-
(trifluoromethyl)benzene	(1.21	g,	5.00	mmol,	1.00	eq)	and	dry	THF	(8.3	mL).		The	stirring	solution	as	
cooled	to	-78°C	in	a	dry	ice	/	acetone	bath.		nbutyllithium	(1.6	Molar	in	hexanes,	3.1	mL,	4.96	mmol,	0.99	
eq)	was	added	dropwise	over	10	minutes,	resulting	in	a	green/grey	solution.		Over	the	next	hour	of	
stirring	at	-78°C,	the	reaction	color	changed	from	green	to	yellow,	to	orange,	and	finally	to	dark	red.		
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After	one	hour	and	15	minutes,	a	solution	of	phosphorus	trichloride	(0.131	mL,	0.206	g,	1.50	mmol,	0.30	
eq)	in	THF	(2.5	mL)	was	added	dropwise	over	five	minutes.		The	resulting	dark	red-colored	reaction	was	
allowed	to	stir	and	gradually	warm	to	room	temperature	over	the	next	seven	hours.	
	 The	reaction	was	cooled	to	0°C	and	quenched	by	addition	of	H2O	(0.8	mL)	while	under	nitrogen.		
The	septum	was	then	removed,	and	saturated	NH4Cl	(10	mL)	was	added.		The	reaction	was	diluted	using	
H2O	(20	mL)	and	toluene	(20	mL).		After	extraction	of	the	aqueous	layer	(3x30	mL	toluene),	the	
combined	organics	were	washed	with	brine	(100	mL),	dried	(MgSO4),	filtered,	and	concentrated	to	
afford	a	mixture	of	a	yellow	oil	and	white	crystalline	product.		The	crude	reaction	was	purified	by	normal	
phase	column	chromatography	(150	mL	silica	gel,	isocratic	100%	hexanes).		The	ligand	was	further	
purified	via	recrystallization	by	dissolving	in	a	minimal	amount	of	boiling	MeOH,	cooling	to	0°C,	and	
filtering,	giving	3.51	as	a	white	crystalline	product	(0.2615	g,	0.5144	mmol,	34%	yield).	
1
H	NMR	(500	MHz,	C6D6)	δ	7.27	(d,	J	=	3.9	Hz,	3H),	7.01	(d,	J	=	8.2	Hz,	3H),	6.54	(dd,	J	=	8.0,	3.8	Hz,	3H),	
2.05	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	143.80	(d,	JC-P	=	27.3	Hz),	137.83	(d,	JC-P	=	12.9	Hz),	133.39,	131.64	(q,	JC-F	=	
32.3	Hz),	127.12	app.	quint,	J	=	3.9	Hz),	124.12	(q,	JC-F	=	272.8	Hz),	123.30	(q,	JC-F	=	3.8	Hz),	21.39	(d,	J	=	
21.3	Hz).	
31
P	NMR	(202	MHz,	C6D6	referenced	to	H3PO4	in	D2O)	δ	-28.47.	
19
F	NMR	(470	MHz,	C6D6	referenced	to	CFCl3	in	CDCl3)	δ	-62.99.	
HRMS	(EI
+
)	
Calculated	for	C24H18F9P	(M)
+
:	508.10021	
Found:	508.09941	
	
	
Tris(2-methyl-4-cyanophenyl)phosphine	3.52.		To	a	dry	50	mL,	3-neck,	stir	bar-equipped	round	bottom	
flask	was	added	4-bromo-3-methylbenzonitrile	(0.9803	g,	5.00	mmol,	1.00	eq).		The	aryl	bromide	was	
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put	under	nitrogen,	dry	THF	(5.0	mL)	was	added,	and	the	stirring	solution	was	cooled	to	0°C	in	an	
ice/water	bath.		iPrMgCl●LiCl	(1.3	Molar	in	THF,	3.85	mL,	5.00	mmol,	1.00	eq)	was	added	(dropwise	over	
20	minutes),	causing	the	reaction	appearance	to	change	to	a	cloudy,	dark	yellow.		The	reaction	was	
allowed	to	continue	stirring	at	0°C.		The	reaction	was	monitored	by	NMR	by	removing	a	small	aliquot	
and	reacting	with	a	mixture	of	iodine	in	pentane.		After	quenching	with	saturated	Na2S2O4,	the	organic	
layer	was	separated	and	concentrated.		
1
H	NMR	was	used	to	quantify	the	aryl	iodide	(as	a	readout	for	
the	reactive	organometallic	reagent),	remaining	aryl	bromide,	and	protodehalogenated	side	product.	
1	hour	and	40	minutes:	10%	ArI,	58%	ArBr,	32%	ArH.	
3	hours	and	55	minutes:	28%	ArI,	40%	ArBr,	32%	ArH.	
6	hours	and	50	minutes:	48%	ArI,	31%	ArBr,	21%	ArH.	
	 After	seven	hours,	the	reaction	was	cooled	to	-78°C	in	a	dry	ice	/	acetone	bath.		Phosphorus	
trichloride	(50	μL,	0.0785	g,	0.572	mmol,	0.24	eq	relative	to	aryl	Grignard	as	readout	by	NMR	yield	of	
corresponding	aryl	iodide)	was	added	(neat,	dropwise	over	2	minutes).		The	reaction	changed	from	an	
orange	cloudy	appearance	to	a	yellow	cloudy	appearance.		The	reaction	was	allowed	to	warm	to	room	
temperature	and	stir	overnight.		Nine	hours	later,	the	crude	reaction	was	filtered	through	celite	(20	mL),	
rinsing	with	DCM	(100	mL).		The	filrate	was	concentrated	to	give	a	viscous	orange	oil.		The	crude	product	
was	purified	by	normal	phase	column	chromatography	(5	cm	diameter,	300	mL	silica	gel,	isocratic	8/1	
Hex),	giving	3.52	as	a	white	powder	(40.4	mg,	0.106	mmol,	19%	yield).	
1
H	NMR	(500	MHz,	C6D6)	δ	6.80-6.76	(m,	6H),	6.27	(dd,	J	=	8.0,	3.8	Hz,	3H),	1.86	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	144.23	(d,	JC-P	=	27.5	Hz),	138.77	(d,	JC-P	=	14.5	Hz),	133.71	(d,	JC-P	=	4.7	Hz),	
133.43,	130.11,	118.40,	113.81,	21.20	(d,	JC-P	=	21.4	Hz).	
31
P	NMR	(202	MHz,	C6D6	referenced	to	H3PO4	in	D2O)	δ	-26.84.	
HRMS	(ESI
+
)	
Calculated	for	C24H19N3P	(M+H)
+
:	380.1317	
Found:	380.1301	
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Tris(4-chloro-2-methylphenyl)phosphine	SI-3.15.		A	dry,	stir	bar-equipped	50	mL	Schlenk	flask	was	
sealed	with	a	rubber	septum	and	vac-filled	with	nitrogen	three	times.		In	a	separate	dry	40	mL	vial,	2-
bromo-5-chlorotoluene	(2.055	g,	10.0	mmol,	1.00	eq)	was	massed	out.		The	vial	was	likewise	put	under	
nitrogen,	and	dry	THF	(16.7	mL	total,	0.60	Molar)	was	used	to	transfer	the	aryl	bromide	to	the	Schlenk	
flask.		The	solution	was	cooled	with	stirring	to	-78°C	in	a	dry	ice	/	acetone	bath.		To	this	stirring	solution	
was	added	n-butyllithium	(1.6	Molar	in	hexanes,	5.6	mL,	9.0	mmol,	0.90	eq,	dropwise	over	10	minutes),	
causing	a	change	in	the	reaction	appearance	from	clear	/	colorless	to	opaque	/	cream-colored.		After	
additional	stirring	at	-78°C	for	1	hour	and	50	minutes,	PCl3	(0.218	mL,	0.343	g,	2.50	mmol,	2.50	eq)	was	
added	(neat,	dropwise	over	3-4	minutes).		The	now	opaque	orange	suspension	was	allowed	to	gradually	
warm	to	room	temperature	with	stirring.	
	
Two	days	later,	the	reaction	was	quenched	by	addition	of	saturated	NH4Cl.		The	mixture	was	diluted	
with	H2O	and	extracted	with	DCM	three	times.		Combined	organics	were	washed	with	brine,	dried	with	
Na2SO4,	and	concentrated	by	rotary	evaporation.		The	crude	black	oil	was	filtered	through	a	pad	of	silica	
gel	rinsing	with	5/1	Hex/DCM,	giving	a	light	yellow	oil.		This	material	was	purified	by	column	
chromatography	(4	cm	diameter,	120	mL	SiO2,	isocratic	100%	hexanes,	giving	SI-3.15	as	a	fluffy	white	
solid	(276.0	mg	=	0.6781	mmol	=	27%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.24	(dd,	J	=	4.1,	2.0,	3H),	7.07	(dd,	J	=	8.2,	2.2	Hz,	3H),	6.59	(dd,	J	=	8.2,	3.8	
Hz,	3H),	2.34	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	144.58	(d,	J	=	27.8	Hz),	135.34,	134.27,	132.17	(d,	J	=	11.4	Hz),	130.42	(d,	J	=	
4.9	Hz),	126.68,	21.13	(d,	J	=	21.5	Hz).	
31
P	NMR	(202	MHz,	C6D6	referenced	to	H3PO4	in	D2O)	δ	-31.64.	
Rf	=	0.27	on	normal	phase	TLC	in	100%	hexanes	
HRMS	(EI
+
)	
Calculated	for	C21H18Cl3P	(M)
+
:		406.02121	
Found:	406.02040	
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Tris(2-methyl-4-nitrophenyl)phosphine	3.53.		This	synthesis	was	based	on	a	reported	conversion	of	aryl	
chlorides	to	nitroaromatics.
62
		Sodium	nitrite	was	dried	under	high	vacuum	in	80	°C	sand	bath,	and	tert-
amyl	alcohol	was	degassed	by	bubbling	nitrogen	through	for	20	min.		A	dry,	stir	bar-equipped,	15	mL	
pressure	tube	was	brought	into	an	argon-filled	glovebox	and	charged	with	sodium	nitrite	(0.24877	g,	
3.606	mmol,	6.00	eq),	tris(4-chloro-2-methylphenyl)phosphine	SI-3.15	(0.2450	g,	0.6009	mmol,	1.00	eq),	
Pd2dba3	(41.1	mg,	0.0449	mmol,	7.5	mol%),	and	tBuBrettPhos	(52.2	mg,	0.108	mmol,	18	mol%).		tert-
amyl	alcohol	(4.0	mL)	and	tris[2-(2-methoxyethoxy)ethyl]amine	(28.8	μL,	29.1	mg,	0.0900	mmol,	0.15	
eq)	were	added,	and	the	pressure	tube	was	tightly	capped.		The	reaction	was	brought	out	of	the	
glovebox	and	into	a	fume	hood,	where	it	was	stirred	for	72	hours	at	140	°C.	
After	cooling	to	room	temperature,	the	catalyst	was	removed	by	silica	gel	filtration	(diluting	with	
100	mL	EtOAc).		The	crude	product	was	then	purified	by	normal	phase	column	chromatography	(70	g	
silica	gel,	3.5x15cm,	dry	loading	on	celite,	50:1	to	20:1	Hex/EtOAc),	giving	3.53	as	a	yellow	powder	(74.1	
mg,	0.169	mmol,	28%	yield).	
1
H	NMR	(500	MHz,	C6D6)	δ	8.16	(dd,	J	=	4.4,	2.4	Hz,	3H),	7.97	(dd,	J	=	8.4,	2.3	Hz,	3H),	6.84	(dd,	J	=	8.4,	3.5	
Hz,	3H),	2.50	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	149.12,	144.88	(d,	JC-P	=	28.2	Hz),	140.68	(d,	JC-P	=	14.5	Hz),	133.82,	125.23	
(d,	JC-P	=	4.9	Hz),	121.51,	21.55	(d,	JC-P	=	21.2	Hz).	
31
P	NMR	(202	MHz,	CDCl3	referenced	to	H3PO4	in	D2O)	δ	-26.72.	
HRMS	(ESI
+
)	
Calculated	for	C21H18N3O6P	(M)
+
:	439.0933	
Found:	439.0932	
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1-bromo-2-(bromomethyl)-4-methoxybenzene	SI-3.16.		A	dry,	stir	bar-equipped,	3-neck	250	mL	round	
bottom	flask	was	fitted	with	a	reflux	condenser	and	put	under	nitrogen.		1-bromo-4-methoxy-2-
methylbenzene	(1.39	mL,	2.011	g,	10.0	mmol,	1.00	eq),	CCl4	(20.0	mL,	0.50	Molar,	not	degassed),	N-
bromosuccinimide	(recrystallized,	2.67	g,	15.0	mmol,	1.50	eq),	and	benzoyl	peroxide	(0.121	g,	0.50	
mmol,	5	mol%)	were	added	by	briefly	removing	a	septum	while	under	positive	nitrogen	pressure.		The	
reaction	was	heated	to	reflux	for	18	hours.	
	 The	next	day,	the	reaction	was	filtered	through	a	silica	gel	plug,	rinsing	with	10/1	Hex/Et2O.		The	
crude	product	was	purified	by	normal	phase	column	chromatography	(5	cm	diameter,	300	mL	silica	gel,	
isocratic	4/1	Hex/DCM),	giving	SI-3.16	as	a	fluffy,	slightly	off-white	powder	(1.404	g,	5.015	mmol,	50%	
yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.45	(d,	J	=	8.8	Hz,	1H),	6.99	(d,	J	=	3.0	Hz,	1H),	6.74	(dd,	J	=	8.8,	3.0	Hz,	1H),	
4.56	(s,	2H),	3.80	(s,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	159.28,	137.90,	134.06,	116.67,	116.27,	114.85,	55.71,	33.61.	
HRMS	(EI
+
)	
Calculated	for	C8H8O
79
Br2	(M)
+
:	277.89422	
Found:	277.89402	
	
	
2-benzyl-1-bromo-4-methoxybenzene	SI-3.17.		This	procedure	was	based	on	a	previous	report	of	the	
selective	coupling	of	benzylic	bromides.
74
		A	stir	bar-equipped,	3-neck	250	mL	round	bottom	flask	was	
sealed	with	two	septa	and	equipped	with	a	reflux	condenser	attached	to	a	nitrogen	inlet.		After	the	
system	was	put	under	nitrogen,	reagents	and	solvents	were	added	by	briefly	removing	a	septum	while	
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under	a	positive	nitrogen	pressure.		In	this	manner,	phenylboronic	acid	(0.5990	g,	4.913	mmol,	1.00	eq),	
ethanol	(7.8	mL,	0.63	Molar),	water	(2.1	mL,	2.3	Molar),	1-bromo-2-(bromomethyl)-4-methoxybenzene	
SI-3.16	(1.376	g,	4.913	mmol,	1.00	eq)	as	a	solution	in	toluene	(9.5	mL,	0.52	Molar),	aqueous	sodium	
carbonate	(5.53	mL,	1.00	Molar,	5.53	mmol,	1.13	eq),	and	Pd(PPh3)4	(0.1135	g,	0.09826	mmol,	2	mol%)	
were	added	to	the	reaction.	
The	reaction	was	heated	to	80°C	for	12	hours	and	then	filtered	through	celite,	rinsing	with	Et2O.		
After	concentration,	the	crude	material	was	diluted	with	H2O	(30	mL)	and	extracted	with	Et2O	(3x30	mL).		
Combined	organics	were	washed	with	brine	(100	mL),	dried	with	Na2SO4,	decanted,	and	reconcentrated.		
The	crude	product	was	purified	by	normal	phase	column	chromatography	(5	cm	diameter,	300	mL	silica	
gel,	isocratic	4/1	Hex/DCM),	giving	SI-3.17	as	a	clear	colorless	oil	(0.7136	g,	2.575	mmol,	52%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.45	(d,	J	=	8.6	Hz,	1H),	7.30	(t,	J=	7.4	Hz,	2H),	7.24-7.18	(m,	3H),	6.68	(d,	J	=	
3.0	Hz,	1H),	6.66	(dd,	J	=	8.6,	3.1	Hz,	1H),	4.07	(s,	2H),	3.73	(s,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	159.06,	141.46,	139.43,	133.42,	129.09,	128.61,	126.42,	117.07,	115.44,	
113.44,	55.49,	42.01.	
Rf	=	0.27	on	normal	phase	TLC	in	4/1	Hex/DCM	
HRMS	(EI
+
)	
Calculated	for	C14H13O
79
Br	(M)
+
:	276.01498	
Found:	276.01453	
	
	
Tris(2-benzyl-4-methoxyphenyl)phosphine	3.54.		A	flame	dried,	25	mL	recovery	flask	was	equipped	with	
a	stir	bar,	sealed	with	a	septum,	and	put	under	nitrogen.		To	a	separate,	flame-dried	40	mL	vial	was	
added	2-benzyl-1-bromo-4-methoxybenzene	SI-3.17	(0.6762	g,	2.44	mmol,	1.00	eq).		The	vial	put	under	
nitrogen,	and	THF	(4.1	mL	total)	was	used	to	transfer	the	aryl	bromide	to	the	reaction	flask,	with	rinsing	
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for	quantitative	transfer.		The	solution	was	cooled	to	-78°C	by	submerging	in	a	dry	ice	/	acetone	bath,	
and	then	nbutyllithium	(1.6	Molar	in	hexanes,	1.37	mL,	2.20	mmol,	0.90	eq)	was	added	dropwise	over	5-
10	minutes.		The	reaction	was	allowed	to	stir	for	1.5	hours	at	-78°C.		Phosphorus	trichloride	(53.2	μL,	
83.8	mg,	0.610	mmol,	0.25	eq)	was	added	neat	in	a	dropwise	manner	over	2-3	minutes.		The	reaction	
was	allowed	to	gradually	warm	to	room	temperature	and	stirred	overnight.	
The	next	day,	the	reaction	was	quenched	with	NH4Cl	(10	mL).		Water	(20	mL)	and	DCM	(30	mL)	were	
added,	and	the	aqueous	layer	was	extracted	(3	x	30	mL	DCM).		The	combined	organics	were	washed	
with	brine	(100	mL),	dried	(Na2SO4),	decanted,	and	concentrated.		The	crude	product	was	purified	by	
normal	phase	column	chromatography	(3	cm	diameter,	120	mL	SiO2,	isocratic	1/1	Hex/DCM),	giving	3.54	
as	a	white	powder	(0.2932	g,	0.471	mmol,	77%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.14	(t,	J	=	7.2	Hz,	6H),	7.08	(t,	J	=	7.2	Hz,	3H),	7.02	(d,	J	=	7.0	Hz,	6H),	6.74	
(dd,	J	=	8.8,	3.6	Hz,	3H),	6.65-6.61	(m,	6H),	4.05	(s,	6H),	3.72	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	160.26,	147.19	(d,	JC-P	=	27.8	Hz),	140.58,	135.56,	129.39,	128.26,	126.62	(d,	
JC-P	=	9.3	Hz),	125.91,	116.13	(d,	JC-P	=	5.3	Hz),	111.82,	55.16,	40.21	(d,	JC-P	=	22.2	Hz).	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-35.94.	
HRMS	(EI
+
)	
Calculated	for	C42H39O3P	(M)
+
:	622.2637	
Found:	622.2643	
	
	
1-bromo-2-(bromomethyl)-4-fluorobenzene	SI-3.18.		A	dry,	stir	bar-equipped,	3-neck	300	mL	round	
bottom	flask	was	fitted	with	a	reflux	condenser	and	put	under	nitrogen.		1-bromo-4-fluoro-2-
methylbenzene	(1.26	mL,	1.890	g,	10.0	mmol,	1.00	eq),	CCl4	(20.0	mL,	0.50	Molar,	not	degassed),	N-
bromosuccinimide	(recrystallized,	2.67	g,	15.0	mmol,	1.50	eq),	and	benzoyl	peroxide	(0.121	g,	0.50	
mmol,	5	mol%)	were	added	by	briefly	removing	a	septum	while	under	positive	nitrogen	pressure.		The	
reaction	was	heated	to	reflux	for	18	hours.	
125	
	
	 The	next	day,	the	reaction	was	filtered	through	a	silica	gel	plug,	rinsing	with	hexanes.		The	crude	
product	was	purified	by	normal	phase	column	chromatography	(5	cm	diameter,	300	mL	silica	gel,	
isocratic	100%	hexanes),	giving	SI-3.18	(1.219	g,	4.55	mmol,	45%	yield).	
1
H	NMR	(500	MHz,	C6D6)	δ	7.53	(dd,	J	=	8.8,	5.2	Hz,	1H),	7.20	(dd,	J	=	8.8,	3.0	Hz,	1H),	6.92	(ddd,	J	=	8.8,	
7.8,	3.0	Hz,	1H),	4.54	(s,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	161.94	(d,	JC-F	=	248.1	Hz),	138.96	(d,	JC-F	=	7.6	Hz),	134.67	(d,	JC-F	=	7.8	Hz),	
118.62	(d,	JC-F	=	3.4	Hz),	118.27	(d,	JC-F	=	23.6	Hz),	117.48	(d,	JC-F	=	22.3	Hz),	32.59	(d,	JC-F	=	1.6	Hz).	
19
F	NMR	(470	MHz,	CDCl3,	referenced	to	CFCl3	in	CDCl3)	δ	-114.28	
HRMS	(EI
+
)	
Calculated	for	C7H5
79
Br2F	(M)
+
:	265.87423	
Found:	265.87446	
	
	
2-benzyl-1-bromo-4-fluorobenzene	SI-3.19.		This	procedure	was	based	on	a	previous	report	of	the	
selective	coupling	of	benzylic	bromides.
74
		A	stir	bar-equipped,	3-neck	300	mL	round	bottom	flask	was	
sealed	with	two	septa	and	equipped	with	a	reflux	condenser	attached	to	a	nitrogen	inlet.		After	the	
system	was	put	under	nitrogen,	reagents	and	solvents	were	added	by	briefly	removing	a	septum	while	
under	a	positive	nitrogen	pressure.		In	this	manner,	phenylboronic	acid	(0.5548	g,	4.550	mmol,	1.00	eq),	
ethanol	(7.1	mL,	0.63	Molar),	water	(2.0	mL,	2.3	Molar),	1-bromo-2-(bromomethyl)-4-fluorobenzene	SI-
3.18	(1.219	g,	4.550	mmol,	1.00	eq)	as	a	solution	in	toluene	(8.75	mL,	0.52	Molar),	aqueous	sodium	
carbonate	(5.12	mL,	1.00	Molar,	5.12	mmol,	1.13	eq),	and	Pd(PPh3)4	(0.1052	g,	0.0910	mmol,	2	mol%)	
were	added	to	the	reaction.	
The	reaction	was	heated	to	80°C	for	12	hours	and	then	filtered	through	celite,	rinsing	with	Et2O.		
After	concentration,	the	crude	material	was	diluted	with	H2O	(30	mL)	and	extracted	with	Et2O	(3x30	mL).		
Combined	organics	were	washed	with	brine	(100	mL),	dried	with	Na2SO4,	decanted,	and	reconcentrated.		
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The	crude	product	was	purified	by	normal	phase	column	chromatography	(5	cm	diameter,	300	mL	silica	
gel,	isocratic	100%	hexanes)	followed	by	reverse	phase	column	chromatography	(3	cm	diameter,	50	mL	
C18	silica	gel,	isocratic	3/1	MeCN/H2O,	extracting	with	4x100	mL	pentane	and	drying	with	Na2SO4),	
giving	SI-3.19	as	a	clear	colorless	oil	(0.5966	g,	2.250	mmol,	49%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.52	(m,	1H),	7.32	(m,	2H),	7.25	(m,	1H),	7.19	(d,	J	=	7.4	Hz,	2H),	6.85-6.79	
(m,	2H),	4.08	(s,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	162.11	(d,	JC-F	=	246.5	Hz),	142.75	(d,	JC-F	=	7.1	Hz),	138.73,	133.97	(d,	JC-F	=	
7.9	Hz),	129.18,	128.78,	126.72,	118.93	(d,	JC-F	=	3.3	Hz),	118.01	(d,	JC-F	=	23.0	Hz),	115.16	(d,	JC-F	=	22.5	
Hz),	41.94	(d,	JC-F	=	1.4	Hz).	
19
F	NMR	(470	MHz,	CDCl3,	referenced	to	CFCl3	in	CDCl3)	δ	-115.30	
Rf	=	0.25	on	reverse	phase	TLC	in	3/1	MeCN/H2O	
HRMS	(EI
+
)	
Calculated	for	C13H10
79
BrF	(M)
+
:	263.99498	
Found:	263.99517	
	
	
Tris(2-benzyl-4-fluorophenyl)phosphine	3.55.		A	flame	dried,	25	mL	recovery	flask	was	equipped	with	a	
stir	bar,	sealed	with	a	septum,	and	put	under	nitrogen.		To	a	separate,	flame-dried	40	mL	vial	was	added	
2-benzyl-1-bromo-4-fluorobenzene	SI-3.19	(0.5583	g,	2.106	mmol,	1.00	eq).		The	vial	put	under	
nitrogen,	and	THF	(3.5	mL	total)	was	used	to	transfer	the	aryl	bromide	to	the	reaction	flask,	with	rinsing	
for	quantitative	transfer.		The	solution	was	cooled	by	submerging	in	a	dry	ice	/	acetone	bath.		To	the	-
78°C	mixture	was	added	nbutyllithium	(1.6	Molar	in	hexanes,	1.18	mL,	1.895	mmol,	0.90	eq)	dropwise	
over	5-10	minutes.		The	reaction	was	allowed	to	stir	for	1.5	hours	at	-78°C.		Phosphorus	trichloride	(45.9	
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μL,	72.3	mg,	0.527	mmol,	0.25	eq)	was	added	neat	in	a	dropwise	manner	over	2-3	minutes.		The	reaction	
was	allowed	to	gradually	warm	to	room	temperature	and	stirred	overnight.	
The	next	day,	the	reaction	was	quenched	with	NH4Cl	(10	mL).		Water	(20	mL)	and	DCM	(30	mL)	
were	added,	and	the	aqueous	layer	was	extracted	(3x30	mL	DCM).		The	combined	organics	were	washed	
with	brine	(100	mL),	dried	(Na2SO4),	decanted,	and	concentrated.		The	crude	product	was	purified	by	
normal	phase	column	chromatography	(3	cm	diameter,	120	mL	SiO2,	isocratic	5/1	Hex/DCM),	giving	3.55	
as	a	white	powder	(0.1394	g,	0.2376	mmol,	45%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.18-7.14	(m,	6H),	7.13-7.09	(m,	3H),	6.99	(d,	J	=	7.0	Hz,	6H),	6.84-6.76	(m,	
6H),	6.71	(ddd,	J	=	8.4,	6.2,	3.5	Hz,	3H),	4.06	(s,	6H)	
13
C	NMR	(126	MHz,	CDCl3)	δ	163.75	(d,	J	=	249.6	Hz),	148.35	(dd,	J	=	28.5,	7.3	Hz),	139.53	(d,	J	=	1.5	Hz),	
135.93	(d,	J	=	7.9	Hz),	129.85	(dd,	J	=	11.1,	3.3	Hz),	129.33,	128.48,	126.36,	117.35	(dd,	J	=	21.3,	5.4	Hz),	
113.88	(d,	J	=	20.4	Hz),	40.23	(dd,	J	=	22.6,	1.3	Hz).	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-39.71	(q,	J	=	2.3	Hz)	
19
F	NMR	(470	MHz,	CDCl3,	referenced	to	CFCl3	in	CDCl3)	δ	-112.80	(q,	J	=	10.2	Hz)	
Rf	=	0.20	on	normal	phase	TLC	in	5/1	Hex/DCM	
HRMS	(EI
+
)	
Calculated	for	C39H30F3P	(M)
+
:	586.2037	
Found:	586.2039	
	
	
1-bromo-2-(bromomethyl)-4-(trifluoromethoxy)benzene	SI-3.20.		A	dry,	stir	bar-equipped,	3-neck	250	
mL	round	bottom	flask	was	fitted	with	a	reflux	condenser	and	put	under	nitrogen.		1-bromo-2-methyl-4-
(trifluoromethoxy)benzene	(2.550	g,	10.0	mmol,	1.00	eq),	CCl4	(20.0	mL,	0.50	Molar,	not	degassed),	N-
bromosuccinimide	(recrystallized,	1.958	g,	11.0	mmol,	1.10	eq),	and	benzoyl	peroxide	(48.4	mg,	0.20	
mmol,	2	mol%)	were	added	by	briefly	removing	a	septum	while	under	positive	nitrogen	pressure.		After	
refluxing	for	2.5	hours,	monitoring	of	the	reaction	by	NMR	showed	no	conversion	to	product.		Additional	
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benzoyl	peroxide	(100	mg,	0.41	mmol,	4.1	mol%)	was	added,	and	the	reaction	was	allowed	to	reflux	for	
24	hours.	
	 The	reaction	was	filtered	through	a	silica	gel	plug	(rinsing	with	5:1	Hex/Et2O),	and	concentrated	
in	vacuo.		The	crude	product	was	purified	by	normal	phase	column	chromatography	(5	cm	diameter,	350	
mL	silica	gel,	isocratic	100%	hexanes),	giving	SI-3.20	(1.548	g,	4.64	mmol,	46%	yield).	
1
H	NMR	(500	MHz,	C6D6)	δ	7.60	(d,	J	=	8.8	Hz,	1H),	7.33	(d,	J	=	2.7	Hz,	1H),	7.06	(ddq,	J	=	8.8,	3.0,	1.0	Hz,	
1H),	4.56	(s,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	148.65	(q,	J	=	1.9	Hz),	139.08,	134.69,	123.75,	122.61,	122.09,	120.39	(q,	J	=	
258.7	Hz),	32.29.	
19
F	NMR	(470	MHz,	CDCl3,	referenced	to	CFCl3	in	CDCl3)	δ	-58.51.	
HRMS	(EI
+
)	
Calculated	for	C8H5OF3Br2	(M)
+
:	331.86596	
Found:	331.86479	
	
	
2-benzyl-1-bromo-4-(trifluoromethoxy)benzene	SI-3.21.		This	procedure	was	based	on	a	previous	
report	of	the	selective	coupling	of	benzylic	bromides.
74
		A	stir	bar-equipped,	3-neck	250	mL	round	
bottom	flask	was	sealed	with	two	septa	and	equipped	with	a	reflux	condenser	attached	to	a	nitrogen	
inlet.		After	the	system	was	put	under	nitrogen,	reagents	and	solvents	were	added	by	briefly	removing	a	
septum	while	under	a	positive	nitrogen	pressure.		In	this	manner,	phenylboronic	acid	(0.4016	g,	3.294	
mmol,	1.00	eq),	ethanol	(5.2	mL,	0.63	Molar),	water	(1.43	mL,	2.3	Molar),	1-bromo-2-(bromomethyl)-4-
(trifluoromethoxy)benzene	SI-3.20	(1.10	g,	3.294	mmol,	1.00	eq)	as	a	solution	in	toluene	(6.3	mL,	0.52	
Molar),	aqueous	sodium	carbonate	(3.7	mL,	1.00	Molar,	3.7	mmol,	1.13	eq),	and	Pd(PPh3)4	(0.1142	g,	
0.0988	mmol,	3	mol%)	were	added	to	the	reaction.	
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The	reaction	was	heated	to	80°C	for	15	hours	and	then	filtered	through	celite,	rinsing	with	Et2O.		
After	concentration,	the	crude	material	was	diluted	with	H2O	and	extracted	with	Et2O.		Combined	
organics	were	washed	with	brine,	dried	with	Na2SO4,	decanted,	and	reconcentrated.		The	crude	product	
was	purified	by	normal	phase	column	chromatography	(isocratic	100%	hexanes),	giving	SI-3.21	as	a	clear	
colorless	oil	(0.3895	g,	1.176	mmol,	36%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.52	(m,	1H),	7.32	(m,	2H),	7.25	(m,	1H),	7.19	(d,	J	=	7.4	Hz,	2H),	6.85-6.79	
(m,	2H),	4.08	(s,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	162.11	(d,	JC-F	=	246.5	Hz),	142.75	(d,	JC-F	=	7.1	Hz),	138.73,	133.97	(d,	JC-F	=	
7.9	Hz),	129.18,	128.78,	126.72,	118.93	(d,	JC-F	=	3.3	Hz),	118.01	(d,	JC-F	=	23.0	Hz),	115.16	(d,	JC-F	=	22.5	
Hz),	41.94	(d,	JC-F	=	1.4	Hz).	
19
F	NMR	(470	MHz,	CDCl3,	referenced	to	CFCl3	in	CDCl3)	δ	-115.30	
Rf	=	0.25	on	reverse	phase	TLC	in	3/1	MeCN/H2O	
HRMS	(EI
+
)	
Calculated	for	C14H10OF3Br	(M)
+
:	329.98671	
Found:	329.98647	
	
	
Tris(2-benzyl-4-(trifluoromethoxy)phenyl)phosphine	3.56.		A	flame	dried,	25	mL	recovery	flask	was	
equipped	with	a	stir	bar,	sealed	with	a	septum,	and	put	under	nitrogen.		To	a	separate,	flame-dried	40	
mL	vial	was	added	2-benzyl-1-bromo-4-(trifluoromethoxy)benzene	SI-3.21	(0.4368	g,	1.319	mmol,	1.00	
eq).		The	vial	put	under	nitrogen,	and	THF	(2.2	mL	total)	was	used	to	transfer	the	aryl	bromide	to	the	
reaction	flask,	with	rinsing	for	quantitative	transfer.		The	solution	was	cooled	by	submerging	in	a	dry	ice	
/	acetone	bath.		To	the	-78°C	mixture	was	added	nbutyllithium	(1.6	Molar	in	hexanes,	0.74	mL,	1.19	
mmol,	0.90	eq)	dropwise	over	5-10	minutes.		The	reaction	was	allowed	to	stir	for	1.5	hours	at	-78°C.		
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Phosphorus	trichloride	(28.8	μL,	45.3	mg,	0.330	mmol,	0.25	eq)	was	added	neat	in	a	dropwise	manner	
over	2-3	minutes.		The	reaction	was	allowed	to	gradually	warm	to	room	temperature	and	stirred	
overnight.	
The	next	day,	the	reaction	was	quenched	with	NH4Cl	(5	mL).		Water	(10	mL)	and	DCM	(15	mL)	were	
added,	and	the	aqueous	layer	was	extracted	(3x15	mL	DCM).		The	combined	organics	were	washed	with	
brine	(50	mL),	dried	(Na2SO4),	decanted,	and	concentrated.		The	crude	product	was	purified	by	normal	
phase	column	chromatography	(isocratic	100%	hexanes),	giving	3.56	as	a	white	powder	(0.1394	g,	
0.2376	mmol,	45%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.13-7.04	(m,	9H),	6.97-6.88	(m,	12H),	6.68	(dd,	J	=	8.4,	3.6	Hz,	3H),	4.06	(s,	
6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	150.29	(d,	J	=	1.6	Hz),	147.87	(d,	J	=	28.3	Hz),	139.05	(d,	J	=	1.1	Hz),	135.82,	
132.55	(d,	J	=	12.1	Hz),	129.19,	128.45,	126.44,	122.59	(d,	J	=	5.4	Hz),	120.53	(q,	J	=	258	Hz),	118.65,	
40.48	(d,	J	=	21.8	Hz).	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-35.83	
19
F	NMR	(470	MHz,	CDCl3,	referenced	to	CFCl3	in	CDCl3)	δ	-58.04	
HRMS	(ESI+)	
Calculated	for	C42H31O3F9P	(M+H)
+
:	785.1867	
Found:	785.1862	
	
	
2-benzyl-1-bromo-4-(trifluoromethyl)benzene	SI-3.22.		In	an	argon-filled	glovebox,	combined	(2-bromo-
5-(trifluoromethyl)phenyl)methanol	(25.0	g,	98.0	mmol,	1.00	eq),	FeCl3	(3.24	g,	20.0	mmol,	0.20	eq),	and	
dry	benzene	(100	mL)	in	a	stir	bar-equipped	200	mL	high	pressure	round	bottom	flask.		The	reaction	was	
sealed,	brought	into	a	fume	hood,	and	stirred	at	100°C	for	two	hours.		Monitoring	the	reaction	by	TLC	
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(10%	EtOAc	in	hexanes)	showed	low	conversion.		Additional	FeCl3	(4.00	g,	24.7	mmol,	0.25	eq)	was	
added,	and	the	reaction	was	stirred	at	100°C	for	15	more	hours.	
At	this	point,	TLC	indicated	that	the	reaction	had	gone	to	full	conversion.		The	mixture	was	then	
filtered	through	celite	(rinsing	with	hexanes)	and	concentrated	in	vacuo.		The	crude	product	was	purified	
by	normal	phase	column	chromatography	(isocratic	100%	hexanes),	giving	SI-3.22	as	a	white	solid	(24.32	
g,	77.2	mmol,	79%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.70	(d,	J	=	8.3	Hz,	1H),	7.39	(s,	1H),	7.36-7.29	(m,	3H),	7.25	(m,	1H),	7.18	(d,	
J	=	7.3	Hz,	2H),	4.16	(s,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	141.62,	138.44,	133.59,	130.14	(q,	JC-F	=	32.7	Hz),	129.05,	128.90	(q,	JC-F	=	5.9	
Hz),		128.84,	127.78	(q,	JC-F	=	3.8	Hz),	126.82,	124.75	(q,	JC-F	=	3.8	Hz).	123.93	(q,	JC-F	=	272.6	Hz),	41.87.	
19
F	NMR	(470	MHz,	CDCl3,	referenced	to	CFCl3	in	CDCl3)	δ	-65.23.	
HRMS	(EI
+
)	
Calculated	for	C14H10BrF3	(M)
+
:	313.99179	
Found:	313.99135	
	
	
Tris(2-benzyl-4-(trifluoromethyl)phenyl)phosphine	3.57.	To	a	suspension	of	magnesium	powder	(0.170	
g,	7.00	mmol,	1.02	eq)	in	THF	(14	mL)	in	a	dry	40	mL	vial	was	added	2-benzyl-1-bromo-4-
(trifluoromethyl)benzene	SI-3.22.		After	addition	of	catalytic	iodine	and	brief	heating,	the	Grignard	
reaction	initiated.		The	reaction	was	allowed	to	stir	overnight	at	room	temperature.		The	next	day,	a	
small	aliquot	was	quenched	with	H2O	and	analyzed	by	TLC	(100%	hexanes),	showing	complete	
consumption	of	the	aryl	bromide.		The	reaction	was	submerged	in	a	dry	ice	/	acetone	bath,	and	upon	
cooling	to	-78°C,	phosphorus	trichloride	(0.198	mL,	0.3109	g,	2.20	mmol,	0.32	eq)	was	added	dropwise.		
The	reaction	was	stirred	for	one	hour	at	-78°C	and	then	at	room	temperature	overnight.	
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The	next	day,	an	orange	solid	was	visible	in	the	reaction.		TLC	of	a	quenched	aliquot	(5%	EtOAc	in	
hexanes)	showed	complete	consumption	of	the	dehalogenated	intermediate.		Saturated	NH4Cl	and	H2O	
were	added,	and	the	crude	mixture	was	extracted	with	EtOAc	twice.		The	combined	organic	layers	were	
dried	with	Na2SO4	and	concentrated	to	afford	a	red	oil.		This	material	was	filtered	through	a	plug	of	silica	
gel,	rinsing	with	5%	EtOAc	in	hexanes	to	remove	the	red	baseline	side	products.		After	concentration	to	
an	oil	and	application	of	high	vac	to	remove	solvent	residue,	the	crude	product	was	recrystallized	from	
hot	methanol	(7	mL).		After	cooling	for	30	minutes	in	an	ice	bath,	the	mixture	was	filtered	through	a	
medium	porosity	glass	frit	to	give	3.57	as	a	white	solid	(0.530	grams,	0.720	mmol,	33%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.39	(dd,	J	=	4.5,	1.9	Hz,	3H),	7.26	(dd,	J	=	7.8,	1.1	Hz,	3H),	7.11-7.03	(m,	9H),	
6.93-6.88	(m,	6H),	6.73	(dd,	J	=	8.0,	3.7	Hz,	3H),	4.09	(s,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	146.40	(d,	J	=	27.5	Hz),	138.78	(d,	J	=	0.8	Hz),	138.25	(d,	J	=	13.6	Hz),	134.80,	
131.65	(d,	J	=	32.4	Hz),	129.11,	128.50,	127.05	(dq,	J	=	3.7,	1.1	Hz),	126.56,	124.01	(q,	J	=	272.9	Hz),	
123.50	(q,	J	=	3.7	Hz),	40.61	(d,	J	=	21.1	Hz).	
31
P	NMR	(202	MHz,	CDCl3,	referenced	to	H3PO4	in	D2O)	δ	-31.72.	
19
F	NMR	(470	MHz,	CDCl3,	referenced	to	CFCl3	in	CDCl3)	δ	-63.23.	
HRMS	(ESI+)	
Calculated	for	C42H31F9P	(M+H)
+
:	737.2020	
Found:	737.2012	
	
	
3.89.	To	a	flame-dried	25	mL	Schlenk	flask	under	nitrogen	was	added	1-benzyl-2-bromobenzene	(0.511	
g,	2.07	mmol,	1.00	eq)	as	a	solution	in	dry	THF	(1.5	mL).		Additional	THF	(1.5	mL)	was	used	for	
quantitative	transfer.		The	resulting	solution	was	cooled	to	-78°C	in	a	dry	ice	/	acetone	bath.		To	this	
stirring	solution	was	added	nbutyllithium	(1.6	Molar	in	hexanes,	1.16	mL,	1.86	mmol,	0.90	eq)	dropwise	
over	five	minutes.		After	stirring	at	-78°C	for	1.5	hours,	chlorodi(o-tolyl)phosphine	(0.515	g,	2.07	mmol,	
1.0	eq)	was	added	as	a	solution	in	THF	(2.0	mL)	dropwise	over	ten	minutes,	using	additional	THF	(1.0	mL)	
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for	quantitative	transfer.		The	reaction	was	then	stirred	for	an	additional	30	minutes	at	-78°C	followed	
by	two	hours	at	room	temperature.	
	 The	reaction	was	quenched	with	saturated	NH4Cl	(19	mL)	and	then	transferred	to	a	separatory	
funnel	with	H2O	(10	mL)	and	DCM	(10	mL).		The	aqueous	layer	was	extracted	with	DCM	(3	x	15	mL	DCM).		
The	organic	layer	was	dried	over	Na2SO4,	decanted,	and	concentrated	by	rotary	evaporation.		The	crude	
product	was	purified	by	normal	phase	column	chromatography	(1x8	in.	silica	gel,	isocratic	5:1	
Hex/DCM),	giving	the	pure	product	as	a	colorless	solid	(170.4	mg,	0.448	mmol,	22%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.28-7.23	(m,	3H),	7.22-7.16	(m,	4H),	7.14-7.04	(m,	7H),	6.81	(ddd,	J	=	7.7,	
4.1,	1.4	Hz,	1H),	6.72	(ddd,	J	=	7.7,	4.2,	1.4	Hz,	2H),	4.20	(s,	2H),	2.35	(s,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	146.23	(d,	JC-P	=	26.3	Hz),	142.72	(d,	JC-P	=	26.4	Hz),	140.92	(d,	JC-P	=	1.2	Hz),	
134.88	(d,	JC-P	=	11.0	Hz),	134.59	(d,	JC-P	=	11.2	Hz),	133.95,	133.36,	130.20	(d,	JC-P	=	4.7	Hz),	130.06	(d,	JC-P	
=	5.0	Hz),	129.50	(d,	JC-P	=	1.2	Hz),	129.11,	128.78,	128.32,	126.74,	126.23,	125.98,	40.13	(d,	JC-P	=	22.9	
Hz),	21.35	(d,	JC-P	=	21.4	Hz).	
31
P	NMR	(202	MHz,	CDCl3	referenced	to	H3PO4	in	D2O)	δ	-29.63.	
HRMS	(ES
+
)	
Calculated	for	C27H26P	(M+H)
+
:	381.1772	
Found:	381.1762	
	
	
3.90.	To	a	flame-dried	25	mL	Schlenk	flask	under	nitrogen	was	added	1-bromo-2-(3-
methoxybenzyl)benzene	(1.00	g,	3.61	mmol,	1.00	eq)	as	a	solution	in	dry	THF	(1.5	mL).		Additional	THF	
(1.5	mL)	was	used	for	quantitative	transfer.		The	resulting	solution	was	cooled	to	-78°C	in	a	dry	ice	/	
acetone	bath.		To	this	stirring	solution	was	added	nbutyllithium	(1.6	Molar	in	hexanes,	2.03	mL,	3.25	
mmol,	0.90	eq)	dropwise	over	five	minutes.		After	stirring	at	-78°C	for	1.5	hours,	PCl3	(78.5μL,	0.1236	g,	
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0.900	mmol,	0.25	eq)	was	added	neat	over	ten	minutes.		The	reaction	was	then	stirred	for	an	additional	
30	minutes	at	-78°C	followed	by	two	hours	at	room	temperature.	
	 The	reaction	was	quenched	with	saturated	NH4Cl	(19	mL)	and	then	transferred	to	a	separatory	
funnel	with	H2O	(10	mL)	and	DCM	(10	mL).		The	aqueous	layer	was	extracted	with	DCM	(3	x	15	mL	DCM).		
The	organic	layer	was	dried	over	Na2SO4,	decanted,	and	concentrated	by	rotary	evaporation.		The	crude	
product	was	purified	by	normal	phase	column	chromatography	(1.5x12	in.	silica	gel,	isocratic	1:1	
Hex/DCM),	giving	the	pure	product	as	a	colorless	solid	(242.2	mg,	0.389	mmol,	11%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ		7.24	(td,	J	=	8.2,	7.4,	1.3	Hz,	1H),	7.12-7.04	(m,	9H),	6.82	(ddd,	J	=	7.8,	4.1,	
1.4	Hz,	1H),	6.67-6.61	(m,	6H),	6.60	(s,	3H),	4.10	(s,	6H),	3.61	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	159.65,	145.69	(d,	JC-P	=	26.4	Hz),	142.34,	134.92	(d,	JC-P	=	11.3	Hz),	134.30,	
130.07	(d,	JC-P	=	4.9	Hz),	129.22,	129.08,	126.64,	121.96,	115.03,	111.54,	55.11,	40.28	(d,	JC-P	=	22.6	Hz).	
31
P	NMR	(202	MHz,	CDCl3	referenced	to	H3PO4	in	D2O)	δ	-31.58.	
HRMS	(ES
+
)	
Calculated	for	C42H40O3P	(M+H)
+
:	623.2715	
Found:	623.2729	
	
	
3.91.	To	a	flame-dried	25	mL	Schlenk	flask	under	nitrogen	was	added	1-(2-bromobenzyl)naphthalene	
(1.00	g,	3.36	mmol,	1.00	eq)	as	a	solution	in	dry	THF	(1.5	mL).		Additional	THF	(1.5	mL)	was	used	for	
quantitative	transfer.		The	resulting	solution	was	cooled	to	-78°C	in	a	dry	ice	/	acetone	bath.		To	this	
stirring	solution	was	added	nbutyllithium	(1.6	Molar	in	hexanes,	1.89	mL,	3.02	mmol,	0.90	eq)	dropwise	
over	five	minutes.		After	stirring	at	-78°C	for	1.5	hours,	PCl3	(73	μL,	0.1149	g,	0.837	mmol,	0.25	eq)	was	
added	neat	over	ten	minutes.		The	reaction	was	then	stirred	for	an	additional	30	minutes	at	-78°C	
followed	by	two	hours	at	room	temperature.	
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	 The	reaction	was	quenched	with	saturated	NH4Cl	(19	mL)	and	then	transferred	to	a	separatory	
funnel	with	H2O	(10	mL)	and	DCM	(10	mL).		The	aqueous	layer	was	extracted	with	DCM	(3	x	15	mL	DCM).		
The	organic	layer	was	dried	over	Na2SO4,	decanted,	and	concentrated	by	rotary	evaporation.		The	crude	
product	was	triturated	from	Et2O,	giving	the	pure	product	as	a	slightly	yellow-colored	solid	(120.3	mg,	
0.176	mmol,	21%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.80	(d,	J	=	8.2	Hz,	3H),	7.76	(d,	J	=	8.6	Hz,	3H),	7.67	(d,	J	=	8.2	Hz,	3H),	7.35	
(ddd,	J	=	8.1,	6.8,	1.1	Hz,	3H),	7.25-7.18	(m,	9H),	7.16-7.09	(m,	9H),	6.90	(ddd,	J	=	6.8,	4.9,	1.7	Hz,	1H),	
4.62	(s,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	145.78	(d,	JC-P	=	25.9	Hz),	136.55	(d,	JC-P	=	2.7	Hz),	134.39	(d,	JC-P	=	10.1	Hz),	
134.14,	133.99,	132.36,	129.51	(d,	JC-P	=	5.0	Hz),	129.35,	128.59,	128.00,	127.13,	126.73,	125.99,	125.60,	
125.53,	124.82	(d,	JC-P	=	2.1	Hz),	37.63	(d,	JC-P	=	24.8	Hz).	
31
P	NMR	(202	MHz,	CDCl3	referenced	to	H3PO4	in	D2O)	δ	-33.86.	
HRMS	(ES
+
)	
Calculated	for	C51H40P	(M+H)
+
:	683.2868	
Found:	683.2878	
	
	
3.92.		To	a	flame-dried	25	mL	Schlenk	flask	under	nitrogen	was	added	2-(2-bromobenzyl)naphthalene	
(1.00	g,	3.36	mmol,	1.00	eq)	as	a	solution	in	dry	THF	(1.5	mL).		Additional	THF	(1.5	mL)	was	used	for	
quantitative	transfer.		The	resulting	solution	was	cooled	to	-78°C	in	a	dry	ice	/	acetone	bath.		To	this	
stirring	solution	was	added	nbutyllithium	(1.6	Molar	in	hexanes,	1.87	mL,	3.02	mmol,	0.90	eq)	dropwise	
over	five	minutes.		After	stirring	at	-78°C	for	1.5	hours,	PCl3	(73	μL,	0.1149	g,	0.837	mmol,	0.25	eq)	was	
added	neat	over	ten	minutes.		The	reaction	was	then	stirred	for	an	additional	30	minutes	at	-78°C	
followed	by	two	hours	at	room	temperature.	
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	 The	reaction	was	quenched	with	saturated	NH4Cl	(19	mL)	and	then	transferred	to	a	separatory	
funnel	with	H2O	(10	mL)	and	DCM	(10	mL).		The	aqueous	layer	was	extracted	with	DCM	(3	x	15	mL	DCM).		
The	organic	layer	was	dried	over	Na2SO4,	decanted,	and	concentrated	by	rotary	evaporation.		The	crude	
product	was	purified	by	normal	phase	column	chromatography	(1.5x10	in.	silica	gel,	isocratic	4:1	
hexanes/DCM),	giving	the	pure	product	as	a	white	solid	(77.6	mg,	0.1136	mmol,	14%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.69	(d,	J	=	7.4	Hz,	3H),	7.55	(d,	J	=	8.4	Hz,	3H),	7.50	(d,	J	=	7.7	Hz,	3H),	7.39	
(s,	3H),	7.36-7.29	(m,	6H),	7.20	(td,	J	=	7.5,	1.4	Hz,	1H),	7.11-7.05	(m,	9H),	6.89	(ddd,	J	=	7.7,	4.1,	1.5	Hz,	
1H),	4.26	(s,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	145.62	(d,	JC-P	=	26.6	Hz),	138.26,	135.05	(d,	JC-P	=	11.5	Hz),	134.48,	133.57,	
132.08,	130.28	(d,	JC-P	=	5.0	Hz),	129.09,	128.00,	127.83,	127.75	(d,	JC-P	=	1.0	Hz),	127.66,	127.59,	126.69,	
125.76,	125.24,	40.50	(d,	JC-P	=	22.4	Hz).	
31
P	NMR	(202	MHz,	CDCl3	referenced	to	H3PO4	in	D2O)	δ	-31.70.	
HRMS	(ES
+
)	
Calculated	for	C51H40P	(M+H)
+
:	683.2868	
Found:	683.2844	
	
	
3.93.		To	a	room	temperature	solution	of	P(o-tol)3	(182.6	mg,	0.600	mmol,	1.00	eq)	and	TMEDA	(0.301	
mL,	0.233	g,	2.01	mmol,	3.35	eq)	in	hexanes	(18	mL)	under	nitrogen	was	added	nbutyllithium	(1.6	Molar	
in	hexanes,	1.25	mL,	2.00	mmol,	3.33	eq).		The	light	yellow	solution	slowly	darkened	to	red	and	was	
allowed	to	stir	for	15	hours	at	room	temperature.	
	 One	third	of	this	solution	(0.200	mmol	P(o-tol)3	trianion,	1.00	eq)	was	transferred	to	a	dry	vial	
under	nitrogen,	and	then	MOMCl	(0.090	mL,	0.0954	g,	1.18	mmol,	0.59	eq)	was	added	dropwise	at	room	
temperature.		The	red	color	faded	quickly.		TLC	(10%	EtOAc	in	hexanes)	showed	full	conversion.	
137	
	
	 Saturated	NH4Cl	was	added,	and	the	aqueous	layer	was	extracted	with	Et2O.		Combined	organic	
layers	were	washed	with	brine,	dried	with	Na2SO4,	decanted,	and	concentrated	by	rotary	evaporation.		
The	crude	product	was	purified	by	normal	phase	column	chromatography	(isocratic	10%	EtOAc	in	
hexanes),	giving	the	pure	product	as	a	white	solid	(65	mg,	0.149	mmol,	75%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.31-7.27	(m,	6H),	7.11	(m,	3H),	6.80	(m,	3H),	3.49	(t,	J	=	7.3	Hz,	6H),	3.23	(s,	
9H),	3.09	(t,	J	=	7.3	Hz,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	143.41	(d,	JC-P	=	26.3	Hz),	135.39	(d,	JC-P	=	11.3	Hz),	134.40,	130.11	(d,	JC-P	=	
5.0	Hz),	129.14,	126.86,	72.92,	58.55,	34.82	(d,	JC-P	=	20.8	Hz).	
31
P	NMR	(202	MHz,	CDCl3	referenced	to	H3PO4	in	D2O)	δ	-33.85.	
HRMS	(ES
+
)	
Calculated	for	C27H34O3P	(M+H)
+
:	437.2246	
Found:	437.2244	
	
LIGAND	TESTING	DATA	
Determination	of	Retention	Times	
Conditions:	OD-H	chiral	column,	2.0	mL/min,	isocratic	100%	hexanes	
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Determination	of	Response	Factors	
All	standard	solutions	were	prepared	by	dissolving	the	compounds	in	HPLC	hexanes	in	25	mL	volumetric	
flasks.	
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Compound	 Amount	
(μmol)	
Injection	
Volume	(μL)	
Absorbance	Area	
(mAU	at	214	nm)	
μmol	/	mAU	
(Normalizing	to	5	μL	
injection)	
(±)-3a	 83.2	 10	 14338.73	 0.01160	
(±)-3a	 79.9	 5	 6909.31	 0.01156	
(±)-3a	 79.9	 2.5	 3463.31	 0.01153	
Average	 	 	 	 0.01156	
	 	 	 	 	
2a	 78.9	 5	 7193.07	 0.01097	
2a	 78.9	 2.5	 3559.17	 0.01108	
Average	 	 	 	 0.01103	
	 	 	 	 	
Biphenyl	 90.1	 5	 5986	 0.01505	
	 	 	 	 	
	
Table	3.1.		Determination	of	HPLC	response	factors	for	standards	of	products,	side	products,	and	starting	
materials.	
	
General	Procedure	for	Testing	Ligands:	
Cross-coupling	reactions	were	assembled	per	general	procedure	D,	using	boronic	acid	(S)-1a	in	≥99:1	e.r	
prepared	by	general	procedure	C.		After	24	hours,	the	reactions	were	cooled	to	room	temperature	and	
filtered	through	a	plug	of	silica	gel	in	a	glass	pipet,	rinsing	with	HPLC	grade	hexanes.		The	filtrate	was	
collected	in	25	mL	volumetric	flasks	and	further	diluted	with	HPLC	grade	hexanes	to	the	25	mL	mark.		
After	thorough	mixing,	an	aliquot	of	this	solution	was	transferred	to	an	HPLC	vial	and	immediately	
subjected	to	HPLC	analysis	using	the	same	conditions	as	above	(OD-H	chiral	column,	2.0	mL/min,	
isocratic	100%	hexanes,	214.4	nm	absorbance).		On	each	new	day	of	HPLC	analysis,	a	standard	solution	
of	the	branched	product	standard	was	analyzed	in	duplicate	to	confirm	the	bulb	brightness	and	to	adjust	
response	factors	if	necessary.		If	peak	retention	times	drifted,	standards	were	repeated	as	necessary	to	
confirm	the	identity	of	the	peaks.	
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Ortho-Substituted	Triarylphosphine	Ligands	Under	Anhydrous	Conditions		
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PtBu3	Under	Aqueous	Biphasic	Conditions	
	 The	BIDA	boronate	3.58,	99:1	d.r.,	was	hydrolyzed	to	the	boronic	acid	(S)-3.22	as	in	general	
procedure	B.		This	boronic	acid	was	then	converted	to	the	potassium	(S)-2-butyltrifluoroborate	(S)-3.13	
by	a	reported	method.
80
	The	chiral	trifluoroborate	salt	was	cross-coupled	using	the	reaction	conditions	
recently	reported	to	proceed	with	stereoinversion.
23
	The	trifluoroborate	salt	(94	mg,	0.57	mmol,	1.5	eq),	
4-chlorobiphenyl	(72	mg,	0.38	mmol,	1.0	eq),	the	palladacycle
81
	(11	mg,	0.019	mmol,	5	mol%),	toluene	
(0.76	mL,	0.5	M),	H2O	(0.38	mL,	1.0	M),	and	K2CO3	(157	mg,	1.14	mmol,	3.0	eq)	were	combined	under	
argon	in	a	7	mL	screw-cap	vial	with	a	stir	bar.		The	vial	was	capped	and	stirred	at	100°C	for	24	hours.		TLC	
(100%	hexanes)	showed	complete	conversion	of	the	aryl	chloride.		The	aqueous	layer	was	extracted	
twice	with	hexanes.		The	combined	organic	layers	were	dried	with	sodium	sulfate	and	concentrated	
under	vacuum.		The	crude	product	was	purified	by	silica	column	using	100%	pentane,	giving	3.25	(65	mg,	
0.309	mmol,	81%	yield).		NMR	spectra	were	identical	to	those	of	the	(S)	enantiomer	3.24.	
	 Using	the	potassium	trifluoroborate	salt	made	from	BIDA	boronate	3.58	of	99:1	d.r.,	the	
coupling	product	3.25	had	an	e.r.	of	96:4	(94%	enantiospecificity),	as	determined	by	Chiralcel	OD-H	
column,	100%	hexanes,	2.0mL/min.,	210nm	absorbance.		The	absolute	configuration	of	the	major	
enantiomer	was	identified	as	(R),	having	identified	the	retention	time	of	the	(S)	enantiomer	by	
independent	synthesis	(Section	IX).		Minor:	5.7,	Major:	9.3.	This	independently	confirms	that	the	cross-
coupling	conditions	developed	by	Biscoe	results	in	stereoinversion.	
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Ligand	Electronic	Effects	Under	Anhydrous	Conditions	
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Ligand	Electronic	Effects	Under	Aqueous	Conditions	
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Ligands	Investigating	the	Role	of	the	Benzyl	Group,	Anhydrous	Conditions	
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SYNTHESIS	AND	CHARACTERIZATION	OF	BORON	CONTAINING	COMPOUNDS	
	
SI-3.23.		To	zinc	dust	(3.24	g,	49.5	mmol,	3.41	eq)	in	a	nitrogen-purged	40	mL	vial	with	stir	bar	were	added	
trimethylsilyl	chloride	(100	μL,	120	mg,	1.1	mmol,	8	mol%)	and	1,2-dibromoethane	(100	μL,	220	mg,	1.2	
mmol,	8	mol%)	by	syringe.		Anhydrous	THF	(16	mL)	was	added,	followed	by	1-iodo-3,3,3-trifluoropropane	
(3.8	g,	17.0	mmol,	1.17	eq)	portionwise	at	RT	with	stirring	over	20	min,	keeping	the	exotherm	below	50	
°C.	The	suspension	was	then	stirred	for	1	h	at	50	°C.	To	a	separate	100	mL	round	bottom	flask	purged	with	
nitrogen	containing	a	stir	bar	were	added	RuPhos	(655	mg,	1.40	mmol,	10	mol%),	Pd2dba3	(629	mg,	0.687	
mmol,	5	mol%),	and	DMF	(20	mL).		This	was	stirred	for	30	min	at	23	°C.	Trans-2-bromo-1-methylvinyl	MIDA	
boronate	(Aldrich	cat.	no.	763853,	3.79	g,	14.5	mmol,	1.00	eq)	was	then	added	to	this	solution	in	13	mL	
DMF.	The	alkyl	zinc	suspension	was	filtered	through	a	syringe	filter	and	the	filtrate	was	added	to	the	DMF	
solution.	The	remaining	alkylzinc	solution	was	washed	over	with	additional	THF	(2	mL).	The	reaction	was	
then	 stirred	 for	24	h	at	 50	 °C,	 after	which	 time	nearly	 complete	 conversion	of	 the	 vinyl	 bromide	was	
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observed	by	TLC	(C18	plate,	2:1	H2O:MeCN,	KMnO4	stain).	In	a	separatory	funnel,	the	reaction	was	diluted	
with	EtOAc	and	saturated	aqueous	NH4Cl	was	added.	The	aqueous	phase	was	extracted	twice	with	EtOAc.	
The	combined	organic	phase	was	washed	three	times	with	H2O,	each	time	adding	a	few	mL	of	brine	to	
break	the	emulsion.	The	organic	phase	was	dried	with	Na2SO4,	concentrated	to	a	dark	orange	foam,	then	
dissolved	in	DCM	and	adsorbed	onto	celite.	The	celite	pad	was	loaded	onto	a	C18	silica	column	of	100	mL	
volume,	 eluting	with	 a	 gradient	 of	 30%	 to	 60%	MeCN	 in	 H2O.	 The	 product-containing	 fractions	were	
combined	and	solid	NaCl	was	added	to	induce	phase	separation.	The	organic	phase	was	separated	and	
the	aqueous	layer	extracted	with	EtOAc	(×2).	The	combined	organic	phases	were	dried	and	concentrated	
to	give	SI-3.23	as	a	yellow	solid	(2.91	g,	9.93	mmol	68%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	5.87	(t,	J	=	7.2	Hz,	1H),	3.81	(d,	J	=	16.3	Hz,	2H),	3.69	(d,	J	=	16.3	Hz,	2H),	2.79	
(s,	3H),	2.41	(q,	J	=	7.3	Hz,	2H),	2.27	–	2.14	(m,	2H),	1.68	(dt,	J	=	1.6,	0.9	Hz,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ166.90,	136.96,	127.02	(q,	JC-F	=	277.6	Hz),	61.77,	46.25,	33.06	(q,	JC-F	=	27.7	
Hz),	21.23	(q,	JC-F	=	2.5	Hz),	14.39.	
19
F	NMR	(470	MHz,	CDCl3)	-66.33	(t,	J	=	11.0	Hz).	
11
B	NMR	(128	MHz,	CDCl3)	δ	11.02	
HRMS	(ESI+)	
Calculated	for	C11H16NO4BF3	(M+H)
+
:	294.1124	
Found:	294.1121	
	
	
	
	
SI-3.24.		A	200	mL	round	bottom	flask	was	charged	with	a	stir	bar,	SI-3.23	(2.59	g,	8.84	mmol),	and	10%	
Pd/C	(1.3	g).	The	flask	was	sealed	with	a	rubber	septum	and	purged	with	nitrogen.		Methanol	(30	mL)	was	
added	 via	 syringe.	 A	 balloon	 of	 hydrogen	was	 affixed	 by	 needle	 and	 the	 headspace	was	 purged	with	
hydrogen.	The	balloon	was	refilled	with	hydrogen	and	affixed	to	the	reaction	again.	The	black	suspension	
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was	stirred	for	two	hours	at	23°C.		Monitoring	the	reaction	by	TLC	(100%	EtOAc,	KMnO4)	showed	complete	
conversion.	The	headspace	was	purged	with	nitrogen	and	the	reaction	was	filtered	through	a	silica	plug	
twice,	washing	with	EtOAc.	The	flow-through	was	concentrated	to	give	SI-3.24	as	a	white	solid	(2.34	g,	
7.93	mmol,	90%	yield).	
1
H	NMR	(500	MHz,	acetone-d6)	δ	4.20	(dd,	J	=	17.0,	4.5	Hz,	2H),	4.03	(dd,	J	=	17.0,	4.1	Hz,	2H),	3.16	(s,	3H),	
2.28	–	2.07	(m,	2H),	1.81	–	1.45	(m,	3H),	1.27	(ddt,	J	=	12.1,	8.7,	4.9	Hz,	1H),	0.93	(m,	4H).	
13
C	NMR	(126	MHz,	acetone-d6)	δ	168.85,	168.69,	128.72	(q,	JC-F	=	276.3	Hz),	63.47,	63.29,	45.20,	34.23	(q,	
JC-F	=	27.7	Hz),	32.15,	21.17	(q,	JC-F	=	2.85	Hz),	14.53.	
19
F	NMR	(470	MHz,	acetone-d6)	δ	-66.32	(t,	J	=	11.1	Hz).	
11
B	NMR	(128	MHz,	acetone-d6)	δ	13.81.	
HRMS	(ESI+)	
Calculated	for	C11H18NO4BF3	(M+H)
+
:	296.1281	
Found:	296.1277	
	
	
BIDA	Boronate	3.59.		To	a	100-mL	round-bottom	flask	with	a	stir	bar	was	added	MIDA	boronate	SI-3.24	
(2.07	g,	7.01	mmol),	THF	(35	mL,	0.20	Molar)	and	freshly	prepared	1M	NaOH	(35	mL,	5.0	eq).		The	
mixture	was	stirred	at	23	°C	until	complete	conversion	was	confirmed	by	TLC	(100%	EtOAc,	KMnO4).		
THF	was	removed	under	rotary	evaporation	(bath	temperature	40°C).		When	most	of	the	THF	was	
removed,	the	receiving	flask	was	emptied	and	dried	and	rotary	evaporation	was	then	continued	until	
water	condensation	began	to	collect	in	the	receiving	flask.		Saturated	NH4Cl	(35	mL)	was	added	to	the	
resulting	aqueous	solution	and	this	was	extracted	with	MTBE	(4x35	mL)	in	a	separatory	funnel.	The	
organic	phase	was	dried	over	Na2SO4,	filtered,	and	concentrated	to	an	oil.	The	oil	was	combined	with	
BIDA	(2.15	g,	7.04	mmol,	1.0	eq),	MgSO4	(2.0	g,	16.6	mmol,	2.4	eq),	and	anhydrous	MeCN	(14	mL,	0.50	
Molar)	in	a	40	mL	vial	and	stirred	at	50	°C	overnight.	The	reaction	was	filtered	through	fluorosil	in	a	glass	
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frit,	rinsing	with	EtOAc.	The	filtrate	was	concentrate	to	a	white	foam.	The	two	diastereomers	were	
resolved	by	silica	gel	column	(125	g	silica,	1:1	Hex/EtOAc).	The	diastereomer	with	the	higher	Rf	was	
isolated	as	3.59	(1.19	g,	2.61	mmol,	37%).	The	stereochemistry	of	the	C2	center	of	3.59	was	assigned	by	
analogy	to	the	other	BIDA	boronates	resolved	by	silica	gel	column.	
1
H-NMR	in	CDCl3	showed	a	diastereomeric	ratio	of	≥99:1	by	integrating	the	methyl	doublets	of	3.59	and	
epi-3.59	at	0.87	and	0.98	ppm,	respectively.		The	absolute	stereochemistry	at	the	boron-bearing	carbon	
was	tentatively	assigned	based	on	analogy	to	other	BIDA	boronates.	
1
H	NMR	(500	MHz,	acetone-d6)	δ	7.44	–	7.29	(m,	5H),	4.65	(d,	J	=	10	Hz,	1H),	4.58	(d,	J	=	10	Hz,	1H),	4.41	
(q,	J	=	6.5	Hz,	1H),	4.13	(d,	J	=	17.6	Hz,	1H),	4.10,	(s,	2H),	3.97	(d,	J	=	17.6	Hz,	1H),	3.77	(td,	J	=	8.7,	6.2	Hz,	
1H),	2.34	–	2.08	(m,	4H),	1.89	–	1.76	(m,	3H),	1.76	–	1.47	(m,	4H),	1.28	(qd,	J	=	9.1,	4.4	Hz,	1H),	1.11	–	
0.90	(m,	1H),	0.87	(d,	J	=	7.0	Hz,	3H).	
13
C	NMR	(126	MHz,	acetone-d6)	δ169.97,	168.15,	138.95,	129.20,	128.84,	128.71	(q,	JC-F	=	276.3	Hz),	
128.57,	81.11,	73.37,	72.33,	61.04,	57.08,	34.19	(q,	JC-F	=	27.8	Hz),	32.49,	30.49,	27.31,	22.07,	20.98	(q,	JC-
F	=	2.7	Hz),	14.98.	
19
F	NMR	(470	MHz,	acetone-d6)	δ	-66.27	(t,	J	=	11.6	Hz).	
11
B	NMR	(128	MHz,	acetone-d6)	δ	14.13.	
[α]20D	=	-6.4	(c	1.46,	CHCl3)		
HRMS	(ESI+)	
Calculated	for	C22H30NO5BF3	(M+H)
+
:	456.2169	
Found:	456.2170	
	
Sodium	alkyltrihydroxyborate	SI-3.25	was	made	from	BIDA	boronate	3.59	according	to	general	procedure	
B.	 	The	product	was	 isolated	by	concentration	 in	vacuo	 (0.268	g,	1.20	mmol,	quantitative	yield,	white	
solid).	
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1
H	NMR	(500	MHz,	CD3OD)	2.12	(dtd,	J	=	14.6,	11.4,	5.1	Hz,	1H),	2.06	–	1.91	(m,	1H),	1.66	(ddt,	J	=	16.0,	
10.7,	5.2	Hz,	1H),	1.60	–	1.47	(m,	1H),	1.39	(ddq,	J	=	17.2,	11.5,	5.7	Hz,	1H),	1.15	–	1.04	(m,	1H),	0.82	(d,	J	
=	7.1	Hz,	3H),	0.46	(s,	1H).	
13
C	NMR	(126	MHz,	CD3OD)	δ	129.34	(q,	JC-F	=	275.7	Hz),	35.26	(q,	JC-F	=	27.7	Hz),	34.20,	22.87	(q,	JC-F	=	
2.5	Hz),	16.18.	
11
B	NMR	(128	MHz,	CD3OD)	δ	6.66.	
19
F	NMR	(470	MHz,	CD3OD)	δ	-67.49	(t,	J	=	11.0	Hz)	
[α]20D	=	-15.9	(c	=	1.53,	CD3OD)	
	
	
SI-3.26.		The	pinacol	boronic	ester	was	synthesized	according	to	a	modified	literature	procedure.82		In	an	
argon-filled	glovebox,	sodium	tert-butoxide	(9.652	g,	100.4	mmol,	3.15	eq)	was	added	to	a	dry,	stir	bar-
equipped	500	mL	round	bottom	flask.		In	a	separate	dry	300	mL	round	bottom	flask,	a	mixture	was	
prepared	containing	Et(Bpin)2	(12.23	g,	43.37	mmol,	1.36	eq)	and	5-benzyloxypentyl	bromide
83
	(8.20	g,	
31.9	mmol,	1.00	eq).		Both	flasks	were	sealed	with	rubber	septa,	brought	out	into	a	fume	hood,	and	
connected	to	nitrogen	lines.		To	the	flask	containing	NaOt-Bu	was	added	anhydrous	THF	(97	mL),	and	
the	suspension	was	cooled	to	0°C	in	an	ice	/	water	bath.		Additional	THF	(25	mL)	was	added	to	the	
Et(Bpin)2	/	alkyl	bromide	mixture,	and	the	resulting	solution	was	transferred	(gradually	over	six	minutes,	
using	an	additional	25	mL	THF	for	quantitative	transfer)	into	the	flask	containing	NaOt-Bu.		During	this	
time,	a	precipitate	began	to	form.		The	reaction	was	allowed	to	stir	overnight,	gradually	warming	to	
room	temperature.	
	 The	next	day,	the	reaction	was	diluted	with	Et2O	(250	mL)	and	filtered	through	a	pad	of	celite	to	
remove	salts.		The	filtrate	was	concentrated	thoroughly	in	vacuo,	giving	a	viscous	orange	oil.		This	crude	
product	was	purified	by	column	chromatography	(1	Liter	silica	gel,	10	cm	diameter,	isocratic	30:10:2	
Hex/DCM/Et2O),	affording	SI-3.26	as	a	clear	colorless	oil	(7.68	g,	23.1	mmol,	72%	yield).	
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1
H	NMR	(500	MHz,	CDCl3)	δ	7.36-7.31	(m,	4H),	7.27	(m,	1H),	4.49	(s,	2H),	3.46	(t,	J	=	6.7	Hz,	2H),	1.65-1.58	
(m,	2H),	1.45	(m,	1H),	1.39-1.25	(m,	5H),	1.23	(s,	12H),	1.03-0.96	(m,	1H),	0.95	(d,	J	=	5.7	Hz,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	138.88,	128.47,	127.75,	127.57,	82.91,	73.00,	70.72,	33.30,	29.91,	28.96,	
26.54,	24.90,	24.87,	15.65.	
11
B	NMR	(128	Hz,	CDCl3)	δ	34.37.	
Rf	=	0.25	on	normal	phase	TLC	in	30:10:2	Hex/DCM/Et2O	
HRMS	(EI
+
)	
Calculated	for	C20H33O3B	(M)
+
:	332.25229	
Found:	332.25227	
	
	
BIDA	Boronate	3.60.		The	pinacol	boronic	ester	SI-3.26	(6.68	g,	20.1	mmol,	1.00	eq)	was	added	to	a	stir	
bar-equipped	1	Liter	round	bottom	flask.		THF	(84	mL,	0.24	M),	H2O	(30	mL,	0.68	M),	and	sodium	
periodate	(21.5	g,	100.5	mmol,	5.00	eq)	were	added.		To	the	resulting	stirring	mixture	was	added	
concentrated	HCl	(12	Molar,	4.2	mL,	50.4	mmol,	2.5	eq).		The	reaction	was	allowed	to	stir	at	room	
temperature	for	two	hours.		Monitoring	the	reaction	by	TLC	showed	the	formation	of	boronic	acid	(with	
1:1	Hex/EtOAc)	and	consumption	of	starting	material	(with	5/1	Hex/EtOAc).	
Solvent	was	removed	by	rotary	evaporation.		The	aqueous	mixture	was	diluted	with	addition	
water	and	extracted	with	methyl	tert-butyl	ether	three	times.		Combined	organic	layers	were	washed	
with	water	six	times	to	remove	any	traces	of	the	oxidant	before	finally	drying	with	Na2SO4	and	
performing	a	solvet	switch	to	dry	acetonitrile	(200	mL,	0.10	Molar).		To	this	solution	was	added	a	stir	
bar,	magnesium	sulfate	(8.04	g,	66.8	mmol,	3.3	eq),	and	BIDA	(6.18	g,	20.2	mmol,	1.00	eq).		The	reaction	
was	sealed	with	a	rubber	septum	and	vac-filled	with	nitrogen	(using	brief	cycles	to	avoid	solvent	
evaporation).		The	reaction	was	stirred	overnight	at	60°C.	
	 The	next	day,	the	reaction	was	filtered	through	a	pad	of	silica	gel,	rinsing	with	EtOAc.		The	crude	
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product	was	resolved	by	normal	phase	column	chromatography	(1/1.3	Hex/EtOAc),	giving	a	fraction	of	
mostly	 the	 first	 diastereomer	 and	 another	 fraction	 of	 mostly	 the	 second	 diastereomer.	 	 The	 first	
diastereomer	was	repurified	with	two	more	columns	(1/1.2	Hex/EtOAc	and	1/1.1	Hex/EtOAc),	giving	the	
pure	product	as	a	sticky	foam	(3.29	g,	6.31	mmol,	31.4%	yield).		
1
H-NMR	in	CDCl3	showed	a	diastereomeric	
ratio	of	≥99:1	by	integrating	the	methyl	signals	of	3.26	and	epi-3.26	at	0.86	and	0.98	ppm,	respectively.		
The	absolute	stereochemistry	at	the	boron-bearing	carbon	was	tentatively	assigned	based	on	analogy	to	
other	BIDA	boronates.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.43-7.25	(m,	10H),	4.65	(d,	J	=	11.5	Hz,	1H),	4.49	(s,	2H),	4.38	(d,	J	=	11.5	Hz,	
1H),	4.00	(d,	J	=	16.7	Hz,	1H),	3.90	(q,	J	=	6.7	Hz,	1H),	3.62	(m,	1H),	3.61	(d,	J	=	16.8	Hz,	1H),	3.46	(t,	J	=	6.6	
Hz,	2H),	3.43	(d,	J	=	16.4	Hz,	1H),	3.32	(d,	J	=	16.9	Hz,	1H),	2.21	(m,	1H),	2.06	(m,	1H),	1.88-1.68	(m,	3H),	
1.65-1.57	(m,	3H),	1.53-1.43	(m,	2H),	1.40-1.19	(m,	4H),	0.86	(d,	J	=	6.1	Hz,	3H),	0.83	(m,	1H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	168.93,	167.39,	138.84,	136.38,	128.97,		128.74,	128.45,	128.43,	127.74,	
127.54,	79.12,	72.90,	72.05,	70.65,	61.03,	56.14,	32.23,	29.85,	29.58,	27.86,	26.57,	26.52,	21.41,	14.72,		
11
B	NMR	(128	MHz,	CDCl3)	δ	13.67.	
Rf	=	0.30	on	normal	phase	TLC	in	1/1.5	Hex/EtOAc		
[α]20D	=		+31.9	(c	=	1.0,	acetone)	
HRMS	(ESI+)	
Calculated	for	C30H41BNO6	(M+H)
+
:	522.3027	
Found:	522.3028	
	
Sodium	alkyltrihydroxyborate	(S)-SI-3.27	was	made	from	BIDA	boronate	3.60	according	to	general	
procedure	B.		The	product	was	isolated	by	concentration	in	vacuo	(1.64	g,	5.65	mmol,	90%	yield).	
1
H	NMR	(500	MHz,	CD3OD)	δ	7.32	(d,	J	=	4.3	Hz,	4H),	7.26	(ddd,	J	=	8.8,	4.9,	3.8	Hz,	1H),	4.48	(s,	2H),	3.48	
(t,	J	=	6.7	Hz,	2H),	1.65-1.57	(m,	2H),	1.55-1.26	(m,	4H),	1.17	(m,	1H),	1.04	(m,	1H),	0.83	(d,	J	=	7.1	Hz,	3H),	
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0.58	(b.	s,	1H).	
13
C	NMR	(126	MHz,	CD3OD)	δ	139.86,	129.33,	128.84,	128.59,	73.80,	71.74,	34.87,	31.02,	30.82,	27.97,	
16.41.	
11
B	NMR	(128	MHz,	CD3OD)	δ	6.83.	
	
	
	
	
Pinacol	boronic	ester	(+)-SI-3.28.		According	to	the	procedure	of	Aggarwal	and	co-workers,84	n-propyl	
carbamate
84
	(3.29	g,	17.6	mmol,	1.2	eq.)	and	(-)-spartiene	(4.20	mL,		17.6	mmol,	1.2	eq.)	were	dissolved	
in	Et2O	(86	mL)	and	s-BuLi	(13.5	mL,	1.6M	in	cyclohexane,	21.6	mmol,	1.5	eq)	was	added	dropwise	at	−78	
°C.	After	five	hours,	n-PrBpin	(2.50	g,	14.7	mmol,	1.0	eq.)	was	added	dropwise.		The	reaction	mixture	
was	stirred	for	one	more	hour	at	−78	°C	before	warming	to	room	temperature,	and	then	a	biphasic	
solution	of	MgBr2•Et2O	was	added	as	a	single	portion.	[MgBr2•Et2O	was	prepared	in	a	separate	flask	
from	1,2-dibromoethane	(1.91	mL,	22	mmol,	1.5	eq.)	and	Mg	turnings	(528	mg,	22	mmol,	1.5	eq.)	in	Et2O	
(22	mL).]	The	reaction	mixture	was	heated	at	reflux	overnight,	cooled	to	room	temperature,	and	
quenched	with	water	(200	mL).	The	organic	layer	was	separated,	and	the	aqueous	phase	extracted	with	
Et2O	(3	x	200	mL).	The	organics	were	combined,	dried	over	MgSO4,	filtered	and	concentrated	in	vacuo.	
Subsequent	purification	by	column	chromatography	(1%	Et2O/hexane)	gave	SI-3.28	as	a	colourless	oil	
(1.39	g,	6.55	mmol,	45%).	
1
H	NMR	(500	MHz,	CDCl3)	δ	1.46-1.35	(m,	3H),	1.34-1.26	(m,	3H),	1.24	(s,	12H),	0.94-0.85	(m,	7H)	
13
C	NMR	(126	MHz,	CDCl3)	δ	82.91,	33.60,	24.97,	24.95,	24.40,	22.51,	14.59,	13.86.	
11
B	NMR	(128	MHz,	CDCl3)	δ	34.40	
	[α]20D	=	+0.9	(c	1.69,	CHCl3)		
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HRMS	(CI
+
)	
Calculated	for	C12H25O2B	(M)
+
:	212.19477	
Found:	212.19490	
	
	
MIDA	boronate	(+)-SI-3.29.		A	flame	dried,	stir	bar-equipped	3-neck	500mL	RBF	was	sealed	with	septa,	
fitted	with	a	Schlenk	adaptor,	and	put	under	nitrogen	via	three	vac-fill	cycles.		Separately,	pinacol	
boronic	ester	(+)-SI-3.28	(0.849	g,	4.00	mmol,	1.00	eq)	was	massed	out	into	a	dry	40	mL	vial	and	likewise	
put	under	nitrogen.		(+)-SI-3.28	was	transferred	to	the	RBF	using	DCM,	and	then	additional	DCM	was	
added	to	reach	51	mL.		The	stirring	solution	was	cooled	to	0°C	with	an	ice/water	bath,	and	then	BBr3	(1.0	
M	in	DCM,	20.8	mL,	20.8	mmol,	5.2	eq)	was	added	(dropwise	over	10	minutes).		The	reaction	was	stirred	
for	another	10	minutes	a	0°C	and	then	allowed	to	warm	to	room	temperature	and	stirred	for	an	
additional	hour.	
	
	 At	this	point,	TLC	confirmed	that	the	starting	material	was	consumed	(4/1	Hex/DCM)	and	that	
boronic	acid	was	present	(1/1	Hex/EtOAc).		The	reaction	was	cooled	to	0°C	and	quenched	with	H2O	(120	
mL).		Additional	H2O	(80	mL)	and	methyl	tert-butyl	ether	(200	mL)	were	added,	and	the	layers	were	
mixed	and	separated.		The	organic	layer	was	washed	with	0.1	Molar	HCl	(200	mL)	and	then	H2O	(200	
mL).		The	organic	layer	was	then	dried	with	Na2SO4,	decanted,	and	partially	concentrated	to	a	volume	of	
20	mL.		Toluene	(21	mL)	and	DMSO	(2	mL)	were	added,	and	then	the	remaining	MTBE	and	DCM	were	
removed	by	rotary	evaporation.		The	resulting	solution	(in	a	100	mL	recovery	flask)	was	charged	with	a	
stir	bar	and	MIDA.		The	flask	was	then	equipped	with	a	Dean	Stark	trap	and	reflux	condenser.		After	
refluxing	for	1.5	hours,	TLC	confirmed	that	the	boronic	acid	was	gone	(1/1	Hex/EtOAc)	and	that	MIDA	
boronate	was	present	(100%	EtOAc).		The	stir	bar	was	removed,	and	then	toluene	was	removed	by	
rotary	evaporation	using	the	pump	cart.	
	
	 The	resulting	DMSO	solution	was	diluted	with	H2O	(60	mL)	and	extracted	with	EtOAc	(3x60mL	
EtOAc).		Combined	organics	were	repeatedly	washed	with	H2O	(5x180	mL),	washed	with	brine	(1x180	
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mL),	dried	with	Na2SO4,	decanted	and	concentrated	in	vacuo.		The	resulting	yellow	solid	was	purified	by	
column	chromatography	(5	cm	diameter,	250	mL	SiO2,	isocratic	1/1	Hex/acetone),	affording	the	pure	
product	as	a	fluffy	white	powder	(0.6801	g,	2.82	mmol,	71%	yield).	
1
H	NMR	(500	MHz,	DMSO-d6)	δ	4.15	(d,	J	=	17.2	Hz,	2H),	3.98	(d,	J	=	17.2	Hz,	2H),	2.87	(s,	3H),	1.42-1.30	
(m,	2H),	1.29-1.14	(m,	4H),	0.88-0.82	(m,	6H),	0.67	(m,	1H).	
13
C	NMR	(126	MHz,	DMSO-d6)	δ	169.07,	169.03,	62.23,	62.21,	45.53,	30.31,	21.12,	20.77,	14.54,	12.49.	
11
B	NMR	(128	MHz,	acetone-d6)	δ	18.39.	
Rf	=	0.35	on	normal	phase	TLC	in	1/1	Hex/acetone	
[α]20D	=	+6.1	(c	1.05,	acetone)		
HRMS	(CI
+
)	
Calculated	for	C11H21O4NB	(M+H)
+
:	242.15637	
Found:	242.15626	
	
	
Sodium	alkyltrihydroxyborate	(+)-SI-3.30	was	made	from	MIDA	boronate	(+)-SI-3.29	according	to	
general	procedure	B.		The	product	was	isolated	by	concentration	in	vacuo	(0.3109	g,	1.828	mmol,	91%	
yield).	
1
H	NMR	(500	MHz,	CD3OD)	δ	1.52-1.31	(m,	3H),	1.31-1.16	(m,	6H),	0.92-0.84	(m,	6H),	0.84-0.59	(b.	s,	1H).	
13
C	NMR	(126	MHz,	CD3OD)	δ	35.99,	30.77,	26.04,	24.79,	15.46.	
11
B	NMR	(128	MHz,	CD3OD)	δ	6.70.	
[α]20D	=	+4.4	(c	1.05,	methanol)		
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SI-3.32.		To	a	stir	bar-equipped	7	mL	vial	were	added	trihydroxyborate	(+)-SI-3.30	(4.2	mg,	0.025	mmol,	
1.0	eq),	THF	(0.25	mL,	0.10	Molar),	1M	NaOH	(0.25	mL,	0.25	mmol,	10	eq),	and	30%	aqueous	H2O2	(0.025	
mL).		The	mixture	was	stirred	at	room	temperature.		After	one	hour,	TLC	(2:1	Hex/EtOAc,	KMnO4)	
indicated	full	conversion	of	the	boronic	acid.		The	reaction	was	quenched	by	treatment	with	saturated	
aqueous	Na2S2O3	(0.5	mL)	and	then	extracted	with	Et2O	(3x0.5	mL	Et2O).		The	combined	organic	layers	
were	passed	through	a	short	(0.5	cm)	plug	of	silica	gel	in	a	glass	pipet,	rinsing	with	Et2O.		The	filtrate	was	
collected	in	a	flame-dried	7	mL	vial	and	then	subjected	to	rotary	evaporation	using	mild	vacuum,	giving	
crude	(R)-SI-3.31.	
	 To	the	vial	containing	(R)-SI-3.31	were	added	a	dry	stir	bar,	anhydrous	pyridine	(0.10	mL,	0.098	
g,	1.24	mmol,	50	eq),	and	(S)	-(+)-α-Methoxy-α-(trifluoromethyl)phenylacetyl	chloride	(6.1	μL,	8.2	mg,	
0.035	mmol,	1.4	eq).		The	reaction	was	capped	and	stirred	at	room	temperature	overnight.		The	next	
day,	the	reaction	was	quenched	with	1M	HCl	(2	mL),	extracted	with	Et2O	(3x1.5	mL	Et2O),	dried	with	
Na2SO4,	and	concentrated.		The	crude	product	(3S)-SI-3.32	was	collected	by	passing	through	a	plug	of	
silica	gel,	rinsing	with	Et2O.	
	 This	crude	ester	(3S)-SI-3.32	was	determined	to	be	97.2:2.8	d.r.	by	chiral	HPLC	(OD-H	chiral	
column,	isocratic	100%	hexanes,	1.0	mL/min,	215.4	nm	absorbance).		Major	=	9.7	minutes,	minor	=	10.4	
minutes.		A	standard	of	SI-3.32	in	1:1	d.r.	was	prepared	from	3-hexanol,	following	the	same	procedure	
as	for	(3S)-SI-3.32	
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BIDA	Boronate	3.61.		AcOH	(11.7	mL,	12.3	g,	204	mmol,	0.82	eq.)	was	added	as	a	single	portion	to	a	slurry	
of	NaIO4	(125	g,	584	mmol,	2.3	eq.)	and	pinacol	boronic	ester	SI-3.33	2-(1-cyclohexylpropan-2-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane
85
	(62.8	g,	249	mmol,	1.00	eq.)	in	THF	(1.5	L,	0.17	Molar).	The	reaction	
mixture	was	stirred	at	room	temperature,	filtered	to	remove	salts	and	the	filter	cake	washed	with	Et2O	
(200	mL).	The	filtrate	was	concentrated	in	vacuo	and	then	partitioned	between	H2O	(500	mL)	and	methyl	
tert-butyl	ether	(1	L).	The	organic	layer	was	separated,	and	then	the	aqueous	phase	was	extracted	with	a	
MTBE	 (1	 L).	 The	 combined	 organics	 were	 washed	 with	 water	 (5x300	 mL)	 until	 free	 of	 peroxide	 (as	
determined	 by	 peroxide	 test	 strips).	 The	 organics	 were	 diluted	 with	 DMSO	 (196	mL,	 1.3	Molar)	 and	
concentrated	 in	vacuo	to	afford	a	DMSO	solution	of	boronic	acid.	The	DMSO	solution	was	diluted	with	
toluene	(2.1	L,	0.12	Molar)	and	BIDA	(50	g,	163	mmol,	0.65	eq.)	was	added.		The	reaction	mixture	was	
then	heated	at	reflux	with	a	Dean-Stark	Trap	for	3	hours.		The	reaction	mixture	was	concentrated	in	vacuo	
to	afford	90	g	of	crude	material	which	was	purified	with	the	following	gradient	elution	of	hexanes/EtOAc	
(80:20	3L,	70:30	2L,	60:40	1L,	55:45	1L,	50:50	1L,	45:55	1L,	30:70	1L),	affording	the	mostly	resolved	BIDA	
boronate	(12.5	g,	28.3	mmol	17%	yield,	~97:3	dr)	after	5	columns.	This	material	was	then	suspended	in	
boiling	hexanes	 (3	 L),	 and	a	minimal	amount	of	EtOAc	 (~90	mL)	was	added	 to	effect	dissolution.	 	 The	
mixture	was	cooled	to	room	temperature,	cooled	in	an	ice	bath	for	one	hour,	and	then	filtered	to	give	the	
BIDA	boronate.		After	a	second	crop	was	recrystallized,	the	product	was	isolated	as	a	white	powder	(8.66	
g,	20.1	mmol,	12%	yield).		
1
H-NMR	in	DMSO-d6	showed	a	diastereomeric	ratio	of	≥99:1	by	integrating	the	
methyl	signals	of	3.61	and	epi-3.61	at	0.72	and	0.80	ppm,	respectively.	
1
H	NMR	(500	MHz,	DMSO-d6,	40°C)	δ	7.40	–	7.26	(m,	5H),	4.53	(d,	J	=	11.3	Hz,	1H),	4.46	(d,	J	=	11.3	Hz,	1H),	
4.18	–	4.09	(m,	3H),	4.06	(d,	J	=	17.7	Hz,	1H),	3.93	(d,	J	=	17.0	Hz,	1H),	3.56	(td,	J	=	8.7,	6.1	Hz,	1H),	2.13	–	
1.95	(m,	2H),	1.76	–	1.52	(m,	8H),	1.50	–	1.39	(m,	1H),	1.36	–	0.84	(m,	8H),	0.74	(d,	J	=	6.7	Hz,	3H),	0.65	(q,	
J	=	12.5,	11.8	Hz,	1H).	
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13
C	NMR	(126	MHz,	CDCl3)	δ	169.24,	167.66,	136.67,	128.85,	128.52,	128.32,	79.50,	72.21,	72.07,	60.85,	
56.29,	39.55,	34.94,	34.52,	31.97,	29.76,	26.91,	26.68,	26.66,	26.42,	21.52,	14.59.	
11
B	NMR	(128	MHz,	CDCl3)	δ	14.48.	
[α]20D	=	+2.25	(c	1.0,	acetone)		
HRMS	(ESI+)	
Calculated	for	C25H37BNO5	(M+H)
+
:	442.2765	
Found:	442.2760	
	
	
Sodium	alkyltrihydroxyborate	(-)-SI-3.34	was	made	from	BIDA	boronate	3.61	according	to	general	
procedure	B.		The	product	was	isolated	by	concentration	in	vacuo	(3.9	g,	18.5	mmol,	92%	yield,	white	
solid).	
1
H	NMR	(400	MHz,	D2O)	δ	1.71	(d,	J	=	13.4	Hz,	1H),	1.65	–	1.45	(m,	4H),	1.29	–	0.99	(m,	5H),	0.92	–	0.75	
(m,	2H),	0.70-0.56	(m,	4H),	0.38	(b.	s,	1H).		
13
C	NMR	(101	MHz,	D2O)	δ	42.20,	36.28,	36.01,	32.93,	27.58,	27.26,	27.06,	16.22.	
11
B	NMR	(128	MHz,	D2O)	δ	8.71.	
[α]20D	=	-16.9	(c	0.7,	H2O)		
	
SYNTHESIS	AND	CHARACTERIZATION	OF	CROSS-COUPLED	PRODUCTS	
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Boronic	acid	(S)-3.22	(≥99:1	e.r.)	was	prepared	in	77%	yield	by	general	procedure	C	and	coupled	to	4-
bromobiphenyl	3.23	to	give	product	(+)-3.24	by	general	procedure	D.	The	branched/linear	product	ratio	
of	the	crude	reaction	was	determined	to	be	268/1	by	HPLC	(OD-H	chiral	column,	isocratic	100%	hexanes,	
2.0	mL/min,	214.4	nm	absorbance).	Branched	=	6.0	and	10.3	minutes;	linear	=	19.9	minutes.	The	product	
was	isolated	in	81%	yield	(17.0	mg)	by	purification	with	reverse	phase	flash	chromatography	(6/1	
MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	98.02	:	1.98.	(98%es)	using	chiral	
HPLC	(OD-H	chiral	column,	isocratic	100%	hexanes,	2.0	mL/min,	254.4	nm	absorance).	Major	=	6.0	
minutes;	minor	=	10.3	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	301/1,	isolated	yield	of	83%,	and	
enantiospecificity	of	98%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.60	(d,	J	=	7.3	Hz,	2H),	7.53	(d,	J	=	8.2	Hz,	2H),	7.43	(t,	J	=	7.6	Hz,	2H),	7.33	(t,	
J	=	7.3	Hz,	1H),	7.26	(d,	J	=	8.1	Hz,	2H),	2.65	(sext,	J	=	7.0	Hz,	1H),	1.64	(m,	2H),	1.28	(d,	J	=	6.9	Hz,	3H),	
0.87	(t,	J	=	7.4	Hz,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	146.95,	141.30,	138.81,	128.81,	127.60,	127.12,	127.11,	127.06,	41.48,	
31.32,	21.98,	12.46.	
[α]20D	=	+23.2	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C16H18	(M)
+
:	210.14085	
Found:	210.14096	
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Boronic	acid	(S)-SI-3.35	(≥99:1	e.r.)	was	prepared	in	66%	yield	by	general	procedure	C	and	coupled	to	4-
bromobiphenyl	3.23	to	give	product	(+)-3.66	by	general	procedure	D.	The	branched/linear	product	ratio	
of	the	crude	reaction	was	determined	to	be	243/1	by	HPLC	(Eclipse	XDB-C8	column,	isocratic	68/32	
MeCN/H2O,	1.2	mL/min,	254.4	nm	absorbance).	Branched	=	11.2	minutes;	linear	=	12.0	minutes.	The	
product	was	isolated	in	59%	yield	(17.2	mg)	by	purification	with	reverse	phase	flash	chromatography	
(5/1	MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	99.12	:	0.88.	(˃99%es)	using	
chiral	HPLC	(AD-RH	chiral	column,	isocratic	75/25	MeCN/H2O,	0.5	mL/min,	254.4	nm	absorance).	Major	=	
8.9	minutes;	minor	=	14.6	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	283/1,	isolated	yield	of	61%,	and	
enantiospecificity	of	˃99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.59	(dd,	J	=	8.2,	1.4	Hz,	2H),	7.54	(d,	J	=	8.1	Hz,	2H),	7.43	(t,	J	=	7.7	Hz,	2H),	
7.33	(t,	J	=	7.5	Hz,	1H),	7.25	(d,	J	=	8.3	Hz,	2H),	2.75	(sext,	J	=	7.1	Hz,	1H),	2.06	(dddd,	J	=	19.0,	17.3,	9.3,	
5.4	Hz,	2H),	1.67	(ddd,	J	=	9.7,	7.4,	3.6	Hz,	2H),	1.61	–	1.39	(m,	2H),	1.30	(d,	J	=	7.0	Hz,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	145.98,	141.15,	139.24,	128.86,	127.43,	127.35,	127.30	(q,	J	=	277	Hz),	
127.14,	39.54,	37.47,	33.92	(q,	J	=	29	Hz),	22.34,	20.32	(q,	J	=	2.9	Hz).	
19
F	NMR	(470	MHz,	CDCl3)	δ	-66.88	(t,	J	=	11.0	Hz).	
Rf	=	0.29	on	reverse	phase	TLC	in	5/1	MeCN/H2O	
[α]20D	=	+15.0	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C18H19F3	(M)
+
:	292.14389	
Found:	292.14326	
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Boronic	acid	(S)-3.36	(≥99:1	e.r.)	was	prepared	in	71%	yield	by	general	procedure	C	and	coupled	to	4-
bromobiphenyl	3.23	to	give	product	(+)-3.67	by	general	procedure	D.	The	branched/linear	product	ratio	
of	the	crude	reaction	was	determined	to	be	702/1	by	HPLC	(Eclipse	XDB-C8	column,	isocratic	70/30	
MeCN/H2O,	1.2	mL/min,	254.4	nm	absorbance).	Branched	=	24.8	minutes;	linear	=	26.8	minutes.	The	
product	was	isolated	in	69%	yield	(24.7	mg)	by	purification	with	normal	phase	flash	chromatography	
(20/1	Hex/Et2O).	The	e.r.	of	the	purified	product	was	determined	to	be	99.05	:	0.95	(˃99%es)	using	chiral	
HPLC	(AD-RH	chiral	column,	isocratic	94/6	MeCN/H2O,	0.5	mL/min,	254.4	nm	absorance).	Major	=	10.8	
minutes;	minor	=	19.0	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	550/1,	isolated	yield	of	72%,	and	
enantiospecificity	of	˃99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.61	(d,	J	=	7.7	Hz,	2H),	7.54	(d,	J	=	8.1	Hz,	2H),	7.45	(t,	J	=	7.7	Hz,	2H),	7.38-
7.27	(m,	8H),	4.51	(s,	2H),	3.46	(t,	J	=	6.6	Hz,	2H),	2.74	(sext,	J	=	7.0	Hz,	1H),	1.69-1.58	(m,	4H),	1.43-1.19	
(m,	4H),	1.28	(d,	J	=	6.9	Hz,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	147.12,	141.30,	138.84,	138.83,	128.81,	128.47,	127.73,	127.59,	127.52,	
127.15,	127.13,	127.07,	72.98,	70.56,	39.69,	38.48,	29.82,	27.69,	26.42,	22.47.	
Rf	=	0.27	on	normal	phase	TLC	in	20/1	Hex/Et2O	
[α]20D	=	+30.8	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C26H30O	(M)
+
:	358.2297	
Found:	358.2299	
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Boronic	acid	(S)-3.37	(97.2:2.8	e.r.)	was	prepared	in	76%	yield	by	general	procedure	C	and	coupled	to	4-
bromobiphenyl	3.23	to	give	product	(+)-3.68	by	general	procedure	D.	The	regioisomeric	product	ratio	of	
the	crude	reaction	(3-hexyl	:	2-hexyl	:	1-hexyl)	was	determined	to	be	220/4.7/1	by	GC	(Cyclodex-B	
column,	isothermal	170°C).	3-hexyl	=	13.5	minutes;	2-hexyl	=	15.0	minutes;	1-hexyl	=	20.3	minutes).	The	
product	was	isolated	in	54%	yield	(12.7	mg)	by	purification	with	reverse	phase	flash	chromatography	
(8/1	MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	96.31	:	3.69	(98.1%es)	using	
chiral	HPLC	(OD-H	chiral	column,	isocratic	100%	hexanes,	1.0	mL/min,	254.4	nm	absorance).	Major	=	7.4	
minutes;	minor	=	8.0	minutes.	
A	duplicate	run	of	the	reaction	gave	a	regioisomeric	product	ratio	of	86/2.4/1,	an	isolated	yield	of	58%,	
and	an	enantiospecificity	of	98.0%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.60	(d,	J	=	7.6	Hz,	2H),	7.53	(d,	J	=	8.2	Hz,	2H),	7.43	(t,	J	=	7.7	Hz,	2H),	7.32	(t,	
J	=	7.4	Hz,	1H),	7.21	(d,	J	=	8.1	Hz,	2H),	2.47	(m,	1H),	1.75-1.52	(m,	4H),	1.30-1.15	(m,	2H),	0.87	(t,	J	=	7.3	
Hz,	3H),	0.81	(t,	J	=	7.4	Hz,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	145.40,	141.32,	138.70,	128.81,	128.28,	127.09,	127.03,	126.98,	47.41,	
38.93,	29.82,	20.91,	14.35,	12.41.	
Rf	=	0.26	on	reverse	phase	TLC	in	8/1	MeCN/H2O	
[α]20D	=	+1.8	(c	0.64,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C18H22	(M)
+
:	238.17215	
Found:	238.17177	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	67%	yield	by	general	procedure	C	and	coupled	to	4-
bromobiphenyl	3.23	to	give	product	(+)-3.69	by	general	procedure	D.	The	branched/linear	product	ratio	
of	the	crude	reaction	was	determined	to	be	276/1	by	HPLC	(Eclipse	XDB-C8	column,	isocratic	85/15	
MeCN/H2O,	1.2	mL/min,	254	nm	absorbance).	Branched	=	9.3	minutes;	linear	=	10.2	minutes.	The	
product	was	isolated	in	74%	yield	(20.3	mg)	by	purification	with	reverse	phase	flash	chromatography	
(20/1	MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	98.89	:	1.11	(˃99%es)	using	
chiral	HPLC	(OD-H	chiral	column,	isocratic	100%	hexanes,	2.0	mL/min,	254	nm	absorance).	Major	=	6.2	
minutes;	minor	=	10.2	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	279/1,	isolated	yield	of	72%,	and	
enantiospecificity	of	˃99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.63	–	7.56	(m,	2H),	7.52	(d,	J	=	8.1	Hz,	2H),	7.42	(t,	J	=	7.7	Hz,	2H),	7.32	(t,	J	=	
7.4	Hz,	1H),	7.28	–	7.23	(m,	2H),	2.87	(sext,	J	=	7.0	Hz,	1H),	1.78	(d,	J	=	12.9	Hz,	1H),	1.72	–	1.58	(m,	4H),	
186	
	
1.58	–	1.49	(m,	1H),	1.42	(td,	J	=	13.8,	7.2	Hz,	1H),	1.24	(d,	J	=	6.9	Hz,	3H),	1.22	–	1.09	(m,	4H),	0.89	(q,	J	=	
11.1	Hz,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	147.50,	141.31,	138.73,	128.82,	127.51,	127.16,	127.12,	127.06,	46.51,	
36.44,	35.22,	33.79,	33.55,	26.86,	26.42,	22.90.	
Rf	=	0.26	on	reverse	phase	TLC	in	20/1	MeCN/H2O	
[α]20D	=	+37.6	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C21H26(M)
+
:	278.20345	
Found:	278.20395	
	
	 	
187	
	
	
Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	67%	yield	by	general	procedure	C	and	coupled	to	1-
bromo-4-(tert-butoxy)benzene	to	give	product	(+)-3.70	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	187/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	85/15	MeCN/H2O,	1.2	mL/min,	215.4	nm	absorbance).	Branched	=	9.4	minutes;	linear	=	10.2	
minutes.	The	product	was	isolated	in	76%	yield	(20.4	mg)	by	purification	with	reverse	phase	flash	
chromatography	(15/1	MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	99.32	:	0.68	
(>99%es)	using	chiral	HPLC	(OD-H	chiral	column,	isocratic	100%	hexanes,	2.0	mL/min,	214.4	nm	
absorance).	Major	=	3.07	minutes;	minor	=	3.82	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	160/1,	isolated	yield	of	70%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.04	(d,	J	=	8.4	Hz,	2H),	6.89	(d,	J	=	8.4	Hz,	2H),	2.77	(sext,	J	=	7.3	Hz,	1H),	1.73	
(d,	J	=	13.0	Hz,	1H),	1.70-1.55	(m,	4H),	1.44	(ddd,	J	=	14.3,	8.2,	6.6	Hz,	1H),	1.39-1.34	(m,	1H),	1.33	(s,	9H),	
1.18	(d,	J	=	6.9	Hz,	3H),	1.16-1.08	(m,	4H),	0.90-0.80	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	153.18,	143.17,	127.25,	124.09,	78.11,	46.68,	36.11,	35.26,	33.69,	33.62,	
29.02,	26.87,	26.46,	22.84.	
Rf	=	0.26	on	reverse	phase	TLC	in	15/1	MeCN/H2O	
[α]20D	=	+19.3	(c	1.9,	CHCl3)	
HRMS	(EI
+
)	
Calculated	for	C19H30O	(M)
+
	274.22967	
Found:	274.22963	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	66%	yield	by	general	procedure	C	and	coupled	to	1-
bromo-4-nitrobenzeneto	give	product	(+)-3.71	by	general	procedure	D.	The	branched/linear	product	
ratio	of	the	crude	reaction	was	determined	to	be	108/1	by	HPLC	(Eclipse	XDB-C8	column,	isocratic	70/30	
MeCN/H2O,	1.2	mL/min,	215.4	nm	absorbance).	Branched	=	12.7	minutes;	linear	=	14.2	minutes.	The	
product	was	isolated	in	59%	yield	(14.3	mg)	by	purification	with	reverse	phase	flash	chromatography	
(8/1	MeCN/H2O)	followed	by	normal	phase	flash	chromatography	(4/1	Hex/DCM).	The	e.r.	of	the	
purified	product	was	determined	to	be	98.65	:	1.35	(>99%es)	using	chiral	HPLC	(AD-RH	chiral	column,	
isocratic	75/25	MeCN/H2O,	0.5	mL/min,	214	nm	absorance).	Major	=	22.1	minutes;	minor	=	27.1	
minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	106/1,	isolated	yield	of	62%,	and	
enantiospecificity	of	>99%es.	
1
H	NMR	(500	MHz,	CDCl3)	δ	8.15	(d,	J	=	8.7	Hz,	2H),	7.33	(d,	J	=	8.7	Hz,	2H),	2.95	(sext,	J	=	8.2	Hz,	1H),	1.73	
(d,	J	=	13.1	Hz,	1H),	1.70-1.58	(m,	4H),	1.51	(ddd,	J	=	14.4	Hz,	8.5	Hz,	6.2	Hz,	1H)	1.43	(dt,	J	=	13.9	Hz,	7.1	
Hz,	1H),	1.23	Hz	(d,	J	=	6.9	Hz,	3H),	1.18-1.03	(m,	4H),	0.93-0.82	(m,	2H)	
13
C	NMR	(126	MHz,	CDCl3)	δ	156.19,	146.40,	127.91,	123.85,	46.07,	37.04,	35.23,	33.75,	33.33,	26.69,	
26.31,	22.63.	
Rf	=	0.30	on	reverse	phase	TLC	in	8/1	MeCN/H2O	
Rf	=	0.27	on	normal	phase	TLC	in	4.1	Hex/DCM		
[α]20D	=	+56.5	(c	1.0,	CDCl3)		
HRMS	(EI
+
)	
Calculated	for	C15H22NO2	(M+H)
+
:	248.1651	
Found:	248.1660	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	67%	yield	by	general	procedure	C	and	coupled	to	
methyl	4-bromobenzoate	to	give	product	(+)-3.72	by	general	procedure	D.	The	branched/linear	product	
ratio	of	the	crude	reaction	was	determined	to	be	220/1	by	HPLC	(Eclipse	XDB-C8	column,	isocratic	70/30	
MeCN/H2O,	1.2	mL/min,	254.4	nm	absorbance).	Branched	=	13.7	minutes;	linear	=	15.5	minutes.	The	
product	was	isolated	in	84%	yield	(21.7	mg)	by	purification	with	reverse	phase	flash	chromatography	
(10/1	MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	99.53	:	0.47	(>99%es)	using	
chiral	HPLC	(OD-H	chiral	column,	isocratic	100%	hexanes,	2.0	mL/min,	214.4	nm	absorance).	Major	=	6.4	
minutes;	minor	=	8.3	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	207/1,	isolated	yield	of	88%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.96	(d,	J	=	8.3	Hz,	2H),	7.24	(d,	J	=	8.3	Hz,	2H),	3.90	(s,	3H),	2.88	(h,	J	=	8.6	Hz,	
1H),	1.74	(d,	J	=	11.3	Hz,	1H),	1.68-1.54	(m,	4H),	1.50	(ddd,	J	=	14.3,	8.6,	6.1	Hz,	1H),	1.40	(dt,	J	=	13.9,	7.1	
Hz,	1H),	1.21	(d,	J	=	6.9	Hz,	3H),	1.17-1.04	(m,	4H),	0.91-0.80	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	167.34,	153.85,	129.86,	127.89,	127.17,	52.06,	46.19,	36.98,	35.22,	33.81,	
33.38,	26.77,	26.37,	22.73.	
Rf	=	0.27	on	reverse	phase	TLC	in	10/1	MeCN/H2O	
[α]20D	=	+39.1	(c	1.7,	CDCl3)		
HRMS	(AP
+
)	
Calculated	for	C17H25O2	(M+H)
+
:	261.1855	
Found:	261.1851	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	65%	yield	by	general	procedure	C	and	coupled	to	1-(4-
bromophenyl)-1H-pyrroleto	give	product	(-)-3.73	by	general	procedure	D.	The	branched/linear	product	
ratio	of	the	crude	reaction	was	determined	to	be	266/1	by	HPLC	(Eclipse	XDB-C8	column,	isocratic	75/25	
MeCN/H2O,	1.2	mL/min,	250	nm	absorbance).	Branched	=	14.6	minutes;	linear	=	16.4	minutes.	The	
product	was	isolated	in	68%	yield	(18.3	mg)	by	purification	with	reverse	phase	flash	chromatography	
(9/1	MeCN/H2O)	as	an	off-white	solid.	The	e.r.	of	the	purified	product	was	determined	to	be	99.70	:	0.30	
(>99%es)	using	chiral	HPLC	(AD-RH	chiral	column,	isocratic	85/15	MeCN/H2O,	0.5	mL/min,	214	nm	
absorance).	Major	=	14.7	minutes;	minor	=	24.7	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	246/1,	isolated	yield	of	62%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.31	(d,	J	=	8.4	Hz,	2H),	7.22	(d,	J	=	8.5	Hz,	2H),	7.07	(t,	J	=	2.1	Hz,	2H),	6.33	(t,	
J	=	2.1	Hz,	2H),	2.85	(sext,	J	=	7.9	Hz,	1H),	1.77	(d,	J	=	13.1	Hz,	1H),	1.70-1.59	(m,	4H),	1.50	(m,	1H),	1.41	
(dt,	J	=	13.9,	7.1	Hz,	1H),	1.22	(d,	J	=	6.8	Hz,	3H),	1.19-1.10	(m,	4H),	0.93-0.83	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	145.84,	138.79,	128.07,	120.73,	119.52,	110.14,	46.48,	36.28,	35.22,	33.80,	
33.46,	26.82,	26.41,	26.41,	22.96	
Rf	=	0.26	on	reverse	phase	TLC	in	9/1	MeCN/H2O	
[α]20D	=	-112.8	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C19H25N	(M)
+
:	267.19870	
Found:	267.19823	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	65%	yield	by	general	procedure	C	and	coupled	to	1-
bromo-4-(methylsulfonyl)benzene	to	give	product	(-)-3.74	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	118/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	68/32	MeCN/H2O,	1.2	mL/min,	230	nm	absorbance).	Branched	=	6.3	minutes;	linear	=	7.0	
minutes.	The	product	was	isolated	in	78%	yield	(21.8	mg)	by	purification	with	reverse	phase	flash	
chromatography	(4/1	MeCN/H2O)	as	a	clear	oil.	The	e.r.	of	the	purified	product	was	determined	to	be	
99.74	:	0.26	(>99%es)	using	chiral	HPLC	(AD-RH	chiral	column,	isocratic	75/25	MeCN/H2O,	0.5	mL/min,	
214	nm	absorance).	Major	=	11.9	minutes;	minor	=	17.2	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	119/1,	isolated	yield	of	82%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.85	(d,	J	=	8.3	Hz,	2H),	7.37	(d,	J	=	8.3	Hz,	2H),	3.06	(s,	3H),	2.93	(sext,	J	=	8.0	
Hz,	1H),	1.73	(d,	12.8	Hz,	1H),	1.69-1.58	(m,	4H),	1.51	(ddd,	J	=	14.3,	8.5,	6.2	Hz,	1H),	1.43	(dt,	J	=	13.9,	7.1	
Hz,	1H),	1.22	(d,	J	=	6.9	Hz,	3H),	1.19-1.04	(m,	4H),	0.92-0.82	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	154.92,	138.02,	128.09,	127.62,	46.08,	44.70,	36.99,	35.13,	33.72,	33.31,	
26.69,	26.30,	26.28,	22.65.	
Rf	=	0.33	on	reverse	phase	TLC	in	4/1	MeCN/H2O	
[α]20D	=	-79.6	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C16H24O2S	(M)
+
:	280.14970	
Found:	280.14856	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	65%	yield	by	general	procedure	C	and	coupled	to	(4-
bromophenyl)trimethylsilane	to	give	product	(-)-3.75	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	596/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	85/15	MeCN/H2O,	1.2	mL/min,	214.4	nm	absorbance).	Branched	=	14.6	minutes;	linear	=	16.5	
minutes.	The	product	was	isolated	in	67%	yield	(19.8	mg)	by	purification	with	reverse	phase	flash	
chromatography	(20/1	MeCN/H2O)	as	clear	oil.	The	e.r.	of	the	purified	product	was	determined	to	be	
99.67	:	0.33	(>99%es)	using	chiral	HPLC	(AD-RH	chiral	column,	isocratic	80/20	MeCN/H2O,	0.5	mL/min,	
214.4	nm	absorance).	Major	=	19.3	minutes;	minor	=	21.6	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	624/1,	isolated	yield	of	78%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.44	(d,	J	=	7.9	Hz,	2H),	7.17	(d,	J	=	7.9	Hz,	2H),	2.81	(sext,	J	=	7.1	Hz,	1H),	1.75	
(d,	J	=	13.0	Hz,	1H),	1.69-1.58	(m,	4H),	1.50	(ddd,	J	=	14.1,	7.9,	6.5	Hz,	1H),	1.38	(dt,	J	=	13.8,	7.2	Hz,	1H),	
1.20	(d,	J	=	6.9	Hz,	3H),	1.19-1.06	(m,	4H),	0.91-0.81	(m,	2H),	0.26	(s,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	149.03,	137.30,	133.53,	126.58,	46.45,	36.64,	35.14,	33.68,	33.63,	26.87,	
26.40,	22.66,	-0.85.	
Rf	=	0.21	on	reverse	phase	TLC	in	20/1	MeCN/H2O	
[α]20D	=	-110.0	(c	1.0,	CDCl3)		
HRMS	(EI
+
)	
Calculated	for	C18H30Si	(M)
+
:	274.21168	
Found:	274.21214	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	65%	yield	by	general	procedure	C	and	coupled	to	4-
bromophenyl	trifluoromethanesulfonate	to	give	product	(-)-3.76	by	general	procedure	D.	The	
branched/linear	product	ratio	of	the	crude	reaction	was	determined	to	be	74/1	by	HPLC	(Eclipse	XDB-C8	
column,	isocratic	80/20	MeCN/H2O,	1.2	mL/min,	220.4	nm	absorbance).	Branched	=	9.8	minutes;	linear	
=	10.9	minutes.	The	product	was	isolated	in	81%	yield	(29.5	mg)	by	purification	with	reverse	phase	flash	
chromatography	(8/1	MeCN/H2O)	as	clear	oil.	The	e.r.	of	the	purified	product	was	determined	to	be	
99.41	:	0.59	(>99%es)	using	chiral	HPLC	(AD-RH	chiral	column,	isocratic	75/25	MeCN/H2O,	0.5	mL/min,	
214.4	nm	absorance).	Major	=	9.1	minutes;	minor	=	10.6	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	76/1,	isolated	yield	of	76%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.24	(d,	J	=	8.7	Hz,	2H),	7.17	(d,	J	=	8.7	Hz,	2H),	2.86	(sext,	J	=	7.1	Hz,	1H),	1.72	
(d,	J	=	12.4	Hz,	1H),	1.69-1.58	(m,	4H),	1.46	(ddd,	J	=	14.3,	8.1,	6.4	Hz,	1H),	1.39	(dt,	J	=	13.9,	7.2	Hz,	1H),	
1.19	(d,	J	=	6.9	Hz,	3H),	1.18-1.06	(m,	4H),	0.91-0.82	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	148.86,	147.72,	128.76,	121.20,	118.9	(q,	J	=	319	Hz),	46.35,	36.37,	35.16,	
33.67,	33.47,	26.76,	26.35,	22.75.	
19
F	NMR	(470	Hz,	CDCl3)	δ	-75.06	
Rf	=	0.30	on	reverse	phase	TLC	in	8/1	MeCN/H2O	
[α]20D	=	-62.6	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C16H21O3F3S	(M)
+
:	350.11636	
Found:	350.11738	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	66%	yield	by	general	procedure	C	and	coupled	to	4’-
bromoacetophenone	to	give	product	(+)-3.77	by	general	procedure	D.	The	branched/linear	product	
ratio	of	the	crude	reaction	was	determined	to	be	274/1	by	HPLC	(Eclipse	XDB-C8	column,	isocratic	70/30	
MeCN/H2O,	1.2	mL/min,	254.4	nm	absorbance).	Branched	=	9.8	minutes;	linear	=	11.1	minutes.	The	
product	was	isolated	in	54%	yield	(13.6	mg)	by	purification	with	reverse	phase	flash	chromatography	
(6/1	MeCN/H2O)	followed	by	normal	phase	flash	chromatography	(1/2	Hex/DCM).	The	e.r.	of	the	
purified	product	was	determined	to	be	99.64	:	0.36	(>99%ES)	using	chiral	HPLC	(AD-RH	chiral	column,	
isocratic	72/28	MeCN/H2O,	0.5	mL/min,	214	nm	absorance).	Major	=	27.4	minutes;	minor	=	33.5	
minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	285/1,	isolated	yield	of	61%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.89	(d,	J	=	8.3	Hz,	2H),	7.27	(d,	J	=	8.3	Hz,	2H),	2.89	(sext,	J	=	8.3	Hz,	1H),	2.59	
(s,	3H),	1.74	(d,	J	=	12.6	Hz,	1H),	1.68-1.58	(m,	4H),	1.51	(ddd,	J	=	14.3,	8.6,	6.1	Hz,	1H),	1.41	(m,	1H),	1.21	
(d,	J	=	6.9	Hz,	3H),	1.18-1.05	(m,	4H),	0.91-0.82	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	198.04,	154.17,	135.21,	128.71,	127.33,	46.14,	37.00,	35.22,	33.80,	33.36,	
26.76,	26.69,	26.36,	26.34,	22.71	
Rf	=	0.23	on	reverse	phase	TLC	in	6/1	MeCN/H2O	
Rf	=	0.29	on	normal	phase	TLC	in	1/2	Hex/DCM	
[α]20D	=	+24.2	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C17H24O	(M)
+
:	244.18272	
Found:	244.18204	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	65%	yield	by	general	procedure	C	and	coupled	to	1-(4-
bromophenyl)pyrrolidin-2-one	to	give	product	(+)-3.78	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	307/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	65/35	MeCN/H2O,	1.2	mL/min,	250	nm	absorbance).	Branched	=	9.6	minutes;	linear	=	10.9	
minutes.	The	product	was	isolated	in	74%	yield	(21.4	mg)	by	purification	with	reverse	phase	flash	
chromatography	(7/1	MeCN/H2O)	followed	by	normal	phase	flash	chromatography	(2/1	Hex/EtOAc).	The	
e.r.	of	the	purified	product	was	determined	to	be	99.56	:	0.44	(>99%ES)	using	chiral	HPLC	(AD-RH	chiral	
column,	isocratic	45/45/10	MeCN/MeOH/H2O,	0.5	mL/min,	214	nm	absorance).	Major	=	24.2	minutes;	
minor	=	21.3	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	254/1,	isolated	yield	of	61%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.50	(d,	J	=	8.6	Hz,	2H),	7.17	(d,	J	=	8.5	Hz,	2H),	3.86	(t,	J	=	7.0	Hz,	2H),	2.80	
(app.	sext,	J	=	8.3	Hz,	1H),	2.60	(t,	J	=	8.1	Hz,	2H),	2.15	(app.	quint,	J	=	7.5	Hz,	2H),	1.75	(d,	J	=	13.0	Hz,	1H),	
1.67-1.55	(m,	4H),	1.48	(ddd,	J	=	14.2,	8.7,	5.9	Hz,	1H),	1.36	(ddd,	J	=	13.8,	7.9,	6.5	Hz,	1H),	1.17	(d,	J	=	6.9	
Hz,	3H),	1.16-1.06	(m,	4H),	0.91-0.79	(m,	2H),		
13
C	NMR	(126	MHz,	CDCl3)	δ	174.17,	144.56,	137.19,	127.41,	120.19,	49.05,	46.40,	36.26,	35.10,	33.88,	
33.32,	32.84,	26.82,	26.38,	26.35,	23.12,	18.25.	
Rf	=	0.22	on	reverse	phase	TLC	in	7/1	MeCN/H2O	
Rf	=	0.24	on	normal	phase	TLC	in	2/1	Hex/EtOAc	
[α]20D	=	+38.2	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C19H27ON	(M)
+
:	285.20927	
Found:	285.20903	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	66%	yield	by	general	procedure	C	and	coupled	to	1-
bromo-3-chlorobenzene	to	give	product	(+)-3.79	by	general	procedure	D.	The	branched/linear	product	
ratio	of	the	crude	reaction	was	determined	to	be	94/1	by	HPLC	(Eclipse	XDB-C8	column,	isocratic	83/17	
MeCN/H2O,	1.2	mL/min,	215.4	nm	absorbance).	Branched	=	8.5	minutes;	linear	=	9.6	minutes.	The	
product	was	isolated	in	78%	yield	(20.6	mg)	by	purification	with	reverse	phase	flash	chromatography	
(15/1	MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	99.18	:	0.82	(100%ES)	using	
chiral	HPLC	(AD-RH	chiral	column,	isocratic	75/25	MeCN/H2O,	0.5	mL/min,	214	nm	absorance).	Major	=	
13.2	minutes;	minor	=	11.6	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	86/1,	isolated	yield	of	81%,	and	
enantiospecificity	of	100%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.20	(td,	J	=	7.6,	0.9	Hz,	1H),	7.17-7.13	(m,	2H),	7.05	(dt,	J	=	7.6,	1.4	Hz,	1H),	
2.80	(sext,	J	=	7.7	Hz,	1H),	1.73	(d,	J	=	12.9	Hz,	1H),	1.69-1.58	(m,	4H),	1.47	(m,	1H),	1.37	(dt,	J	=	13.9,	7.2	
Hz,	1H),	1.18	(d,	J	=	6.9	Hz,	3H),	1.18-1.07	(m,	4H),	0.92-0.81	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	150.45,	134.18,	129.68,	127.24,	126.02,	125.40,	46.25,	36.70,	35.15,	33.73,	
33.45,	26.80,	26.37,	22.78	
Rf	=	0.25	on	reverse	phase	TLC	in	15/1	MeCN/H2O	
[α]20D	=	+6.7	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C15H21Cl	(M)
+
:	236.13318	
Found:	236.13205	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	66%	yield	by	general	procedure	C	and	coupled	to	3-
bromobenzonitrile	to	give	product	(-)-3.80	by	general	procedure	D.	The	branched/linear	product	ratio	of	
the	crude	reaction	was	determined	to	be	44/1	by	HPLC	(Eclipse	XDB-C8	column,	isocratic	70/30	
MeCN/H2O,	1.2	mL/min,	215.4	nm	absorbance).	Branched	=	10.8	minutes;	linear	=	12.3	minutes.	The	
product	was	isolated	in	56%	yield	(12.9	mg)	by	purification	with	reverse	phase	flash	chromatography	
(6/1	MeCN/H2O)	followed	by	normal	phase	flash	chromatography	(2/1	Hex/DCM).	The	e.r.	of	the	
purified	product	was	determined	to	be	99.15	:	0.85	(>99%es)	using	chiral	HPLC	(AD-RH	chiral	column,	
isocratic	75/25	MeCN/H2O,	0.5	mL/min,	214.4	nm	absorance).	Major	=	10.0	minutes;	minor	=	7.4	
minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	42/1,	isolated	yield	of	55%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.49-7.45	(m,	2H),	7.43-7.36	(m,	2H),	2.86	(sext,	J	=	8.1	Hz,	1H),	1.75-1.58	(m,	
5H),	1.47	(ddd,	J	=	14.4,	8.4,	6.3	Hz,	1H),	1.40	(dt,	J	=	13.9,	7.2	Hz,	1H),	1.20	(d,	J	=	6.9	Hz,	3H),	1.17-1.03	
(m,	4H),	0.92-0.82	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	149.63,	131.83,	130.81,	129.72,	129.24,	119.39,	112.43,	46.10,	36.65,	35.15,	
33.70,	33.35,	26.71,	26.32,	22.68.	
Rf	=	0.26	on	reverse	phase	TLC	in	6/1	MeCN/H2O	
Rf	=	0.26	on	normal	phase	TLC	in	2/1	Hex/DCM	
[α]20D	=	-74.4	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C16H21N	(M)
+
:	227.16740	
Found:	227.16723	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	67%	yield	by	general	procedure	C	and	coupled	to	4-
bromo-1-(trimethylsilyl)-1H-indole	to	give	product	(+)-3.81	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	250/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	90/10	MeCN/H2O,	1.2	mL/min,	215.4	nm	absorbance).	Branched	=	12.0	minutes;	linear	=	13.4	
minutes.	The	product	was	isolated	in	68%	yield	(24.7	mg)	by	purification	with	reverse	phase	flash	
chromatography	(20/1	MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	99.43	:	0.57	
(>99%es)	using	chiral	HPLC	(AD-RH	chiral	column,	isocratic	72/28	MeCN/H2O,	0.4	mL/min,	214	nm	
absorance).	Major	=	22.7	minutes;	minor	=	21.2	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	226/1,	isolated	yield	of	75%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.35	(d,	J	=	8.4	Hz,	1H),	7.16	(d,	J	=	3.3	Hz,	1H),	7.10	(dd,	J	=	8.3,	7.3	Hz,	1H),	
6.95	(d,	J	=	7.2	Hz,	1H),	6.68	(d,	J	=	3.0	Hz,	1H),	3.29	(sext,	J	=	7.0	Hz,	1H),	1.81	(d,	J	=	12.8	Hz,	1H),	1.77-
1.58	(m,	5H),	1.48	(ddd,	J	=	13.8,	8.1,	6.2	Hz,	1H),	1.32	(d,	J	=	6.9	Hz,	3H),	1.35-1.27	(m,	1H),	1.23-1.09	(m,	
3H),	0.94	(s,	9H),	0.97-0.86	(m,	2H),	0.60	(s,	3H),	0.59	(s,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	141.17,	140.64,	130.29,	121.59,	116.24,	111.56,	103.20,	45.82,	35.46,	34.19,	
33.69,	33.37,	26.92,	26.53,	26.50,	26.47,	21.49,	19.65,	-3.75.	
Rf	=	0.19	on	reverse	phase	TLC	in	20/1	MeCN/H2O	
[α]20D	=	+26.3	(c	1.0,	CHCl3)		
HRMS	(EI
+
)	
Calculated	for	C23H38NSi	(M+H)
+
:	356.2774	
Found:	356.2769	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	67%	yield	by	general	procedure	C	and	coupled	to	4-
bromo-1,2-dimethoxybenzene	to	give	product	(+)-3.82	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	266/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	70/30	MeCN/H2O,	1.2	mL/min,	215.4	nm	absorbance).	Branched	=	9.8	minutes;	linear	=	11.1	
minutes.	The	product	was	isolated	in	62%	yield	(15.0	mg)	by	purification	with	reverse	phase	flash	
chromatography	(6/1	MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	99.52	:	0.48	
(>99%ES)	using	chiral	HPLC	(OD-H	chiral	column,	isocratic	99.8/0.2	Hex/IPA,	2.0	mL/min,	210	nm	
absorance).	Major	=	7.3	minutes;	minor	=	8.8	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	256/1,	isolated	yield	of	55%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	6.80	(d,	J	=	8.1	Hz,	1H),	6.74-6.69	(m,	2H),	3.88	(s,	3H),	3.86	(s,	3H),	2.76	(sext,	
J	=	7.8	Hz,	1H),	1.75	(d,	J	=	12.7	Hz,	1H),	1.68-1.56	(m,	4H),	1.45	(ddd,	J	=	14.3,	8.3,	6.3	Hz,	1H),	1.36	(dt,	J	
=	13.8,	7.1	Hz,	1H),	1.18	(d,	J	=	6.9	Hz,	3H),	1.18-1.09	(m,	4H),	0.91-0.81	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	148.88,	147.12,	141.07,	118.81,	111.25,	110.42,	56.01,	55.98,	46.65,	36.43,	
35.24,	33.80,	33.54,	26.85,	26.43,	23.09.	
[α]20D	=	+19.8	(c	1.2,	CHCl3)	
HRMS	(EI
+
)	
Calculated	for	C17H26O2	(M)
+
:	262.19328	
Found:	262.19324	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	67%	yield	by	general	procedure	C	and	coupled	to	5-
bromo-1,2,3-trimethoxybenzene	to	give	product	(+)-3.83	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	100/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	65/35	MeCN/H2O,	1.2	mL/min,	215.4	nm	absorbance).	Branched	=	13.0	minutes;	linear	=	15.1	
minutes.	The	product	was	isolated	in	71%	yield	(20.3	mg)	by	purification	with	reverse	phase	flash	
chromatography	(5/1	MeCN/H2O).	The	e.r.	of	the	purified	product	was	determined	to	be	99.57	:	0.43	
(>99%ES)	using	chiral	HPLC	(OD-H	chiral	column,	isocratic	99.5/0.5	Hex/IPA,	2.0	mL/min,	214.4	nm	
absorance).	Major	=	4.69	minutes;	minor	=	5.43	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	128/1,	isolated	yield	of	74%,	and	
enantiospecificity	of	>99%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	6.39	(s,	2H),	3.86	(s,	6H),	3.83	(s,	3H),	2.75	(sext,	J	=	7.1	Hz,	1H),	1.76	(d,	J	=	
13.1	Hz,	1H),	1.70-1.58	(m,	4H),	1.45	(dt,	J	=	14.2,	7.2	Hz,	1H),	1.37	(dt,	J	=	13.8,	7.1	Hz,	1H),	1.19	(d,	J	=	6.8	
Hz,	3H),	1.22-1.11	(m,	4H),	0.92-0.82	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	153.15,	144.26,	136.07,	103.91,	60.97,	56.21,	46.56,	37.23,	35.23,	33.68,	
26.83,	26.42,	22.80.	
Rf	=	0.24	on	reverse	phase	TLC	in	5/1	MeCN/H2O	
[α]20D	=	+17.1	(c	1.8,	CHCl3)	
HRMS	(EI
+
)	
Calculated	for	C18H28O3	(M)
+
:	292.20385	
Found:	292.20380	
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Boronic	acid	(S)-3.38	(≥99:1	e.r.)	was	prepared	in	65%	yield	by	general	procedure	C	and	coupled	to	tert-
butyl	(E)-3-bromo-2-methylacrylate	to	give	product	(+)-3.84	by	general	procedure	D.	The	
branched/linear	product	ratio	of	the	crude	reaction	was	determined	to	be	888/1	by	HPLC	(Eclipse	XDB-
C8	column,	isocratic	85/15	MeCN/H2O,	1.2	mL/min,	214.4	nm	absorbance).	Branched	=	8.2	minutes;	
linear	=	8.9	minutes.	The	product	was	isolated	in	64%	yield	(17.9	mg)	by	purification	with	normal	phase	
phase	flash	chromatography	(3/1	Hex/DCM).	The	e.r.	of	the	purified	product	50/50	MeCN/H2O,	0.5	
mL/min,	214.4	nm	absorance).	Major	=	24.3	minutes;	minor	=	26.5	minutes.	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	1303/1,	isolated	yield	of	68%,	
and	enantiospecificity	of	100%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	6.41	(dd,	J	=	10.0,	1.5	Hz,	1H),	2.57	(dq,	J	=	10.3,	6.7	Hz,	1H),	1.78	(d,	J	=	1.4	
Hz,	3H),	1.71-1.60	(m,	5H),	1.49	(s,	9H),	1.26-1.07	(m,	6H),	0.95	(d,	J	=	6.6	Hz,	3H),	0.90-0.78	(m,	2H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	168.07,	147.62,	127.37,	107.71,	80.01,	44.93,	35.34,	33.85,	33.59,	30.34,	
28.31,	26.81,	26.43,	26.42,	20.38,	12.63.	
Rf	=	0.25	on	normal	phase	TLC	in	3/1	Hex/DCM	
[α]20D	=	+28.7	(c	1.0,	CHCl3)		
HRMS	(ESI+)	
Calculated	for	C17H30O2Na	(M+Na)
+
:	289.2144	
Found:	289.2136	
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SYNTHESIS	AND	CHARACTERIZATION	OF	XYLARINIC	ACID	B	
	
	
Compound	SI-3.40.		A	flame-dried	Schlenk	flask	was	charged	with	alkyl	bromide	SI-3.3986	(5.47	g,	14.89	
mmol,	1.0	eq).	The	flask	was	sealed,	evacuated,	and	vac-filled	with	nitrogen	three	times.		Anhydrous	THF	
(14	mL),	Li2CuCl4	(0.1M	in	THF,	4.5	mL,	0.45	mmol,	3	mol%),	and	N-methyl-2-pyrrolidone	(5.7	mL,	59.23	
mmol,	 4.0	 eq)	was	 added	 via	 syringe	under	N2.	 The	 reaction	was	 cooled	 in	 an	 18	 °C	water	 bath,	 and	
MeMgCl	solution	(1.7M	in	THF,	10.5	mL,	17.85	mmol,	1.2	eq)	was	added	dropwise	over	10	minutes.	The	
reaction	was	stirred	for	1	hour	and	45	minutes.	The	reaction	was	then	cooled	to	0	°C,	then	1N	HCl	(50	mL)	
was	 added	 in	 one	 portion.	 The	 mixture	 was	 stirred	 until	 the	 solids	 dissolved	 and	 transferred	 to	 a	
separatory	funnel	with	Et2O	(10	mL).		After	phase	separation,	the	aqueous	layer	was	extracted	with	Et2O	
(2x30	 mL).	 The	 organics	 were	 washed	 with	 H2O	 (30	 mL),	 brine,	 dried	 over	 MgSO4,	 filtered,	 and	
concentrated	 in	 vacuo.	 The	 crude	product	was	purified	on	a	 silica	 gel	 column	 (isocratic	 15%	EtOAc	 in	
hexanes).	Mixed	fractions	were	combined	for	a	second	silica	gel	column	purification,	affording	the	product	
SI-3.40	as	a	colorless	oil	(2.92	g,	9.65	mmol,	65%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	4.17	(dd,	J	=	9.4,	5.8	Hz,	1H),	4.05	(dd,	J	=	9.4,	6.6	Hz,	1H),	3.60	(d,	J	=	15.1	Hz,	
1H),	2.98	(d,	J	=	15.1	Hz,	1H),	2.50	(ddd,	J	=	14.7,	11.8,	3.9	Hz,	1H),	2.39	(m,	1H),	2.12,	(t,	J	=	4.5	Hz,	1H),	
2.06	(m,	1H),	1.95	(d,	J	=	18.5	Hz,	1H),	1.79	(m,	1H),	1.65	(ddd,	J	=	14.1,	9.4,	4.7	Hz,	1H),	1.52	–	1.41	(m,	
2H),	1.22	(dquint,	J	=	13.5,	7.6	Hz,	1H),	1.12	(s,	3H),	0.97	(d,	J	=	6.8	Hz,	3H),	0.92	(t,	J	=	7.5	Hz,	3H),	0.88	(s,	
3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	214.71,	74.90,	58.08,	48.09,	46.64,	42.88,	42.66,	34.75,	27.02,	25.67,	25.01,	
19.98,	19.84,	16.19,	11.23.	
HRMS	(ESI
+
)	
Calculated	for	C15H26O4NaS	(M+Na)
+
:	325.1449	
Found:	325.1450	
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(R)-1-bromo-2-methylbutane,	(R)-SI-3.41.		A	solution	of	SI-3.40	(4.60	g,	15.2	mmol)	in	anhydrous	DMF	
(6.5	mL)	was	prepared	in	a	dry,	stir	bar-equipped	40	mL	vial.		This	solution	was	then	added	to	LiBr	(1.98	
g,	22.8	mmol,	1.5	eq)	in	another	dry,	stir	bar-equipped	40	mL	vial	via	syringe	under	nitrogen,	rinsing	with	
DMF	(2x0.5	mL,	total	DMF	=	7.5	mL	=	2.0	Molar)	for	quantitative	transfer.	The	reaction	was	stirred	at	70	
°C	for	one	hour,	then	cooled	to	room	temperature	and	transferred	to	two	50	mL	centrifuge	tubes,	
rinsing	with	DMF	(3×0.5	mL).		To	each	centrifuge	tube	was	added	H2O	(40	mL).		After	shaking,	the	phases	
were	separated	by	centrifugation	(3000	rpm	for	three	minutes,	then	4000	rpm	for	three	minutes).		In	
both	centrifuge	tubes,	the	aqueous	layer	on	top	was	removed	by	pipet	and	fresh	H2O	was	added	to	the	
40	mL	mark.		After	mixing,	the	phases	were	again	separated	by	centrifugation	by	the	same	procedure.	
The	oil	at	the	bottom	of	each	centrifuge	tube	was	removed	and	passed	through	a	short	pad	of	a	mixture	
consisting	of	celite	and	Na2SO4	in	a	Pasteur	pipette	into	a	tared	7	mL	vial,	giving	the	(R)-SI-3.41	as	a	clear	
colorless	oil	(1.76	g,	11.6	mmol,	76%).	NMR	matches	that	reported	in	the	literature.
87
	
	
	
SI	Compound	(4R)-SI-3.42.		The	pinacol	boronic	ester	was	synthesized	by	a	modified	literature	
procedure.		In	an	argon-filled	glovebox,	a	stir	bar-equipped	250	mL	Schlenk	flask	was	charged	with	
NaOt-Bu	(2.87	g,	29.8	mmol,	3.15	eq).		A	separate	40	mL	vial	was	charged	with	(R)-1-bromo-2-
methylbutane	(R)-SI-3.41	(1.43	g,	9.47	mmol,	1.00	eq)	and	Et(Bpin)282	(3.63	g,	12.9	mmol,	1.36	eq).		The	
Schlenk	flask	was	sealed	with	a	rubber	septum,	and	the	40	mL	was	sealed	with	a	septa	cap.		Both	vessels	
were	brought	out	of	the	glovebox	and	into	a	fume	hood	and	connected	to	nitrogen	lines.		Anhydrous	
THF	(29	mL)	was	added	to	the	Schlenk	flask,	resulting	in	a	cloudy,	light	yellow	suspension.		The	mixture	
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of	alkyl	bromide	and	Et(Bpin)2	was	then	added	(at	room	temperature,	dropwise	over	five	minutes)	to	the	
Schlenk	flask,	using	additional	THF	(2x7	mL,	total	THF	=	43	mL	=	0.22	Molar)	for	quantitative	transfer.		
The	reaction	was	stirred	efficiently	at	room	temperature	overnight.	
	 The	next	day,	the	reaction	was	diluted	with	Et2O	(75	mL)	and	filtered	through	a	pad	of	silica	gel	
in	a	coarse	glass	frit.		The	filtrate	was	concentrated	by	rotary	evaporation,	giving	a	colorless	oil	of	low	
viscosity.		The	crude	product	was	purified	by	normal	phase	column	chromatography	(6	cm	diameter,	250	
mL	silica	gel,	isocratic	4/1	Hex/DCM),	giving	(4R)-SI-3.42	as	a	colorless	oil	(1.34	g,	5.94	mmol,	63%	yield).	
1
H	NMR	(500	MHz,	CDCl3)	δ	1.47	(ddd,	J	=	12.9,	8.9,	5.4	Hz,	1H),	1.40	–	1.27	(m,	4H),	1.22	(d,	J	=	2.2	Hz,	
26H),	1.15	–	1.00	(m,	5H),	0.93	(dd,	J	=	8.9,	7.3	Hz,	6H),	0.89	–	0.78	(m,	12H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	82.72,	82.70,	40.53,	39.87,	33.62,	32.96,	29.68,	29.51,	24.74,	24.70,	24.69,	
24.65,	19.45,	18.88,	16.08,	15.35,	11.43.	
	
	
(4S)-SI-3.42.	was	synthesized	from	(S)-SI-3.4188	by	the	same	procedure	as	(4R)-SI-3.42,	giving	the	
product	as	a	colorless	oil	(1.869	g,	8.22	mmol,	62%	yield).	
NMR	of	(4S)-SI-3.42	matches	that	of	(4R)-SI-3.42.	
	
	
	
BIDA	Boronates	3.63	and	3.64.		To	a	stir	bar-equipped	300	mL	round	bottom	flask	was	added	the	
pinacol	boronic	ester	(4R)-SI-3.42	(1.442	g,	6.37	mmol,	1.00	eq)	followed	by	THF	(43	mL,	0.15	M),	H2O	
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(6.1	mL),	NaIO4	(6.02	g,	28.1	mmol,	3.00	eq),	and	1	Molar	HCl	(4.3	mL,	4.3	mmol,	0.68	eq).		After	five	
hours,	monitoring	of	the	reaction	by	TLC	(3/1	Hex/EtOAc)	still	showed	a	substantial	amount	of	the	
starting	boronic	ester.		Additional	5.5	Molar	HCl	(4.6	mL,	25.3	mmol,	4.0	eq)	was	added	to	increase	the	
total	amount	of	HCl	(2	Molar,	4.7	eq).		The	reaction	was	stirred	for	another	hour	and	15	minutes,	at	
which	point	TLC	indicated	full	consumption	of	the	pinacol	boronic	ester.		The	stir	bar	was	removed,	
additional	H2O	(15	mL)	was	added,	and	THF	was	removed	by	rotary	evaporation.		The	reaction	was	
diluted	with	additional	H2O	(15	mL)	and	extracted	with	methyl	tert-butyl	ether	(2x40	mL).		Combined	
organics	were	washed	repeatedly	with	H2O	(10x35	mL)	to	remove	any	remaining	oxidant	and	then	once	
with	brine	(35	mL).		After	drying	with	MgSO4	and	filtering	through	a	glass	frit	into	a	500	mL	round	
bottom	flask,	the	solution	was	partially	concentrated	(remaining	volume	of	5-10	mL)	and	then	the	
solvent	was	switched	to	anhydrous	MeCN	(64	mL,	0.10	Molar).		BIDA	(2.01	g,	6.54	mmol,	1.03	eq)	and	
MgSO4	(2.55	g,	21.2	mmol,	3.3	eq)	were	added,	along	with	a	stir	bar.		The	reaction	was	sealed	with	a	
rubber	septum	and	connected	to	a	nitrogen	line	before	stirring	overnight	at	60°C.	
	 The	next	day,	the	reaction	mixture	was	filtered	through	a	plug	of	silica	gel,	rinsing	with	EtOAc.		
The	filtrate	was	concentrated	by	rotary	evaporation,	giving	a	red	foam	(2.06	g,	4.97	mmol,	78%	crude	
yield).		This	material	was	subjected	to	normal	phase	column	chromatography	(15/1	MTBE/EtOAc	or	1/1	
Hex/EtOAc).		Mixed	fractions	were	repurified	until	the	d.r.	of	both	diastereomers	was	≥99:1	as	
determined	by	a	sequence	of	stereospecific	oxidation	to	the	alcohol	and	derivatization	to	the	para-
nitrobenzoate	ester	(described	below).		The	absolute	configuration	of	the	stereocenters	was	determined	
as	described	in	section	IX	part	A.		The	higher	Rf	diastereomer	(3.63,	R,S;	0.549	g,	1.32	mmol,	21%	yield)	
was	isolated	as	a	white	powder,	and	so	was	the	lower	Rf	diastereomer	(3.64,	R,R;	0.498	g,	1.20	mmol,	
19%	yield).	
	
1
H	NMR	(500	MHz,	acetone-d6)	δ	7.43	–	7.39	(m,	2H),	7.38	–	7.34	(m,	2H),	7.33	–	7.27	(m,	1H),	4.65	(d,	J	
=	11.3	Hz,	1H),	4.59	(d,	J	=	11.2	Hz,	1H),	4.41	(m,	1H),	4.16	–	4.04	(m,	3H),	3.95	(d,	J	=	17.5	Hz,	1H),	3.79	
(td,	J	=	8.7,	6.4	Hz,	1H),	2.28	(m,	1H),	2.19	(m,	1H),	1.88-1.77	(m	3H),	1.62	(m,	1H),	1.45	(dtd,	J	=	13.5,	6.6,	
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3.4	Hz,	1H),	1.33	–	1.13	(m,	4H),	1.08	(dqd,	J	=	10.1,	6.6,	3.3	Hz,	1H),	0.87	(t,	J	=	7.4	Hz,	3H),	0.81	(dd,	J	=	
6.7,	1.4	Hz,	6H).	
13
C	NMR	(126	MHz,	acetone-d6)	δ	169.70,	167.90,	138.63,	128.85,	128.49,	128.20,	80.79,	72.88,	71.98,	
60.70,	56.80,	39.57,	31.94,	31.30,	30.17,	27.01,	21.74,	18.32,	14.44,	11.65.	
11
B	NMR	(128	MHz,	acetone-d6)	δ	14.48.	
[α]20D	=		-0.5	(c	=	1.0,	acetone)	
HRMS	(ESI+)	
Calculated	for	C23H35BNO5	(M+H)
+
:	416.2608	
Found:	416.2608	
	
	
1
H	NMR	(500	MHz,	acetone-d6)	δ	7.41	–	7.34	(m,	4H),	7.30	(m,	1H),	4.65	(d,	J	=	11.5	Hz,	1H),	4.58	(d,	J	=	
11.5	Hz,	1H),	4.37	(dt,	J	=	7.5,	5.0	Hz,	1H),	4.13	(dd,	J	=	17.2,	2.8	Hz,	2H),	4.05	(d,	J	=	16.9	Hz,	1H),	3.97	(d,	
J	=	17.4	Hz,	1H),	3.77	(td,	J	=	8.7,	6.0	Hz,	1H),	2.28	(m,	1H),	2.14	(m,	1H),	1.88	–	1.74	(m,	3H),	1.68	(ddt,	J	=	
13.3,	9.2,	7.9	Hz,	1H),	1.52	(ddtd,	J	=	18.2,	14.7,	7.0,	3.6	Hz,	2H),	1.22	(m,	1H),	1.12	–	1.02	(m,	2H),	1.01	–	
0.93	(m,	1H),	0.93	(d,	J	=	6.4	Hz,	3H),	0.86	–	0.81	(m,	6H).	
13
C	NMR	(126	MHz,	acetone-d6)	δ	169.30,	168.02,	138.68,	128.82,	128.17,	128.13,	80.63,	73.12,	71.79,	
60.28,	57.54,	39.87,	31.80,	30.34,	27.56,	27.24,	21.90,	20.54,	14.82,	11.02.	
11
B	NMR	(128	MHz,	acetone-d6)	δ	13.67.	
[α]20D	=		+55.6	(c	1.0,	acetone)	
HRMS	(ESI+)	
Calculated	for	C23H35BNO5	(M+H)
+
:	416.2608	
Found:	416.2608	
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BIDA	Boronates	3.65	and	3.62.		To	a	stir	bar-equipped	300	mL	round	bottom	flask	was	added	the	
pinacol	boronic	ester	(4S)-SI-3.42	(1.859	g,	8.22	mmol,	1.00	eq)	followed	by	THF	(55	mL,	0.15	M),	NaIO4	
(5.28	g,	24.7	mmol,	3.00	eq),	and	2	Molar	HCl	(19	mL,	38	mmol,	6.0	eq).		Once	the	reaction	was	
complete	by	TLC	(3/1	Hex/EtOAc),	the	stir	bar	was	removed,	additional	H2O	(20	mL)	was	added,	and	THF	
was	removed	by	rotary	evaporation.		The	reaction	was	diluted	with	more	H2O	(20	mL)	and	extracted	
with	methyl	tert-butyl	ether	(2x50	mL).		Combined	organics	were	washed	repeatedly	with	H2O	(10x45	
mL)	to	remove	any	remaining	oxidant	and	then	once	with	brine	(50	mL).		After	drying	with	MgSO4	and	
filtering	through	a	glass	frit	into	a	500	mL	round	bottom	flask,	the	solution	was	partially	concentrated	
(remaining	volume	of	5-10	mL)	and	then	the	solvent	was	switched	to	anhydrous	MeCN	(84	mL,	0.10	
Molar).		BIDA	(2.53	g,	8.22	mmol,	1.00	eq)	and	MgSO4	(3.28	g,	27.3	mmol,	3.3	eq)	were	added,	along	
with	a	stir	bar.		The	reaction	was	sealed	with	a	rubber	septum	and	connected	to	a	nitrogen	line	before	
stirring	overnight	at	60°C.	
	 The	next	day,	the	reaction	mixture	was	filtered	through	a	plug	of	silica	gel,	rinsing	with	EtOAc.		
The	filtrate	was	concentrated	by	rotary	evaporation,	giving	a	red	foam.		This	material	was	subjected	to	
normal	phase	column	chromatography	(gradient	1.2/1	Hex/EtOAc	to	1/1.2	Hex/EtOAc).		Mixed	fractions	
were	repurified	until	the	d.r.	of	both	diastereomers	was	≥99:1	as	determined	by	a	sequence	of	
stereospecific	oxidation	to	the	alcohol	and	derivatization	to	the	para-nitrobenzoate	ester	(described	
below).		The	absolute	configuration	of	the	stereocenters	was	determined	as	described	in	section	IX	part	
A.		The	higher	Rf	diastereomer	(3.65,	S,S;	0.8222	g,	1.98	mmol,	24%	yield)	was	isolated	as	white	powder,	
and	so	was	the	lower	Rf	diastereomer	(3.62,	S,R;	1.2124	g,	2.92	mmol,	36%	yield).	
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1
H	NMR	(500	MHz,	CDCl3)	δ	7.43-7.35	(m,	3H),	7.31-7.28	(2H),	4.65	(d,	J	=	11.5	Hz,	1H),	4.38	(d,	J	=	11.5	Hz,	
1H),	4.02	(d,	J	=	16.7	Hz,	1H),	3.91	(q,	J	=	6.8	Hz,	1H),	3.65	(m,	1H),	3.61	(d,	J	=	17.0	Hz,	1H),	3.44	(d,	J	=	16.6	
Hz,	1H),	3.32	(d,	J	=	16.9	Hz,	1H),	2.21	(m,	1H),	2.08	(m,	1H),	1.88	(m,	1H),	1.82-1.69	(m,	2H),	1.50	(m,	3H),	
1.40	(dqd,	J	=	14.8,	7.5,	3.2	Hz,	1H),	1.09	(app.	quint,	J	=	9.1	Hz,	1H),	1.02-0.89	(m,	2H),	0.88-0.82	(m,	9H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	169.02,	167.43,	136.44,	128.73,	128.43,	128.19,	79.27,	71.98,	71.92,	60.79,	
56.05,	39.35,	31.16,	29.56,	27.55,	26.45,	21.36,	20.16,	14.86,	10.99.	
11
B	NMR	(128	MHz,	CDCl3)	δ	14.14.	
[α]20D	=		+6.5	(c	1.09,		CDCl3)	
HRMS	(ESI+)	
Calculated	for	C23H33BNO5	(M-H)
+
:	414.2452	
Found:	414.2448	
	
	
1
H	NMR	(500	MHz,	CDCl3)	δ	7.43-7.35	(m,	3H),	7.31-7.28	(m,	2H),	4.66	(d,	J	=	11.7	Hz,	1H),	4.39	(d,	J	=	11.6	
Hz,	1H),	4.04	(d,	J	=	16.7	Hz,	1H),	3.89	(q,	J	=	6.6	Hz,	1H),	3.65	(q,	J	=	8.1	Hz,	1H),	3.63	(dd,	J	=	17.0	Hz,	1H),	
3.41	(d,	J	=	16.7	Hz,	1H),	3.33	(d,	J	=	16.9	Hz,	1H),	2.23	(m,	1H),	2.05	(m,	1H),	1.88-1.69	(m,	3H),	1.53-1.44	
(m,	2H),	1.33-1.13	(m,	4H),	0.99-0.92	(m,	4H),	0.87	(t,	J	=	7.4	Hz,	3H),	0.83	(d,	J	=	6.5	Hz,	3H),	0.79	(m,	1H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	168.96,	167.56,	136.62,	128.89,	128.58,	128.23,	79.17,	71.92,	61.00,	56.66,	
38.96,	31.61,	31.19,	29.66,	26.75,	21.48,	18.54,	14.35,	11.83.	
[α]20D	=		+32.4	(c	1.09,	CDCl3)	
HRMS	(ESI+)	
Calculated	for	C23H34BNO5Na	(M+Na)
+
:	438.2428	
Found:	438.2423	
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SI-3.44.		BIDA	boronate	(-)-3.63	(10.4	mg,	0.025	mmol,	1.0	eq)	was	added	to	a	stir	bar-equipped	7	mL	
vial.		THF	(0.25	mL)	and	1	M	NaOH	(0.25	mL,	10	eq)	were	added.		The	reaction	was	stirred	at	room	
temperature	until	full	conversion	to	the	boronic	acid	was	observed	by	TLC	(1:1	Hex/EtOAc,	KMnO4	
stain).		To	the	reaction	was	added	30%	aqueous	H2O2	(0.05	mL,	0.5	mmol,	20	eq),	and	the	reaction	was	
allowed	to	stir	at	room	temperature	until	full	conversion	of	the	alcohol	was	observed	by	TLC	(1:1	
Hex/EtOAc,	KMnO4	stain).		The	reaction	was	diluted	with	Et2O	(15	mL)	and	quenched	with	saturated	
aqueous	Na2S2O3	(15	mL).		After	the	organic	layer	was	mixed	and	separated,	it	was	washed	with	brine	
(15	mL),	dried	with	Na2SO4,	and	concentrated	under	mild	vacuum	to	afford	(2S,4R)-4-methylhexan-2-ol	
(SI-3.43).	
	 To	a	solution	of	the	crude	SI-3.43	in	anhydrous	DCM	(0.5	mL,	0.05	Molar)	in	a	stir	bar-equipped	
7	mL	vial	was	added	anhydrous	pyridine	(7	μL,	7	mg,	0.09	mmol,	1.8	eq),	4-nitrobenzoyl	chloride	(13	mg,	
0.07	mmol,	1.4	eq)	and	4-(dimethylamino)pyridine	(0.6	mg,	0.005	mmol,	10	mol%).		The	vial	was	capped	
and	stirred	at	room	temperature	overnight.		The	next	day,	the	reaction	mixture	was	passed	through	a	
pad	of	MgSO4	in	a	cotton-plugged	glass	pipet,	and	filtrate	was	concentrated	in	vacuo.		The	crude	product	
was	purified	by	normal	phase	column	chromatography	(1:1	Hex/DCM),	giving	the	pure	4-nitrobenzoate	
ester	SI-3.44.	
	
The	product	was	analyzed	by	
reverse	phase	HPLC	(AD-RH	
column,	isocratic	62:38	
MeCN/H2O,	0.5	mL/min,	
214.4	nm),	giving	a	d.r.	of	
99.9:0.1.	
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SI-3.46	was	prepared	from	(+)-3.64	following	the	same	procedure	as	for	SI-3.44.		Using	the	same	HPLC	
conditions	as	for	SI-3.44,	the	d.r.	was	determined	to	be	98.7:1.3.	
	
	
	
	
SI-3.48	was	prepared	from	(+)-3.65	following	the	same	procedure	as	for	SI-3.44.		Using	the	same	HPLC	
conditions	as	for	SI-3.44,	the	d.r.	was	determined	to	be	99.9:0.1.	
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SI-3.50	was	prepared	following	the	same	procedure	as	for	SI-3.44.		Using	the	same	HPLC	conditions	as	
for	SI-3.44,	the	d.r.	was	determined	to	be	99.3:0.7.	
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SI-3.51	was	made	from	BIDA	boronate	(-)-3.63	in	quantitative	yield	as	a	white	solid	using	general	
procedure	B	by	directly	concentrating	the	suspension	without	filtration.	
1
H	NMR	(500	MHz,	CD3OD)	1.38	(dq,	J	=	12.8,	6.2	Hz,	1H),	1.26	(ddd,	J	=	13.5,	7.6,	5.9	Hz,	1H),	1.21	–	1.10	
(m,	3H),	0.88	(t,	J	=	7.4	Hz,	3H),	0.81	(d,	J	=	6.5	Hz,	3H),	0.78	(d,	J	=	7.1	Hz,	3H),	0.66	(d,	J	=	10.7	Hz,	1H).	
13
C	NMR	(126	MHz,	CD3OD)	δ	41.78,	33.89,	32.73,	19.00,	16.08,	12.26.	
11
B	NMR	(128	MHz,	CD3OD)	δ	7.47	
[α]20D	=	-32.8	(c	1.03,	CD3OD)	
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SI-3.52	was	made	from	BIDA	boronate	(+)-3.64	in	quantitative	yield	as	a	white	solid	using	general	
procedure	B	by	directly	concentrating	the	suspension	without	filtration.	
1
H	NMR	(500	MHz,	CD3OD)	1.54	(m,	1H),	1.45-1.32	(m,	2H),	1.02	–	0.88	(m,	2H),	0.88-0.83	(m,	6H),	0.80	
(d,	J	=	7.1	Hz,	3H),	0.68	(br	s,	1H).	
13
C	NMR	(126	MHz,	CD3OD)	δ	42.60,	34.06,	28.99,	21.36,	16.59,	11.91.	
11
B	NMR	(128	MHz,	CD3OD)	δ	7.74	
	
	
SI-3.53	was	made	from	BIDA	boronate	(+)-3.65	in	quantitative	yield	as	a	white	solid	using	general	
procedure	B	by	directly	concentrating	the	suspension	without	filtration.		
1
H	NMR	matches	that	of	SI-
3.52.	
	
	
SI-3.54	was	made	from	BIDA	boronate	(+)-3.62	in	quantitative	yield	as	a	white	solid	using	general	
procedure	B	by	directly	concentrating	the	suspension	without	filtration.		NMR	matches	that	of	SI-3.51.	
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Boronic	acid	SI-3.55	(99.9:0.1	e.r.)	was	prepared	in	73%	yield	by	general	procedure	C	and	coupled	to	(E)-
3-bromo-2-methylacrylate	to	give	product	(+)-SI-3.56	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	396/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	75/25	MeCN/H2O,	1.2	mL/min,	214.4	nm	absorbance).	Branched	=	10.8	minutes;	linear	=	11.7	
minutes.	The	product	was	isolated	in	69%	yield	(16.6	mg)	by	purification	with	normal	phase	flash	
chromatography	(2/1	Hex/DCM).		The	d.r.	of	the	purified	product	was	determined	by	a	sequence	of	
deprotection	and	derivatization	to	the	corresponding	phenyl	amide	(SI-3.63)	to	be	99.6:0.4	(99.4%DS).	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	516/1,	isolated	yield	of	65%,	and	
diastereospecificity	of	99.4%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	6.43	(dq,	J	=	9.8,	1.4	Hz,	1H),	2.55	(dquint,	J	=	10.0,	6.7	Hz,	1H),	1.78	(d,	J	=	1.5	
Hz,	3H),	1.48	(s,	9H),	1.38	–	1.24	(m,	3H),	1.16	–	1.04	(m,	2H),	0.95	(d,	J	=	6.6	Hz,	3H),	0.88	–	0.80	(m,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	168.07,	147.64,	127.21,	80.01,	43.96,	32.05,	30.85,	29.50,	28.30,	19.94,	19.51,	
12.60,	11.35.	
[α]22D	=	+13.3	(c.	0.43,	CDCl3)		
HRMS	(ESI+)	
Calculated	for	C15H28O2Na	(M+Na)
+
:	263.1987	
Found:	263.1980	
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Boronic	acid	SI-3.57	(98.7:1.3	e.r.)	was	prepared	in	56%	yield	by	general	procedure	C	and	coupled	to	(E)-
3-bromo-2-methylacrylate	to	give	product	(-)-SI-3.58	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	402/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	75/25	MeCN/H2O,	1.2	mL/min,	214.4	nm	absorbance).	Branched	=	11.0	minutes;	linear	=	11.9	
minutes.	The	product	was	isolated	in	57%	yield	(14.0	mg)	by	purification	with	normal	phase	flash	
chromatography	(2/1	Hex/DCM).		The	d.r.	of	the	purified	product	was	determined	by	a	sequence	of	
deprotection	and	derivatization	to	the	corresponding	phenyl	amide	(SI-3.64)	to	be	98.0:2.0	(98.6%DS).	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	381/1,	isolated	yield	of	57%,	and	
diastereospecificity	of	98.5%.	
1
H	NMR	(500	MHz,	CDCl3)	δ	6.39	(dq,	J	=	10.2,	1.5	Hz,	1H),	2.57	(dddd,	J	=	16.2,	11.8,	8.2,	5.6	Hz,	1H),	1.79	
(d,	J	=	1.5	Hz,	3H),	1.48	(s,	9H),	1.37	–	1.20	(m,	3H),	1.17	–	1.06	(m,	2H),	0.97	(d,	J	=	6.6	Hz,	3H),	0.85	(t,	J	=	
7.4	Hz,	3H),	0.82	(d,	J	=	6.4	Hz,	3H).	
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13
C	NMR	(126	MHz,	CDCl3)	δ	168.02,	147.41,	127.59,	80.00,	44.34,	32.33,	30.95,	30.09,	28.30,	20.72,	
19.26,	12.67,	11.35.	
[α]22D	=	-39.1	(c.	0.99,	CDCl3)	
HRMS	(ESI+)	
Calculated	for	C15H28O2Na	(M+Na)
+
:	263.1987	
Found:	263.1978	
	
	
	
	
Boronic	acid	SI-3.59	(99.9:0.1	e.r.)	was	prepared	in	65%	yield	by	general	procedure	C	and	coupled	to	(E)-
3-bromo-2-methylacrylate	to	give	product	(-)-SI-3.60	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	181/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	75/25	MeCN/H2O,	1.2	mL/min,	214.4	nm	absorbance).	Branched	=	10.7	minutes;	linear	=	11.7	
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minutes.	The	product	was	isolated	in	46%	yield	(11.9	mg)	by	purification	with	normal	phase	flash	
chromatography	(2/1	Hex/DCM).		The	d.r.	of	the	purified	product	was	determined	by	a	sequence	of	
deprotection	and	derivatization	to	the	corresponding	phenyl	amide	(SI-3.65)	to	be	99.2:0.4	(98.6%DS).	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	600/1,	isolated	yield	of	54%,	and	
diastereospecificity	of	99.0%.	
1
H	NMR	matches	that	of	(-)-3u.	
13
C	NMR	matches	that	of	(-)-3u.	
[α]22D	=	-39.1	(c.	0.99,	CDCl3)	
	
	
Boronic	acid	SI-3.61	(99.3:0.7	e.r.)	was	prepared	in	73%	yield	by	general	procedure	C	and	coupled	to	(E)-
3-bromo-2-methylacrylate	to	give	product	(-)-SI-3.62	by	general	procedure	D.	The	branched/linear	
product	ratio	of	the	crude	reaction	was	determined	to	be	618/1	by	HPLC	(Eclipse	XDB-C8	column,	
isocratic	75/25	MeCN/H2O,	1.2	mL/min,	214.4	nm	absorbance).	Branched	=	10.8	minutes;	linear	=	11.7	
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minutes.	The	product	was	isolated	in	69%	yield	(17.0	mg)	by	purification	with	normal	phase	flash	
chromatography	(2/1	Hex/DCM).		The	d.r.	of	the	purified	product	was	determined	by	a	sequence	of	
deprotection	and	derivatization	to	the	corresponding	phenyl	amide	(SI-3.66)	to	be	99.4:0.6	(100%DS).	
A	duplicate	run	of	the	reaction	gave	a	branched/linear	product	ratio	of	669/1,	isolated	yield	of	64%,	and	
diastereospecificity	of	99.8%.	
1
H	NMR	matches	that	of	(+)-3x.	
13
C	NMR	matches	that	of	(+)-3x.	
[α]23D	=	-26.3	(c.	0.58,	MeOH)		
	
	
	
4-epi-xylarinic	acid	B	(3.88).	A	stir	bar-equipped,	2	mL	screw-cap	vial	was	charged	with	the	tert-butyl	ester	
(+)-SI-3.56	(12.1	mg,	0.0503	mmol).		DCM	(0.50	mL,	0.10	Molar)	was	added,	followed	by	trifluoroacetic	
acid	(dropwise	over	1	minute	at	room	temperature,	39	μL,	58	mg,	0.51	mmol,	10	eq).		The	vial	was	capped	
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and	stirred	at	room	temperature	for	four	hours.		At	this	time,	TLC	(10%	EtOAc	in	hexanes,	KMnO4	stain)	
showed	complete	conversion	to	a	more	polar	spot.		The	solvent	and	trifluoroacetic	acid	were	removed	by	
rotary	evaporation.		Toluene	was	added	and	evaporated	three	times	to	remove	residual	trifluoroacetic	
acid.		The	carboxylic	acid	was	obtained	as	a	colorless	oil	(9.55	mg,	0.518	mmol,	quantitative	yield)	without	
purification.	
1
H	NMR	(500	MHz,	CDCl3)	δ	6.70	(dq,	J	=	10.2,	1.4	Hz,	1H),	2.61	(dsext,	J	=	9.4,	6.7	Hz,	1H),	1.84	(d,	J	=	1.4	
Hz,	3H),	1.40	–	1.28	(m,	3H),	1.20	–	1.04	(m,	2H),	0.98	(d,	J	=	6.6	Hz,	3H),	0.89	–	0.81	(m,	6H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	173.71,	151.55,	125.13,	43.86,	32.20,	31.21,	29.38,	19.83,	19.57,	12.18,	11.34.	
[α]23D	=	+30.6	(c.	0.55,	MeOH)		
HRMS	(ESI+)	
Calculated	for	C11H20O2	(M)
+
:	184.1463	
Found:	184.1465	
	
	
Xylarinic	acid	B	(3.85)	was	prepared	(colorless	oil,	6.18	mg,	0.0335	mmol,	99%	yield)	using	the	same	
procedure	as	for	4-epi-xylarinic	acid	B	(3.88).	
1
H	NMR	(500	MHz,	CDCl3)	δ	6.66	(dq,	J	=	10.2,	1.4	Hz	Hz,	1H),	2.63	(tdd,	J	=	13.4,	9.1,	5.7	Hz,	1H),	1.86	(d,	
J	=	1.4	Hz,	3H),	1.37	(ddd,	J	=	13.5,	9.6,	4.2	Hz,	1H)	1.33	–	1.19	(m,	2H),	1.18	–	1.08	(m,	2H),	0.99	(d,	J	=	6.6	
Hz,	3H),	0.85	(t,	J	=	7.2	Hz,	3H),	0.83	(d,	J	=	6.3	Hz,	3H).	
13
C	NMR	(126	MHz,	CDCl3)	δ	173.48,	151.27,	125.51,	44.21,	32.51,	31.28,	30.20,	20.55,	19.18,	12.27,	11.39.	
[α]23D	=	-41.0	(c.	0.10,	MeOH)		
HRMS	(ESI+)	
Calculated	for	C11H20O2	(M)
+
:	184.1463	
Found:	184.1465	
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Table	3.2		Comparison	of	
13
C-NMR	data	for	xylarinic	acid	with	literature	values.	
	
ent-xylarinic	acid	B	(3.86)	was	prepared	(colorless	oil,	5.08	mg,	0.0276	mmol,	quantitative	yield)	using	
the	same	procedure	as	for	4-epi-xylarinic	acid	B	(3.88).	
1
H	NMR	matches	that	of	xylarinic	acid	B.	
13
C	NMR	matches	that	of	xylarinic	acid	B.	
[α]23D	=	+52.5	(c.	0.40,	MeOH)		
	
	
6-epi-xylarinic	acid	B	(3.87)	was	prepared	(colorless	oil,	5.04	mg,	0.0273	mmol,	92%	yield)	using	the	
same	procedure	as	for	4-epi-xylarinic	acid	B	(3.88).	
1
H	NMR	matches	that	of	4-epi-xylarinic	acid	B.	
13
C	NMR	matches	that	of	4-epi-xylarinic	acid	B.	
Observed	 Reported	
173.48	 172.7	
151.27	 151.3	
125.51	 125.4	
44.21	 44.2	
32.51	 32.5	
31.28	 31.3	
30.20	 30.2	
20.55	 20.6	
19.18	 19.2	
12.27	 12.3	
11.39	 11.4	
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[α]23D	=	-26.3	(c.	0.58,	MeOH)		
	
	
Phenyl	amide	SI-3.63.		4-epi-xylarinic	acid	B	(3.88,	6.49	mg,	0.0352	mmol,	1.00	eq)	was	massed	out	in	a	
stir	bar-equipped	2	mL	screw	cap	vial.		Under	nitrogen,	anhydrous	DCM	(0.100	mL)	was	added,	followed	
by	a	solution	of	oxalyl	chloride	in	DCM	(1.17	Molar,	60	μL,	0.0070	mmol,	2.0	eq)	and	a	solution	of	DMF	in	
DCM	(1.3	Molar,	2.7	μL,	3.5	μmol,	10	mol%).		The	mixture	was	stirred	under	nitrogen	for	20	minutes	at	
room	temperature,	and	then	the	volatiles	(DCM	and	excess	oxalyl	chloride)	were	removed	by	a	stream	
of	nitrogen.		Additional	DCM	(100	μL)	was	added,	followed	by	a	solution	of	aniline	in	DCM	(0.548	Molar,	
129	μL,	0.71	mmol,	2.0	eq).		The	reaction	was	stirred	for	10	more	minutes	and	then	quenched	by	
addition	of	1M	HCl	(0.50	mL).		The	aqueous	layer	was	extracted	twice	with	DCM,	and	the	extracts	were	
passed	through	silica	gel	in	a	cotton-plugged	glass	pipet,	rinsing	with	10%	EtOAc/hexanes.		The	filtrate	
was	concentrated	in	vacuo.		The	d.r.	of	the	crude	phenyl	amide	was	determined	to	be	99.6:0.4	(99.4	
%DS)	by	HPLC	(OD-H	chiral	column,	1%	IPA	in	hexanes,	2.0	mL/min,	254.4	nm	absorbance).		Major	=	17.7	
minutes;	minor	=	15.5	minutes.		The	second	of	the	run	reaction	also	gave	99.4%DS.	
	 	
237	
	
	
Phenyl	Amide	SI-3.64	was	prepared	from	xylarinic	acid	B	(3.85)	using	the	same	procedure	for	phenyl	
amide	SI-3.63.		The	d.r.	of	the	crude	phenyl	amide	was	determined	to	be	98.0:2.0	(98.6%DS)	by	HPLC	
(OD-H	chiral	column,	1%	IPA	in	hexanes,	2.0	mL/min,	254.4	nm	absorbance).		Major	=	15.2	minutes;	
minor	=	17.8	minutes.		The	second	of	the	run	reaction	gave	98.5%DS.	
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Phenyl	Amide	SI-3.65	was	prepared	from	ent-xylarinic	acid	B	(3.86)	using	the	same	procedure	for	
phenyl	amide	SI-3.63.		The	d.r.	of	the	crude	phenyl	amide	was	determined	to	be	99.2:0.8	(98.6%DS)	by	
HPLC	(OD-H	chiral	column,	1%	IPA	in	hexanes,	2.0	mL/min,	254.4	nm	absorbance).		Major	=	21.7	
minutes;	minor	=	17.8	minutes.		The	second	of	the	run	reaction	gave	99.0%DS.	
	
	
Phenyl	Amide	SI-3.66	was	prepared	from	6-epi-xylarinic	acid	B	(3.87)	using	the	same	procedure	for	
phenyl	amide	SI-3.63.		The	d.r.	of	the	crude	phenyl	amide	was	determined	to	be	99.4:0.6	(100%DS)	by	
HPLC	(OD-H	chiral	column,	1%	IPA	in	hexanes,	2.0	mL/min,	254.4	nm	absorbance).		Major	=	17.7	
minutes;	minor	=	21.9	minutes.		The	second	of	the	run	reaction	gave	99.8%DS.	
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DETERMINATION	OF	THE	STEREOCHEMICAL	OUTCOME	
A.	Absolute	Configuration	of	BIDA	Boronates	
Determining	the	absolute	configuration	of	the	C2	stereocenter	of	3.58:	
The	 absolute	 stereochemistry	 of	 the	 2-butyl	 stereocenter	was	 determined	by	 x-ray	 crystallography	 of	
crystals	 grown	 by	 slow	 diffusion	 of	 Et2O	 into	 an	 acetone	 solution	 of	 3.58	 at	 23°C	 using	 the	 known	
stereocenters	of	the	cyclopentyl	ring	as	reference.		
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B.	Absolute	Configuration	of	Coupled	Products	
To	determine	the	absolute	stereochemistry	of	(+)-3.24	obtained	from	the	coupling	reaction	of	(S)-3.22	
and	3.23,	(S)-3.24	was	independently	synthesized	from	(S)-3-phenylbutyric	acid:	
	
(S)-3-phenylbutyl	4-methylbenzenesulfonate	SI-3.67.		In	a	glovebox,	lithium	aluminum	hydride	powder	
(88	mg,	2.2	mmol)	was	added	to	a	dry	3-neck	flask.		This	was	fitted	with	a	reflux	condenser	and	2	septa.		
In	a	fume	hood,	dry	THF	(10	mL)	was	added	and	the	mixture	was	stirred	at	23°C.		(+)-(S)-3-phenylbutyric	
acid	(Sigma	Aldrich	78240,	Lot	#	BCBF9385V),	was	added	dropwise	as	a	solution	in	THF	(3.5	mL)	and	the	
mixture	was	stirred	at	reflux	for	12	hours.		TLC	(3:1	Hex/EtOAc,	KMnO4)	showed	complete	conversion.		
The	reaction	was	quenched	with	1M	aqueous	Rochelle	salt	and	extracted	three	times	with	DCM.		The	
combined	DCM	phase	was	dried	over	sodium	sulfate	and	concentrated	under	vacuum.		The	crude	
material	(310	mg)	was	used	directly	in	the	next	step.			
The	crude	alcohol	(310	mg)	was	combined	in	a	7	mL	vial	with	distilled	pyridine	(1.0	mL)	and	toluenesulfonyl	
chloride	(0.419	g,	2.2	mmol)	that	had	been	recrystallized	from	hot	hexanes.		The	reaction	was	capped	and	
stirred	at	23	°C	until	complete	conversion	of	the	alcohol	as	seen	by	TLC.		At	5	h,	1M	HCl	was	added	and	
the	mixture	was	extracted	three	times	with	Et2O.		The	combined	Et2O	phase	was	washed	with	1M	HCl,	
then	H2O,	then	saturated	NaHCO3.		The	solution	was	dried	over	sodium	sulfate	and	concentrated	under	
vacuum.		The	crude	was	purified	by	silica	column	using	a	gradient	of	5%	to	15%	EtOAc	in	hexanes,	giving	
the	product	SI-3.67	as	a	colorless	oil	(0.460	g,	1.51	mmol,	74%	from	(S)-3-phenylbutyric	acid).	
1
H	NMR	(400	MHz,	CDCl3)	δ	7.74	(d,	J	=	8.3	Hz,	2H),	7.32	(d,	J	=	8.0	Hz,	2H),	7.25	–	7.13	(m,	3H),	7.04	(d,	J	
=	7.1	Hz,	2H),	3.97	(dt,	J	=	9.8,	5.9	Hz,	1H),	3.82	(ddd,	J	=	9.8,	7.9,	5.8	Hz,	1H),	2.81	(m,	1H),	2.45	(s,	3H),	
2.00	–	1.80	(m,	2H),	1.21	(d,	J	=	7.0	Hz,	3H).	
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13
C	NMR	(101	MHz,	CDCl3)	δ	145.46,	144.78,	133.16,	129.93,	128.66,	128.02,	127.01,	126.47,	68.98,	37.17,	
35.97,	22.15,	21.79.	
[α]20D	=	+97.1	(c	1.0,	CDCl3)		
HRMS	(EI
+
)	
Calculated	for	C17H20O3S	(M)
+
:	304.1133	
Found:	304.1132	
	
(S)-sec-butylbenzene	SI-3.68.		To	a	20	mL	vial	with	a	septum	cap	and	stir	bar	were	added	(S)-3-phenylbutyl	
4-methylbenzenesulfonate	SI-3.67	(0.450	g,	1.45	mmol,	1.00	eq),	followed	by	DMSO	(8	mL)	and	NaBH4	
(0.281	g,	7.43	mmol,	5.1	eq).		The	headspace	was	purged	with	nitrogen	the	reaction	was	stirred	at	70°C,	
during	which	time	the	reaction	became	homogeneous.		Monitoring	of	the	reaction	by	TLC	(4:1	Hex/EtOAc,	
KMnO4)	showed	complete	conversion	of	the	substrate	at	20	hours.		H2O	(8	mL)	was	added	and	the	solution	
was	extracted	four	times	with	pentane.		The	combined	pentane	phase	was	washed	twice	with	H2O,	then	
with	3%	H2O2,	and	again	with	H2O.		The	solution	was	dried	over	sodium	sulfate	and	concentrated	under	
light	vacuum	to	give	SI-3.68	as	an	oil	 (0.128	g,	0.770	mmol,	47%	yield.	 	This	was	used	in	the	next	step	
without	 purification.	 	 The	 spectral	 properties	 of	 sec-butylbenzene	 were	 identical	 to	 those	 reported	
previously.
73
	 	 Comparison	 of	 the	 optical	 rotation	 to	 the	 literature	 value	 showed	 a	 high	 level	 of	
enantiopurity.		
[α]20D	=	+27.4	(c	1.0,	CHCl3)	
Lit:
89
	[α]20D	=	+25.0	(c	1.0,	CHCl3)	
	
(S)-4-(sec-butyl)-1,1'-biphenyl	 (S)-3.24.	 	Elemental	bromine	(12.4	µl,	38.5	mg,	0.241	mmol)	was	added	
dropwise	to	a	solution	of	sec-butylbenzene	SI-3.68	(27	mg,	0.16	mmol,	1.0	eq)	and	iodine	(2.5	mg,	0.010	
mmol,	6	mol%)	in	DCM	(0.5	mL,	0.3	Molar)	in	an	ice	bath	under	nitrogen.		The	reaction	was	stirred	at	23	
°C	 for	 2	 hours.	 	 The	 conversion	 could	 not	 be	 determined	 by	 TLC	 (100%	 pentane).	 	 The	 reaction	was	
quenched	with	0.5M	KOH	and	extracted	twice	with	DCM.		The	DCM	phase	was	dried	over	sodium	sulfate	
and	 concentrated	 under	 vacuum.	 	 This	 material	 was	 filtered	 through	 a	 silica	 plug	 with	 pentane	 and	
concentrated	to	afford	an	oil	(23mg).		
1
H-NMR	shows	a	1:1	ratio	of	starting	material	(0.061	mmol,	10.1	
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mg)	 to	 product	 (0.061	mmol,	 12.9	mg).	 	 This	mixture	was	 taken	 on	 to	 the	 coupling	 reaction	without	
purification.	
To	the	crude	product	from	the	above	reaction	in	a	7	mL	vial	in	a	glove	box	were	added	Pd(PPh3)4	(1.7	mg,	
1.5	µmol,	2.5	mol%),	phenylboronic	acid	(12.1	mg,	0.10	mmol,	1.6	eq),	K2CO3	(0.236	g,	1.9	mmol,	32	eq),	
and	THF	(0.8	mL,	0.08	Molar).		In	a	fume	hood,	H2O	(0.57	mL,	0.11	Molar)	was	added.		The	headspace	was	
purged	with	nitrogen,	capped	and	stirred	10	hours	at	75°C.		TLC	(100%	pentane,	UV)	showed	product.		The	
THF	was	removed	under	vacuum.		The	solution	was	then	extracted	three	times	with	pentane.		The	pentane	
phase	was	dried	over	 sodium	sulfate,	 concentrated	under	 vacuum,	and	purified	by	 silica	 column	with	
100%	pentane,	giving	(S)-3.24	as	a	colorless	oil	(12.3	mg,	0.0507	mmol,	32%	yield).		
1
H	NMR	(500	MHz,	CDCl3)	δ	7.61	(d,	J	=	7.1	Hz,	2H),	7.55	(d,	J	=	8.2	Hz,	2H),	7.45	(t,	J	=	7.7	Hz,	2H),	7.34	(t,	
J	=	7.4	Hz,	1H),	7.28	(d,	J	=	8.3	Hz,	2H),	2.66	(sext,	J	=	7.0	Hz,	1H),	1.65	(pd,	J	=	7.3,	2.2	Hz,	2H),	1.30	(d,	J	=	
7.0	Hz,	3H),	0.88	(t,	J	=	7.4	Hz,	3H).	
13
C	NMR	(101	MHz,	CDCl3)	δ	146.95,	141.30,	
138.81,	 128.81,	 127.60,	 127.12,	 127.11,	
127.06,	41.48,	31.32,	21.98,	12.46.	
The	product	(S)-3.24	had	an	e.r.	of	>	99.5:0.5	
as	determined	using	a	Chiralcel	OD-H	column	
of	4.6	mm	x	250	mm,	hexanes,	2.0	mL/min.,	
210	nm	absorbance.		Major:	5.7,	Minor:	9.3.	
The	retention	time	of	 the	 (S)-3.24	obtained	
here	matches	that	of	the	coupling	product	(+)-3.24,	thus	confirming	that	the	coupling	reaction	went	with	
stereoretention.	
	
CRYSTAL	STRUCTURES	
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Bis[tris(2-benzyl-phenyl)phosphine]	SI-3.69.		A	solution	of	P(2-benzyl-phenyl)3	3.37	(0.533	g,	1.00	mmol,	
1.00	eq)	and	Pd2dba3	(0.229	g,	0.25	mmol,	0.50	eq)	was	prepared	in	anhydrous	DMF	(40	mL,	0.025	
Molar)	under	nitrogen.		The	reaction	was	stirred	for	10	hours	at	room	temperature,	during	which	time	a	
yellow-green	precipitate	formed	and	the	dark	red	color	of	Pd2dba3	faded.		The	DMF	was	removed	by	
filteration	with	by	syringe.		The	filtered	solid	was	washed	with	Et2O	(5	mL),	and	the	color	began	to	
change.		The	solid	was	dissolved	in	THF,	causing	a	color	change	to	dark	orange.		The	solution	was	drawn	
portionwise	into	a	20	mL	syringe.		A	disc-shaped	filter	was	fitted	to	the	syringe,	and	then	it	was	
equipped	with	a	needle.		After	filtration,	solution	was	recrystallized	from	DCM	(20	mL)	and	pentane	(60	
mL)	with	overnight	stirring	at	0°C.		Crystals	of	SI-3.69	were	collected	by	filtration	(0.340	g,	0.290	mmol,	
58%	yield).	
	 X-ray	crystals	were	prepared	by	dissolving	the	product	in	benzene	with	slow	diffusion	into	Et2O.	
{[(2-Benzyl-phenyl)3P]Pd(4-OMe-phenyl)(Br)}2	3.38.		Bis[tris(2-benzyl-phenyl)phosphine]Pd(0)	SI-3.69	
(50	mg,	0.0427	mmol,	1.00	eq)	was	combined	with	4-bromoanisole	(32	mg,	0.171	mmol,	4.0	eq).		Dry	
benzene	(3.0	mL,	0.014	Molar)	was	added	under	a	nitrogen	stream,	and	a	solid	cap	was	fitted	on	the	
vial.		The	yellow	suspension	was	stirred	for	24	hours	at	room	temperature.		Solvent	was	removed	by	
rotary	evaporation,	and	then	the	product	3.38	was	washed	with	Et2O	(2x2.5	mL)	using	a	centrifuge.	
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	 X-ray	crystals	were	obtained	by	dissolving	the	dimeric	complex	in	a	minimal	sufficient	amount	of	
DCM.		This	solution	was	passed	through	a	syringe	filter	into	a	7	mL	vial	containing	Et2O	(approximately	6	
mL)	using	a	needle	to	slowly	load	the	solution	into	a	bottom	layer.		The	vial	was	filled	to	the	top	with	
Et2O	and	fitted	with	a	solid	screw	cap,	allowing	crystals	to	form	by	slow	diffusion.	
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